EC 3.2.* (glycosylase) inhibitor - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	*EC 3.2. (glycosylase) inhibitor**	go back to main search page
Accession:	CHEBI:76761	browse the term
Definition:	A hydrolase inhibitor that interferes with the action of any glycosylase (EC 3.2..).
Synonyms:	related_synonym:	EC 3.2.* (glycosylase) inhibitors; EC 3.2.* inhibitor; EC 3.2.* inhibitors; glycosylase inhibitor; glycosylase inhibitors

show annotations for term's descendants Sort by:
Rat (5480 ) Mouse (5516 ) Human (5460 ) Chinchilla (0 ) Bonobo (0 ) Dog (0 ) Squirrel (0 ) Pig (5 ) Green Monkey (0) Naked Mole-rat (0 ) All
Genes (5480)

(Z)-3-butylidenephthalide

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aryl hydrocarbon receptor

multiple interactions

ISO

[butylidenephthalide co-treated with ligustilide] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; butylidenephthalide inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]

NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901

G

apoptosis inducing factor, mitochondria associated 1

increases expression

EXP
ISO

butylidenephthalide results in increased expression of AIFM1 protein

PMID:16987298 PMID:23770345

NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237

G

annexin A5

decreases expression

ISO

butylidenephthalide results in decreased expression of ANXA5 protein

NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400

G

Rho GTPase activating protein 1

increases expression

ISO

butylidenephthalide results in increased expression of ARHGAP1 protein

NCBI chr 3:98,077,064...98,099,163
Ensembl chr 3:98,077,150...98,099,154

G

Rho GDP dissociation inhibitor alpha

increases expression

ISO

butylidenephthalide results in increased expression of ARHGDIA protein

NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347

G

ATP synthase F1 subunit alpha

increases expression

ISO

butylidenephthalide results in increased expression of ATP5F1A protein

NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922

G

ATP synthase F1 subunit beta

decreases expression

ISO

butylidenephthalide results in decreased expression of ATP5F1B protein

NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462

G

BCL2 associated X, apoptosis regulator

increases expression

EXP
ISO

butylidenephthalide results in increased expression of BAX protein

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

BCL2-interacting killer

increases expression

ISO

butylidenephthalide results in increased expression of BIK protein

NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317

G

complement C1q binding protein

increases expression

ISO

butylidenephthalide results in increased expression of C1QBP protein

NCBI chr10:56,198,534...56,203,185
Ensembl chr10:56,198,540...56,203,235

G

calreticulin

decreases expression

ISO

butylidenephthalide results in decreased expression of CALR protein

NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236

G

caspase 3

increases cleavage

ISO
EXP

butylidenephthalide results in increased cleavage of CASP3 protein

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 8

increases cleavage

ISO
EXP

butylidenephthalide results in increased cleavage of CASP8 protein

NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699

G

caspase 9

increases cleavage

EXP
ISO

butylidenephthalide results in increased cleavage of CASP9 protein

Ensembl chr 5:159,391,188...159,409,648

G

cyclin D1

decreases expression

EXP
ISO

butylidenephthalide results in decreased expression of CCND1 protein

PMID:16987298 PMID:23770345

NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810

G

cyclin E1

decreases expression

ISO
EXP

butylidenephthalide results in decreased expression of CCNE1 protein

NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822

G

cyclin dependent kinase 2

decreases expression

EXP
ISO

butylidenephthalide results in decreased expression of CDK2 protein

PMID:16987298 PMID:23770345

NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878

G

cyclin-dependent kinase 4

decreases expression

EXP
ISO

butylidenephthalide results in decreased expression of CDK4 protein

NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163

G

cyclin-dependent kinase 6

decreases expression

EXP
ISO

butylidenephthalide results in decreased expression of CDK6 protein

NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701

G

cyclin-dependent kinase inhibitor 1A

decreases expression
increases expression

EXP
ISO

butylidenephthalide results in decreased expression of CDKN1A protein
butylidenephthalide results in increased expression of CDKN1A protein

PMID:16987298 PMID:23770345

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969

G

cyclin-dependent kinase inhibitor 1B

increases expression

EXP

butylidenephthalide results in increased expression of CDKN1B protein

NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498

G

cyclin-dependent kinase inhibitor 2A

increases expression

ISO

butylidenephthalide results in increased expression of CDKN2A protein

PMID:16987298 PMID:23770345

NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248

G

cytochrome c, somatic

increases expression

ISO

butylidenephthalide results in increased expression of CYCS protein

NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816

G

cytochrome P450, family 1, subfamily a, polypeptide 1

multiple interactions
increases expression

ISO

butylidenephthalide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
butylidenephthalide results in increased expression of CYP1A1 mRNA

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

DNA-damage inducible transcript 3

increases expression

ISO

butylidenephthalide results in increased expression of DDIT3 protein

NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509

G

eukaryotic translation elongation factor 1 alpha 1

decreases expression

ISO

butylidenephthalide results in decreased expression of EEF1A1 protein

NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072

G

eukaryotic translation elongation factor 1 alpha 2

decreases expression

ISO

butylidenephthalide results in decreased expression of EEF1A2 protein

NCBI chr 3:188,643,455...188,652,633
Ensembl chr 3:188,643,458...188,677,712

G

eukaryotic translation elongation factor 2

increases expression

ISO

butylidenephthalide results in increased expression of EEF2 protein

NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544

G

eukaryotic translation initiation factor 4A1

decreases expression

ISO

butylidenephthalide results in decreased expression of EIF4A1 protein

NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602

G

ELAV like RNA binding protein 1

decreases expression

ISO

butylidenephthalide results in decreased expression of ELAVL1 protein

NCBI chr12:7,441,699...7,482,625
Ensembl chr12:7,441,699...7,482,631

G

enolase 1

decreases expression

ISO

butylidenephthalide results in decreased expression of ENO1 protein

NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003

G

endoplasmic reticulum to nucleus signaling 1

increases expression

ISO

butylidenephthalide results in increased expression of ERN1 protein

NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791

G

Fas cell surface death receptor

increases expression

ISO

butylidenephthalide results in increased expression of FAS protein

PMID:16987298 PMID:23770345

NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104

G

Fus RNA binding protein

increases expression

ISO

butylidenephthalide results in increased expression of FUS protein

NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884

G

glutamic-oxaloacetic transaminase 1

increases expression

ISO

butylidenephthalide results in increased expression of GOT1 protein

NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871

G

heterogeneous nuclear ribonucleoprotein A3

decreases expression

ISO

butylidenephthalide results in decreased expression of HNRNPA3 protein

NCBI chr 3:80,984,470...80,999,413
Ensembl chr 3:80,985,969...80,996,043

G

heterogeneous nuclear ribonucleoprotein D

increases expression

ISO

butylidenephthalide results in increased expression of HNRNPD protein

NCBI chr14:9,918,630...9,938,072
Ensembl chr14:9,919,739...9,938,066

G

heterogeneous nuclear ribonucleoprotein F

decreases expression

ISO

butylidenephthalide results in decreased expression of HNRNPF protein

NCBI chr 4:152,755,668...152,776,867
Ensembl chr 4:152,722,617...152,815,769

G

heat shock protein 90 alpha family class B member 1

decreases expression

ISO

butylidenephthalide results in decreased expression of HSP90AB1 protein

NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926

G

heat shock protein family A (Hsp70) member 5

increases expression

ISO

butylidenephthalide results in increased expression of HSPA5 protein

NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790

G

lactate dehydrogenase A

decreases expression

ISO

butylidenephthalide results in decreased expression of LDHA protein

NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521

G

macrophage migration inhibitory factor

increases expression

ISO

butylidenephthalide results in increased expression of MIF protein

NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121
Ensembl chr20:134,041,774...134,042,121

G

marker of proliferation Ki-67

decreases expression

ISO
EXP

butylidenephthalide results in decreased expression of MKI67 protein

NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593

G

nucleolin

decreases expression

ISO

butylidenephthalide results in decreased expression of NCL protein

NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:94,446,682...94,456,083

G

NME/NM23 nucleoside diphosphate kinase 1

increases expression

ISO

butylidenephthalide results in increased expression of NME1 protein

NCBI chr10:79,403,939...79,426,620
Ensembl chr10:79,403,940...79,413,310

G

proliferating cell nuclear antigen

decreases expression

ISO

butylidenephthalide results in decreased expression of PCNA protein

NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901

G

phosphoglycerate kinase 1

decreases expression

ISO

butylidenephthalide results in decreased expression of PGK1 protein

NCBI chr X:75,336,988...75,352,962
Ensembl chr X:75,336,687...75,352,959

G

prohibitin 1

decreases expression

ISO

butylidenephthalide results in decreased expression of PHB1 protein

NCBI chr10:81,102,043...81,114,815
Ensembl chr10:81,102,028...81,116,233

G

protein phosphatase 2 scaffold subunit A alpha

increases expression

ISO

butylidenephthalide results in increased expression of PPP2R1A protein

NCBI chr 1:69,213,198...69,232,441
Ensembl chr 1:69,213,038...69,238,242

G

phosphoribosyl pyrophosphate synthetase 1

decreases expression

ISO

butylidenephthalide results in decreased expression of PRPS1 protein

NCBI chr X:108,920,663...108,942,713
Ensembl chr X:108,920,651...108,942,711

G

proteasome 20S subunit alpha 1

increases expression

ISO

butylidenephthalide results in increased expression of PSMA1 protein

NCBI chr 1:177,876,838...177,887,857
Ensembl chr 1:177,875,353...177,887,949

G

proteasome 26S subunit, non-ATPase 11

decreases expression

ISO

butylidenephthalide results in decreased expression of PSMD11 protein

NCBI chr10:65,923,669...65,977,523
Ensembl chr10:65,931,279...65,976,234

G

RB transcriptional corepressor 1

decreases phosphorylation

ISO
EXP

butylidenephthalide results in decreased phosphorylation of RB1 protein

NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857

G

ribosomal protein SA

decreases expression

ISO

butylidenephthalide results in decreased expression of RPSA protein

NCBI chr 8:128,728,761...128,732,736
Ensembl chr 8:128,728,862...128,732,737

G

splicing factor 3b, subunit 3

increases expression

ISO

butylidenephthalide results in increased expression of SF3B3 protein

NCBI chr19:55,692,124...55,729,640
Ensembl chr19:55,692,126...55,729,621

G

stratifin

increases expression

ISO

butylidenephthalide results in increased expression of SFN protein

NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:151,110,530...151,111,995

G

tumor protein p53

increases expression
increases phosphorylation

ISO

butylidenephthalide results in increased expression of TP53 protein
butylidenephthalide results in increased phosphorylation of TP53 protein

NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299

G

tumor protein, translationally-controlled 1

decreases expression

ISO

butylidenephthalide results in decreased expression of TPT1 protein

NCBI chr15:57,562,217...57,568,968
Ensembl chr15:57,566,067...57,569,554

G

Tu translation elongation factor, mitochondrial

increases expression

ISO

butylidenephthalide results in increased expression of TUFM protein

NCBI chr 1:190,504,373...190,507,980
Ensembl chr 1:190,504,373...190,508,952

G

WASP actin nucleation promoting factor

decreases expression

ISO

butylidenephthalide results in decreased expression of WAS protein

NCBI chr X:17,077,057...17,085,802
Ensembl chr X:17,073,314...17,085,802

G

Y box binding protein 1

decreases expression

ISO

butylidenephthalide results in decreased expression of YBX1 protein

NCBI chr 5:138,167,444...138,188,155
Ensembl chr 5:138,167,444...138,184,188

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

erb-b2 receptor tyrosine kinase 3

increases phosphorylation
multiple interactions

ISO

N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime results in increased phosphorylation of ERBB3 protein
[N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime results in increased phosphorylation of ERBB3 protein] which results in decreased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine

NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120

G

heat shock protein family A (Hsp70) member 1A

multiple interactions

ISO

N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime inhibits the reaction [sodium arsenite results in increased expression of HSPA1A mRNA]

NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979

G

interleukin 1 beta

increases secretion
multiple interactions

EXP

N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime results in increased secretion of IL1B protein
[N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime co-treated with N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime] results in increased secretion of IL1B protein

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 6

multiple interactions
increases secretion

EXP

[N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime co-treated with tetrabromobisphenol A] results in increased secretion of IL6 protein
N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime results in increased secretion of IL6 protein

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

mitogen activated protein kinase kinase 1

multiple interactions

ISO

[N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] results in decreased phosphorylation of MAP2K1 protein

NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184

G

mitogen activated protein kinase kinase 2

multiple interactions

ISO

[N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime co-treated with 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] results in decreased phosphorylation of MAP2K2 protein

NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940

G

tumor necrosis factor

multiple interactions

EXP

[N-acetylglucosaminono-1,5-lactone O-(phenylcarbamoyl)oxime co-treated with tetrabromobisphenol A] results in increased secretion of TNF protein

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

AKT serine/threonine kinase 1

multiple interactions
decreases phosphorylation

ISO

Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of AKT1 protein]

NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610

G

BCL2 associated X, apoptosis regulator

increases expression

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of BAX protein

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

BCL2, apoptosis regulator

decreases expression

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased expression of BCL2 protein

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

caspase 3

increases cleavage
multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of CASP3 protein
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of CASP3 protein]

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 9

increases cleavage

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of CASP9 protein

Ensembl chr 5:159,391,188...159,409,648

G

cyclin B1

increases expression

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CCNB1 protein

NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225

G

cell division cycle 25C

increases expression

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CDC25C protein

NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292

G

cyclin-dependent kinase 1

increases expression

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CDK1 protein

NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455

G

cyclin-dependent kinase inhibitor 1A

decreases expression

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased expression of CDKN1A protein

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969

G

cyclin-dependent kinase inhibitor 1B

decreases expression

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased expression of CDKN1B protein

NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498

G

cytochrome c, somatic

increases expression

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CYCS protein

NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816

G

glutamate-cysteine ligase, catalytic subunit

increases expression
multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]

NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893

G

heme oxygenase 1

multiple interactions
increases expression

ISO

Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA]
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA; 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

interleukin 1 beta

multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 6

multiple interactions
increases expression

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of IL6 mRNA]

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

microtubule-associated protein 1 light chain 3 beta

multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased lipidation of and results in increased localization of MAP1LC3B protein; Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased lipidation of and results in increased localization of MAP1LC3B protein]

NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358

G

mitogen activated protein kinase 1

multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]

NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825

G

mitogen activated protein kinase 3

multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]

NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411

G

mitogen-activated protein kinase 8

increases phosphorylation
multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased phosphorylation of MAPK8 protein
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein]

NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427

G

mechanistic target of rapamycin kinase

decreases phosphorylation
multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of MTOR protein
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of MTOR protein]

NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435

G

NFE2 like bZIP transcription factor 2

affects localization
multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone affects the localization of NFE2L2 protein
NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of IL6 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of TNF mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone affects the localization of NFE2L2 protein]

NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090

G

NFKB inhibitor alpha

multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of and affects the stability of NFKBIA protein]

NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072

G

nitric oxide synthase 2

increases expression
multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA
NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA]

NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880

G

NAD(P)H quinone dehydrogenase 1

increases expression
multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA]

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260

G

poly (ADP-ribose) polymerase 1

multiple interactions
increases cleavage

ISO

Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of PARP1 protein]

NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567

G

phosphoinositide-3-kinase regulatory subunit 1

multiple interactions
decreases phosphorylation

ISO

Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of PIK3R1 protein]

NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347

G

sequestosome 1

increases expression

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of SQSTM1 protein

NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750

G

tumor necrosis factor

multiple interactions

ISO

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of TNF mRNA]

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

angiotensin converting enzyme 2

decreases expression

ISO

Acarbose results in decreased expression of ACE2 mRNA

NCBI chr X:33,925,458...33,972,851
Ensembl chr X:33,925,458...33,971,596

G

adiponectin, C1Q and collagen domain containing

increases expression

EXP

Acarbose results in increased expression of ADIPOQ protein

NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169

G

C-C motif chemokine ligand 2

multiple interactions

EXP

Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 mRNA]; Acarbose inhibits the reaction [Fructose results in increased expression of CCL2 protein]

NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875

G

cytochrome P450, family 2, subfamily e, polypeptide 1

decreases expression

EXP

Acarbose results in decreased expression of CYP2E1 mRNA

NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495

G

fatty acid synthase

decreases expression

EXP

Acarbose results in decreased expression of FASN mRNA; Acarbose results in decreased expression of FASN protein

NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583

G

insulin 1

increases response to substance
decreases secretion
decreases expression
increases secretion
multiple interactions

EXP

Acarbose results in increased susceptibility to INS1 protein
Acarbose results in decreased secretion of INS1 protein
Acarbose results in decreased expression of INS1 protein
Acarbose results in increased secretion of INS1 protein
Acarbose inhibits the reaction [[Dietary Sucrose co-treated with Sodium Chloride, Dietary] results in increased expression of INS1 protein]

PMID:1767839 PMID:8101498 PMID:9313782 PMID:18290871

NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682

G

leptin

decreases expression

EXP

Acarbose results in decreased expression of LEP protein

NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661

G

maltase-glucoamylase

decreases activity

ISO

Acarbose results in decreased activity of MGAM protein

PMID:17585022 PMID:20349118

NCBI chr 4:70,408,263...70,568,752
Ensembl chr 4:70,408,263...70,568,752

G

neuropeptide Y

decreases expression

EXP

Acarbose results in decreased expression of NPY protein

NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310

G

PPARG coactivator 1 alpha

affects response to substance

ISO

PPARGC1A protein polymorphism affects the susceptibility to Acarbose

NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213

G

solute carrier family 2 member 1

increases expression

EXP

Acarbose results in increased expression of SLC2A1 protein

NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742

G

solute carrier family 2 member 4

increases expression

EXP

Acarbose results in increased expression of SLC2A4 mRNA; Acarbose results in increased expression of SLC2A4 protein

NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270

G

sequestosome 1

affects response to substance

ISO

SQSTM1 affects the susceptibility to Acarbose

NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750

G

tumor necrosis factor

decreases expression
multiple interactions

ISO
EXP

Acarbose results in decreased expression of TNF mRNA
Acarbose results in decreased expression of TNF mRNA; Acarbose results in decreased expression of TNF protein
Acarbose inhibits the reaction [Oxygen deficiency results in increased expression of TNF mRNA]

PMID:12717270 PMID:14975757 PMID:20703014

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

advanced glycosylation end product-specific receptor

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of AGER mRNA]; afzelechin inhibits the reaction [decamethrin results in increased expression of AGER protein]

NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685

G

alkaline phosphatase, biomineralization associated

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of ALPL protein]

NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167

G

BCL2 associated X, apoptosis regulator

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of BAX protein]

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

BCL2, apoptosis regulator

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in decreased expression of BCL2 protein]

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

caspase 3

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of and results in increased activity of CASP3 protein]

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 9

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of and results in increased activity of CASP9 protein]

Ensembl chr 5:159,391,188...159,409,648

G

gamma-glutamyltransferase 1

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of GGT1 protein]

NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050

G

glutamic-oxaloacetic transaminase 1

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of GOT1 protein]

NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871

G

glutamic--pyruvic transaminase

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of GPT protein]

NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160

G

glutathione-disulfide reductase

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in decreased activity of GSR protein]

NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394

G

high mobility group box 1

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of HMGB1 mRNA]; afzelechin inhibits the reaction [decamethrin results in increased expression of HMGB1 protein]

NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327

G

heme oxygenase 1

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in decreased activity of HMOX1 protein]

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

interleukin 1 beta

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of IL1B mRNA]; afzelechin inhibits the reaction [decamethrin results in increased expression of IL1B protein]

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 6

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of IL6 mRNA]; afzelechin inhibits the reaction [decamethrin results in increased expression of IL6 protein]

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

MYD88, innate immune signal transduction adaptor

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of MYD88 mRNA]

NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230

G

prostaglandin-endoperoxide synthase 2

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of PTGS2 mRNA]; afzelechin inhibits the reaction [decamethrin results in increased expression of PTGS2 protein]

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of RELA mRNA]; afzelechin inhibits the reaction [decamethrin results in increased expression of RELA protein]

NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817

G

toll-like receptor 4

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of TLR4 mRNA]; afzelechin inhibits the reaction [decamethrin results in increased expression of TLR4 protein]

NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007

G

tumor necrosis factor

multiple interactions

EXP

afzelechin inhibits the reaction [decamethrin results in increased expression of TNF protein]

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

bisdemethoxycurcumin

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily C member 1

decreases activity

ISO

bisdemethoxycurcumin results in decreased activity of ABCC1 protein; curcumin III results in decreased activity of ABCC1 protein

PMID:15885658 PMID:16021489

NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404

G

ATP binding cassette subfamily C member 2

decreases activity

ISO

bisdemethoxycurcumin results in decreased activity of ABCC2 protein

NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471

G

AKT serine/threonine kinase 1

increases phosphorylation
decreases expression
multiple interactions

ISO

bisdemethoxycurcumin results in increased phosphorylation of AKT1 protein
bisdemethoxycurcumin results in decreased expression of AKT1 protein modified form
AKT1 protein affects the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA]
[bisdemethoxycurcumin co-treated with Curcumin co-treated with demethoxycurcumin] inhibits the reaction [VEGFA protein results in increased phosphorylation of AKT1 protein]; bisdemethoxycurcumin inhibits the reaction [VEGFA protein results in increased phosphorylation of AKT1 protein]

PMID:17535857 PMID:35735092 PMID:35752269

NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610

G

amyloid beta precursor protein

multiple interactions

ISO

[bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of MGAT3 mRNA; [bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of TLR2 mRNA; [bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of TLR3 mRNA; [bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of TLR4 mRNA; [bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of VDR mRNA; [bisdemethoxycurcumin co-treated with APP protein] results in increased expression of MGAT3 mRNA; [bisdemethoxycurcumin co-treated with APP protein] results in increased expression of TLR2 mRNA; [bisdemethoxycurcumin co-treated with APP protein] results in increased expression of TLR3 mRNA; [bisdemethoxycurcumin co-treated with APP protein] results in increased expression of TLR4 mRNA; bisdemethoxycurcumin inhibits the reaction [APP protein binds to APP protein]

PMID:19715544 PMID:22029407

NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971

G

CD36 molecule

increases expression
multiple interactions

ISO

bisdemethoxycurcumin results in increased expression of CD36 mRNA
bisdemethoxycurcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD36 mRNA]

NCBI chr 4:18,209,088...18,302,142

G

cytochrome P450, family 19, subfamily a, polypeptide 1

decreases activity
multiple interactions

EXP
ISO

bisdemethoxycurcumin results in decreased activity of CYP19A1 protein
bisdemethoxycurcumin binds to and results in decreased activity of CYP19A1 protein

NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917

G

epidermal growth factor receptor

decreases expression

ISO

bisdemethoxycurcumin results in decreased expression of EGFR protein modified form

NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358

G

erb-b2 receptor tyrosine kinase 2

increases response to substance
decreases expression

ISO

ERBB2 protein results in increased susceptibility to bisdemethoxycurcumin
bisdemethoxycurcumin results in decreased expression of ERBB2 protein

NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481

G

glutamate cysteine ligase, modifier subunit

increases expression

ISO

bisdemethoxycurcumin results in increased expression of GCLM mRNA; bisdemethoxycurcumin results in increased expression of GCLM protein

PMID:17535857 PMID:19188863

NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003

G

growth factor receptor bound protein 2

decreases expression

ISO

bisdemethoxycurcumin results in decreased expression of GRB2 protein

NCBI chr10:101,380,354...101,448,138
Ensembl chr10:101,380,356...101,448,138

G

heme oxygenase 1

increases expression
multiple interactions

ISO

bisdemethoxycurcumin results in increased expression of HMOX1 mRNA; bisdemethoxycurcumin results in increased expression of HMOX1 protein
[demethoxycurcumin co-treated with bisdemethoxycurcumin] results in increased expression of HMOX1 mRNA; AKT1 protein affects the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA]; KEAP1 protein inhibits the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA]; PRKCD protein affects the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA]; rottlerin inhibits the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA]; rottlerin inhibits the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 protein]; Wortmannin inhibits the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA]; Wortmannin inhibits the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 protein]

PMID:17535857 PMID:19188863 PMID:23386263

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

interleukin 1 beta

multiple interactions

EXP
ISO

bisdemethoxycurcumin inhibits the reaction [Freund's Adjuvant results in increased secretion of IL1B protein]
bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 6

multiple interactions

EXP
ISO

bisdemethoxycurcumin inhibits the reaction [Freund's Adjuvant results in increased secretion of IL6 protein]
bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

kinase insert domain receptor

multiple interactions

ISO

[bisdemethoxycurcumin co-treated with Curcumin co-treated with demethoxycurcumin] inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein]; bisdemethoxycurcumin inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein]

NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192

G

Kelch-like ECH-associated protein 1

multiple interactions

ISO

KEAP1 protein inhibits the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA]

NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042

G

mitogen activated protein kinase 1

increases phosphorylation
decreases expression
multiple interactions

ISO

bisdemethoxycurcumin results in increased phosphorylation of MAPK1 protein
bisdemethoxycurcumin results in decreased expression of MAPK1 protein modified form
[bisdemethoxycurcumin co-treated with Curcumin co-treated with demethoxycurcumin] inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK1 protein]; bisdemethoxycurcumin inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK1 protein]

PMID:17535857 PMID:35735092 PMID:35752269

NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825

G

mitogen activated protein kinase 3

increases phosphorylation
decreases expression
multiple interactions

ISO

bisdemethoxycurcumin results in increased phosphorylation of MAPK3 protein
bisdemethoxycurcumin results in decreased expression of MAPK3 protein modified form
[bisdemethoxycurcumin co-treated with Curcumin co-treated with demethoxycurcumin] inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK3 protein]; bisdemethoxycurcumin inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK3 protein]

PMID:17535857 PMID:35735092 PMID:35752269

NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411

G

beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

multiple interactions
increases expression

ISO

[bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of MGAT3 mRNA; [bisdemethoxycurcumin co-treated with APP protein] results in increased expression of MGAT3 mRNA
bisdemethoxycurcumin results in increased expression of MGAT3 mRNA

PMID:19090986 PMID:22029407

NCBI chr 7:113,614,011...113,640,201
Ensembl chr 7:113,598,059...113,643,481

G

matrix metallopeptidase 14

decreases expression

ISO

bisdemethoxycurcumin results in decreased expression of MMP14 protein

NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893

G

matrix metallopeptidase 2

multiple interactions
decreases expression

ISO

bisdemethoxycurcumin results in decreased secretion of and results in decreased activity of MMP2 protein modified form
bisdemethoxycurcumin results in decreased expression of MMP2 protein

PMID:18495463 PMID:35735092

NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856

G

matrix metallopeptidase 9

multiple interactions
decreases expression

ISO

bisdemethoxycurcumin results in decreased secretion of and results in decreased activity of MMP9 protein
bisdemethoxycurcumin results in decreased expression of MMP9 protein

PMID:18495463 PMID:35735092

NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442

G

macrophage scavenger receptor 1

multiple interactions

ISO

bisdemethoxycurcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA]

NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070

G

NFE2 like bZIP transcription factor 2

affects localization
multiple interactions

ISO

bisdemethoxycurcumin affects the localization of NFE2L2 protein
[demethoxycurcumin co-treated with bisdemethoxycurcumin] affects the localization of NFE2L2 protein; NFE2L2 protein affects the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA]

NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090

G

nuclear factor kappa B subunit 1

multiple interactions

ISO
EXP

bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKB1 protein]
bisdemethoxycurcumin inhibits the reaction [Freund's Adjuvant results in increased phosphorylation of NFKB1 protein]

NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088

G

NFKB inhibitor alpha

multiple interactions

ISO
EXP

bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein]; bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
bisdemethoxycurcumin inhibits the reaction [Freund's Adjuvant results in decreased expression of NFKBIA protein]

PMID:18449507 PMID:38056805

NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072

G

nitric oxide synthase 2

multiple interactions

ISO
EXP

bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]

PMID:18449507 PMID:18481332 PMID:18838107 PMID:19188055

NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880

G

NAD(P)H quinone dehydrogenase 1

increases expression

ISO

bisdemethoxycurcumin results in increased expression of NQO1 mRNA; bisdemethoxycurcumin results in increased expression of NQO1 protein

PMID:17535857 PMID:19188863

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260

G

3-phosphoinositide dependent protein kinase-1

decreases expression

ISO

bisdemethoxycurcumin results in decreased expression of PDPK1 protein modified form

NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181

G

plasminogen activator, urokinase

decreases secretion

ISO

bisdemethoxycurcumin results in decreased secretion of PLAU protein

NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030

G

peroxisome proliferator-activated receptor gamma

affects binding

ISO

bisdemethoxycurcumin binds to PPARG protein

NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104

G

protein kinase C, delta

multiple interactions

ISO

PRKCD protein affects the reaction [bisdemethoxycurcumin results in increased expression of HMOX1 mRNA]

NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839

G

prostaglandin-endoperoxide synthase 2

multiple interactions

ISO
EXP

bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
bisdemethoxycurcumin inhibits the reaction [Freund's Adjuvant results in increased expression of PTGS2 protein]

PMID:18449507 PMID:38056805

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

Raf-1 proto-oncogene, serine/threonine kinase

decreases expression

ISO

bisdemethoxycurcumin results in decreased expression of RAF1 protein modified form

NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813

G

SOS Ras/Rac guanine nucleotide exchange factor 1

decreases expression

ISO

bisdemethoxycurcumin results in decreased expression of SOS1 protein

NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:20,286,117...20,363,350

G

TIMP metallopeptidase inhibitor 1

decreases expression

ISO

bisdemethoxycurcumin results in decreased expression of TIMP1 protein

NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135

G

TIMP metallopeptidase inhibitor 2

decreases expression

ISO

bisdemethoxycurcumin results in decreased expression of TIMP2 protein

NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214

G

toll-like receptor 2

multiple interactions

ISO

[bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of TLR2 mRNA; [bisdemethoxycurcumin co-treated with APP protein] results in increased expression of TLR2 mRNA

NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194

G

toll-like receptor 3

multiple interactions

ISO

[bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of TLR3 mRNA; [bisdemethoxycurcumin co-treated with APP protein] results in increased expression of TLR3 mRNA

NCBI chr16:53,554,916...53,572,321
Ensembl chr16:53,555,131...53,568,385

G

toll-like receptor 4

multiple interactions

ISO

[bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of TLR4 mRNA; [bisdemethoxycurcumin co-treated with APP protein] results in increased expression of TLR4 mRNA

NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007

G

tumor necrosis factor

multiple interactions

EXP
ISO

bisdemethoxycurcumin inhibits the reaction [Freund's Adjuvant results in increased secretion of TNF protein]; bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
bisdemethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]

PMID:18838107 PMID:38056805

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

G

vitamin D receptor

multiple interactions

ISO

[bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of VDR mRNA

NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757

G

vascular endothelial growth factor A

multiple interactions

ISO

[bisdemethoxycurcumin co-treated with Curcumin co-treated with demethoxycurcumin] inhibits the reaction [VEGFA protein results in increased phosphorylation of AKT1 protein]; [bisdemethoxycurcumin co-treated with Curcumin co-treated with demethoxycurcumin] inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein]; [bisdemethoxycurcumin co-treated with Curcumin co-treated with demethoxycurcumin] inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK1 protein]; [bisdemethoxycurcumin co-treated with Curcumin co-treated with demethoxycurcumin] inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK3 protein]; bisdemethoxycurcumin inhibits the reaction [VEGFA protein results in increased phosphorylation of AKT1 protein]; bisdemethoxycurcumin inhibits the reaction [VEGFA protein results in increased phosphorylation of KDR protein]; bisdemethoxycurcumin inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK1 protein]; bisdemethoxycurcumin inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK3 protein]

NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194

G

WT1 transcription factor

decreases expression

ISO

bisdemethoxycurcumin results in decreased expression of WT1 mRNA; bisdemethoxycurcumin results in decreased expression of WT1 protein

NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:112,021,641...112,068,444

conduritol B epoxide

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

glucosylceramidase beta 1

multiple interactions
decreases activity

ISO
EXP

[conduritol epoxide binds to and results in decreased activity of GBA1 protein] which results in increased expression of SNCA protein
[conduritol epoxide binds to and results in decreased activity of GBA1 protein] which affects the localization of SNCA protein; [conduritol epoxide binds to and results in decreased activity of GBA1 protein] which results in increased expression of SNCA protein
conduritol epoxide analog results in decreased activity of GBA1 protein

PMID:9101438 PMID:19576930

NCBI chr 2:176,902,141...176,916,015
Ensembl chr 2:176,907,154...176,916,985

G

synuclein alpha

multiple interactions

ISO

[conduritol epoxide binds to and results in decreased activity of GBA1 protein] which affects the localization of SNCA protein; [conduritol epoxide binds to and results in decreased activity of GBA1 protein] which results in increased expression of SNCA protein

NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:91,026,474...91,126,315

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily A member 1

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ABCA1 mRNA

NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473

G

ATP binding cassette subfamily B member 1A

multiple interactions

ISO

daidzein inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]

NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135

G

ATP binding cassette subfamily C member 1

multiple interactions

ISO

daidzein promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate]

NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404

G

ATP binding cassette subfamily C member 4

multiple interactions

ISO

daidzein inhibits the reaction [ABCC4 protein results in increased export of Cyclic GMP]; daidzein promotes the reaction [ABCC4 protein results in increased hydrolysis of Adenosine Triphosphate]

NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375

G

ATP binding cassette subfamily C member 5

multiple interactions

ISO

daidzein inhibits the reaction [ABCC5 protein results in decreased susceptibility to Thioguanine]; daidzein inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]

NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655

G

ATP binding cassette subfamily G member 2

affects transport

ISO

ABCG2 protein affects the transport of daidzein

NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493

G

acyl-CoA synthetase long-chain family member 3

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA

NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097

G

adducin 2

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ADD2 mRNA

NCBI chr 4:120,001,977...120,101,090
Ensembl chr 4:120,002,054...120,101,091

G

aryl hydrocarbon receptor

multiple interactions
affects binding
increases activity

ISO

daidzein binds to and results in increased activity of AHR protein
daidzein binds to AHR protein
daidzein results in increased activity of AHR protein

PMID:14644660 PMID:17869316 PMID:20436506

NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901

G

aldehyde dehydrogenase 1 family, member A2

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of ALDH1A2 mRNA

NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883

G

alkaline phosphatase, germ cell

increases expression

ISO

daidzein metabolite results in increased expression of ALPG mRNA

NCBI chr 9:95,187,995...95,205,127
Ensembl chr 9:95,198,334...95,205,742

G

alkaline phosphatase, biomineralization associated

multiple interactions

ISO

[daidzein binds to ESR1 protein] which results in increased activity of ALPL protein; fulvestrant inhibits the reaction [[daidzein binds to ESR1 protein] which results in increased activity of ALPL protein]

NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167

G

alanyl aminopeptidase, membrane

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of ANPEP mRNA

NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101

G

androgen receptor

multiple interactions
decreases expression

ISO
EXP

daidzein promotes the reaction [TGFB1I1 protein results in increased activity of AR protein]
daidzein inhibits the reaction [Flutamide results in decreased expression of AR mRNA]; daidzein inhibits the reaction [Flutamide results in decreased expression of AR protein]
daidzein results in decreased expression of AR mRNA

PMID:10822019 PMID:17252558 PMID:23135684

NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467

G

Rho GDP dissociation inhibitor alpha

decreases expression

ISO

daidzein results in decreased expression of ARHGDIA mRNA

NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347

G

atonal bHLH transcription factor 8

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of ATOH8 mRNA

NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379

G

ATPase H+ transporting V0 subunit a2

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ATP6V0A2 mRNA

NCBI chr12:37,608,211...37,640,860
Ensembl chr12:37,472,813...37,640,860

G

bromodomain adjacent to zinc finger domain, 1A

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of BAZ1A mRNA

NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:78,124,872...78,247,648

G

branched chain ketoacid dehydrogenase kinase

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of BCKDK mRNA

NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:191,946,471...191,953,453

G

BCL2, apoptosis regulator

decreases expression

ISO

daidzein results in decreased expression of BCL2 protein

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

Bcl2-like 1

decreases expression

ISO

daidzein results in decreased expression of BCL2L1 protein

NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907

G

bone gamma-carboxyglutamate protein

multiple interactions

ISO

[daidzein co-treated with ESR1 protein] results in increased expression of BGLAP mRNA; [daidzein co-treated with ESR2 protein] results in increased expression of BGLAP mRNA

NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318

G

bisphosphoglycerate mutase

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of BPGM mRNA

NCBI chr 4:64,106,809...64,135,749
Ensembl chr 4:64,106,804...64,135,627

G

BRCA1, DNA repair associated

increases expression

ISO

daidzein results in increased expression of BRCA1 mRNA

NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763

G

BUB1 mitotic checkpoint serine/threonine kinase B

affects expression

ISO

daidzein affects the expression of BUB1B mRNA

NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796

G

complement C3

increases expression

EXP

daidzein results in increased expression of C3 mRNA

NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339

G

calcium binding protein 5

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CABP5 mRNA

NCBI chr 1:83,486,396...83,499,421
Ensembl chr 1:83,486,396...83,499,421

G

calcyclin binding protein

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CACYBP mRNA

NCBI chr13:74,970,917...74,981,298
Ensembl chr13:74,970,923...74,981,505

G

caspase 3

increases activity
increases expression

ISO
EXP

daidzein results in increased activity of CASP3 protein
daidzein results in increased expression of CASP3 protein

PMID:12791511 PMID:29217487

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 8 associated protein 2

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA

NCBI chr 5:51,809,366...51,848,633
Ensembl chr 5:51,810,972...51,848,632

G

catalase

multiple interactions

ISO
EXP

[Genistein co-treated with daidzein] inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased activity of CAT protein]
daidzein inhibits the reaction [Flutamide results in decreased activity of CAT protein]

PMID:22981962 PMID:23135684

NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526

G

cyclin A2

decreases expression

ISO

daidzein results in decreased expression of CCNA2

NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701

G

cyclin D1

increases expression

ISO

daidzein results in increased expression of CCND1 mRNA

PMID:17266178 PMID:19800779

NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810

G

CD200 receptor 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CD200R1 mRNA

NCBI chr11:69,392,943...69,427,213
Ensembl chr11:69,392,975...69,427,128

G

CD40 molecule

multiple interactions

ISO

daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 protein]

NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847

G

Cd80 molecule

multiple interactions

ISO

daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of CD80 protein]

NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540

G

CD86 molecule

multiple interactions

ISO

daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 protein]

NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361

G

cyclin dependent kinase 2

multiple interactions
decreases activity

ISO

daidzein promotes the reaction [CDKN1A protein binds to CDK2 protein]
daidzein results in decreased activity of CDK2 protein

NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878

G

cyclin-dependent kinase 4

decreases activity

ISO

daidzein results in decreased activity of CDK4 protein

NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163

G

cyclin-dependent kinase inhibitor 1A

multiple interactions
increases expression

ISO

daidzein promotes the reaction [CDKN1A protein binds to CDK2 protein]; ESR2 affects the reaction [daidzein results in increased expression of CDKN1A]

PMID:11322924 PMID:21161820

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969

G

cilia and flagella associated protein 251

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of CFAP251 mRNA

NCBI chr12:38,923,154...38,997,881
Ensembl chr12:38,922,330...38,954,783

G

choline O-acetyltransferase

increases activity

ISO

daidzein results in increased activity of CHAT protein

NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416

G

creatine kinase B

increases activity
multiple interactions

ISO

daidzein results in increased activity of CKB protein
Glucose inhibits the reaction [daidzein results in increased activity of CKB protein]

NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478

G

clusterin

decreases expression

EXP

daidzein results in decreased expression of CLU mRNA

NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860

G

catechol-O-methyltransferase

decreases activity
multiple interactions
decreases expression

ISO

daidzein results in decreased activity of COMT protein
daidzein inhibits the reaction [COMT protein results in increased methylation of 4-hydroxyestradiol]; fulvestrant inhibits the reaction [daidzein results in decreased expression of COMT mRNA]

PMID:18192686 PMID:18497090

NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533

G

cytochrome c oxidase subunit 7A2 like

increases expression

ISO

daidzein results in increased expression of COX7A2L mRNA

NCBI chr 6:16,936,574...16,950,797
Ensembl chr 6:16,936,795...16,950,798

G

carnitine palmitoyltransferase 1A

increases expression

ISO

daidzein results in increased expression of CPT1A mRNA; daidzein results in increased expression of CPT1A protein

NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326

G

cAMP responsive element binding protein 1

multiple interactions

EXP

daidzein results in increased phosphorylation of and results in increased activity of CREB1 protein

NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339

G

C-reactive protein

multiple interactions

ISO

[Genistein co-treated with daidzein] results in decreased expression of CRP protein

NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514

G

casein kinase 2 alpha 2

affects expression

ISO

daidzein affects the expression of CSNK2A2 mRNA

NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,562,321...9,602,136

G

C-X-C motif chemokine ligand 12

increases expression
multiple interactions

ISO

daidzein results in increased expression of CXCL12 mRNA
ESR1 protein inhibits the reaction [daidzein results in increased expression of CXCL12 mRNA]

PMID:23384675 PMID:28396216

NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627

G

cytochrome b reductase 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA

NCBI chr 3:76,342,231...76,369,846
Ensembl chr 3:76,342,404...76,370,061

G

cytochrome P450, family 11, subfamily a, polypeptide 1

multiple interactions

EXP

[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of CYP11A1 mRNA

NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196

G

cytochrome P450, family 19, subfamily a, polypeptide 1

decreases activity
multiple interactions
decreases expression

ISO

daidzein results in decreased activity of CYP19A1 protein
[Genistein co-treated with biochanin A co-treated with daidzein] results in decreased activity of CYP19A1 protein; [Genistein co-treated with biochanin A co-treated with daidzein] results in decreased expression of CYP19A1 mRNA
daidzein results in decreased expression of CYP19A1 mRNA

PMID:16023337 PMID:16965912

NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917

G

cytochrome P450, family 1, subfamily a, polypeptide 1

decreases activity
multiple interactions
decreases expression

ISO
EXP

daidzein results in decreased activity of CYP1A1 protein
daidzein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 mRNA]; daidzein inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein]
daidzein results in decreased expression of CYP1A1 mRNA
daidzein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; fulvestrant inhibits the reaction [daidzein results in decreased expression of CYP1A1 mRNA]

PMID:9395520 PMID:18420780 PMID:18451504 PMID:18497090 PMID:28985473

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

cytochrome P450, family 1, subfamily a, polypeptide 2

decreases activity

ISO

daidzein results in decreased activity of CYP1A2 protein

NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149

G

cytochrome P450, family 1, subfamily b, polypeptide 1

affects chemical synthesis
decreases activity

ISO

CYP1B1 protein affects the chemical synthesis of daidzein
daidzein results in decreased activity of CYP1B1 protein

PMID:15479032 PMID:18420780

NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142

G

cytochrome P450, family 2, subfamily a, polypeptide 3

decreases activity

ISO

daidzein results in decreased activity of CYP2A4 protein

NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:91,299,561...91,307,649

G

cytochrome P450, family 2, subfamily C, polypeptide 6

decreases activity

ISO

daidzein results in decreased activity of CYP2C29 protein

NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798

G

cytochrome P450, family 2, subfamily d, polypeptide 4

decreases activity

ISO

daidzein results in decreased activity of CYP2D6 protein
daidzein results in decreased activity of CYP2D22 protein

NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837

G

cytochrome P450, family 2, subfamily e, polypeptide 1

decreases activity
multiple interactions

ISO
EXP

daidzein results in decreased activity of CYP2E1 protein
daidzein inhibits the reaction [[CYP2E1 protein results in increased metabolism of 4-nitrophenol] which results in increased chemical synthesis of 4-nitrocatechol]

PMID:18420780 PMID:31870919

NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495

G

cytochrome P450, family 3, subfamily a, polypeptide 2

increases expression
decreases activity

EXP
ISO

daidzein results in increased expression of CYP3A4 mRNA
daidzein results in decreased activity of CYP3A4 protein

PMID:18420780 PMID:31870919

NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857

G

death effector domain-containing

affects expression

ISO

daidzein affects the expression of DEDD mRNA

NCBI chr13:86,286,341...86,301,789
Ensembl chr13:86,288,350...86,302,446

G

DENN domain containing 2D

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of DENND2D mRNA

NCBI chr 2:196,661,465...196,680,505
Ensembl chr 2:196,661,345...196,682,397

G

iodothyronine deiodinase 1

affects expression

EXP

daidzein affects the expression of DIO1 mRNA

NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:127,303,083...127,319,771

G

DNA methyltransferase 1

multiple interactions

EXP

[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT1 mRNA

NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119

G

DNA methyltransferase 3 alpha

multiple interactions

EXP

[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of DNMT3A mRNA

NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970

G

dedicator of cyto-kinesis 3

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of DOCK3 mRNA

NCBI chr 8:116,431,158...116,782,218
Ensembl chr 8:116,431,159...116,782,195

G

dipeptidyl peptidase 9

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of DPP9 mRNA

NCBI chr 9:1,098,505...1,133,500
Ensembl chr 9:1,095,929...1,177,715

G

dual specificity phosphatase 4

decreases expression

ISO

daidzein results in decreased expression of DUSP4 mRNA

NCBI chr16:64,079,893...64,101,396
Ensembl chr16:64,079,893...64,093,700

G

estrogen receptor binding site associated antigen 9

increases expression

ISO

daidzein results in increased expression of EBAG9 mRNA

NCBI chr 7:77,695,213...77,713,565
Ensembl chr 7:77,695,072...77,713,557

G

erythroid differentiation regulatory factor 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of EDRF1 mRNA

NCBI chr 1:197,869,873...197,908,693
Ensembl chr 1:197,870,962...197,908,731

G

EF-hand domain family, member D1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of EFHD1 mRNA

NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:95,386,169...95,432,798

G

epidermal growth factor receptor

multiple interactions

ISO

[daidzein co-treated with ESR1 protein] results in decreased expression of EGFR mRNA; [daidzein co-treated with ESR1 protein] results in decreased expression of EGFR protein; [daidzein co-treated with ESR2 protein] results in decreased expression of EGFR mRNA; [daidzein co-treated with ESR2 protein] results in decreased expression of EGFR protein

NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358

G

ETS transcription factor ELK1

multiple interactions

EXP

daidzein results in increased phosphorylation of and results in increased activity of ELK1 protein

NCBI chr X:3,692,367...3,709,252
Ensembl chr X:3,693,293...3,709,249

G

enolase 3

decreases expression

ISO

daidzein results in decreased expression of ENO3 mRNA

NCBI chr10:55,868,880...55,876,099
Ensembl chr10:55,866,101...55,874,540

G

Eph receptor A1

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA

NCBI chr 4:72,213,022...72,227,543
Ensembl chr 4:72,213,037...72,227,474

G

ERCC excision repair 5, endonuclease

affects expression

ISO

daidzein affects the expression of ERCC5 mRNA

NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:53,801,714...53,875,084

G

espin

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ESPN mRNA

NCBI chr 5:167,909,271...167,943,168
Ensembl chr 5:167,909,271...167,942,984

G

estrogen receptor 1

multiple interactions
increases expression
increases activity
affects response to substance
affects binding
decreases expression

ISO
EXP

[daidzein binds to ESR1 protein] which results in increased activity of ALPL protein; [daidzein co-treated with ESR1 protein] results in decreased expression of EGFR mRNA; [daidzein co-treated with ESR1 protein] results in decreased expression of EGFR protein; [daidzein co-treated with ESR1 protein] results in increased expression of BGLAP mRNA; [daidzein co-treated with ESR1 protein] results in increased expression of BSP mRNA; daidzein binds to and results in increased activity of ESR1 protein; daidzein inhibits the reaction [bisphenol A results in decreased expression of ESR1 mRNA]; daidzein inhibits the reaction [Estradiol binds to ESR1 protein]; daidzein metabolite binds to and results in increased activity of ESR1 protein; daidzein metabolite promotes the reaction [NCOA2 protein binds to ESR1 protein]; daidzein promotes the reaction [Estradiol results in increased activity of ESR1 protein]; ESR1 protein affects the reaction [daidzein results in decreased expression of IL6 mRNA]; ESR1 protein affects the reaction [daidzein results in decreased secretion of IL6 protein]; ESR1 protein inhibits the reaction [daidzein results in increased expression of CXCL12 mRNA]; ESR1 protein inhibits the reaction [daidzein results in increased expression of GREB1 mRNA]; ESR1 protein inhibits the reaction [daidzein results in increased expression of PGR mRNA]; ESR1 protein inhibits the reaction [daidzein results in increased expression of PRSS23 mRNA]; ESR1 protein inhibits the reaction [daidzein results in increased expression of TFF1 mRNA]; Estradiol affects the reaction [daidzein metabolite affects the activity of ESR1 protein]; Fulvestrant inhibits the reaction [[daidzein binds to ESR1 protein] which results in increased activity of ALPL protein]
daidzein results in increased expression of ESR1 mRNA; daidzein results in increased expression of ESR1 protein
daidzein results in increased activity of ESR1 protein
ESR1 protein affects the susceptibility to daidzein
daidzein results in decreased expression of ESR1 mRNA; daidzein results in decreased expression of ESR1 protein

PMID:9751507 PMID:12598185 PMID:12650720 PMID:14579009 PMID:15084758 More...

NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354

G

estrogen receptor 2

multiple interactions
increases expression
affects binding
affects response to substance
increases activity

ISO
EXP

[daidzein co-treated with ESR2 protein] results in decreased expression of EGFR mRNA; [daidzein co-treated with ESR2 protein] results in decreased expression of EGFR protein; [daidzein co-treated with ESR2 protein] results in increased expression of BGLAP mRNA; [daidzein co-treated with ESR2 protein] results in increased expression of BSP mRNA; [daidzein co-treated with ESR2 protein] results in increased expression of PTGS2 mRNA; daidzein binds to and results in increased activity of ESR2 protein; daidzein inhibits the reaction [Estradiol binds to ESR2 protein]; daidzein inhibits the reaction [KAT5 protein results in increased activity of ESR2 protein]; daidzein metabolite binds to and results in increased activity of ESR2 protein; daidzein promotes the reaction [Estradiol results in increased activity of ESR2 protein]; ESR2 affects the reaction [daidzein results in increased expression of CDKN1A]; ESR2 gene polymorphism affects the reaction [[Genistein co-treated with daidzein] affects the expression of VCAM1 protein]; ESR2 gene polymorphism affects the susceptibility to [Genistein co-treated with daidzein]; Estradiol affects the reaction [daidzein metabolite affects the activity of ESR2 protein]
daidzein results in increased expression of ESR2 mRNA; daidzein results in increased expression of ESR2 protein
[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased expression of ESR2 mRNA
daidzein binds to ESR2 protein
ESR2 affects the susceptibility to daidzein
daidzein results in increased activity of ESR2 protein
daidzein results in increased activity of ESR2 protein; daidzein results in increased activity of ESR2 protein alternative form

PMID:9751507 PMID:12224631 PMID:15084758 PMID:15993745 PMID:16033089 More...

NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709

G

estrogen related receptor, alpha

multiple interactions

ISO

daidzein binds to and results in increased activity of ESRRA protein; daidzein binds to and results in increased activity of ESRRA protein mutant form; daidzein promotes the reaction [ESRRA protein binds to PNRC1 protein]

NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811

G

estrogen-related receptor beta

multiple interactions

ISO

daidzein binds to and results in increased activity of ESRRB protein; daidzein promotes the reaction [ESRRB protein binds to PNRC1 protein]

NCBI chr 6:111,738,662...111,894,087
Ensembl chr 6:111,738,662...111,894,087

G

estrogen-related receptor gamma

multiple interactions

ISO

daidzein inhibits the reaction [bisphenol A results in increased expression of ESRRG mRNA]; daidzein inhibits the reaction [bisphenol A results in increased expression of ESRRG protein]; daidzein promotes the reaction [ESRRG protein binds to PNRC1 protein]

PMID:14638870 PMID:32963737

NCBI chr13:101,699,043...102,316,877
Ensembl chr13:101,889,706...102,316,877

G

fatty acid binding protein 4

multiple interactions
increases expression

ISO

2-chloro-5-nitrobenzanilide inhibits the reaction [daidzein results in increased expression of FABP4 mRNA]

NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972

G

family with sequence similarity 171, member A2

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of FAM171A2 mRNA

NCBI chr10:87,894,049...87,904,213
Ensembl chr10:87,893,543...87,904,247

G

family with sequence similarity 180, member A

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM180A mRNA

NCBI chr 4:64,959,999...64,975,176
Ensembl chr 4:64,959,999...64,975,176

G

family with sequence similarity 210, member B

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FAM210B mRNA

NCBI chr 3:181,536,665...181,546,830
Ensembl chr 3:181,536,673...181,546,834

G

family with sequence similarity 241 member B

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA

NCBI chr20:30,595,082...30,598,007
Ensembl chr20:30,595,084...30,597,844
Ensembl chr 6:30,595,084...30,597,844

G

FERM domain containing kindlin 2

affects expression

ISO

daidzein affects the expression of FERMT2 mRNA

NCBI chr15:21,162,603...21,257,995
Ensembl chr15:21,162,605...21,258,115

G

FYVE, RhoGEF and PH domain containing 6

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of FGD6 mRNA

NCBI chr 7:30,484,600...30,599,898
Ensembl chr 7:30,484,600...30,595,806

G

four and a half LIM domains 2

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of FHL2 mRNA

NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326

G

formin 2

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of FMN2 mRNA

NCBI chr13:88,986,863...89,303,789
Ensembl chr13:88,986,842...89,303,789

G

Fos proto-oncogene, AP-1 transcription factor subunit

multiple interactions
increases expression

ISO

daidzein inhibits the reaction [Estradiol results in increased expression of FOS mRNA]
daidzein results in increased expression of FOS mRNA

PMID:11473722 PMID:17142977

NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598

G

polypeptide N-acetylgalactosaminyltransferase 15

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of GALNT15 mRNA

NCBI chr16:7,233,524...7,273,290
Ensembl chr16:7,233,606...7,273,285

G

G protein subunit beta 1

multiple interactions

EXP

daidzein promotes the reaction [GNB1 protein results in increased activity of PLCB2 protein results in increased activity of MAPK1 protein]; daidzein promotes the reaction [GNB1 protein results in increased activity of PLCB2 protein results in increased activity of MAPK3 protein]; daidzein promotes the reaction [GNB1 protein results in increased activity of PLCB2 protein]

NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:171,357,797...171,424,488

G

G protein subunit gamma 5

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of GNG5 mRNA

NCBI chr 2:238,054,954...238,063,451
Ensembl chr11:58,096,362...58,096,565
Ensembl chr 2:58,096,362...58,096,565

G

G protein-coupled estrogen receptor 1

multiple interactions

ISO

daidzein inhibits the reaction [bisphenol A results in decreased expression of GPER1 mRNA]

NCBI chr12:20,331,073...20,336,527
Ensembl chr12:20,327,679...20,337,144

G

growth regulating estrogen receptor binding 1

increases expression
multiple interactions

ISO

daidzein results in increased expression of GREB1 mRNA
ESR1 protein inhibits the reaction [daidzein results in increased expression of GREB1 mRNA]; Fulvestrant inhibits the reaction [daidzein results in increased expression of GREB1 mRNA]

PMID:23384675 PMID:33405908

NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126

G

glutathione-disulfide reductase

multiple interactions

EXP

daidzein inhibits the reaction [Flutamide results in decreased activity of GSR protein]

NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394

G

homeodomain interacting protein kinase 4

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of HIPK4 mRNA

NCBI chr 1:91,938,308...91,948,680
Ensembl chr 1:91,938,278...91,948,683

G

hemicentin 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of HMCN1 mRNA

NCBI chr13:65,165,532...65,634,681
Ensembl chr13:65,165,532...65,634,519

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1

multiple interactions

EXP

[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of HSD3B1 mRNA

NCBI chr 2:188,858,574...188,864,694

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2

multiple interactions

ISO

daidzein inhibits the reaction [Colforsin results in increased expression of HSD3B2 mRNA]

NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:188,784,614...188,790,569

G

integrin-binding sialoprotein

multiple interactions

ISO

[daidzein co-treated with ESR1 protein] results in increased expression of BSP mRNA; [daidzein co-treated with ESR2 protein] results in increased expression of BSP mRNA

NCBI chr14:5,744,497...5,757,242
Ensembl chr14:5,744,501...5,775,299

G

interferon-related developmental regulator 2

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of IFRD2 mRNA

NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836

G

insulin-like growth factor 1 receptor

decreases expression

ISO

daidzein results in decreased expression of IGF1R mRNA

NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664

G

insulin-like growth factor binding protein 4

increases expression

ISO

daidzein results in increased expression of IGFBP4 mRNA

NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473

G

interleukin 12A

multiple interactions

ISO

daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of IL12A mRNA]

NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997

G

interleukin 12B

multiple interactions

ISO

daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]; daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein]

NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194

G

interleukin 17A

multiple interactions

ISO

daidzein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL17A mRNA]

NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331

G

interleukin 1 alpha

multiple interactions

ISO

daidzein inhibits the reaction [Estradiol results in increased expression of IL1A mRNA]

NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013

G

interleukin 1 beta

multiple interactions

ISO

daidzein inhibits the reaction [IL1B protein results in increased secretion of IL6 protein]
[Genistein co-treated with daidzein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1B protein]

PMID:17266178 PMID:22981962

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 4

increases expression

ISO

daidzein results in increased expression of IL4 mRNA; daidzein results in increased expression of IL4 protein

NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549

G

interleukin 6

multiple interactions
decreases expression
decreases secretion

ISO

daidzein inhibits the reaction [IL1B protein results in increased secretion of IL6 protein]; ESR1 protein affects the reaction [daidzein results in decreased expression of IL6 mRNA]; ESR1 protein affects the reaction [daidzein results in decreased secretion of IL6 protein]
[Genistein co-treated with daidzein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL6 protein]; daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; daidzein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]

PMID:17266178 PMID:21945492 PMID:21972936 PMID:22981962 PMID:27576059

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

interleukin 6 receptor

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of IL6R mRNA

NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221

G

interferon regulatory factor 2 binding protein 1

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of IRF2BP1 mRNA

NCBI chr 1:87,780,782...87,783,483
Ensembl chr 1:87,779,406...87,785,661

G

interferon stimulated exonuclease gene 20-like 2

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of ISG20L2 mRNA

NCBI chr 2:175,694,638...175,704,125
Ensembl chr 2:175,695,615...175,705,095

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression

ISO

daidzein results in increased expression of JUN mRNA

NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285

G

lysine acetyltransferase 5

multiple interactions

ISO

daidzein inhibits the reaction [KAT5 protein results in increased activity of ESR2 protein]

NCBI chr 1:212,325,089...212,332,640
Ensembl chr 1:212,325,090...212,332,587

G

potassium voltage-gated channel modifier subfamily G member 2

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of KCNG2 mRNA

NCBI chr18:76,017,225...76,085,377
Ensembl chr18:76,018,047...76,083,688

G

lysine demethylase 5A

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA

NCBI chr 4:155,238,124...155,316,121
Ensembl chr 4:155,238,044...155,316,121

G

KIT ligand

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KITLG mRNA

NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793

G

kallikrein 1-related peptidase C10

decreases expression

ISO

daidzein results in decreased expression of KLK3 mRNA

NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586

G

kinetochore-localized astrin/SPAG5 binding protein

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KNSTRN mRNA

NCBI chr 3:126,254,633...126,274,412
Ensembl chr 3:126,254,663...126,274,418

G

lysosomal-associated membrane protein 3

decreases expression

ISO

daidzein results in decreased expression of LAMP3 mRNA

NCBI chr11:94,657,817...94,726,451
Ensembl chr11:94,661,399...94,726,195

G

low density lipoprotein receptor adaptor protein 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of LDLRAP1 mRNA

NCBI chr 5:152,239,296...152,262,290
Ensembl chr 5:152,229,505...152,262,290

G

leiomodin 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of LMOD1 mRNA

NCBI chr13:49,305,693...49,347,970
Ensembl chr13:49,305,830...49,348,116

G

leucine-rich alpha-2-glycoprotein 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of LRG1 mRNA

NCBI chr 9:1,034,691...1,036,937
Ensembl chr 9:1,034,679...1,037,337

G

lipolysis stimulated lipoprotein receptor

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of LSR mRNA

NCBI chr 1:95,313,830...95,329,471
Ensembl chr 1:95,313,033...95,329,354

G

mitogen activated protein kinase 1

multiple interactions
increases phosphorylation

ISO
EXP

AG 1879 inhibits the reaction [daidzein results in increased phosphorylation of MAPK1 protein]
daidzein promotes the reaction [GNB1 protein results in increased activity of PLCB2 protein results in increased activity of MAPK1 protein]; daidzein results in increased phosphorylation of and results in increased activity of MAPK1 protein

PMID:16840783 PMID:16972265 PMID:24859791

NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825

G

mitogen activated protein kinase 3

multiple interactions
increases phosphorylation

ISO
EXP

AG 1879 inhibits the reaction [daidzein results in increased phosphorylation of MAPK3 protein]
daidzein promotes the reaction [GNB1 protein results in increased activity of PLCB2 protein results in increased activity of MAPK3 protein]; daidzein results in increased phosphorylation of and results in increased activity of MAPK3 protein

PMID:16840783 PMID:16972265 PMID:24859791

NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411

G

malic enzyme 1

increases expression

ISO

daidzein results in increased expression of ME1 mRNA

NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275

G

matrix metallopeptidase 9

multiple interactions

EXP

daidzein inhibits the reaction [Flutamide results in increased expression of MMP9 mRNA]

NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442

G

mitochondrial ribosomal protein L33

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of MRPL33 mRNA

NCBI chr 6:30,545,794...30,553,987
Ensembl chr 6:30,545,794...30,553,987

G

metallothionein 2

increases expression

ISO

daidzein results in increased expression of MT2A mRNA

NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709

G

myotubularin related protein 11

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of MTMR11 mRNA

NCBI chr 2:186,410,851...186,421,024
Ensembl chr 2:186,412,291...186,421,026

G

MYB proto-oncogene like 1

increases expression
multiple interactions

ISO

daidzein results in increased expression of MYBL1 mRNA
Fulvestrant inhibits the reaction [daidzein results in increased expression of MYBL1 mRNA]

NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588

G

MYC proto-oncogene, bHLH transcription factor

increases expression

ISO

daidzein results in increased expression of MYC mRNA

NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028

G

myoferlin

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of MYOF mRNA

NCBI chr 1:245,086,109...245,234,768
Ensembl chr 1:245,086,109...245,234,768

G

nuclear receptor coactivator 1

multiple interactions
increases expression

ISO

[daidzein binds to THRB protein] promotes the reaction [NCOA1 protein binds to THRB protein]; daidzein promotes the reaction [NCOA1 protein binds to THRB protein]
daidzein results in increased expression of NCOA1 mRNA; daidzein results in increased expression of NCOA1 protein

PMID:27576059 PMID:29688519

NCBI chr 6:32,952,090...33,229,829
Ensembl chr 6:32,952,090...33,195,924

G

nuclear receptor coactivator 2

multiple interactions

ISO

daidzein metabolite promotes the reaction [NCOA2 protein binds to ESR1 protein]

NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:10,618,722...10,852,776

G

nuclear factor kappa B subunit 1

multiple interactions

ISO

daidzein inhibits the reaction [Lipopolysaccharides results in increased localization of NFKB1 protein]

NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088

G

NFKB inhibitor alpha

multiple interactions

ISO

daidzein inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]

NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072

G

NK3 homeobox 1

decreases expression

ISO

daidzein results in decreased expression of NKX3-1 mRNA

NCBI chr15:50,883,661...50,886,253
Ensembl chr15:50,883,597...50,886,251

G

nitric oxide synthase 2

multiple interactions
decreases activity

ISO

daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
daidzein results in decreased activity of NOS2 protein

PMID:11308324 PMID:18274639

NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880

G

nitric oxide synthase 3

increases activity

ISO

daidzein results in increased activity of NOS3 protein

NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664

G

NAD(P)H quinone dehydrogenase 1

decreases expression

ISO

daidzein results in decreased expression of NQO1 mRNA

NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260

G

nuclear receptor subfamily 1, group I, member 2

multiple interactions

ISO

daidzein binds to and results in increased activity of NR1I2 protein
daidzein binds to and results in decreased activity of NR1I2 protein

PMID:16054614 PMID:33049310

NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380

G

nuclear receptor subfamily 4, group A, member 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of NR4A1 mRNA

NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041

G

nuclear receptor subfamily 5, group A, member 1

multiple interactions

EXP

[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of NR5A1 mRNA; [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of NR5A1 protein; [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in increased methylation of NR5A1 promoter; decitabine inhibits the reaction [[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of NR5A1 mRNA]

NCBI chr 3:42,874,505...42,896,109
Ensembl chr 3:42,875,221...42,896,046

G

nuclear receptor interacting protein 1

increases expression

ISO

daidzein results in increased expression of NRIP1 mRNA

NCBI chr11:28,382,835...28,466,483
Ensembl chr11:28,378,878...28,467,353

G

olfactomedin-like 3

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of OLFML3 mRNA

NCBI chr 2:193,932,665...193,935,494
Ensembl chr 2:193,932,665...193,935,494

G

poly (ADP-ribose) polymerase 1

increases cleavage

ISO

daidzein results in increased cleavage of PARP1 protein

NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567

G

proliferating cell nuclear antigen

decreases expression

ISO
EXP

daidzein results in decreased expression of PCNA
daidzein results in decreased expression of PCNA protein

PMID:21161820 PMID:29217487

NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901

G

PDZ and LIM domain 2

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of PDLIM2 mRNA

NCBI chr15:51,647,195...51,659,904
Ensembl chr15:51,647,197...51,658,958

G

PDZ domain containing 1

increases expression

ISO

daidzein results in increased expression of PDZK1 mRNA

NCBI chr 2:187,064,995...187,096,348
Ensembl chr 2:187,065,013...187,096,806

G

progesterone receptor

increases expression
multiple interactions

ISO

daidzein results in increased expression of PGR mRNA; daidzein results in increased expression of PGR protein
ESR1 protein inhibits the reaction [daidzein results in increased expression of PGR mRNA]

PMID:17142977 PMID:23384675

NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271

G

plasminogen activator, urokinase receptor

multiple interactions

EXP

daidzein inhibits the reaction [Flutamide results in increased expression of PLAUR mRNA]

NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130

G

phospholipase C, beta 2

multiple interactions

EXP

daidzein promotes the reaction [GNB1 protein results in increased activity of PLCB2 protein results in increased activity of MAPK1 protein]; daidzein promotes the reaction [GNB1 protein results in increased activity of PLCB2 protein results in increased activity of MAPK3 protein]; daidzein promotes the reaction [GNB1 protein results in increased activity of PLCB2 protein]

NCBI chr 3:126,134,925...126,158,303
Ensembl chr 3:126,138,736...126,158,221

G

pinin, desmosome associated protein

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of PNN mRNA

NCBI chr 6:82,493,032...82,501,345
Ensembl chr 6:82,492,978...82,501,933

G

proline-rich nuclear receptor coactivator 1

multiple interactions

ISO

daidzein promotes the reaction [ESRRA protein binds to PNRC1 protein]; daidzein promotes the reaction [ESRRB protein binds to PNRC1 protein]; daidzein promotes the reaction [ESRRG protein binds to PNRC1 protein]

NCBI chr 5:52,443,400...52,489,303
Ensembl chr 5:52,443,400...52,446,491

G

POU class 4 homeobox 2

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of POU4F2 mRNA

NCBI chr19:46,390,958...46,394,599
Ensembl chr19:46,390,958...46,394,599

G

protein kinase cAMP-activated catalytic subunit alpha

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA

NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494

G

protein kinase C, alpha

increases activity

EXP

daidzein results in increased activity of PRKCA protein

NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572

G

protein kinase C, beta

increases activity

EXP

daidzein results in increased activity of PRKCB protein

NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740

G

protein kinase C, delta

decreases expression

ISO

daidzein results in decreased expression of PRKCD mRNA

NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839

G

protein kinase C, epsilon

multiple interactions

EXP

daidzein affects the localization of and results in increased activity of PRKCE protein

NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288

G

protein kinase C, gamma

increases activity

EXP

daidzein results in increased activity of PRKCG protein

NCBI chr 1:74,748,272...74,777,611
Ensembl chr 1:74,748,272...74,774,814

G

prolactin

increases secretion

EXP

daidzein results in increased secretion of PRL protein

NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217

G

pre-mRNA processing factor 40 homolog A

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of PRPF40A mRNA

NCBI chr 3:58,036,779...58,098,996
Ensembl chr 3:58,038,042...58,099,363

G

serine protease 23

increases expression
multiple interactions

ISO

daidzein results in increased expression of PRSS23 mRNA
ESR1 protein inhibits the reaction [daidzein results in increased expression of PRSS23 mRNA]

NCBI chr 1:152,815,301...152,835,005
Ensembl chr 1:152,813,670...152,947,871

G

paraspeckle component 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of PSPC1 mRNA

NCBI chr15:34,941,445...35,027,460
Ensembl chr15:34,967,477...35,026,828

G

prostaglandin-endoperoxide synthase 2

multiple interactions

ISO

[daidzein co-treated with ESR2 protein] results in increased expression of PTGS2 mRNA; daidzein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; daidzein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]
daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]

PMID:16870006 PMID:19347870 PMID:21341175

NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320

G

parathyroid hormone 1 receptor

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of PTH1R mRNA

NCBI chr 8:119,572,295...119,597,405
Ensembl chr 8:119,575,868...119,598,108

G

protein tyrosine kinase 2

increases phosphorylation

ISO

daidzein results in increased phosphorylation of PTK2 protein

NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091

G

Rac family small GTPase 1

increases activity

ISO

daidzein results in increased activity of RAC1 protein

NCBI chr12:16,150,411...16,170,864
Ensembl chr12:16,128,649...16,172,109

G

Ras association domain family member 5

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of RASSF5 mRNA

NCBI chr13:45,189,768...45,255,277
Ensembl chr13:45,189,804...45,255,277

G

RB binding protein 8, endonuclease

increases expression

ISO

daidzein results in increased expression of RBBP8 mRNA

NCBI chr18:3,198,188...3,263,643
Ensembl chr18:3,197,310...3,263,985

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

ISO

daidzein inhibits the reaction [Lipopolysaccharides affects the localization of and results in increased activity of RELA protein]

NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817

G

regulator of G-protein signaling 22

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of RGS22 mRNA

NCBI chr 7:69,073,681...69,194,041
Ensembl chr 7:69,075,562...69,194,102

G

ribosomal protein S6 kinase A3

increases expression

ISO

daidzein results in increased expression of RPS6KA3 mRNA

NCBI chr X:39,325,926...39,432,017
Ensembl chr X:39,325,926...39,433,678

G

RT1 class II, locus Bb

multiple interactions

ISO

daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of H2-AB1 protein]

NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118

G

sphingosine-1-phosphate receptor 3

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of S1PR3 mRNA

NCBI chr17:13,932,773...13,946,213
Ensembl chr17:13,928,444...13,947,197

G

selectin P ligand

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SELPLG mRNA

NCBI chr12:48,457,102...48,470,444
Ensembl chr12:48,456,932...48,473,154

G

serum/glucocorticoid regulated kinase 1

multiple interactions
increases expression

ISO

Fulvestrant inhibits the reaction [daidzein results in increased expression of SGK1 mRNA]

NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231

G

sphingosine-1-phosphate phosphatase 1

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of SGPP1 mRNA

NCBI chr 6:100,161,024...100,182,214
Ensembl chr 6:100,161,024...100,182,259

G

sialic acid binding Ig-like lectin 10

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of SIGLEC10 mRNA

NCBI chr 1:102,953,894...102,962,964
Ensembl chr 1:102,953,918...102,962,964

G

solute carrier family 10 member 1

multiple interactions
increases transport

ISO

daidzein metabolite inhibits the reaction [SLC10A1 protein results in increased transport of estrone sulfate]; daidzein metabolite promotes the reaction [SLC10A1 protein results in increased transport of estrone sulfate]; estrone sulfate inhibits the reaction [SLC10A1 protein results in increased transport of daidzein metabolite]; Taurocholic Acid inhibits the reaction [SLC10A1 protein results in increased transport of daidzein metabolite]

NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944

G

solute carrier family 10 member 6

multiple interactions
increases transport

ISO

daidzein inhibits the reaction [SLC10A6 protein results in increased transport of estrone sulfate]; daidzein metabolite inhibits the reaction [SLC10A6 protein results in increased transport of estrone sulfate]; estrone sulfate inhibits the reaction [SLC10A6 protein results in increased transport of daidzein metabolite]

NCBI chr14:6,385,348...6,407,532
Ensembl chr14:6,385,537...6,408,894

G

solute carrier family 12 member 2

decreases expression

ISO

daidzein results in decreased expression of SLC12A2 mRNA

NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470

G

solute carrier family 16 member 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SLC16A1 mRNA

NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:194,812,502...194,832,977

G

solute carrier family 22 member 8

increases uptake

ISO

SLC22A8 protein results in increased uptake of daidzein analog

NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588

G

solute carrier family 2 member 1

multiple interactions
decreases activity

ISO

daidzein inhibits the reaction [SLC2A1 protein affects the transport of Glucose]
daidzein results in decreased activity of SLC2A1 protein

NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742

G

solute carrier family 7 member 5

increases expression

ISO

daidzein results in increased expression of SLC7A5 mRNA

NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412

G

solute carrier organic anion transporter family, member 2b1

increases transport
multiple interactions

ISO

SLCO2B1 protein results in increased transport of daidzein metabolite
daidzein inhibits the reaction [SLCO2B1 protein results in increased transport of estrone sulfate]; daidzein metabolite inhibits the reaction [SLCO2B1 protein results in increased transport of estrone sulfate]; estrone sulfate inhibits the reaction [SLCO2B1 protein results in increased transport of daidzein metabolite]

NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:163,371,410...163,419,279

G

sorting nexin family member 30

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of SNX30 mRNA

NCBI chr 5:79,478,804...79,608,118
Ensembl chr 5:79,478,912...79,607,052

G

superoxide dismutase 2

increases expression
affects response to substance
multiple interactions

ISO

daidzein results in increased expression of SOD2 protein
SOD2 protein affects the susceptibility to daidzein
fulvestrant inhibits the reaction [daidzein results in increased expression of SOD2 protein]

NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168

G

scavenger receptor cysteine rich family member with 5 domains

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of SSC5D mRNA

NCBI chr 1:77,920,781...77,939,284
Ensembl chr 1:77,920,783...77,938,574

G

steroidogenic acute regulatory protein

multiple interactions

EXP

[Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of STAR mRNA; [Genistein co-treated with daidzein co-treated with glycitin co-treated with genistin co-treated with daidzin co-treated with glycitein] results in decreased expression of STAR protein

NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447

G

signal transducer and activator of transcription 1

multiple interactions

ISO

daidzein inhibits the reaction [Lipopolysaccharides affects the localization of and results in increased activity of STAT1 protein alternative form]; daidzein inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein]

PMID:18274639 PMID:21972936

NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346

G

stanniocalcin 1

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of STC1 mRNA

NCBI chr15:50,709,439...50,720,093
Ensembl chr15:50,709,415...50,720,082

G

serine threonine kinase 39

decreases expression

ISO

daidzein results in decreased expression of STK39 mRNA

NCBI chr 3:73,321,522...73,588,397
Ensembl chr 3:73,321,522...73,586,740

G

serine/threonine/tyrosine interacting-like 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of STYXL1 mRNA

NCBI chr12:26,544,059...26,576,365
Ensembl chr12:26,544,067...26,576,366

G

sulfotransferase family 1A member 1

multiple interactions

ISO

daidzein inhibits the reaction [SULT1A1 protein results in increased sulfation of 4-nitrophenol]

NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131

G

small ubiquitin-like modifier 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of SUMO1 mRNA

NCBI chr 9:68,572,901...68,602,803
Ensembl chr 9:68,572,911...68,602,890

G

tachykinin receptor 3

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of TACR3 mRNA

NCBI chr 2:225,940,497...226,037,756
Ensembl chr 2:225,940,444...226,037,756

G

tandem C2 domains, nuclear

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of TC2N mRNA

NCBI chr 6:126,526,006...126,622,163
Ensembl chr 6:126,526,009...126,614,215

G

trefoil factor 1

increases expression
multiple interactions

ISO

daidzein results in increased expression of TFF1 mRNA
ESR1 protein inhibits the reaction [daidzein results in increased expression of TFF1 mRNA]

PMID:16965913 PMID:23384675

NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,237,095...9,240,956

G

thyroglobulin

decreases expression

EXP

daidzein results in decreased expression of TG mRNA

NCBI chr 7:100,307,349...100,492,246
Ensembl chr 7:100,307,349...100,314,539
Ensembl chr 7:100,307,349...100,314,539

G

transforming growth factor beta 1 induced transcript 1

multiple interactions

ISO

daidzein promotes the reaction [TGFB1I1 protein results in increased activity of AR protein]

NCBI chr 1:192,258,992...192,265,903
Ensembl chr 1:192,258,598...192,265,903

G

transglutaminase 2

increases expression

ISO

daidzein results in increased expression of TGM2 mRNA; daidzein results in increased expression of TGM2 protein

NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240

G

thyroid hormone receptor alpha

multiple interactions
affects binding

ISO

daidzein promotes the reaction [Triiodothyronine results in increased activity of THRA protein]
daidzein binds to THRA protein

NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657

G

thyroid hormone receptor beta

multiple interactions

ISO

[daidzein binds to THRB protein] promotes the reaction [NCOA1 protein binds to THRB protein]; daidzein promotes the reaction [NCOA1 protein binds to THRB protein]; daidzein promotes the reaction [Triiodothyronine results in increased activity of THRB protein]

NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680

G

thyroid hormone responsive

increases expression

EXP

daidzein results in increased expression of THRSP mRNA

NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:161,133,453...161,139,827

G

tumor necrosis factor

multiple interactions

ISO

[Genistein co-treated with daidzein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein]; daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; daidzein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]

PMID:21945492 PMID:22981962

NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303

G

TNF alpha induced protein 6

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of TNFAIP6 mRNA

NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796

G

TNF receptor superfamily member 11B

multiple interactions
increases expression

ISO

Fulvestrant inhibits the reaction [daidzein results in increased expression of TNFRSF11B mRNA]; Fulvestrant inhibits the reaction [daidzein results in increased expression of TNFRSF11B protein]
daidzein results in increased expression of TNFRSF11B mRNA; daidzein results in increased expression of TNFRSF11B protein

NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075

G

TNF superfamily member 11

multiple interactions
decreases expression

ISO

Fulvestrant inhibits the reaction [daidzein results in decreased expression of TNFSF11 mRNA]; Fulvestrant inhibits the reaction [daidzein results in decreased expression of TNFSF11 protein]
daidzein results in decreased expression of TNFSF11 mRNA; daidzein results in decreased expression of TNFSF11 protein

NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479

G

tumor protein p53

increases expression

ISO

daidzein results in increased expression of TP53 protein

NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299

G

tumor protein p53 inducible protein 11

decreases expression
multiple interactions

ISO

daidzein results in decreased expression of TP53I11 mRNA
[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of TP53I11 mRNA

PMID:15757668 PMID:27424125

NCBI chr 3:99,600,213...99,615,462
Ensembl chr 3:99,600,159...99,615,432

G

TPD52 like 1

increases expression

ISO

daidzein results in increased expression of TPD52L1 mRNA

NCBI chr 1:27,991,114...28,109,767
Ensembl chr 1:27,991,131...28,110,158

G

thyroid peroxidase

decreases expression
decreases activity

EXP
ISO

daidzein results in decreased expression of TPO mRNA
daidzein results in decreased activity of TPO protein

PMID:24793811 PMID:31629072

NCBI chr 6:52,425,998...52,495,793
Ensembl chr 6:52,426,010...52,495,793

G

tyrosinase

increases expression

ISO

daidzein results in increased expression of TYR mRNA

NCBI chr 1:150,527,687...150,622,857
Ensembl chr 1:150,527,687...150,622,857

G

ubiquitin C-terminal hydrolase L1

multiple interactions

ISO

[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of UCHL1 mRNA

NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,838,861...41,849,417

G

UDP glucuronosyltransferase family 1 member A1

increases glucuronidation
increases activity

ISO

UGT1A1 protein results in increased glucuronidation of daidzein
daidzein results in increased activity of UGT1A1 protein

PMID:14557274 PMID:16051636

NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264

G

UDP glucuronosyltransferase family 1 member A9

increases glucuronidation

ISO

UGT1A9 protein results in increased glucuronidation of daidzein

NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264

G

UDP glucuronosyltransferase 2 family, polypeptide B1

increases expression

ISO

daidzein results in increased expression of UGT2B17 mRNA

NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,378,853...21,392,331

G

vascular cell adhesion molecule 1

multiple interactions

ISO

ESR2 gene polymorphism affects the reaction [[Genistein co-treated with daidzein] affects the expression of VCAM1 protein]

NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801

G

valosin containing protein interacting protein 1

multiple interactions

ISO

[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of VCPIP1 mRNA

NCBI chr 5:14,317,083...14,343,724
Ensembl chr 5:14,316,918...14,347,778

dibutyl phthalate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RIKEN cDNA 2510039O18 gene like

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KIAA2013 mRNA

NCBI chr 5:163,655,082...163,661,346
Ensembl chr 5:163,655,106...163,661,660

G

RIKEN cDNA 6430548M08 gene like

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of 6430548M08RIKL mRNA

NCBI chr19:65,076,626...65,125,185
Ensembl chr19:65,077,790...65,125,177

G

alpha-1-B glycoprotein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of A1BG protein

NCBI chr 7:94,383,333...94,387,922
Ensembl chr 7:94,383,333...94,387,496

G

alpha 1,4-galactosyltransferase

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of A4GALT mRNA

NCBI chr 7:116,248,571...116,272,917
Ensembl chr 7:116,247,880...116,273,171

G

aladin WD repeat nucleoporin

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AAAS mRNA

NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:135,342,901...135,362,545

G

acetoacetyl-CoA synthetase

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of AACS mRNA
Dibutyl Phthalate results in increased expression of AACS mRNA

PMID:17361019 PMID:21266533

NCBI chr12:36,774,471...36,817,835
Ensembl chr12:36,774,471...36,822,543

G

AADACL2 family member 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of AADACL2FM3 mRNA

NCBI chr 2:146,086,384...146,125,291
Ensembl chr 2:146,086,384...146,125,291

G

alanine and arginine rich domain containing protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AARD mRNA

NCBI chr 7:85,254,322...85,259,163
Ensembl chr 7:85,253,992...85,259,163

G

alanyl-tRNA synthetase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AARS1 mRNA

NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497

G

apoptosis antagonizing transcription factor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AATF mRNA

NCBI chr10:69,796,502...69,889,671
Ensembl chr10:69,794,007...69,889,634

G

4-aminobutyrate aminotransferase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ABAT mRNA

NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474

G

ATP binding cassette subfamily A member 1

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of ABCA1 mRNA; Dibutyl Phthalate results in decreased expression of ABCA1 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ABCA1 mRNA
MIR200C mRNA affects the reaction [Dibutyl Phthalate results in decreased expression of ABCA1 protein]

PMID:32417575 PMID:39150890

NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473

G

ATP binding cassette subfamily A member 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of ABCA6 mRNA

NCBI chr10:95,642,026...95,711,535
Ensembl chr10:95,641,900...95,710,899

G

ATP binding cassette subfamily B member 10

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ABCB10 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:68,850,108...68,881,689
Ensembl chr19:68,850,134...68,880,203

G

ATP binding cassette subfamily C member 2

multiple interactions

ISO

[dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of ABCC2 mRNA

NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471

G

ATP binding cassette subfamily C member 3

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of ABCC3 mRNA
[dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of ABCC3 mRNA

NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494

G

ATP binding cassette subfamily C member 4

multiple interactions
increases expression

EXP
ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ABCC4 promoter
[dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of ABCC4 mRNA
Dibutyl Phthalate results in increased expression of ABCC4 mRNA

PMID:23359474 PMID:35739735

NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375

G

ATP binding cassette subfamily C member 5

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ABCC5 mRNA
Dibutyl Phthalate results in decreased expression of ABCC5 mRNA

NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655

G

ATP binding cassette subfamily C member 6

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of ABCC6 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ABCC6 promoter

PMID:21266533 PMID:23359474

NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895

G

ATP binding cassette subfamily F member 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ABCF1 mRNA

NCBI chr20:2,807,315...2,820,240
Ensembl chr20:2,807,106...2,820,240

G

ATP binding cassette subfamily G member 1

increases expression
multiple interactions
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ABCG1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ABCG1 mRNA
Dibutyl Phthalate results in decreased expression of ABCG1 mRNA

PMID:21266533 PMID:32417575 PMID:39150890

NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563

G

ATP binding cassette subfamily G member 2

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of ABCG2 mRNA
[dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of ABCG2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ABCG2 mRNA

PMID:17361019 PMID:21266533 PMID:31199487 PMID:35739735

NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493

G

ATP binding cassette subfamily G member 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ABCG4 mRNA

NCBI chr 8:53,508,005...53,525,314
Ensembl chr 8:53,508,005...53,523,571

G

ATP binding cassette subfamily G member 5

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ABCG5 mRNA

NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376

G

abhydrolase domain containing 11

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ABHD11 mRNA

NCBI chr12:27,318,739...27,322,016
Ensembl chr12:27,318,749...27,321,970

G

abhydrolase domain containing 12, lysophospholipase

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ABHD12 mRNA
Dibutyl Phthalate results in decreased expression of ABHD12 mRNA

NCBI chr 3:160,119,724...160,179,959
Ensembl chr 3:160,119,724...160,179,969

G

abhydrolase domain containing 14A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ABHD14A mRNA

NCBI chr 8:115,957,853...115,965,697
Ensembl chr 8:115,957,858...115,965,697

G

abhydrolase domain containing 14b

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ABHD14B mRNA

NCBI chr 8:115,966,792...115,970,829
Ensembl chr 8:115,965,932...115,970,833

G

abhydrolase domain containing 17A, depalmitoylase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ABHD17A mRNA

NCBI chr 7:9,775,016...9,781,447

G

abhydrolase domain containing 3, phospholipase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ABHD3 mRNA

NCBI chr18:1,996,010...2,051,311
Ensembl chr18:1,993,525...2,075,492

G

abhydrolase domain containing 6, acylglycerol lipase

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of ABHD6 mRNA

NCBI chr15:19,289,967...19,337,500
Ensembl chr15:19,289,969...19,337,193

G

abhydrolase domain containing 8

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ABHD8 mRNA

NCBI chr16:18,178,441...18,185,178
Ensembl chr16:18,178,441...18,191,638

G

ABI family, member 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of ABI3 mRNA

NCBI chr10:81,266,571...81,277,561
Ensembl chr10:81,266,571...81,277,561

G

ABI family member 3 binding protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ABI3BP mRNA

PMID:21266533 PMID:31841868

NCBI chr11:57,381,282...57,597,989
Ensembl chr11:57,381,422...57,598,120

G

ABR activator of RhoGEF and GTPase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ABR mRNA

NCBI chr10:61,760,743...61,959,526
Ensembl chr10:61,760,743...61,959,467

G

ankyrin repeat and BTB domain containing 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of ABTB2 mRNA

NCBI chr 3:110,409,672...110,563,488
Ensembl chr 3:110,409,627...110,563,487

G

acetyl-CoA acyltransferase 1A

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of ACAA1 mRNA
[PPARA protein affects the susceptibility to Dibutyl Phthalate] which results in increased expression of ACAA1A mRNA; [PPARA protein affects the susceptibility to Dibutyl Phthalate] which results in increased expression of ACAA1A protein
Dibutyl Phthalate results in increased expression of ACAA1A mRNA; Dibutyl Phthalate results in increased expression of ACAA1A protein

PMID:21266533 PMID:22792086

NCBI chr 8:127,956,126...127,966,348
Ensembl chr 8:127,956,129...127,966,241

G

acetyl-CoA acyltransferase 2

increases expression
multiple interactions
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ACAA2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACAA2 mRNA
Dibutyl Phthalate results in decreased expression of ACAA2 mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420

G

acetyl-CoA carboxylase alpha

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACACA mRNA

NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888

G

acyl-CoA dehydrogenase family, member 10

affects expression

EXP

Dibutyl Phthalate affects the expression of ACAD10 mRNA

NCBI chr12:40,561,900...40,604,378
Ensembl chr12:40,566,701...40,604,378

G

acyl-CoA dehydrogenase family, member 9

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of ACAD9 mRNA
Dibutyl Phthalate results in increased expression of ACAD9 mRNA

NCBI chr 2:120,871,329...120,894,306
Ensembl chr 2:120,871,227...120,894,709

G

acyl-CoA dehydrogenase, long chain

increases expression

EXP

Dibutyl Phthalate results in increased expression of ACADL mRNA

NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164

G

acyl-CoA dehydrogenase medium chain

increases expression

ISO

Dibutyl Phthalate results in increased expression of ACADM mRNA

NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864

G

acyl-CoA dehydrogenase short chain

increases expression

EXP

Dibutyl Phthalate results in increased expression of ACADS mRNA

PMID:17379624 PMID:21266533

NCBI chr12:47,154,259...47,163,580
Ensembl chr12:47,154,276...47,164,103

G

acyl-CoA dehydrogenase, very long chain

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of ACADVL mRNA
Dibutyl Phthalate results in increased expression of ACADVL protein
[PPARA protein affects the susceptibility to Dibutyl Phthalate] which results in increased expression of ACADVL protein

PMID:21266533 PMID:22792086

NCBI chr10:55,231,558...55,236,786
Ensembl chr10:55,231,440...55,236,750

G

ArfGAP with coiled-coil, ankyrin repeat and PH domains 3

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ACAP3 promoter

NCBI chr 5:171,783,382...171,797,709
Ensembl chr 5:171,783,382...171,798,191

G

acetyl-CoA acetyltransferase 1

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ACAT1 mRNA
Dibutyl Phthalate results in decreased expression of ACAT1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042

G

acetyl-CoA acetyltransferase 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of ACAT2 mRNA

NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095

G

acyl-CoA binding domain containing 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of ACBD3 mRNA

NCBI chr13:94,987,643...95,016,356
Ensembl chr13:94,987,541...95,016,355

G

ACD, shelterin complex subunit and telomerase recruitment factor

increases expression

EXP

Dibutyl Phthalate results in increased expression of ACD mRNA

NCBI chr19:50,496,634...50,499,397
Ensembl chr19:50,496,635...50,499,326

G

ATP citrate lyase

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of ACLY mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA

PMID:17379624 PMID:35739755

NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631

G

aminocarboxymuconate semialdehyde decarboxylase

multiple interactions

EXP

Dibutyl Phthalate affects the reaction [ACMSD protein affects the abundance of Niacin]

NCBI chr13:41,752,894...41,798,427
Ensembl chr13:41,752,875...41,798,427

G

aconitase 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ACO2 mRNA

NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892

G

acyl-CoA thioesterase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of ACOT1 mRNA

NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749

G

acyl-CoA thioesterase 13

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ACOT13 mRNA

NCBI chr17:40,668,404...40,680,876
Ensembl chr17:40,668,316...40,680,876

G

acyl-CoA thioesterase 2

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of ACOT2 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ACOT2 protein

PMID:21266533 PMID:38995844

NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:109,342,646...109,350,502

G

acyl-CoA thioesterase 9

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ACOT9 mRNA

NCBI chr X:43,922,943...43,973,311
Ensembl chr X:43,914,923...43,973,205

G

acyl-CoA oxidase 1

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of ACOX1 mRNA; [Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of ACOX1 protein

PMID:35739755 PMID:38285958

NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136

G

acyl-CoA oxidase-like

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ACOXL promoter

NCBI chr 3:135,514,340...135,820,291
Ensembl chr 3:135,514,275...135,820,291

G

acid phosphatase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ACP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:53,233,937...53,249,576
Ensembl chr 6:53,233,948...53,251,959

G

acrosomal vesicle protein 1

affects expression

ISO

Dibutyl Phthalate affects the expression of ACRV1 mRNA

NCBI chr 8:44,593,246...44,598,823
Ensembl chr 8:44,592,344...44,599,019

G

acyl-CoA synthetase bubblegum family member 1

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of ACSBG1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSBG1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 8:63,887,433...63,943,486
Ensembl chr 8:63,887,435...63,984,178

G

acyl-CoA synthetase family member 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSF2 mRNA

NCBI chr10:80,001,389...80,043,796
Ensembl chr10:80,001,389...80,045,050

G

acyl-CoA synthetase long-chain family member 4

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ACSL4 mRNA
Dibutyl Phthalate results in decreased expression of ACSL4 mRNA

NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261

G

acyl-CoA synthetase long-chain family member 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of ACSL6 mRNA

NCBI chr10:38,940,668...38,999,515
Ensembl chr10:38,940,747...39,002,873

G

acyl-CoA synthetase medium-chain family member 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ACSM3 mRNA

NCBI chr 1:183,564,652...183,591,328
Ensembl chr 1:183,564,635...183,591,437

G

acyl-CoA synthetase short-chain family member 1

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of ACSS1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSS1 mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:159,910,809...159,960,748

G

acyl-CoA synthetase short-chain family member 2

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ACSS2 mRNA
Dibutyl Phthalate results in increased expression of ACSS2 mRNA

NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830

G

actin alpha 2, smooth muscle

increases expression
multiple interactions
decreases expression
affects expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ACTA2 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACTA2 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACTA2 protein
Dibutyl Phthalate results in decreased expression of ACTA2 mRNA; Dibutyl Phthalate results in decreased expression of ACTA2 protein
[Nanotubes, Carbon co-treated with Dibutyl Phthalate] results in increased expression of ACTA2 mRNA; Y 27632 affects the reaction [Dibutyl Phthalate affects the expression of ACTA2 mRNA]; Y 27632 affects the reaction [Dibutyl Phthalate affects the expression of ACTA2 protein]; Y 27632 inhibits the reaction [Dibutyl Phthalate results in increased expression of ACTA2 mRNA]; Y 27632 inhibits the reaction [Dibutyl Phthalate results in increased expression of ACTA2 protein]
Dibutyl Phthalate affects the expression of ACTA2 mRNA; Dibutyl Phthalate affects the expression of ACTA2 protein
Dibutyl Phthalate results in increased expression of ACTA2 mRNA; Dibutyl Phthalate results in increased expression of ACTA2 protein

PMID:17361019 PMID:21266533 PMID:28415704 PMID:28919491 PMID:32860865 More...

NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503

G

actin, beta

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ACTB mRNA

NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242

G

actin, gamma 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ACTG1 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951

G

actin gamma 2, smooth muscle

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of ACTG2 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ACTG2 promoter

PMID:17361019 PMID:21266533 PMID:23359474

NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295

G

actin-like 6A

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of ACTL6A mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ACTL6A promoter

PMID:21266533 PMID:23359474

NCBI chr 2:117,413,206...117,436,758
Ensembl chr 2:117,418,601...117,436,754

G

actinin, alpha 1

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of ACTN1 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ACTN1 mRNA

PMID:21266533 PMID:25607892

NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172

G

actinin alpha 3

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ACTN3 promoter

NCBI chr 1:211,588,473...211,604,401
Ensembl chr 1:211,588,474...211,604,401

G

actinin alpha 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of ACTN4 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:93,310,278...93,379,320

G

actin related protein 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ACTR2 mRNA

NCBI chr14:98,500,119...98,535,092
Ensembl chr14:98,500,138...98,541,998

G

actin related protein 3

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ACTR3 mRNA

NCBI chr13:39,353,413...39,396,509
Ensembl chr13:39,353,079...39,396,711

G

activin A receptor type 2A

increases expression

EXP

Dibutyl Phthalate results in increased expression of ACVR2A mRNA

NCBI chr 3:53,614,143...53,701,933
Ensembl chr 3:53,614,171...53,701,941

G

aminoacylase 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ACY1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:115,951,068...115,956,405

G

adenosine deaminase

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ADA mRNA
Dibutyl Phthalate results in increased expression of ADA mRNA

PMID:17361019 PMID:21266533 PMID:24893172

NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293

G

ADAM metallopeptidase domain 19

increases expression

EXP

Dibutyl Phthalate results in increased expression of ADAM19 mRNA

NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,992,754...31,084,455

G

ADAM metallopeptidase domain 33

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADAM33 mRNA

NCBI chr 3:138,715,428...138,736,392
Ensembl chr 3:138,724,046...138,736,347

G

ADAM metallopeptidase domain 6A

increases expression

ISO

Dibutyl Phthalate results in increased expression of ADAM6A mRNA

NCBI chr 6:138,488,008...138,490,496
Ensembl chr 6:138,488,008...138,490,493

G

ADAM metallopeptidase domain 9

increases expression

ISO

Dibutyl Phthalate results in increased expression of ADAM9 mRNA

PMID:17361019 PMID:21266533

NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646

G

ADAM metallopeptidase with thrombospondin type 1 motif, 1

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of ADAMTS1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein affects the expression of ADAMTS1 mRNA]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]

PMID:17361019 PMID:21266533 PMID:33316053 PMID:37552060

NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390

G

ADAM metallopeptidase with thrombospondin type 1 motif, 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ADAMTS2 mRNA

NCBI chr10:35,422,030...35,627,483
Ensembl chr10:35,422,030...35,627,483

G

adenosine deaminase, RNA-specific

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of ADAR mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of ADAR mRNA

PMID:21266533 PMID:28611354

NCBI chr 2:177,436,076...177,475,969
Ensembl chr 2:177,436,094...177,475,971

G

adenosine deaminase, RNA-specific, B1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ADARB1 mRNA

NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,164...11,350,415

G

aarF domain containing kinase 5

increases expression

EXP

Dibutyl Phthalate results in increased expression of ADCK5 mRNA

NCBI chr 7:110,182,275...110,200,088
Ensembl chr 7:110,181,981...110,200,088

G

adenylate cyclase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADCY3 mRNA

NCBI chr 6:32,819,602...32,923,174
Ensembl chr 6:32,843,961...32,923,173

G

adenylate cyclase 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of ADCY4 mRNA

NCBI chr15:33,236,201...33,252,070
Ensembl chr15:33,236,208...33,252,026

G

adenylate cyclase 5

increases expression

ISO

Dibutyl Phthalate results in increased expression of ADCY5 mRNA

NCBI chr11:78,976,861...79,123,343
Ensembl chr11:78,976,861...79,123,343

G

adenylate cyclase 6

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADCY6 mRNA

NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:131,621,860...131,642,770

G

adenylate cyclase 9

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADCY9 mRNA

NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,645,282...11,765,792

G

ADCYAP receptor type I

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ADCYAP1R1 mRNA

NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:85,924,100...85,972,973

G

adducin 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADD3 mRNA

NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504

G

adhesion G protein-coupled receptor A1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADGRA1 mRNA

NCBI chr 1:204,059,218...204,102,869
Ensembl chr 1:204,059,367...204,102,869

G

adhesion G protein-coupled receptor B1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ADGRB1 mRNA

NCBI chr 7:108,293,681...108,365,892
Ensembl chr 7:108,293,818...108,365,870

G

adhesion G protein-coupled receptor D1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ADGRD1 mRNA

NCBI chr12:33,124,981...33,239,778
Ensembl chr12:33,125,915...33,272,509

G

adhesion G protein-coupled receptor L1

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of ADGRL1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ADGRL1 mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr19:41,107,162...41,148,752
Ensembl chr19:41,109,117...41,148,896

G

adhesion G protein-coupled receptor L2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ADGRL2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:240,356,176...240,987,246
Ensembl chr 2:240,356,177...240,855,933

G

alcohol dehydrogenase 1C (class I), gamma polypeptide

multiple interactions

ISO

[Dibutyl Phthalate results in increased abundance of monobutyl phthalate] which affects the expression of ADH1 mRNA

NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291

G

alcohol dehydrogenase 5 (class III), chi polypeptide

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ADH5 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:229,648,557...229,660,964
Ensembl chr 2:229,648,501...229,665,232

G

alcohol dehydrogenase 6A (class V)

increases expression

EXP

Dibutyl Phthalate results in increased expression of ADH6A mRNA

NCBI chr 2:229,497,121...229,519,403
Ensembl chr 2:229,497,173...229,519,401

G

acireductone dioxygenase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADI1 mRNA

NCBI chr 6:51,035,267...51,042,229
Ensembl chr 6:51,034,931...51,042,855

G

adiponectin, C1Q and collagen domain containing

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of ADIPOQ mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of ADIPOQ protein

PMID:37021957 PMID:38954831

NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169

G

adiponectin receptor 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ADIPOR1 mRNA

NCBI chr13:48,411,438...48,431,251
Ensembl chr13:48,411,826...48,431,255

G

adiponectin receptor 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADIPOR2 mRNA

NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:154,172,567...154,231,666

G

adenosine kinase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ADK mRNA

NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,912,544...3,295,745

G

activity-dependent neuroprotector homeobox

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADNP mRNA

NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:177,310,258...177,336,188

G

2-aminoethanethiol dioxygenase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ADO mRNA

NCBI chr20:21,043,694...21,044,862
Ensembl chr20:21,043,317...21,048,483

G

adenosine A1 receptor

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ADORA1 mRNA
Dibutyl Phthalate results in decreased expression of ADORA1 mRNA

PMID:15620428 PMID:17361019 PMID:21266533

NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190

G

adenosine A2a receptor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADORA2A mRNA

NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802

G

adrenoceptor alpha 1A

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of ADRA1A mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ADRA1A promoter

PMID:15620428 PMID:23359474

NCBI chr15:45,005,648...45,111,416
Ensembl chr15:45,005,799...45,102,534

G

adrenoceptor alpha 2B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ADRA2B mRNA

NCBI chr 3:135,038,481...135,042,527
Ensembl chr 3:135,038,474...135,042,525

G

adrenoceptor beta 3

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of ADRB3 mRNA

NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420

G

ADRM1 26S proteasome ubiquitin receptor

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ADRM1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:187,642,654...187,648,483

G

adenylosuccinate lyase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ADSL mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:114,359,440...114,383,618
Ensembl chr 7:114,359,440...114,384,872

G

androgen-dependent TFPI-regulating protein

increases expression

EXP

Dibutyl Phthalate results in increased expression of ADTRP mRNA

NCBI chr17:23,113,578...23,199,616
Ensembl chr17:23,135,809...23,216,622

G

AE binding protein 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AEBP1 mRNA

NCBI chr14:84,951,577...84,962,840
Ensembl chr14:84,952,822...84,962,843

G

apoptosis enhancing nuclease

increases expression

EXP

Dibutyl Phthalate results in increased expression of AEN mRNA

NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898

G

actin filament associated protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of AFAP1 mRNA

NCBI chr14:78,967,961...79,081,032
Ensembl chr14:78,967,961...79,080,939

G

ALF transcription elongation factor 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AFF2 mRNA

NCBI chr X:152,972,579...153,477,080
Ensembl chr X:152,972,581...153,477,080

G

ALF transcription elongation factor 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AFF3 mRNA

NCBI chr 9:47,894,903...48,352,380
Ensembl chr 9:47,894,903...48,353,000

G

ALF transcription elongation factor 4

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of AFF4 mRNA
Dibutyl Phthalate results in increased expression of AFF4 mRNA

NCBI chr10:37,998,319...38,080,580
Ensembl chr10:37,999,579...38,080,580

G

arylformamidase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AFMID mRNA

NCBI chr10:103,544,822...103,560,408
Ensembl chr10:103,544,841...103,560,408

G

alpha-fetoprotein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AFP mRNA

NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649

G

aspartylglucosaminidase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AGA mRNA

PMID:17361019 PMID:21266533

NCBI chr16:45,191,215...45,249,537
Ensembl chr16:45,223,339...45,249,551

G

ArfGAP with GTPase domain, ankyrin repeat and PH domain 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of AGAP3 mRNA

NCBI chr 4:11,567,191...11,617,610
Ensembl chr 4:11,567,191...11,617,285

G

ArfGAP with FG repeats 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of AGFG1 mRNA

NCBI chr 9:91,572,962...91,630,688
Ensembl chr 9:91,573,157...91,626,910

G

acylglycerol kinase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AGK mRNA

PMID:17361019 PMID:21266533

NCBI chr 4:70,081,550...70,160,642
Ensembl chr 4:70,081,035...70,160,709

G

argonaute RISC catalytic component 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AGO2 mRNA

NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980

G

angiotensin II receptor, type 1a

increases expression

ISO

Dibutyl Phthalate results in increased expression of AGTR1 protein

NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660

G

angiotensin II receptor-associated protein

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of AGTRAP mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:163,790,565...163,802,174
Ensembl chr 5:163,791,887...163,802,174

G

adenosylhomocysteinase-like 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AHCYL2 mRNA

NCBI chr 4:59,348,747...59,498,503
Ensembl chr 4:59,348,217...59,498,502

G

AHNAK nucleoprotein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AHNAK mRNA

NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:215,321,931...215,400,675

G

aryl hydrocarbon receptor

affects activity
increases expression
affects expression
decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate affects the activity of AHR protein
Dibutyl Phthalate results in increased expression of AHR mRNA; Dibutyl Phthalate results in increased expression of AHR protein
Dibutyl Phthalate affects the expression of AHR protein
Dibutyl Phthalate results in decreased expression of AHR mRNA
Dibutyl Phthalate binds to and results in increased activity of AHR protein

PMID:18294747 PMID:23220035 PMID:24893172 PMID:27581038

NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901

G

alpha hemoglobin stabilizing protein

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of AHSP mRNA
Dibutyl Phthalate results in increased expression of AHSP mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:192,310,306...192,315,943
Ensembl chr 1:192,310,244...192,315,942

G

AIF family member 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AIFM2 mRNA

NCBI chr20:30,195,781...30,222,014
Ensembl chr20:30,193,829...30,220,957

G

androgen-induced 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of AIG1 mRNA

NCBI chr 1:9,866,546...10,089,454
Ensembl chr 1:9,866,548...10,089,155

G

aryl-hydrocarbon receptor-interacting protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AIP mRNA

NCBI chr 1:210,837,473...210,848,691
Ensembl chr 1:210,836,755...210,848,634

G

ajuba LIM protein

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of AJUBA mRNA

PMID:17361019 PMID:21266533

NCBI chr15:31,989,796...32,000,042
Ensembl chr15:31,989,799...32,000,042

G

adenylate kinase 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of AK2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610

G

adenylate kinase 5

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of AK5 mRNA

NCBI chr 2:244,057,240...244,241,372
Ensembl chr 2:244,057,240...244,241,366

G

A-kinase anchoring protein 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of AKAP1 mRNA

NCBI chr10:74,118,232...74,151,366
Ensembl chr10:74,119,124...74,138,190

G

A-kinase anchoring protein 12

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AKAP12 mRNA

NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557

G

A-kinase anchoring protein 13

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of AKAP13 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:138,722,445...139,029,401
Ensembl chr 1:138,724,150...139,029,401

G

A-kinase anchoring protein 17A

multiple interactions
increases expression

EXP
ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of AKAP17A promoter
Dibutyl Phthalate results in increased expression of AKAP17B mRNA

PMID:21266533 PMID:23359474

NCBI chr12:21,424,202...21,428,308
Ensembl chr12:21,424,202...21,428,247

G

A-kinase anchoring protein 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AKAP4 mRNA

NCBI chr X:18,107,256...18,117,549
Ensembl chr X:18,107,275...18,117,549

G

A-kinase anchoring protein 5

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AKAP5 mRNA

NCBI chr 6:100,787,169...100,796,712
Ensembl chr 6:100,790,148...100,796,620

G

A-kinase anchoring protein 7

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AKAP7 mRNA

NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:21,906,676...22,037,090

G

A-kinase interacting protein 1

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of AKIP1 mRNA
Dibutyl Phthalate results in decreased expression of AKIP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:173,169,520...173,178,445
Ensembl chr 1:173,169,458...173,178,445

G

aldo-keto reductase family 1 member B1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AKR1B1 mRNA

NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315

G

aldo-keto reductase family 1 member B15

increases expression

EXP

Dibutyl Phthalate results in increased expression of AKR1B8 mRNA

NCBI chr 4:63,964,421...63,976,995
Ensembl chr 4:63,960,880...63,978,349

G

aldo-keto reductase family 1, member B7

increases expression

EXP

Dibutyl Phthalate results in increased expression of AKR1B7 mRNA

NCBI chr 4:64,043,901...64,083,751
Ensembl chr 4:64,020,686...64,064,909

G

aldo-keto reductase family 1, member C1

increases expression

ISO

Dibutyl Phthalate results in increased expression of AKR1C1 mRNA

NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247

G

aldo-keto reductase family 1, member C14

decreases expression
decreases activity

EXP

Dibutyl Phthalate results in decreased expression of AKR1C14 mRNA
Dibutyl Phthalate results in decreased activity of AKR1C14 protein

NCBI chr17:71,066,197...71,083,184
Ensembl chr17:71,066,200...71,083,157

G

aldo-keto reductase family 1, member C19

increases expression

EXP

Dibutyl Phthalate results in increased expression of AKR1C19 mRNA

NCBI chr17:70,913,916...70,934,959
Ensembl chr17:70,919,236...70,934,959

G

aldo-keto reductase family 1, member C3

increases expression

EXP

Dibutyl Phthalate results in increased expression of AKR1C18 mRNA

NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438

G

aldo-keto reductase family 1 member C3-like 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of AKR1C3L1 mRNA

NCBI chr17:70,745,496...70,791,411
Ensembl chr17:70,745,496...70,791,322

G

aldo-keto reductase family 7, member A2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of AKR7A2 mRNA
Dibutyl Phthalate results in decreased expression of AKR7A5 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109

G

aldo-keto reductase family 7 member A3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AKR7A3 mRNA

NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153

G

AKT serine/threonine kinase 1

multiple interactions
increases phosphorylation
decreases phosphorylation
decreases expression

ISO
EXP

HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of AKT1 protein]
Dibutyl Phthalate results in decreased phosphorylation of AKT1 protein
Dibutyl Phthalate results in decreased expression of AKT1 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased phosphorylation of AKT1 protein; AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in decreased phosphorylation of AKT1 protein]; AKT1 protein affects the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in decreased expression of BCL2 protein]]; AKT1 protein affects the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in decreased phosphorylation of MTOR protein]]; AKT1 protein affects the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased cleavage of CASP3 protein]]; AKT1 protein affects the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased expression of BAX protein]]; AKT1 protein affects the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased expression of H2AX protein]]; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in decreased expression of AKT1 mRNA]; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of AKT1 protein]; ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of AKT1 mRNA]; ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in decreased phosphorylation of AKT1 protein]; MK 2206 inhibits the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in decreased phosphorylation of AKT1 protein]]; PTEN protein affects the reaction [Dibutyl Phthalate results in decreased phosphorylation of AKT1 protein]

PMID:22552774 PMID:30952838 PMID:31841868 PMID:33091774 PMID:33331133 More...

NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610

G

AKT serine/threonine kinase 2

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased phosphorylation of AKT2 protein

NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420

G

AKT serine/threonine kinase 3

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased phosphorylation of AKT3 protein

NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020

G

aminolevulinate dehydratase

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of ALAD mRNA
[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of ALAD protein

PMID:21266533 PMID:34864091

NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041

G

5'-aminolevulinate synthase 1

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of ALAS1 mRNA
Dibutyl Phthalate results in decreased expression of ALAS1 mRNA

PMID:17379624 PMID:21266533 PMID:21745491

NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:115,755,238...115,768,642

G

5'-aminolevulinate synthase 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ALAS2 mRNA

PMID:21266533 PMID:32028152

NCBI chr X:22,890,650...22,914,046
Ensembl chr X:22,890,689...22,914,043

G

activated leukocyte cell adhesion molecule

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ALCAM mRNA
Dibutyl Phthalate results in increased expression of ALCAM mRNA

PMID:17361019 PMID:21266533

NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876

G

aldehyde dehydrogenase 16 family, member A1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ALDH16A1 mRNA

NCBI chr 1:104,763,200...104,776,270
Ensembl chr 1:104,763,055...104,776,270

G

aldehyde dehydrogenase 1 family, member A1

multiple interactions

ISO

[Dibutyl Phthalate results in increased abundance of monobutyl phthalate] which affects the expression of ALDH1A1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDH1A1 mRNA

PMID:30768133 PMID:34175954

NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500

G

aldehyde dehydrogenase 1 family, member A2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ALDH1A2 mRNA

NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883

G

aldehyde dehydrogenase 1 family, member A3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ALDH1A3 mRNA

NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777

G

aldehyde dehydrogenase 1 family, member B1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ALDH1B1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365

G

aldehyde dehydrogenase 1 family, member L1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ALDH1L1 mRNA

PMID:21266533 PMID:21745491

NCBI chr 4:124,617,182...124,663,674
Ensembl chr 4:124,617,217...124,664,704

G

aldehyde dehydrogenase 2 family member

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ALDH2 mRNA

PMID:17379624 PMID:21266533 PMID:21745491

NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219

G

aldehyde dehydrogenase 3 family, member A2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ALDH3A2 mRNA

NCBI chr10:46,427,789...46,448,449
Ensembl chr10:46,407,993...46,448,648

G

aldehyde dehydrogenase 5 family, member A1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ALDH5A1 mRNA

PMID:17361019 PMID:21266533

NCBI chr17:40,560,373...40,586,711
Ensembl chr17:40,558,347...40,586,714

G

aldehyde dehydrogenase 6 family, member A1

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of ALDH6A1 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ALDH6A1 promoter

PMID:21266533 PMID:23359474

NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:109,809,122...109,829,743

G

aldehyde dehydrogenase 7 family, member A1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ALDH7A1 mRNA

NCBI chr18:52,208,035...52,240,293
Ensembl chr18:52,204,161...52,240,467

G

aldehyde dehydrogenase 9 family, member A1

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ALDH9A1 mRNA
Dibutyl Phthalate results in decreased expression of ALDH9A1 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:82,038,679...82,055,478
Ensembl chr13:82,038,533...82,055,481

G

aldolase, fructose-bisphosphate A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ALDOA mRNA

PMID:17379624 PMID:21266533

NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211

G

aldolase, fructose-bisphosphate B

increases expression

EXP

Dibutyl Phthalate results in increased expression of ALDOB mRNA

NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:68,684,542...68,716,740

G

aldolase, fructose-bisphosphate C

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of ALDOC mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDOC protein

PMID:21266533 PMID:31199487 PMID:37690569

NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133

G

ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ALG1 mRNA

NCBI chr10:10,853,014...10,863,250
Ensembl chr10:10,853,014...10,863,239

G

ALG11, alpha-1,2-mannosyltransferase

increases expression

EXP

Dibutyl Phthalate results in increased expression of ALG11 mRNA

NCBI chr16:76,642,979...76,654,052
Ensembl chr16:76,646,795...76,654,040

G

ALG13, UDP-N-acetylglucosaminyltransferase subunit

increases expression

EXP

Dibutyl Phthalate results in increased expression of ALG13 mRNA

NCBI chr X:112,703,015...112,764,924
Ensembl chr X:112,702,796...112,739,356

G

ALG2, alpha-1,3/1,6-mannosyltransferase

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of ALG2 mRNA

NCBI chr 5:66,564,328...66,568,887
Ensembl chr 5:66,564,330...66,568,887

G

ALG8, alpha-1,3-glucosyltransferase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ALG8 mRNA

NCBI chr 1:161,095,570...161,115,533
Ensembl chr 1:161,095,412...161,115,527

G

alkB homolog 2, alpha-ketoglutarate-dependent dioxygenase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ALKBH2 mRNA

NCBI chr12:48,156,825...48,161,489
Ensembl chr12:48,156,827...48,161,483

G

alkB homolog 3, alpha-ketoglutarate-dependent dioxygenase

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of ALKBH3 mRNA
Dibutyl Phthalate results in increased expression of ALKBH3 mRNA

NCBI chr 3:100,394,942...100,429,466
Ensembl chr 3:100,380,273...100,427,294

G

alkB homolog 4, lysine demethylase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ALKBH4 mRNA

NCBI chr12:26,160,643...26,166,560
Ensembl chr12:26,160,643...26,166,560

G

alkB homolog 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ALKBH6 mRNA

NCBI chr 1:94,690,979...94,696,429
Ensembl chr 1:94,691,822...94,696,427

G

alkB homolog 7

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ALKBH7 mRNA

NCBI chr 9:1,925,896...1,928,048
Ensembl chr 9:1,925,743...1,928,048

G

allantoicase

increases expression

EXP

Dibutyl Phthalate results in increased expression of ALLC mRNA

NCBI chr 6:50,907,575...50,942,665
Ensembl chr 6:50,907,580...50,942,614

G

alkaline phosphatase, biomineralization associated

multiple interactions
increases expression

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ALPL protein
Dibutyl Phthalate results in increased expression of ALPL protein

PMID:33167028 PMID:35739755

NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167

G

alpha-methylacyl-CoA racemase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of AMACR mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:61,673,291...61,685,381
Ensembl chr 2:61,670,475...61,685,379

G

adenosylmethionine decarboxylase 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of AMD1 mRNA

NCBI chr20:45,250,289...45,324,939
Ensembl chr20:45,250,289...45,265,982

G

APC membrane recruitment protein 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of AMER3 mRNA

NCBI chr 9:44,286,274...44,298,246
Ensembl chr 9:44,268,722...44,351,398

G

anti-Mullerian hormone

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of AMH mRNA; Dibutyl Phthalate results in increased expression of AMH protein
[butylbenzyl phthalate co-treated with Dibutyl Phthalate] results in decreased expression of AMH mRNA; Dibutyl Phthalate promotes the reaction [4-vinyl-1-cyclohexene dioxide results in decreased expression of AMH protein]

PMID:17379624 PMID:21266533 PMID:29969652 PMID:36215882

NCBI chr 7:9,557,451...9,559,867
Ensembl chr 7:9,557,451...9,559,867

G

anti-Mullerian hormone receptor type 2

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of AMHR2 mRNA
Dibutyl Phthalate results in decreased expression of AMHR2 mRNA

NCBI chr 7:135,454,517...135,470,183
Ensembl chr 7:135,457,922...135,471,104

G

adhesion molecule with Ig like domain 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AMIGO2 mRNA

NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218

G

AMMECR1 like

increases expression

EXP

Dibutyl Phthalate results in increased expression of AMMECR1L mRNA

NCBI chr18:23,661,649...23,685,391
Ensembl chr18:23,661,341...23,685,649

G

antagonist of mitotic exit network 1 homolog

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of AMN1 promoter

NCBI chr 4:183,886,469...183,913,411
Ensembl chr 4:183,886,474...183,913,411

G

angiomotin like 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of AMOTL2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:112,182,060...112,198,032
Ensembl chr 8:112,181,863...112,198,030

G

adenosine monophosphate deaminase 3

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of AMPD3 mRNA

NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:174,294,867...174,364,608

G

archaelysin family metallopeptidase 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of AMZ2 promoter

NCBI chr10:94,901,053...94,911,629
Ensembl chr10:94,901,129...94,911,627

G

anaphase promoting complex subunit 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ANAPC1 mRNA

NCBI chr 3:136,303,350...136,383,464
Ensembl chr 3:136,303,413...136,383,464

G

anaphase promoting complex subunit 11

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ANAPC11 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:106,373,610...106,384,633
Ensembl chr10:106,373,634...106,384,633

G

anaphase promoting complex subunit 16

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ANAPC16 mRNA

NCBI chr20:28,470,282...28,484,601
Ensembl chr20:28,470,282...28,484,987

G

anaphase-promoting complex subunit 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ANAPC5 mRNA

NCBI chr12:39,409,519...39,442,518
Ensembl chr12:39,385,399...39,442,762

G

angiopoietin 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of ANGPT2 protein

NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239

G

angiopoietin-like 3

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of ANGPTL3 protein

NCBI chr 5:118,818,494...118,825,531
Ensembl chr 5:118,818,499...118,826,444

G

angiopoietin-like 4

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of ANGPTL4 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ANGPTL4 mRNA

PMID:21266533 PMID:39150890

NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681

G

ankyrin repeat and EF-hand domain containing 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of ANKEF1 mRNA

NCBI chr 3:144,300,500...144,335,759
Ensembl chr 3:144,300,529...144,335,753

G

ankyrin repeat domain 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ANKRD1 mRNA

NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751

G

ankyrin repeat domain 10

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ANKRD10 mRNA

NCBI chr16:84,566,021...84,591,849
Ensembl chr16:84,568,506...84,591,846

G

ankyrin repeat domain 13a

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ANKRD13A mRNA

NCBI chr12:47,458,828...47,488,959
Ensembl chr12:47,458,831...47,489,312

G

ankyrin repeat domain 13C

increases expression

ISO

Dibutyl Phthalate results in increased expression of ANKRD13C mRNA

NCBI chr 2:249,679,752...249,729,272
Ensembl chr 2:249,681,872...249,729,272

G

ankyrin repeat domain 24

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ANKRD24 mRNA

NCBI chr 7:8,712,720...8,731,910
Ensembl chr 7:8,712,722...8,731,910

G

ankyrin repeat domain 28

increases expression

EXP

Dibutyl Phthalate results in increased expression of ANKRD28 mRNA

NCBI chr16:6,924,868...7,056,593
Ensembl chr16:6,924,882...7,056,593

G

ankyrin repeat domain 29

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ANKRD29 mRNA

NCBI chr18:3,711,052...3,768,997
Ensembl chr18:3,711,059...3,769,098

G

ankyrin repeat domain 35

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ANKRD35 mRNA

NCBI chr 2:186,895,896...186,915,903
Ensembl chr 2:186,895,945...186,915,902

G

ankyrin repeat domain 37

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ANKRD37 mRNA

NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545

G

ankyrin repeat domain 46

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of ANKRD46 mRNA

NCBI chr 7:69,532,303...69,553,311
Ensembl chr 7:69,532,304...69,545,421

G

ankyrin repeat domain containing 50

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ANKRD50 mRNA

NCBI chr 2:123,394,311...123,428,788
Ensembl chr 2:123,396,606...123,427,340

G

ankyrin repeat domain 54

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ANKRD54 mRNA

NCBI chr 7:112,495,396...112,508,186
Ensembl chr 7:112,495,462...112,508,128

G

ankyrin repeat domain 6

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ANKRD6 mRNA

NCBI chr 5:51,999,225...52,139,623
Ensembl chr 5:51,999,221...52,139,594

G

anoctamin 10

increases expression

ISO

Dibutyl Phthalate results in increased expression of ANO10 mRNA

NCBI chr 8:130,719,177...130,838,243
Ensembl chr 8:130,718,755...130,877,636

G

anoctamin 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of ANO6 mRNA

NCBI chr 7:128,812,842...128,992,805
Ensembl chr 7:128,813,068...128,992,799

G

acidic nuclear phosphoprotein 32 family member A

decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of ANP32A mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ANP32A promoter

PMID:21266533 PMID:23359474

NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:71,724,531...71,760,922

G

acidic nuclear phosphoprotein 32 family member B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ANP32B mRNA

NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:65,538,535...65,561,437

G

acidic nuclear phosphoprotein 32 family member E

decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of ANP32E mRNA
[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of ANP32E protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ANP32E promoter

PMID:21266533 PMID:23359474 PMID:34864091

NCBI chr 2:186,161,520...186,177,984
Ensembl chr 2:186,161,532...186,177,986

G

alanyl aminopeptidase, membrane

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ANPEP mRNA

NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101

G

adenine nucleotide translocase lysine methyltransferase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ANTKMT mRNA

NCBI chr10:15,316,797...15,320,950
Ensembl chr10:15,316,772...15,318,656

G

ANTXR cell adhesion molecule 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ANTXR1 mRNA

NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892

G

annexin A1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ANXA1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831

G

annexin A11

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ANXA11 mRNA

NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839

G

annexin A3

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ANXA3 mRNA

NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849

G

annexin A5

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ANXA5 mRNA
Dibutyl Phthalate results in decreased expression of ANXA5 mRNA

PMID:17361019 PMID:17379624 PMID:21266533

NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400

G

annexin A7

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ANXA7 mRNA

NCBI chr15:3,869,180...3,897,827
Ensembl chr15:3,870,974...3,898,891

G

annexin A9

increases expression

EXP

Dibutyl Phthalate results in increased expression of ANXA9 mRNA

NCBI chr 2:185,562,174...185,572,560
Ensembl chr 2:185,562,174...185,572,560

G

amine oxidase, copper containing 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AOC3 mRNA

NCBI chr10:86,773,018...86,780,961

G

aminopeptidase O

increases expression

EXP

Dibutyl Phthalate results in increased expression of AOPEP mRNA

NCBI chr17:1,817,001...2,133,008
Ensembl chr17:1,817,001...2,133,104

G

adaptor related protein complex 1 subunit sigma 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of AP1S2 mRNA

PMID:17361019 PMID:21266533

NCBI chr X:34,204,601...34,230,819
Ensembl chr X:34,204,603...34,228,529

G

adaptor related protein complex 2 subunit alpha 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of AP2A1 promoter

NCBI chr 1:104,520,789...104,550,655
Ensembl chr 1:104,520,792...104,550,655

G

adaptor related protein complex 3 subunit mu 1

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of AP3M1 mRNA
Dibutyl Phthalate results in increased expression of AP3M1 mRNA

PMID:17361019 PMID:21266533

NCBI chr15:3,285,591...3,314,139
Ensembl chr15:3,295,444...3,313,104

G

adaptor related protein complex 5 subunit mu 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of AP5M1 mRNA

NCBI chr15:24,835,122...24,864,854
Ensembl chr15:24,835,100...24,862,606

G

apoptotic peptidase activating factor 1

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of APAF1 protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of APAF1 mRNA

PMID:34864091 PMID:37364641

NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772

G

amyloid beta precursor protein binding family A member 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of APBA2 mRNA

NCBI chr 1:127,465,026...127,698,124
Ensembl chr 1:127,465,009...127,698,117

G

APC regulator of WNT signaling pathway

increases expression

EXP

Dibutyl Phthalate results in increased expression of APC mRNA; Dibutyl Phthalate results in increased expression of APC protein

NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022

G

APC regulator of WNT signaling pathway 2

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of APC2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APC2 mRNA

PMID:21266533 PMID:39150890

NCBI chr 7:10,043,010...10,065,037
Ensembl chr 7:10,043,010...10,065,210

G

antisense paternally expressed gene 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of APEG3 mRNA

NCBI chr 1:76,154,484...76,155,415
Ensembl chr 1:76,154,982...76,155,263

G

acylaminoacyl-peptide hydrolase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of APEH mRNA

NCBI chr 8:117,652,390...117,661,502
Ensembl chr 8:117,652,393...117,661,711

G

apurinic/apyrimidinic endodeoxyribonuclease 1

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of APEX1 mRNA
Dibutyl Phthalate results in increased expression of APEX1 mRNA

PMID:17361019 PMID:21266533 PMID:33120273

NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329

G

aph-1 homolog A, gamma secretase subunit

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of APH1A mRNA

NCBI chr 2:186,123,023...186,130,886
Ensembl chr 2:186,127,323...186,132,045

G

APAF1 interacting protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of APIP mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:109,886,919...109,913,295
Ensembl chr 3:109,886,953...109,915,862

G

aprataxin and PNKP like factor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of APLF mRNA

NCBI chr 4:121,627,800...121,679,980
Ensembl chr 4:121,627,800...121,679,961

G

apelin

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of APLN mRNA

PMID:17361019 PMID:21266533 PMID:24893172

NCBI chr X:132,058,739...132,091,518
Ensembl chr X:132,081,759...132,091,246

G

amyloid beta precursor like protein 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APLP1 mRNA

NCBI chr 1:94,824,330...94,834,705
Ensembl chr 1:94,824,072...94,834,610

G

amyloid beta precursor like protein 2

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of APLP2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APLP2 mRNA

PMID:21266533 PMID:39150890

NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031

G

apolipoprotein A4

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of APOA4 protein

NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164

G

apolipoprotein B mRNA editing enzyme catalytic subunit 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of APOBEC3 mRNA

NCBI chr 7:113,314,196...113,333,306
Ensembl chr 7:113,314,171...113,333,431

G

apolipoprotein D

increases expression

EXP

Dibutyl Phthalate results in increased expression of APOD mRNA

NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263

G

apolipoprotein E

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of APOE mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APOE mRNA

PMID:33983380 PMID:39150890

NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855

G

aquaporin 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AQP1 mRNA

NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504

G

aquaporin 12A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AQP12 mRNA

NCBI chr 9:101,001,939...101,007,425
Ensembl chr 9:101,001,939...101,007,425

G

aquaporin 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AQP5 mRNA

NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:132,601,059...132,605,062

G

aquaporin 7

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of AQP7 mRNA

NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618

G

aquaporin 9

increases expression

EXP

Dibutyl Phthalate results in increased expression of AQP9 mRNA

NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240

G

androgen receptor

affects binding
multiple interactions
decreases expression
increases response to substance
decreases activity
increases activity
increases expression

EXP
ISO

Dibutyl Phthalate binds to AR protein
Dibutyl Phthalate promotes the reaction [Dihydrotestosterone results in decreased localization of AR protein]
Dibutyl Phthalate results in decreased expression of AR mRNA; Dibutyl Phthalate results in decreased expression of AR protein
AR protein results in increased susceptibility to Dibutyl Phthalate
Dibutyl Phthalate results in decreased activity of AR protein
bisphenol A promotes the reaction [Dibutyl Phthalate results in increased expression of AR mRNA]; Dibutyl Phthalate promotes the reaction [bisphenol A results in increased expression of AR mRNA]; Dibutyl Phthalate results in decreased expression of and results in decreased localization of AR protein
Dibutyl Phthalate results in increased activity of AR protein
Dibutyl Phthalate results in increased expression of AR mRNA; Dibutyl Phthalate results in increased expression of AR protein
Dibutyl Phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dibutyl Phthalate inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; Dibutyl Phthalate inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; Dibutyl Phthalate results in decreased expression of and results in decreased localization of AR protein; Flutamide inhibits the reaction [Dibutyl Phthalate results in increased activity of AR protein]; TGFB1I1 protein inhibits the reaction [Dibutyl Phthalate results in decreased localization of AR protein]

PMID:14565775 PMID:15829613 PMID:15840436 PMID:18923996 PMID:19549552 More...

NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467

G

ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of ARAP2 mRNA

PMID:17361019 PMID:21266533

NCBI chr14:50,921,323...51,120,972
Ensembl chr14:50,921,713...51,120,962

G

activity-regulated cytoskeleton-associated protein

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ARC mRNA
Dibutyl Phthalate results in decreased expression of ARC mRNA; Dibutyl Phthalate results in decreased expression of ARC protein

PMID:21266533 PMID:31841868

NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220

G

archain 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ARCN1 mRNA

NCBI chr 8:53,954,401...53,979,005
Ensembl chr 8:53,954,404...53,979,005

G

amphiregulin

increases expression

EXP

Dibutyl Phthalate results in increased expression of AREG mRNA

NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641

G

ARF GTPase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ARF3 mRNA

NCBI chr 7:131,765,039...131,792,075
Ensembl chr 7:131,750,672...131,770,123

G

ARF GTPase 4

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ARF4 mRNA

NCBI chr16:1,903,238...1,920,012
Ensembl chr16:1,903,371...1,920,011

G

ARF GTPase 5

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ARF5 mRNA

NCBI chr 4:58,003,919...58,006,898
Ensembl chr 4:58,003,932...58,006,835

G

ARF GTPase 6

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of ARF6 mRNA
Dibutyl Phthalate results in increased expression of ARF6 mRNA

NCBI chr 6:93,589,777...93,590,925
Ensembl chr 6:93,569,234...93,610,536

G

ARF GTPase activating protein 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ARFGAP1 mRNA

NCBI chr 3:188,462,125...188,477,515
Ensembl chr 3:188,465,648...188,511,078

G

arginase 1

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of ARG1 mRNA; Dibutyl Phthalate results in decreased expression of ARG1 protein
Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in decreased expression of ARG1 mRNA]; Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in decreased expression of ARG1 protein]; Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in decreased expression of ARG1 mRNA]; Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in decreased expression of ARG1 protein]

PMID:21266533 PMID:35378083

NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713

G

arginase 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of ARG2 mRNA

NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:103,668,988...103,694,375

G

Rho GTPase activating protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ARHGAP1 mRNA

NCBI chr 3:98,077,064...98,099,163
Ensembl chr 3:98,077,150...98,099,154

G

Rho GTPase activating protein 10

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARHGAP10 mRNA

NCBI chr19:47,352,783...47,614,532
Ensembl chr19:47,352,276...47,614,531

G

Rho GTPase activating protein 18

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of ARHGAP18 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr 1:20,222,948...20,456,827
Ensembl chr 1:20,222,954...20,456,670

G

Rho GTPase activating protein 21

increases expression

ISO

Dibutyl Phthalate results in increased expression of ARHGAP21 mRNA

NCBI chr17:88,256,961...88,380,478
Ensembl chr17:88,256,961...88,380,797

G

Rho GTPase activating protein 22

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ARHGAP22 mRNA

NCBI chr16:8,480,222...8,637,823
Ensembl chr16:8,479,956...8,637,822

G

Rho GTPase activating protein 45

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARHGAP45 mRNA

NCBI chr 7:10,325,515...10,340,955
Ensembl chr 7:10,325,539...10,341,890

G

Rho GTPase activating protein 6

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of ARHGAP6 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP6 mRNA

PMID:21266533 PMID:39150890

NCBI chr X:28,525,912...29,062,344
Ensembl chr X:28,525,917...29,061,244

G

Rho GDP dissociation inhibitor alpha

increases expression

EXP

Dibutyl Phthalate results in increased expression of ARHGDIA mRNA

NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347

G

Rho GDP dissociation inhibitor beta

increases expression

EXP

Dibutyl Phthalate results in increased expression of ARHGDIB mRNA

NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068

G

Rho guanine nucleotide exchange factor 10

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ARHGEF10 mRNA

NCBI chr16:81,349,429...81,440,439
Ensembl chr16:81,349,429...81,440,054

G

Rho guanine nucleotide exchange factor 12

increases expression

ISO

Dibutyl Phthalate results in increased expression of ARHGEF12 mRNA

NCBI chr 8:52,247,047...52,373,158
Ensembl chr 8:52,247,047...52,372,376

G

Rho guanine nucleotide exchange factor 17

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ARHGEF17 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:164,642,690...164,702,241
Ensembl chr 1:164,642,690...164,702,241

G

Rho/Rac guanine nucleotide exchange factor 18

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARHGEF18 mRNA

NCBI chr12:6,192,958...6,300,997
Ensembl chr12:6,128,661...6,300,997

G

Rho/Rac guanine nucleotide exchange factor 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA

NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646

G

Rho guanine nucleotide exchange factor 25

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ARHGEF25 mRNA

NCBI chr 7:64,891,260...64,898,382
Ensembl chr 7:64,890,879...64,898,697

G

Rho guanine nucleotide exchange factor 28

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARHGEF28 mRNA

NCBI chr 2:30,998,292...31,294,757
Ensembl chr 2:30,998,295...31,294,853

G

Rho guanine nucleotide exchange factor 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of ARHGEF3 mRNA

NCBI chr16:2,308,311...2,588,634
Ensembl chr16:2,308,400...2,588,819

G

Rho guanine nucleotide exchange factor 4

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ARHGEF4 mRNA
Dibutyl Phthalate results in decreased expression of ARHGEF4 mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:44,357,716...44,500,959
Ensembl chr 9:44,357,736...44,501,550

G

AT-rich interaction domain 3B

increases expression

EXP

Dibutyl Phthalate results in increased expression of ARID3B mRNA

NCBI chr 8:67,089,141...67,136,764
Ensembl chr 8:67,083,802...67,152,245

G

AT-rich interaction domain 5B

increases expression

ISO

Dibutyl Phthalate results in increased expression of ARID5B mRNA

PMID:17361019 PMID:21266533

NCBI chr20:20,305,693...20,489,689
Ensembl chr20:20,306,712...20,489,686

G

ariadne RBR E3 ubiquitin protein ligase 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ARIH1 mRNA

NCBI chr 8:68,673,199...68,775,648
Ensembl chr 8:68,673,200...68,775,572

G

ariadne RBR E3 ubiquitin protein ligase 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ARIH2 mRNA

NCBI chr 8:118,175,267...118,234,425
Ensembl chr 8:118,175,267...118,234,284

G

ARF like GTPase 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ARL2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:212,863,422...212,875,425
Ensembl chr 1:212,863,423...212,875,373

G

ARF like GTPase 2 binding protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARL2BP mRNA

NCBI chr19:10,342,895...10,352,529
Ensembl chr19:10,342,895...10,352,514

G

ARF like GTPase 4C

increases expression

EXP

Dibutyl Phthalate results in increased expression of ARL4C mRNA

NCBI chr 9:96,748,075...96,751,510
Ensembl chr 9:96,745,069...96,752,772

G

ARF like GTPase 4D

increases expression

ISO

Dibutyl Phthalate results in increased expression of ARL4D mRNA

NCBI chr10:87,092,276...87,103,079
Ensembl chr10:87,077,523...87,106,199

G

ARF like GTPase 5A

increases expression

EXP

Dibutyl Phthalate results in increased expression of ARL5A mRNA

NCBI chr 3:57,287,599...57,312,488
Ensembl chr 3:57,289,846...57,312,488

G

ARF like GTPase 5B

increases expression

ISO

Dibutyl Phthalate results in increased expression of ARL5B mRNA

NCBI chr17:82,864,315...82,888,458
Ensembl chr17:82,864,287...82,890,646

G

ARL6 interacting reticulophagy regulator 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARL6IP1 mRNA

NCBI chr 1:181,864,717...181,874,232
Ensembl chr 1:181,864,746...181,874,232

G

ARF like GTPase 6 interacting protein 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARL6IP4 mRNA

NCBI chr12:38,140,566...38,142,711
Ensembl chr12:38,140,550...38,142,724

G

ARF like GTPase 6 interacting protein 5

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ARL6IP5 mRNA

NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:131,367,289...131,400,130

G

armadillo repeat containing 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARMC2 mRNA

NCBI chr20:46,976,442...47,083,888
Ensembl chr20:46,977,421...47,084,160

G

armadillo repeat containing 6

increases expression

EXP

Dibutyl Phthalate results in increased expression of ARMC6 mRNA

NCBI chr16:19,225,058...19,235,479
Ensembl chr16:19,225,049...19,240,032

G

armadillo repeat containing 8

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARMC8 mRNA

NCBI chr 8:108,916,274...109,010,877
Ensembl chr 8:108,916,274...109,010,717

G

armadillo repeat containing, X-linked 2

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of ARMCX2 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ARMCX2 promoter

PMID:21266533 PMID:23359474

NCBI chr X:102,273,915...102,278,789
Ensembl chr X:102,273,565...102,278,905

G

armadillo repeat containing, X-linked 3

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ARMCX3 mRNA

NCBI chr X:102,230,464...102,234,017
Ensembl chr X:102,219,848...102,263,297

G

armadillo repeat containing, X-linked 6

increases expression

EXP

Dibutyl Phthalate results in increased expression of ARMCX6 mRNA

NCBI chr X:102,222,288...102,229,871
Ensembl chr X:102,222,220...102,240,052

G

aryl hydrocarbon receptor nuclear translocator

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARNT mRNA

NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:185,680,683...185,745,546

G

aryl hydrocarbon receptor nuclear translocator 2

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ARNT2 mRNA

NCBI chr 1:147,645,354...147,801,986
Ensembl chr 1:147,599,058...147,801,997

G

actin related protein 2/3 complex, subunit 1A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARPC1A mRNA

NCBI chr12:14,616,245...14,639,052
Ensembl chr12:14,616,248...14,639,052

G

actin related protein 2/3 complex, subunit 1B

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ARPC1B mRNA

PMID:17361019 PMID:21266533

NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504

G

actin related protein 2/3 complex, subunit 2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ARPC2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:83,269,884...83,300,610
Ensembl chr 9:83,269,932...83,305,409

G

actin related protein 2/3 complex, subunit 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of ARPC4 mRNA

NCBI chr 4:148,077,799...148,088,427
Ensembl chr 4:148,077,240...148,088,428

G

actin related protein 2/3 complex, subunit 5

increases expression

EXP

Dibutyl Phthalate results in increased expression of ARPC5 mRNA

NCBI chr13:67,454,379...67,463,288
Ensembl chr13:67,437,027...67,463,283

G

actin-related protein 2/3 complex inhibitor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ARPIN mRNA

NCBI chr 1:143,273,590...143,282,426
Ensembl chr 1:143,273,590...143,282,532

G

cAMP-regulated phosphoprotein 19

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARPP19 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:84,660,166...84,683,012
Ensembl chr 8:119,691,942...119,692,385
Ensembl chr 8:119,691,942...119,692,385

G

arrestin, beta 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARRB2 mRNA

NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,645,357...55,653,487

G

arrestin domain containing 3

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARRDC3 mRNA

NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875

G

arrestin domain containing 4

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of ARRDC4 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARRDC4 mRNA

PMID:21266533 PMID:39150890

NCBI chr 1:131,779,436...131,793,438
Ensembl chr 1:131,779,437...131,793,565

G

arylsulfatase B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ARSB mRNA

NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:26,736,957...26,897,611

G

ADP-ribosyltransferase 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ART1 mRNA

NCBI chr 1:165,890,032...165,899,154
Ensembl chr 1:165,890,086...165,899,146

G

ADP-ribosyltransferase 4

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ART4 mRNA

NCBI chr 4:171,468,415...171,482,435
Ensembl chr 4:171,471,534...171,481,868

G

aristaless related homeobox

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ARX mRNA

NCBI chr X:62,010,097...62,022,009
Ensembl chr X:62,010,097...62,022,002

G

adipocyte-related X-chromosome expressed sequence 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ARXES1 mRNA

NCBI chr X:103,742,157...103,743,676

G

arsenite methyltransferase

increases expression

EXP

Dibutyl Phthalate results in increased expression of AS3MT mRNA

NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249

G

activating signal cointegrator 1 complex subunit 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ASCC1 mRNA

NCBI chr20:28,484,044...28,574,195
Ensembl chr20:28,483,956...28,574,200

G

anti-silencing function 1B histone chaperone

decreases expression
increases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of ASF1B mRNA
Dibutyl Phthalate results in increased expression of ASF1B mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of ASF1B mRNA]

PMID:17361019 PMID:21266533 PMID:36828243

NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352

G

agouti signaling protein

multiple interactions
increases methylation

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of A mRNA; [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate] results in increased methylation of A promoter mutant form
Dibutyl Phthalate results in increased methylation of A promoter mutant form

PMID:29991372 PMID:39150890

NCBI chr 3:163,933,768...164,021,377
Ensembl chr 3:164,015,903...164,021,378

G

argininosuccinate lyase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ASL mRNA

PMID:17361019 PMID:21266533

NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261

G

acetylserotonin O-methyltransferase

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ASMT promoter

NCBI chr12:21,418,477...21,423,336
Ensembl chr12:21,418,487...21,423,336

G

acetylserotonin O-methyltransferase-like

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ASMTL promoter

NCBI chr12:21,429,119...21,431,847
Ensembl chr12:21,429,171...21,431,847

G

asparagine synthetase (glutamine-hydrolyzing)

increases expression

EXP

Dibutyl Phthalate results in increased expression of ASNS mRNA

NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050

G

ASPSCR1 tether for SLC2A4, UBX domain containing

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ASPSCR1 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:106,450,600...106,488,231
Ensembl chr10:106,450,567...106,488,579

G

asparaginase and isoaspartyl peptidase 1

multiple interactions

ISO

Dibutyl Phthalate inhibits the reaction [Vitamin A results in increased expression of ALP1 mRNA]

NCBI chr 1:215,436,180...215,456,188
Ensembl chr 1:215,435,218...215,456,198

G

argininosuccinate synthase 1

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ASS1 mRNA
Dibutyl Phthalate results in decreased expression of ASS1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627

G

astrotactin 1

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN1 mRNA

NCBI chr13:73,070,754...73,388,902
Ensembl chr13:73,071,267...73,388,895

G

astrotactin 2

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA

NCBI chr 5:83,772,988...84,759,439
Ensembl chr 5:83,773,633...84,759,485

G

ASXL transcriptional regulator 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ASXL3 mRNA

NCBI chr18:13,868,223...14,040,867
Ensembl chr18:13,868,674...14,037,373

G

ATPase family, AAA domain containing 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATAD2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238

G

ATPase family, AAA domain containing 2B

increases expression

ISO

Dibutyl Phthalate results in increased expression of ATAD2B mRNA

NCBI chr 6:33,646,075...33,789,532
Ensembl chr 6:33,646,075...33,789,532

G

ATPase family, AAA domain containing 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATAD5 mRNA

NCBI chr10:65,568,569...65,616,379
Ensembl chr10:65,568,591...65,616,376

G

alpha tubulin acetyltransferase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of ATAT1 mRNA

NCBI chr20:2,849,399...2,862,614
Ensembl chr20:2,849,421...2,862,389

G

activating transcription factor 3

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of ATF3 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ATF3 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ATF3 promoter

PMID:21266533 PMID:23359474 PMID:39150890

NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750

G

activating transcription factor 4

increases expression
multiple interactions
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ATF4 mRNA; Dibutyl Phthalate results in increased expression of ATF4 protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ATF4 mRNA
Dibutyl Phthalate results in decreased expression of ATF4 mRNA

PMID:17361019 PMID:17379624 PMID:21266533 PMID:30173778 PMID:37364641

NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739

G

activating transcription factor 5

increases expression

EXP

Dibutyl Phthalate results in increased expression of ATF5 mRNA

NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:104,432,094...104,436,183

G

activating transcription factor 6

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of ATF6 protein
4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]

NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033

G

autophagy related 10

increases expression

EXP

Dibutyl Phthalate results in increased expression of ATG10 mRNA

NCBI chr 2:23,843,695...24,133,459
Ensembl chr 2:23,844,482...24,133,368

G

autophagy related 16-like 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of ATG16L2 mRNA

NCBI chr 1:165,100,946...165,123,307
Ensembl chr 1:165,102,936...165,115,473

G

autophagy related 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of ATG3 mRNA

NCBI chr11:69,130,948...69,159,280
Ensembl chr11:69,121,952...69,159,280

G

autophagy related 5

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of ATG5 mRNA
Dibutyl Phthalate results in increased expression of ATG5 protein
3-methyladenine affects the reaction [Dibutyl Phthalate results in increased expression of ATG5 protein]

PMID:30053495 PMID:37277016

NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821

G

autophagy related 9A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATG9A mRNA

NCBI chr 9:84,126,071...84,136,723
Ensembl chr 9:84,126,071...84,136,666

G

atlastin GTPase 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of ATL2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:20,891,220...20,932,644
Ensembl chr 6:20,891,227...20,933,320

G

atlastin GTPase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATL3 mRNA

NCBI chr 1:214,110,127...214,151,098
Ensembl chr 1:214,109,702...214,152,510

G

ATM serine/threonine kinase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATM mRNA

PMID:17361019 PMID:21266533 PMID:31318015

NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629

G

atonal bHLH transcription factor 8

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATOH8 mRNA

NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379

G

atos homolog B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATOSB mRNA

NCBI chr 5:62,056,654...62,070,338
Ensembl chr 5:62,056,654...62,064,613

G

ATPase phospholipid transporting 10D (putative)

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ATP10D mRNA

NCBI chr14:36,265,696...36,366,460
Ensembl chr14:36,265,696...36,366,460

G

ATPase 13A3

increases expression

ISO

Dibutyl Phthalate results in increased expression of ATP13A3 mRNA

NCBI chr11:83,860,725...83,946,899
Ensembl chr11:83,870,218...83,944,662

G

ATPase Na+/K+ transporting subunit alpha 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of ATP1A1 mRNA

NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425

G

ATPase Na+/K+ transporting subunit alpha 2

increases expression
decreases expression

ISO

Dibutyl Phthalate results in increased expression of ATP1A2 mRNA
Dibutyl Phthalate results in decreased expression of ATP1A2 mRNA

NCBI chr13:87,261,964...87,286,911
Ensembl chr13:87,261,968...87,286,911

G

ATPase Na+/K+ transporting subunit alpha 3

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of ATP1A3 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ATP1A3 mRNA

PMID:21266533 PMID:31199487

NCBI chr 1:89,700,645...89,729,782
Ensembl chr 1:89,700,649...89,729,825

G

ATPase Na+/K+ transporting subunit beta 1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ATP1B1 mRNA
Dibutyl Phthalate results in decreased expression of ATP1B1 mRNA

NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549

G

ATPase Na+/K+ transporting subunit beta 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATP1B3 mRNA

NCBI chr 8:105,789,824...105,821,151
Ensembl chr 8:65,253,361...65,254,304
Ensembl chr 8:65,253,361...65,254,304

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATP2A2 mRNA

NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of ATP2A3 mRNA

NCBI chr10:58,079,710...58,111,279
Ensembl chr10:58,079,852...58,111,278

G

ATPase plasma membrane Ca2+ transporting 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of ATP2B1 mRNA

NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904

G

ATPase plasma membrane Ca2+ transporting 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATP2B3 mRNA

NCBI chr X:156,367,582...156,464,085
Ensembl chr X:156,367,852...156,438,153

G

ATPase H+/K+ transporting subunit beta

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATP4B mRNA

NCBI chr16:82,846,329...82,855,242
Ensembl chr16:82,846,329...82,855,242

G

ATP synthase F1 subunit alpha

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATP5F1A mRNA

NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922

G

ATP synthase F1 subunit gamma

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ATP5F1C mRNA

PMID:17361019 PMID:21266533

NCBI chr17:73,333,584...73,355,872
Ensembl chr17:73,333,588...73,383,073

G

ATP synthase F1 subunit delta

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATP5F1D mRNA

NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583

G

ATP synthase F1 subunit epsilon

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATP5F1E mRNA

NCBI chr 3:183,677,270...183,680,172
Ensembl chr 3:183,677,273...183,680,214

G

ATP synthase inhibitory factor subunit 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ATP5IF1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677

G

ATP synthase membrane subunit c locus 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ATP5MC1 mRNA

NCBI chr10:81,520,762...81,523,735
Ensembl chr10:81,520,765...81,523,363

G

ATP synthase membrane subunit e

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ATP5ME mRNA
Dibutyl Phthalate results in decreased expression of ATP5ME mRNA

NCBI chr14:1,464,788...1,465,989
Ensembl chr14:1,464,800...1,465,988

G

ATP synthase membrane subunit f

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATP5MF mRNA

NCBI chr12:14,535,435...14,542,007
Ensembl chr12:14,522,832...14,542,709

G

ATP synthase membrane subunit G

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATP5MG mRNA

NCBI chr 8:54,122,457...54,130,407
Ensembl chr 8:54,122,457...54,132,831

G

ATP synthase membrane subunit K

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ATP5MK promoter

NCBI chr 1:255,915,255...255,922,185
Ensembl chr 1:255,915,259...255,922,106
Ensembl chr10:255,915,259...255,922,106

G

ATP synthase peripheral stalk-membrane subunit b

increases expression

EXP

Dibutyl Phthalate results in increased expression of ATP5PB mRNA

NCBI chr 2:196,112,459...196,123,737
Ensembl chr 2:196,112,108...196,124,387

G

ATP synthase peripheral stalk subunit F6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATP5PF mRNA

NCBI chr11:37,368,045...37,375,721
Ensembl chr11:37,368,042...37,375,466

G

ATP synthase peripheral stalk subunit OSCP

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATP5PO mRNA

NCBI chr11:44,651,171...44,657,483
Ensembl chr11:44,651,173...44,657,520

G

ATPase H+ transporting accessory protein 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATP6AP1 mRNA

NCBI chr X:157,231,243...157,238,323
Ensembl chr X:157,225,327...157,238,323

G

ATPase H+ transporting V0 subunit a1

increases expression

EXP

Dibutyl Phthalate results in increased expression of ATP6V0A1 mRNA

NCBI chr10:86,436,089...86,490,185
Ensembl chr10:86,436,141...86,490,181

G

ATPase H+ transporting V0 subunit B

increases expression

ISO

Dibutyl Phthalate results in increased expression of ATP6V0B mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:136,708,823...136,710,339
Ensembl chr 5:136,708,823...136,716,828

G

ATPase, H+ transporting V0 subunit e2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATP6V0E2 mRNA

NCBI chr 4:78,815,771...78,818,919
Ensembl chr 4:78,813,129...78,819,680

G

ATPase H+ transporting V1 subunit C2

affects expression

ISO

Dibutyl Phthalate affects the expression of ATP6V1C2 mRNA

NCBI chr 6:45,809,269...45,872,914
Ensembl chr 6:45,809,271...45,848,747

G

ATPase H+ transporting V1 subunit F

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATP6V1F mRNA

NCBI chr 4:59,033,020...59,035,980

G

ATPase copper transporting alpha

increases expression

ISO

Dibutyl Phthalate results in increased expression of ATP7A mRNA

NCBI chr X:75,159,635...75,267,094
Ensembl chr X:75,159,782...75,267,093

G

ATPase phospholipid transporting 8A1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATP8A1 mRNA

NCBI chr14:40,668,932...40,911,465
Ensembl chr14:40,731,846...40,911,463

G

ATPase phospholipid transporting 8B1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ATP8B1 mRNA

PMID:17361019 PMID:21266533

NCBI chr18:60,286,605...60,427,862
Ensembl chr18:60,288,464...60,427,027

G

ATPase phospholipid transporting 8B2

increases expression

ISO

Dibutyl Phthalate results in increased expression of ATP8B2 mRNA

NCBI chr 2:177,676,205...177,699,575
Ensembl chr 2:177,676,208...177,699,575

G

ATP synthase mitochondrial F1 complex assembly factor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATPAF1 mRNA

NCBI chr 5:134,503,164...134,530,323
Ensembl chr 5:134,499,687...134,530,321

G

ATP synthase mitochondrial F1 complex assembly factor 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATPAF2 mRNA

NCBI chr10:45,705,157...45,721,282
Ensembl chr10:45,697,027...45,721,383

G

ATP synthase c subunit lysine N-methyltransferase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ATPSCKMT mRNA

NCBI chr 2:84,313,991...84,329,195
Ensembl chr 2:84,313,921...84,329,194

G

all-trans retinoic acid-induced differentiation factor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATRAID mRNA

NCBI chr 6:31,035,194...31,039,779
Ensembl chr 6:31,035,194...31,040,946

G

attractin

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATRN mRNA

NCBI chr 3:138,563,271...138,697,360
Ensembl chr 3:138,563,312...138,697,360

G

ataxin 10

increases expression
decreases expression

ISO

Dibutyl Phthalate results in increased expression of ATXN10 mRNA
Dibutyl Phthalate results in decreased expression of ATXN10 mRNA

NCBI chr 7:118,321,516...118,444,967
Ensembl chr 7:118,319,490...118,445,636

G

ataxin 1 like

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of ATXN1L mRNA
Dibutyl Phthalate results in increased expression of ATXN1L mRNA

NCBI chr19:54,609,852...54,621,024
Ensembl chr19:54,609,132...54,680,582

G

ataxin 2-like

affects expression

EXP

Dibutyl Phthalate affects the expression of ATXN2L mRNA

NCBI chr 1:190,508,878...190,526,263
Ensembl chr 1:190,508,878...190,520,579

G

ataxin 7-like 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ATXN7L1 mRNA

NCBI chr 6:55,487,309...55,709,751
Ensembl chr 6:55,649,362...55,701,996

G

AUP1, lipid droplet regulating VLDL assembly factor

increases expression

EXP

Dibutyl Phthalate results in increased expression of AUP1 mRNA

NCBI chr 4:117,118,035...117,121,063
Ensembl chr 4:117,117,999...117,121,061

G

aurora kinase B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AURKB mRNA

NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285

G

arginine vasopressin

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AVP mRNA

NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:138,246,554...138,248,522

G

arginine vasopressin receptor 1A

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of AVPR1A mRNA
Dibutyl Phthalate results in increased expression of AVPR1A mRNA

NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837

G

arginine vasopressin receptor 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AVPR2 mRNA

NCBI chr X:156,785,009...156,787,477
Ensembl chr X:156,785,139...156,787,477

G

axin 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of AXIN1 mRNA

NCBI chr10:15,667,894...15,720,092
Ensembl chr10:15,667,958...15,720,092

G

axin 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of AXIN2 mRNA

NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575

G

Axl receptor tyrosine kinase

increases expression

EXP

Dibutyl Phthalate results in increased expression of AXL mRNA

NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009

G

5-azacytidine induced 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of AZI2 mRNA

NCBI chr 8:126,651,268...126,674,795
Ensembl chr 8:126,651,206...126,676,182

G

antizyme inhibitor 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of AZIN1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:71,539,711...71,566,515
Ensembl chr 7:71,539,711...71,566,515

G

antizyme inhibitor 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of AZIN2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:146,568,187...146,594,777
Ensembl chr 5:146,565,437...146,594,777

G

beta-2 microglobulin

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of B2M mRNA
Dibutyl Phthalate results in increased expression of B2M mRNA

NCBI chr 3:129,549,236...129,555,354
Ensembl chr 3:129,549,318...129,555,356

G

Beta-1,3-galactosyltransferase 5

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of B3GALT5 mRNA
Dibutyl Phthalate results in increased expression of B3GALT5 mRNA

PMID:17361019 PMID:21266533

NCBI chr11:49,053,959...49,100,398
Ensembl chr11:49,006,560...49,101,283

G

beta 3-glucosyltransferase

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of B3GLCT mRNA

NCBI chr12:10,291,910...10,383,190
Ensembl chr12:10,291,910...10,426,357

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of B3GNT2 mRNA
Dibutyl Phthalate results in increased expression of B3GNT2 mRNA

NCBI chr14:101,009,682...101,034,507
Ensembl chr14:100,967,131...101,043,412

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7

increases expression

EXP

Dibutyl Phthalate results in increased expression of B3GNT7 mRNA

NCBI chr 9:94,404,197...94,408,148
Ensembl chr 9:94,404,135...94,408,147

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of B3GNT8 mRNA

NCBI chr 1:90,263,387...90,266,292
Ensembl chr 1:90,263,827...90,270,287

G

beta-1,4-galactosyltransferase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of B4GALT1 mRNA

NCBI chr 5:60,731,601...60,778,456
Ensembl chr 5:60,731,602...60,778,445

G

beta-1,4-galactosyltransferase 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of B4GALT2 promoter

NCBI chr 5:136,697,981...136,707,783
Ensembl chr 5:136,697,981...136,710,422

G

beta-1,4-galactosyltransferase 6

increases expression

EXP

Dibutyl Phthalate results in increased expression of B4GALT6 mRNA

NCBI chr18:12,233,350...12,290,204
Ensembl chr18:12,233,351...12,290,204

G

beta-1,4-glucuronyltransferase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of B4GAT1 mRNA

NCBI chr 1:211,772,644...211,774,866
Ensembl chr 1:211,772,606...211,775,442

G

BPTF associated chromatin complex component 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BACC1 promoter

NCBI chr10:55,450,648...55,453,409
Ensembl chr10:55,450,250...55,453,311

G

beta-secretase 1

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BACE1 mRNA

NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918

G

beta-secretase 2

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BACE2 mRNA

NCBI chr11:50,176,852...50,258,948
Ensembl chr11:50,176,621...50,259,008

G

BTB domain and CNC homolog 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of BACH2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:51,428,802...51,779,030
Ensembl chr 5:51,434,870...51,774,234

G

BCL2-associated agonist of cell death

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of BAD mRNA
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of BAD mRNA

PMID:21266533 PMID:25765776 PMID:39947446

NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034

G

BAG cochaperone 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BAG1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:60,864,476...60,878,161

G

BAG cochaperone 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of BAG2 mRNA

NCBI chr 9:43,465,993...43,476,637
Ensembl chr 9:43,465,995...43,476,752

G

BAG cochaperone 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BAG4 mRNA

PMID:17361019 PMID:21266533

NCBI chr16:72,991,407...73,008,620
Ensembl chr16:72,991,362...73,013,273

G

BAR/IMD domain containing adaptor protein 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of BAIAP2 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:105,721,371...105,788,549
Ensembl chr10:105,721,417...105,788,549

G

BAR/IMD domain containing adaptor protein 2 like 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of BAIAP2L1 mRNA

NCBI chr12:15,364,090...15,453,602
Ensembl chr12:15,364,109...15,453,605

G

BCL2-antagonist/killer 1

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA

NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974

G

BMP and activin membrane-bound inhibitor

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of BAMBI mRNA

NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247

G

barrier to autointegration nuclear assembly factor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BANF1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:212,101,523...212,103,568
Ensembl chr 1:212,101,523...212,103,552

G

brain abundant, membrane attached signal protein 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of BASP1 mRNA

NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178

G

basic leucine zipper ATF-like transcription factor

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BATF promoter

NCBI chr 6:111,084,717...111,107,052
Ensembl chr 6:111,084,717...111,107,052

G

BCL2 associated X, apoptosis regulator

decreases expression
multiple interactions
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of BAX mRNA
Y 27632 inhibits the reaction [Dibutyl Phthalate results in increased expression of BAX mRNA]
Dibutyl Phthalate results in increased expression of BAX protein
Dibutyl Phthalate results in increased expression of BAX mRNA; Dibutyl Phthalate results in increased expression of BAX protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of BAX protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAX protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BAX mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BAX mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] results in increased expression of BAX mRNA; AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased expression of BAX protein]; AKT1 protein affects the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased expression of BAX protein]]; DDIT3 protein promotes the reaction [Dibutyl Phthalate results in increased expression of BAX protein]; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in increased expression of BAX protein]; MK 2206 inhibits the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased expression of BAX protein]]

PMID:25765776 PMID:26804720 PMID:28013214 PMID:28067064 PMID:28486587 More...

NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429

G

bromodomain adjacent to zinc finger domain, 1A

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of BAZ1A mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:78,124,872...78,247,648

G

bromodomain adjacent to zinc finger domain, 1B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of BAZ1B mRNA

NCBI chr12:27,068,541...27,126,511
Ensembl chr12:27,068,541...27,126,511

G

bromodomain adjacent to zinc finger domain, 2B

increases expression

ISO

Dibutyl Phthalate results in increased expression of BAZ2B mRNA

NCBI chr 3:64,792,984...65,034,547
Ensembl chr 3:64,794,001...65,001,781

G

Bcl-2 binding component 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of BBC3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666

G

Bardet-Biedl syndrome 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BBS5 mRNA

NCBI chr 3:74,818,104...74,839,658
Ensembl chr 3:74,818,473...74,857,023

G

BBX high mobility group box domain containing

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BBX mRNA

NCBI chr11:63,850,034...64,097,700
Ensembl chr11:63,850,018...64,093,265

G

basal cell adhesion molecule (Lutheran blood group)

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BCAM mRNA

NCBI chr 1:88,542,971...88,557,358
Ensembl chr 1:88,542,972...88,557,888

G

B-cell receptor-associated protein 29

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BCAP29 mRNA

NCBI chr 6:53,910,209...53,950,206
Ensembl chr 6:53,910,216...53,949,963

G

branched chain amino acid transaminase 1

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of BCAT1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA

PMID:21266533 PMID:31199487

NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288

G

branched chain amino acid transaminase 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BCAT2 promoter

NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463

G

branched chain keto acid dehydrogenase E1 subunit beta

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of BCKDHB mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:93,725,277...93,907,799
Ensembl chr 8:93,725,275...93,907,798

G

branched chain ketoacid dehydrogenase kinase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of BCKDK mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:191,945,809...191,950,480
Ensembl chr 1:191,946,471...191,953,453

G

BCL10, immune signaling adaptor

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of BCL10 mRNA

NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829

G

BCL11 transcription factor B

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of BCL11B mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:132,598,968...132,692,123
Ensembl chr 6:132,598,968...132,691,301

G

BCL2, apoptosis regulator

increases expression
decreases methylation
multiple interactions
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of BCL2 mRNA
Dibutyl Phthalate results in decreased methylation of BCL2 promoter
Dibutyl Phthalate results in increased expression of BCL2 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA; taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of BCL2 protein]; Y 27632 inhibits the reaction [Dibutyl Phthalate results in decreased expression of BCL2 mRNA]
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of BCL2 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of BCL2 protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] results in decreased expression of BCL2 mRNA; AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in decreased expression of BCL2 protein]; AKT1 protein affects the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in decreased expression of BCL2 protein]]; DDIT3 protein promotes the reaction [Dibutyl Phthalate results in decreased expression of BCL2 protein]; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in decreased expression of BCL2 protein]; MK 2206 inhibits the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in decreased expression of BCL2 protein]]
Dibutyl Phthalate results in decreased expression of BCL2 mRNA; Dibutyl Phthalate results in decreased expression of BCL2 protein

PMID:21266533 PMID:23242528 PMID:26804720 PMID:28013214 PMID:28067064 More...

NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900

G

Bcl2-like 10

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2L10 mRNA

NCBI chr 8:84,987,833...84,993,878
Ensembl chr 8:84,987,833...84,993,872

G

Bcl2-like 11

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BCL2L11 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695

G

Bcl2-like 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of BCL2L2 mRNA

NCBI chr15:32,326,686...32,337,834
Ensembl chr15:32,326,020...32,335,379

G

BCL6, transcription repressor

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BCL6 mRNA

NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047

G

BAF chromatin remodeling complex subunit BCL7C

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BCL7C mRNA

NCBI chr 1:191,703,432...191,754,751
Ensembl chr 1:191,691,089...191,754,641

G

BCL9 like

multiple interactions
increases expression

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BCL9L promoter
Dibutyl Phthalate results in increased expression of BCL9L mRNA

PMID:23359474 PMID:32028152

NCBI chr 8:53,708,770...53,738,880
Ensembl chr 8:53,708,770...53,737,395

G

BCL2-associated transcription factor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BCLAF1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:16,914,118...16,936,801

G

BCR activator of RhoGEF and GTPase

increases expression

EXP

Dibutyl Phthalate results in increased expression of BCR mRNA

NCBI chr20:13,468,732...13,596,333
Ensembl chr20:13,468,732...13,596,333

G

3-hydroxybutyrate dehydrogenase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of BDH1 mRNA

NCBI chr11:82,806,125...82,848,133
Ensembl chr11:82,807,503...82,842,636

G

bradykinin receptor B2

increases expression

EXP

Dibutyl Phthalate results in increased expression of BDKRB2 mRNA

NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:130,237,255...130,267,209

G

brain-derived neurotrophic factor

increases expression
decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of BDNF mRNA
Dibutyl Phthalate results in decreased expression of BDNF protein
[alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased expression of BDNF protein]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BDNF mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of BDNF mRNA
Dibutyl Phthalate results in increased expression of BDNF mRNA; Dibutyl Phthalate results in increased expression of BDNF protein

PMID:17361019 PMID:21266533 PMID:21787579 PMID:25607892 PMID:30776390 More...

NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657

G

BDP1 general transcription factor IIIB subunit

increases expression

ISO

Dibutyl Phthalate results in increased expression of BDP1 mRNA

NCBI chr 2:33,112,518...33,204,270
Ensembl chr 2:33,112,518...33,204,241

G

beclin 1

increases expression
multiple interactions
affects expression

EXP
ISO

Dibutyl Phthalate results in increased expression of BECN1 mRNA; Dibutyl Phthalate results in increased expression of BECN1 protein
3-methyladenine affects the reaction [Dibutyl Phthalate results in increased expression of BECN1 protein]; Dibutyl Phthalate inhibits the reaction [NOTCH2 protein alternative form binds to BECN1 protein]; Melatonin inhibits the reaction [Dibutyl Phthalate results in increased expression of BECN1 protein]
Dibutyl Phthalate affects the expression of BECN1 protein

PMID:30053495 PMID:30453174 PMID:32622864 PMID:37277016

NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002

G

BEN domain containing 6

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA

NCBI chr 9:43,576,982...43,631,437
Ensembl chr 9:43,576,982...43,631,194

G

bestrophin 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BEST2 promoter

NCBI chr19:40,047,191...40,053,216
Ensembl chr19:40,047,191...40,053,216

G

Bet1 golgi vesicular membrane trafficking protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BET1 mRNA

NCBI chr 4:33,070,892...33,081,162
Ensembl chr 4:33,070,891...33,081,164

G

brain expressed X-linked 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BEX2 mRNA

NCBI chr X:104,010,639...104,012,143
Ensembl chr X:104,010,371...104,011,236

G

brain expressed X-linked 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of BEX3 mRNA

NCBI chr X:104,064,896...104,066,425
Ensembl chr X:104,064,515...104,075,906

G

brain expressed, X-linked 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of BEX4 mRNA

NCBI chr X:103,923,609...103,925,041
Ensembl chr X:103,923,338...103,925,496

G

bifunctional apoptosis regulator

increases expression

EXP

Dibutyl Phthalate results in increased expression of BFAR mRNA

NCBI chr10:2,059,189...2,092,207
Ensembl chr10:2,059,058...2,094,183

G

basic helix-loop-helix family, member e40

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of BHLHE40 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BHLHE40 mRNA

PMID:21266533 PMID:39150890

NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783

G

basic helix-loop-helix family, member e41

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BHLHE41 mRNA

NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355

G

betaine-homocysteine S-methyltransferase

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BHMT mRNA

NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715

G

BicC family RNA binding protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of BICC1 mRNA

NCBI chr20:17,448,745...17,685,887
Ensembl chr20:17,448,765...17,685,885

G

BICD cargo adaptor 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of BICD2 mRNA

NCBI chr17:15,449,011...15,511,423
Ensembl chr17:15,435,894...15,511,305

G

BH3 interacting domain death agonist

increases expression
multiple interactions
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of BID mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BID mRNA
Dibutyl Phthalate results in decreased expression of BID mRNA

PMID:21266533 PMID:23242528 PMID:25765776 PMID:28486587 PMID:39150890

NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275

G

BCL2-interacting killer

increases expression

ISO

Dibutyl Phthalate results in increased expression of BIK mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317

G

bridging integrator 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BIN1 mRNA

NCBI chr18:24,282,840...24,341,461
Ensembl chr18:24,283,801...24,341,458

G

bridging integrator 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of BIN2 mRNA

NCBI chr 7:133,620,782...133,647,019
Ensembl chr 7:133,620,140...133,647,218

G

baculoviral IAP repeat-containing 5

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of BIRC5 mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of BIRC5 mRNA]
Nimodipine inhibits the reaction [Dibutyl Phthalate results in decreased expression of BIRC5 protein]
Dibutyl Phthalate results in decreased expression of BIRC5 mRNA; Dibutyl Phthalate results in decreased expression of BIRC5 protein

PMID:17361019 PMID:17379624 PMID:21266533 PMID:28973377 PMID:33336902 More...

NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155

G

baculoviral IAP repeat-containing 6

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BIRC6 promoter

NCBI chr 6:26,474,843...26,668,275
Ensembl chr 6:26,474,843...26,668,507

G

basophilic leukemia expressed protein BLES03

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of BLES03 mRNA

NCBI chr 1:212,163,892...212,166,146
Ensembl chr 1:212,163,892...212,166,141

G

biogenesis of lysosomal organelles complex 1 subunit 5

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of BLOC1S5 mRNA

PMID:17361019 PMID:21266533

NCBI chr17:26,377,549...26,402,869
Ensembl chr17:26,377,560...26,402,865

G

biliverdin reductase A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BLVRA mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:134,793,397...134,819,367
Ensembl chr 3:134,794,203...134,819,785

G

biliverdin reductase B

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of BLVRB mRNA
Dibutyl Phthalate results in increased expression of BLVRB mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225

G

bone morphogenetic protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of BMP1 mRNA

NCBI chr15:51,961,310...52,005,597
Ensembl chr15:51,961,310...52,005,485

G

bone morphogenetic protein 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of BMP2 mRNA

NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760

G

bone morphogenetic protein 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of BMP3 mRNA

NCBI chr14:11,012,564...11,041,282
Ensembl chr14:11,016,620...11,041,282

G

bone morphogenetic protein 4

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of BMP4 mRNA
Dibutyl Phthalate results in decreased expression of BMP4 mRNA; Dibutyl Phthalate results in decreased expression of BMP4 protein

PMID:15829613 PMID:19464577 PMID:22027561 PMID:25213187 PMID:26948521 More...

NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172

G

bone morphogenetic protein 6

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of BMP6 mRNA

NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261

G

bone morphogenetic protein 7

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of BMP7 mRNA

NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137

G

bone morphogenetic protein receptor type 1B

increases expression

ISO

Dibutyl Phthalate results in increased expression of BMPR1B mRNA

NCBI chr 2:233,211,525...233,544,344
Ensembl chr 2:233,211,525...233,544,311

G

BMS1 ribosome biogenesis factor

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BMS1 mRNA

NCBI chr 4:153,230,471...153,267,437
Ensembl chr 4:153,230,471...153,267,429

G

brain expressed myelocytomatosis oncogene

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of BMYC mRNA

NCBI chr 3:28,910,689...28,911,448
Ensembl chr 3:28,910,220...28,912,171

G

BCL2 interacting protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BNIP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:16,891,317...16,903,561
Ensembl chr10:16,891,317...16,903,561

G

BCL2 interacting protein 2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of BNIP2 mRNA

NCBI chr 8:79,521,375...79,539,148
Ensembl chr 8:79,521,363...79,547,368

G

BCL2 interacting protein 3

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of BNIP3 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BNIP3 mRNA

PMID:21266533 PMID:39150890

NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962

G

BCL2 interacting protein 3 like

increases expression

ISO

Dibutyl Phthalate results in increased expression of BNIP3L mRNA

NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282

G

BCL2 family apoptosis regulator BOK

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of BOK mRNA
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of BOK mRNA

PMID:21266533 PMID:39947446

NCBI chr 9:101,670,729...101,681,834
Ensembl chr 9:101,670,625...101,681,833

G

bolA family member 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of BOLA1 mRNA

NCBI chr 2:186,447,386...186,448,402
Ensembl chr 2:186,443,583...186,501,358

G

bolA family member 3

increases expression
decreases expression

ISO

Dibutyl Phthalate results in increased expression of BOLA3 mRNA
Dibutyl Phthalate results in decreased expression of BOLA3 mRNA

NCBI chr 4:117,411,044...117,420,491
Ensembl chr 4:117,410,680...117,420,491

G

BOP1 ribosomal biogenesis factor

increases expression

EXP

Dibutyl Phthalate results in increased expression of BOP1 mRNA

NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529

G

bisphosphoglycerate mutase

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of BPGM mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BPGM mRNA

PMID:21266533 PMID:31199487

NCBI chr 4:64,106,809...64,135,749
Ensembl chr 4:64,106,804...64,135,627

G

biphenyl hydrolase like

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BPHL mRNA

PMID:17361019 PMID:21266533

NCBI chr17:31,006,283...31,042,631
Ensembl chr17:31,004,972...31,042,632

G

BPI fold containing family B, member 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of BPIFB3 mRNA

NCBI chr 3:162,861,234...162,875,850
Ensembl chr 3:162,861,234...162,875,850

G

bromodomain PHD finger transcription factor

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of BPTF mRNA

PMID:17361019 PMID:21266533

NCBI chr10:92,480,007...92,582,485
Ensembl chr10:92,480,007...92,582,413

G

BRCA1-associated ATM activator 1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of BRAT1 mRNA
Dibutyl Phthalate results in decreased expression of BRAT1 mRNA

NCBI chr12:19,043,004...19,065,686
Ensembl chr12:19,042,591...19,055,369

G

BRCA1, DNA repair associated

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BRCA1 mRNA; Dibutyl Phthalate results in decreased expression of BRCA1 protein

PMID:21266533 PMID:31318015

NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763

G

BRCA2, DNA repair associated

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BRCA2 mRNA

PMID:17361019 PMID:21266533 PMID:31318015

NCBI chr12:4,895,092...4,939,340
Ensembl chr12:4,895,447...4,936,194

G

BRCA1/BRCA2-containing complex subunit 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BRCC3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:2,073,927...2,076,469
Ensembl chr 9:2,073,184...2,084,185

G

bromodomain containing 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of BRD1 mRNA

NCBI chr 7:121,653,859...121,701,700
Ensembl chr 7:121,653,859...121,701,700

G

bromodomain containing 7

increases expression

EXP

Dibutyl Phthalate results in increased expression of BRD7 mRNA

NCBI chr19:34,882,238...34,910,944
Ensembl chr19:34,882,304...34,910,944

G

bromodomain containing 8

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BRD8 mRNA

PMID:17361019 PMID:21266533

NCBI chr18:26,455,824...26,504,106
Ensembl chr18:26,455,512...26,504,006

G

BRMS1 like transcriptional repressor

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BRMS1L mRNA

NCBI chr 6:79,001,803...79,035,735
Ensembl chr 6:79,000,615...79,035,734

G

BRO1 domain and CAAX motif containing

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BROX promoter

NCBI chr13:97,451,736...97,471,598
Ensembl chr13:97,451,737...97,471,519

G

BR serine/threonine kinase 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BRSK1 mRNA

NCBI chr 1:78,162,944...78,193,598
Ensembl chr 1:78,163,341...78,188,922

G

BR serine/threonine kinase 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of BRSK2 mRNA

NCBI chr 1:206,465,040...206,518,156
Ensembl chr 1:206,465,040...206,518,156

G

BSCL2 lipid droplet biogenesis associated, seipin

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BSCL2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:215,160,957...215,172,536

G

BSD domain containing 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of BSDC1 mRNA

NCBI chr 5:147,083,044...147,113,997
Ensembl chr 5:147,079,838...147,114,241

G

basigin

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of BSG mRNA

NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005

G

bassoon (presynaptic cytomatrix protein)

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of BSN mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of BSN mRNA

PMID:21266533 PMID:25607892

NCBI chr 8:117,663,447...117,754,412
Ensembl chr 8:117,670,334...117,754,412

G

bone marrow stromal cell antigen 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of BST2 mRNA

NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967

G

B-TFIID TATA-box binding protein associated factor 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of BTAF1 mRNA

NCBI chr 1:244,065,728...244,156,457
Ensembl chr 1:244,065,743...244,156,457

G

betacellulin

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BTC mRNA

NCBI chr14:16,992,668...17,031,178
Ensembl chr14:16,992,193...17,033,078

G

basic transcription factor 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BTF3 mRNA

NCBI chr 2:31,394,010...31,401,138
Ensembl chr 2:31,394,011...31,401,125
Ensembl chr13:31,394,011...31,401,125

G

BTG anti-proliferation factor 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of BTG1 mRNA

NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406

G

BTG anti-proliferation factor 2

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of BTG2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BTG2 mRNA

PMID:17361019 PMID:21266533 PMID:21745491 PMID:39150890

NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690

G

BTG anti-proliferation factor 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of BTG3 mRNA

NCBI chr11:30,517,068...30,532,981
Ensembl chr11:30,517,072...30,533,082

G

beta-transducin repeat containing E3 ubiquitin protein ligase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BTRC mRNA

NCBI chr 1:254,159,085...254,324,819
Ensembl chr 1:254,159,124...254,328,357

G

BUB1 mitotic checkpoint serine/threonine kinase B

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of BUB1B mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of BUB1B mRNA]

PMID:21266533 PMID:28973377 PMID:36828243

NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796

G

BUB3 mitotic checkpoint protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of BUB3 mRNA

NCBI chr 1:195,760,532...195,771,140
Ensembl chr 1:195,758,105...195,791,028

G

BUD31 homolog

increases expression

EXP

Dibutyl Phthalate results in increased expression of BUD31 mRNA

NCBI chr12:14,576,602...14,584,132
Ensembl chr12:14,576,605...14,584,039

G

basic leucine zipper and W2 domains 1

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of BZW1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BZW1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:67,424,866...67,439,684

G

similar to human chromosome 5 open reading frame 15

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of C10H5ORF15 mRNA

NCBI chr10:37,064,889...37,077,493
Ensembl chr10:37,064,728...37,077,493

G

similar to human chromosome 21 open reading frame 91

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of D16ERTD472E mRNA

NCBI chr11:30,716,034...30,749,292
Ensembl chr11:30,716,034...30,749,415

G

similar to human chromosome 3 open reading frame 70

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of C11H3ORF70 mRNA

NCBI chr11:92,850,327...92,900,608
Ensembl chr11:92,850,327...92,900,608

G

similar to human chromosome 1 open reading frame 21

increases expression

EXP

Dibutyl Phthalate results in increased expression of C13H1ORF21 mRNA

NCBI chr13:66,540,245...66,749,631
Ensembl chr13:66,540,245...66,659,684

G

similar to human chromosome 1 open reading frame 53

increases expression

EXP

Dibutyl Phthalate results in increased expression of C13H1ORF53 mRNA

NCBI chr13:52,965,244...52,970,432
Ensembl chr13:52,965,244...52,970,607

G

similar to human chromosome 14 open reading frame 93

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of C15H14ORF93 mRNA
Dibutyl Phthalate results in decreased expression of C15H14ORF93 mRNA

NCBI chr15:32,007,591...32,034,337
Ensembl chr15:32,007,595...32,034,289

G

similar to human chromosome 18 open reading frame 32

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of C18H18ORF32 mRNA

NCBI chr18:70,861,434...70,869,983
Ensembl chr18:70,861,435...70,869,983

G

C1GALT1-specific chaperone 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of C1GALT1C1 mRNA

NCBI chr X:122,243,736...122,248,217
Ensembl chr X:122,234,454...122,248,422

G

similar to human chromosome 11 open reading frame 24

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of C1H11ORF24 mRNA
Dibutyl Phthalate results in decreased expression of C1H11ORF24 mRNA

NCBI chr 1:210,374,426...210,383,191
Ensembl chr 1:210,374,543...210,383,566

G

similar to human chromosome 15 open reading frame 40

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of C1H15ORF40 mRNA

NCBI chr 1:145,135,088...145,144,826
Ensembl chr 1:145,126,868...145,141,356

G

complement C1q binding protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of C1QBP mRNA

PMID:17361019 PMID:21266533

NCBI chr10:56,198,534...56,203,185
Ensembl chr10:56,198,540...56,203,235

G

complement C1q like 2

affects expression

EXP

Dibutyl Phthalate affects the expression of C1QL2 mRNA

NCBI chr13:34,023,902...34,025,437
Ensembl chr13:34,023,177...34,026,020

G

C1q and TNF related 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of C1QTNF1 mRNA

NCBI chr10:104,159,021...104,180,253
Ensembl chr10:104,158,886...104,180,251

G

C1q and TNF related 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of C1QTNF2 mRNA

PMID:21266533 PMID:24893172

NCBI chr10:28,443,326...28,460,400
Ensembl chr10:28,443,425...28,460,395

G

C1q and TNF related 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of C1QTNF3 mRNA

NCBI chr 2:61,644,225...61,666,640
Ensembl chr 2:61,644,276...61,666,559

G

C1q and TNF related 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of C1QTNF4 mRNA

NCBI chr 3:97,310,220...97,328,818
Ensembl chr 3:97,327,670...97,342,587

G

C1q and TNF related 5

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of C1QTNF5 mRNA

NCBI chr 8:53,347,754...53,349,912
Ensembl chr 8:53,347,711...53,349,912

G

C1q and TNF related 7

increases expression

EXP

Dibutyl Phthalate results in increased expression of C1QTNF7 mRNA

NCBI chr14:71,680,415...71,792,931
Ensembl chr14:71,680,479...71,792,865

G

C1q and TNF related 9

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of C1QTNF9 mRNA

NCBI chr15:39,083,883...39,099,167
Ensembl chr15:39,087,163...39,099,398

G

complement C1r

increases expression

ISO

Dibutyl Phthalate results in increased expression of C1R mRNA

PMID:17361019 PMID:21266533

NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714

G

similar to human chromosome 11 open reading frame 91

increases expression

EXP

Dibutyl Phthalate results in increased expression of C3H11ORF91 mRNA

NCBI chr 3:110,934,488...110,941,511
Ensembl chr 3:110,939,526...110,941,508

G

complement C4A (Rodgers blood group)

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of C4A promoter

NCBI chr20:4,010,306...4,024,707

G

similar to human chromosome 2 open reading frame 42

increases expression

EXP

Dibutyl Phthalate results in increased expression of C4H2ORF42 mRNA

NCBI chr 4:120,445,032...120,474,227
Ensembl chr 4:120,445,830...120,474,396

G

complement C5

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of C5 protein

NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468

G

complement C5a receptor 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of C5AR1 mRNA

PMID:15620428 PMID:21266533

NCBI chr 1:86,077,309...86,088,001

G

similar to human chromosome 1 open reading frame 216

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of C5H1ORF216 mRNA

NCBI chr 5:144,168,240...144,189,761
Ensembl chr 5:144,184,603...144,190,546

G

similar to human chromosome 11 open reading frame 54

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of C8H11ORF54 mRNA

NCBI chr 8:20,405,240...20,427,811
Ensembl chr 8:20,405,241...20,427,811

G

similar to human chromosome 11 open reading frame 71

increases expression

EXP

Dibutyl Phthalate results in increased expression of C8H11ORF71 mRNA

NCBI chr 8:57,735,075...57,735,489
Ensembl chr 8:57,734,900...57,738,597

G

carbonic anhydrase 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CAR1 mRNA

NCBI chr 2:88,550,681...88,593,454
Ensembl chr 2:88,495,475...88,593,454

G

carbonic anhydrase 11

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of CAR11 mRNA
Dibutyl Phthalate results in increased expression of CAR11 mRNA

NCBI chr 1:105,306,347...105,311,651
Ensembl chr 1:105,302,289...105,311,832

G

carbonic anhydrase 12

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CAR12 mRNA

NCBI chr 8:76,169,723...76,225,465
Ensembl chr 8:76,169,815...76,225,465

G

calcium binding protein 39

increases expression

EXP

Dibutyl Phthalate results in increased expression of CAB39 mRNA

NCBI chr 9:93,911,099...93,972,542
Ensembl chr 9:93,911,054...93,972,542

G

calcineurin binding protein 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CABIN1 mRNA

NCBI chr20:12,892,750...13,014,801
Ensembl chr20:12,892,771...13,014,800

G

Cdk5 and Abl enzyme substrate 1

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of CABLES1 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CABLES1 promoter

PMID:21266533 PMID:23359474

NCBI chr18:3,349,681...3,455,956
Ensembl chr18:3,351,652...3,455,956

G

calcium binding protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CABP1 mRNA

NCBI chr12:47,045,914...47,109,614
Ensembl chr12:47,085,292...47,109,611

G

calcium voltage-gated channel subunit alpha1 A

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of CACNA1A mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1A mRNA

PMID:21266533 PMID:25607892

NCBI chr19:40,425,560...40,724,810
Ensembl chr19:40,425,560...40,724,599

G

calcium voltage-gated channel subunit alpha1 B

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1B mRNA

NCBI chr 3:27,779,133...27,944,292
Ensembl chr 3:27,779,166...27,944,285

G

calcium voltage-gated channel subunit alpha1 C

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA

NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762

G

calcium voltage-gated channel subunit alpha1 D

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1D mRNA

NCBI chr16:5,233,682...5,527,549
Ensembl chr16:5,233,690...5,674,692

G

calcium voltage-gated channel subunit alpha1 G

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1G mRNA

NCBI chr10:79,851,886...79,919,926
Ensembl chr10:79,851,896...79,919,634

G

calcium voltage-gated channel subunit alpha1 H

affects expression

EXP

Dibutyl Phthalate affects the expression of CACNA1H mRNA

NCBI chr10:14,894,630...14,952,317
Ensembl chr10:14,894,641...14,952,771

G

calcium voltage-gated channel subunit alpha1 I

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNA1I mRNA

NCBI chr 7:113,716,266...113,827,670
Ensembl chr 7:113,716,266...113,827,670

G

calcium voltage-gated channel auxiliary subunit alpha2delta 3

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CACNA2D3 mRNA

NCBI chr16:4,105,048...4,919,037
Ensembl chr16:4,105,048...4,919,098

G

calcium voltage-gated channel auxiliary subunit beta 1

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB1 mRNA

NCBI chr10:83,494,509...83,515,164
Ensembl chr10:83,494,509...83,515,146

G

calcium voltage-gated channel auxiliary subunit beta 3

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNB3 mRNA

NCBI chr 7:131,663,810...131,676,085
Ensembl chr 7:131,662,545...131,676,085

G

calcium voltage-gated channel auxiliary subunit gamma 2

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG2 mRNA

NCBI chr 7:111,451,605...111,579,071
Ensembl chr 7:111,455,006...111,577,757

G

calcium voltage-gated channel auxiliary subunit gamma 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CACNG3 mRNA

NCBI chr 1:186,632,334...186,728,220
Ensembl chr 1:186,632,323...186,728,214

G

calcium voltage-gated channel auxiliary subunit gamma 6

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CACNG6 mRNA

NCBI chr 1:74,648,342...74,663,351
Ensembl chr 1:74,648,063...74,662,753

G

calcium voltage-gated channel auxiliary subunit gamma 7

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNG7 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CACNG7 mRNA

PMID:25607892 PMID:31199487

NCBI chr 1:74,715,483...74,746,669
Ensembl chr 1:74,715,483...74,746,669

G

carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CAD mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297

G

cell adhesion molecule 1

decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of CADM1 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CADM1 mRNA

PMID:17361019 PMID:21266533 PMID:25607892

NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192

G

cell adhesion molecule 3

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CADM3 mRNA

NCBI chr13:88,317,124...88,349,718
Ensembl chr13:88,317,124...88,350,114

G

calcium dependent secretion activator

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of CADPS mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CADPS mRNA

PMID:21266533 PMID:31199487

NCBI chr15:14,719,078...15,173,218
Ensembl chr15:14,720,726...15,173,211

G

calcitonin-related polypeptide alpha

multiple interactions
increases expression

EXP
ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CALCA promoter
Dibutyl Phthalate results in increased expression of CALCA protein
[Dibutyl Phthalate co-treated with Ovalbumin] results in increased expression of CALCA protein; Dibutyl Phthalate promotes the reaction [OVAL protein results in increased expression of CALCA protein]; olcegepant inhibits the reaction [[Dibutyl Phthalate co-treated with Ovalbumin] results in increased expression of CALCA protein]

PMID:23359474 PMID:32446102 PMID:38157815

NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529

G

calcium binding and coiled coil domain 1

multiple interactions
increases expression

EXP
ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CALCOCO1 promoter
Dibutyl Phthalate results in increased expression of CALCOCO1 mRNA

PMID:17361019 PMID:21266533 PMID:23359474

NCBI chr 7:135,713,208...135,728,044
Ensembl chr 7:135,713,208...135,727,928

G

caldesmon 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CALD1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085

G

calmodulin 1

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of CALM1 mRNA
Dibutyl Phthalate results in increased expression of CALM1 mRNA

PMID:21266533 PMID:28415704

NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381

G

calmodulin 3

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CALM3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:86,717,321...86,725,960

G

calmodulin-like 4

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CALML4 mRNA

NCBI chr 8:72,218,870...72,230,650
Ensembl chr 8:72,218,613...72,230,650

G

calreticulin

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CALR mRNA

PMID:17361019 PMID:21266533

NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236

G

calcium/calmodulin-dependent protein kinase ID

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CAMK1D mRNA

NCBI chr17:77,491,191...77,892,018
Ensembl chr17:77,491,220...77,892,012

G

calcium/calmodulin-dependent protein kinase II beta

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of CAMK2B mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CAMK2B mRNA

PMID:21266533 PMID:25607892

NCBI chr14:85,059,166...85,148,121
Ensembl chr14:85,059,191...85,148,485

G

calcium/calmodulin-dependent protein kinase II gamma

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CAMK2G mRNA

NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,553,294...3,612,310

G

calcium/calmodulin-dependent protein kinase IV

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CAMK4 mRNA

NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,857,146...25,077,193

G

calcium/calmodulin-dependent protein kinase kinase 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CAMKK1 mRNA

NCBI chr10:58,135,872...58,159,023
Ensembl chr10:58,135,915...58,159,010

G

calmodulin regulated spectrin-associated protein family, member 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CAMSAP3 mRNA

NCBI chr12:6,440,959...6,464,582
Ensembl chr12:6,441,152...6,464,582

G

cullin-associated and neddylation-dissociated 2 (putative)

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of CAND2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CAND2 mRNA

PMID:21266533 PMID:39150890

NCBI chr 4:150,507,659...150,535,755
Ensembl chr 4:150,507,657...150,541,293

G

cyclase associated actin cytoskeleton regulatory protein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CAP1 mRNA

NCBI chr 5:140,427,265...140,507,678
Ensembl chr 5:140,427,269...140,453,470

G

cyclase associated actin cytoskeleton regulatory protein 2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CAP2 mRNA

PMID:17361019 PMID:21266533

NCBI chr17:18,260,462...18,409,681
Ensembl chr17:18,261,646...18,409,563

G

calpain 10

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CAPN10 mRNA

NCBI chr 9:100,943,665...100,957,910
Ensembl chr 9:100,945,551...100,957,912

G

calpain 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CAPN5 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:161,827,474...161,884,142
Ensembl chr 1:161,827,474...161,884,142

G

calpain 8

increases expression

EXP

Dibutyl Phthalate results in increased expression of CAPN8 mRNA

NCBI chr13:96,783,640...96,847,825
Ensembl chr13:96,783,667...96,847,820

G

carbonic anhydrase 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CAR2 mRNA

NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064

G

calcium regulated heat stable protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CARHSP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:7,453,602...7,467,218
Ensembl chr10:7,452,978...7,467,770

G

cysteinyl-tRNA synthetase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CARS1 mRNA

NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407

G

CAS1 domain containing 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CASD1 mRNA

NCBI chr 4:33,613,805...33,705,821
Ensembl chr 4:33,613,450...33,705,821

G

caspase 1

multiple interactions
increases cleavage

ISO
EXP

KN 62 inhibits the reaction [Dibutyl Phthalate results in increased cleavage of CASP1 protein]
[Benzo(a)pyrene co-treated with Dibutyl Phthalate] results in increased cleavage of CASP1 protein; [Benzo(a)pyrene co-treated with Dibutyl Phthalate] results in increased expression of CASP1 mRNA

PMID:26586371 PMID:36592837

NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275

G

caspase 12

multiple interactions

ISO

Melatonin inhibits the reaction [Dibutyl Phthalate results in increased activity of CASP12 protein]

NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442

G

caspase 14

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CASP14 mRNA

NCBI chr 7:11,577,315...11,583,987
Ensembl chr 7:11,580,339...11,583,171

G

caspase 2

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP2 mRNA

NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022

G

caspase 3

decreases expression
increases expression
increases cleavage
multiple interactions
increases activity

ISO
EXP

Dibutyl Phthalate results in decreased expression of CASP3 mRNA
Dibutyl Phthalate results in increased expression of CASP3 protein
Dibutyl Phthalate results in increased cleavage of CASP3 protein
Dibutyl Phthalate results in increased expression of CASP3 mRNA; Dibutyl Phthalate results in increased expression of CASP3 protein
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine promotes the reaction [Dibutyl Phthalate results in increased activity of CASP3 protein]; Y 27632 inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]
2-chloro-5-nitrobenzanilide promotes the reaction [Dibutyl Phthalate results in increased activity of CASP3 protein]; 4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol promotes the reaction [Dibutyl Phthalate results in increased activity of CASP3 protein]; [1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole co-treated with Dibutyl Phthalate] results in increased activity of CASP3 protein; [alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP3 protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CASP3 mRNA; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CASP3 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased activity of CASP3 protein; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of and results in increased activity of CASP3 protein; AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased cleavage of CASP3 protein]; AKT1 protein affects the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased cleavage of CASP3 protein]]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]; Curcumin inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in increased cleavage of CASP3 protein]; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in increased expression of CASP3 mRNA]; Dibutyl Phthalate results in increased expression of and results in increased activity of CASP3 protein; Diethylhexyl Phthalate promotes the reaction [Dibutyl Phthalate results in increased cleavage of CASP3 protein]; ESR1 protein affects the reaction [Dibutyl Phthalate results in increased activity of CASP3 protein]; ESR2 protein affects the reaction [Dibutyl Phthalate results in increased activity of CASP3 protein]; MK 2206 inhibits the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased cleavage of CASP3 protein]]; NFE2L2 protein affects the reaction [Dibutyl Phthalate results in increased activity of CASP3 protein]; Nimodipine inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]

PMID:17361019 PMID:21266533 PMID:27581038 PMID:28611354 PMID:29029336 More...

NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732

G

caspase 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CASP6 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726

G

caspase 7

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of CASP7 mRNA
Dibutyl Phthalate results in increased expression of CASP7 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512

G

caspase 8

multiple interactions
increases expression

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP8 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of CASP8 protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CASP8 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] results in increased expression of CASP8 mRNA; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in increased expression of CASP8 protein]
Dibutyl Phthalate results in increased expression of CASP8 mRNA; Dibutyl Phthalate results in increased expression of CASP8 protein

PMID:28013214 PMID:31712109 PMID:33091774 PMID:35739755 PMID:37364641 More...

NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699

G

caspase 9

increases activity
increases cleavage
increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased activity of CASP9 protein
Dibutyl Phthalate results in increased cleavage of CASP9 protein
Dibutyl Phthalate results in increased expression of CASP9 mRNA; Dibutyl Phthalate results in increased expression of CASP9 protein
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine promotes the reaction [Dibutyl Phthalate results in increased activity of CASP9 protein]
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP9 protein; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of CASP9 protein; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP9 protein]; Curcumin inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP9 protein]; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in increased cleavage of CASP9 protein]; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in increased expression of CASP9 mRNA]; Melatonin inhibits the reaction [Dibutyl Phthalate results in increased activity of CASP9 protein]; NFE2L2 protein affects the reaction [Dibutyl Phthalate results in increased activity of CASP9 protein]

PMID:30910607 PMID:31712109 PMID:33091774 PMID:33729022 PMID:35739755

Ensembl chr 5:159,391,188...159,409,648

G

calsequestrin 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CASQ2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:192,214,556...192,270,821
Ensembl chr 2:192,214,537...192,270,820

G

calcium-sensing receptor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CASR mRNA

NCBI chr11:77,738,398...77,813,639
Ensembl chr11:77,740,614...77,810,167

G

calpastatin

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of CAST protein

NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:5,707,640...5,817,180

G

cytosolic arginine sensor for mTORC1 subunit 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CASTOR1 mRNA

NCBI chr14:83,309,710...83,314,123
Ensembl chr14:83,309,504...83,314,127

G

catalase

decreases expression
increases activity
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of CAT mRNA
Dibutyl Phthalate results in increased activity of CAT protein
2-aminoethoxydiphenyl borate inhibits the reaction [Ascorbic Acid inhibits the reaction [Dibutyl Phthalate results in decreased expression of CAT mRNA]]; Ascorbic Acid inhibits the reaction [Dibutyl Phthalate results in decreased expression of CAT mRNA]; taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of CAT mRNA]
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of CAT mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CAT mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CAT mRNA; Melatonin inhibits the reaction [Dibutyl Phthalate results in increased activity of CAT protein]
Dibutyl Phthalate results in increased expression of CAT mRNA; Dibutyl Phthalate results in increased expression of CAT protein

PMID:21266533 PMID:24893172 PMID:25172463 PMID:28013214 PMID:28415704 More...

NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526

G

caveolin 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CAV1 mRNA

NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740

G

CBFA2/RUNX1 partner transcriptional co-repressor 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CBFA2T3 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:67,584,319...67,658,533
Ensembl chr19:67,589,258...67,658,136

G

core-binding factor subunit beta

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CBFB mRNA

PMID:17361019 PMID:21266533

NCBI chr19:49,955,133...50,002,661
Ensembl chr19:49,959,096...50,002,657

G

Cbl proto-oncogene C

increases expression

ISO

Dibutyl Phthalate results in increased expression of CBLC mRNA

NCBI chr 1:88,567,930...88,584,709
Ensembl chr 1:88,567,932...88,584,709

G

cerebellin 1 precursor

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CBLN1 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:35,782,151...35,785,960
Ensembl chr19:35,781,952...35,785,960

G

cerebellin 2 precursor

increases expression

EXP

Dibutyl Phthalate results in increased expression of CBLN2 mRNA

NCBI chr18:82,215,210...82,222,648
Ensembl chr18:82,215,220...82,222,648

G

cerebellin 4 precursor

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CBLN4 promoter

NCBI chr 3:181,218,046...181,225,600
Ensembl chr 3:181,218,046...181,225,600

G

carbonyl reductase 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CBR1 mRNA

PMID:17361019 PMID:21266533

NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104
Ensembl chr11:46,378,411...46,381,104

G

carbonyl reductase 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CBR4 mRNA

NCBI chr16:33,625,734...33,695,067
Ensembl chr16:33,617,399...33,656,832

G

cystathionine beta synthase

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CBS mRNA

NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066

G

chromobox 5

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CBX5 mRNA

NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:136,211,649...136,229,118

G

chibby 1, beta catenin antagonist

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CBY1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:113,097,220...113,103,831

G

coiled-coil and C2 domain containing 2A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CC2D2A mRNA

NCBI chr14:71,563,835...71,648,352
Ensembl chr14:71,563,835...71,648,331

G

cell division cycle and apoptosis regulator 1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CCAR1 mRNA
Dibutyl Phthalate results in decreased expression of CCAR1 mRNA

NCBI chr20:31,228,624...31,271,233
Ensembl chr20:31,228,624...31,271,227

G

coiled-coil domain containing 112

increases expression

EXP

Dibutyl Phthalate results in increased expression of CCDC112 mRNA

NCBI chr18:41,184,769...41,218,958
Ensembl chr18:41,184,769...41,218,958

G

coiled-coil domain containing 115

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCDC115 mRNA

NCBI chr 9:44,146,287...44,150,250
Ensembl chr 9:44,145,161...44,149,899

G

coiled-coil domain containing 12

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCDC12 mRNA

NCBI chr 8:119,513,007...119,564,802
Ensembl chr 8:119,514,094...119,564,802

G

coiled-coil domain containing 17

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CCDC17 promoter

NCBI chr 5:135,288,799...135,293,339
Ensembl chr 5:135,289,576...135,293,336

G

coiled-coil domain containing 25

increases expression

ISO

Dibutyl Phthalate results in increased expression of CCDC25 mRNA

NCBI chr15:44,230,927...44,263,317
Ensembl chr15:44,230,940...44,265,236

G

coiled coil domain containing 28B

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CCDC28B mRNA
Dibutyl Phthalate results in increased expression of CCDC28B mRNA

NCBI chr 5:147,246,627...147,251,629
Ensembl chr 5:147,246,628...147,251,629

G

coiled-coil domain containing 3

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of CCDC3 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CCDC3 mRNA

PMID:21266533 PMID:39150890

NCBI chr17:77,941,148...78,044,820
Ensembl chr17:77,944,977...78,044,470

G

coiled-coil domain 39 molecular ruler complex subunit

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCDC39 mRNA

NCBI chr 2:118,593,881...118,631,584
Ensembl chr 2:118,593,881...118,631,647

G

coiled-coil domain containing 69

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCDC69 mRNA

NCBI chr10:39,673,984...39,701,080
Ensembl chr10:39,673,985...39,700,579

G

coiled-coil domain containing 77

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCDC77 mRNA

NCBI chr 4:155,206,402...155,238,235
Ensembl chr 4:155,193,275...155,239,207

G

coiled-coil domain containing 85B

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CCDC85B mRNA

NCBI chr 1:212,192,979...212,193,994
Ensembl chr 1:212,189,468...212,196,911

G

cholecystokinin

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CCK mRNA

NCBI chr 8:130,031,012...130,037,702
Ensembl chr 8:130,031,013...130,037,686

G

cholecystokinin A receptor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CCKAR mRNA

NCBI chr14:61,505,270...61,513,618
Ensembl chr14:61,505,270...61,513,618

G

cholecystokinin B receptor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CCKBR mRNA

NCBI chr 1:169,183,578...169,193,583
Ensembl chr 1:169,183,194...169,193,745

G

C-C motif chemokine ligand 12

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CCL12 mRNA

NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,567,876...67,569,426

G

C-C motif chemokine ligand 17

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of CCL17 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CCL17 mRNA

PMID:17361019 PMID:21266533 PMID:30551395 PMID:40323316

NCBI chr19:10,208,120...10,218,340
Ensembl chr19:10,208,120...10,209,895

G

C-C motif chemokine ligand 2

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of CCL2 mRNA
Dibutyl Phthalate inhibits the reaction [MIR137 mRNA results in decreased expression of CCL2 protein]; Dibutyl Phthalate results in increased expression of and results in increased secretion of CCL2 protein; SP1 protein affects the reaction [Dibutyl Phthalate results in increased expression of CCL2 mRNA]
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL2 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CCL2 mRNA

PMID:21266533 PMID:35397443 PMID:37021957 PMID:40323316

NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875

G

C-C motif chemokine ligand 20

increases expression

EXP

Dibutyl Phthalate results in increased expression of CCL20 mRNA

NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736

G

C-C motif chemokine ligand 21

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CCL21A mRNA

NCBI chr 5:61,776,411...61,777,515
Ensembl chr 5:61,776,413...61,777,540

G

C-C motif chemokine ligand 22

multiple interactions
increases expression
decreases expression

EXP
ISO

Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in decreased expression of CCL22 protein]; Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in decreased expression of CCL22 protein]
Dibutyl Phthalate results in increased expression of CCL22 mRNA

PMID:30551395 PMID:35378083

NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,263,589...10,270,359

G

C-C motif chemokine ligand 5

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL5 mRNA

NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884

G

C-C motif chemokine ligand 7

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CCL7 mRNA

NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947

G

C-C motif chemokine ligand 9

increases expression

EXP

Dibutyl Phthalate results in increased expression of CCL6 mRNA

NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877

G

CCM2 scaffold protein

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CCM2 mRNA
Dibutyl Phthalate results in decreased expression of CCM2 mRNA

NCBI chr14:85,632,338...85,678,016
Ensembl chr14:85,632,001...85,678,028

G

cellular communication network factor 1

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of CCN1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CCN1 mRNA

PMID:17361019 PMID:21266533 PMID:40323316

NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883

G

cellular communication network factor 2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CCN2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976

G

cellular communication network factor 4

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of CCN4 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CCN4 mRNA

PMID:21266533 PMID:39150890

NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094

G

cyclin A2

decreases expression
multiple interactions
increases expression

ISO

Dibutyl Phthalate results in decreased expression of CCNA2 mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of CCNA2 mRNA]

PMID:23242528 PMID:36828243

NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701

G

cyclin B1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCNB1 mRNA

PMID:17361019 PMID:23242528 PMID:28973377

NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225

G

cyclin B2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCNB2 mRNA

PMID:17361019 PMID:21266533 PMID:28973377

NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682

G

cyclin C

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCNC mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:40,063,589...40,081,731
Ensembl chr 5:40,063,623...40,093,370

G

cyclin D1

increases expression
decreases methylation

ISO

Dibutyl Phthalate results in increased expression of CCND1 mRNA
Dibutyl Phthalate results in decreased methylation of CCND1 promoter

PMID:22179484 PMID:35487445

NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810

G

cyclin D2

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of CCND2 mRNA
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CCND2 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CCND2 mRNA

PMID:17361019 PMID:21266533 PMID:23242528 PMID:28013214 PMID:28486587 More...

NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301

G

cyclin D3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CCND3 mRNA

NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033

G

cyclin E1

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of CCNE1 mRNA
Dibutyl Phthalate results in increased expression of CCNE1 mRNA

PMID:23242528 PMID:28486587

NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822

G

cyclin E2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CCNE2 mRNA

NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:29,082,703...29,094,882

G

cyclin F

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCNF mRNA

NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837

G

cyclin G1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CCNG1 mRNA

NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766

G

cyclin H

increases expression

EXP

Dibutyl Phthalate results in increased expression of CCNH mRNA

NCBI chr 2:17,570,449...17,591,078
Ensembl chr 2:17,570,263...17,614,860

G

cyclin L1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CCNL1 mRNA

NCBI chr 2:152,495,169...152,508,855
Ensembl chr 2:152,495,172...152,507,468

G

cyclin L2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CCNL2 mRNA

NCBI chr 5:171,698,951...171,711,037
Ensembl chr 5:171,699,689...171,711,231

G

cyclin T2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCNT2 mRNA

NCBI chr13:41,804,007...41,845,641
Ensembl chr13:41,804,046...41,844,488

G

cyclin Y-like 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CCNYL1 mRNA

NCBI chr 9:73,565,484...73,601,926
Ensembl chr 9:73,565,402...73,601,922

G

chaperonin containing TCP1 subunit 2

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CCT2 mRNA

NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977

G

chaperonin containing TCP1 subunit 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCT3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:176,063,526...176,089,925

G

chaperonin containing TCP1 subunit 7

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCT7 mRNA

NCBI chr 4:119,546,730...119,563,973
Ensembl chr 4:119,546,730...119,563,973

G

CCZ1 homolog, vacuolar protein trafficking and biogenesis associated

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CCZ1 mRNA

NCBI chr12:15,714,768...15,738,273
Ensembl chr12:15,714,748...15,738,268

G

CD151 molecule (Raph blood group)

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CD151 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:205,994,300...205,998,307
Ensembl chr 1:205,994,738...205,998,784

G

CD1d1 molecule

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CD1D1 mRNA

NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:174,721,522...174,725,029

G

CD24 molecule

increases expression

ISO

Dibutyl Phthalate results in increased expression of CD24A mRNA

NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785

G

CD244 molecule

increases expression

EXP

Dibutyl Phthalate results in increased expression of CD244 mRNA

NCBI chr13:86,583,727...86,606,902
Ensembl chr13:86,584,826...86,616,009

G

CD248 molecule

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CD248 mRNA

NCBI chr 1:211,803,052...211,805,616
Ensembl chr 1:211,801,934...211,805,776

G

Cd276 molecule

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CD276 promoter

NCBI chr 8:67,833,587...67,863,918
Ensembl chr 8:67,829,048...67,864,505

G

Cd2 (cytoplasmic tail) binding protein 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CD2BP2 mRNA

NCBI chr 1:191,239,899...191,244,395
Ensembl chr 1:191,239,901...191,243,398

G

CD320 molecule

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CD320 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:15,328,320...15,334,138
Ensembl chr 7:15,311,286...15,334,138

G

CD36 molecule

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of CD36 mRNA
[Dietary Fats co-treated with diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CD36 mRNA
Dibutyl Phthalate results in increased expression of CD36 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CD36 mRNA; Dibutyl Phthalate affects the expression of and affects the localization of CD36 protein
Dibutyl Phthalate inhibits the reaction [[Rosiglitazone co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD36 protein]; Dibutyl Phthalate promotes the reaction [[15-deoxyprostaglandin J2 co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD36 protein]; Dibutyl Phthalate promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD36 protein]

PMID:21266533 PMID:30218697 PMID:30599393 PMID:36736749 PMID:39150890

NCBI chr 4:18,209,088...18,302,142

G

CD3 gamma subunit of T-cell receptor complex

increases expression

EXP

Dibutyl Phthalate results in increased expression of CD3G mRNA

NCBI chr 8:54,177,572...54,184,087
Ensembl chr 8:54,177,977...54,183,918

G

CD40 molecule

increases expression

ISO

Dibutyl Phthalate results in increased expression of CD40 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847

G

CD44 molecule

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of CD44 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CD44 mRNA

PMID:21266533 PMID:25607892

NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424

G

Cd47 molecule

increases expression

EXP

Dibutyl Phthalate results in increased expression of CD47 mRNA

NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272

G

CD52 molecule

increases expression

EXP

Dibutyl Phthalate results in increased expression of CD52 mRNA

NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086

G

CD55 molecule (Cromer blood group)

increases expression

EXP

Dibutyl Phthalate results in increased expression of CD55 mRNA

NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107

G

CD59b molecule

increases expression

EXP

Dibutyl Phthalate results in increased expression of CD59 mRNA

NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310

G

Cd63 molecule

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of CD63 mRNA
Dibutyl Phthalate results in decreased expression of CD63 mRNA

PMID:17379624 PMID:21266533

NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,922,169...1,924,938

G

Cd81 molecule

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CD81 mRNA

NCBI chr 1:207,665,274...207,681,094
Ensembl chr 1:207,664,885...207,681,092

G

Cd82 molecule

increases expression

ISO

Dibutyl Phthalate results in increased expression of CD82 mRNA

NCBI chr 3:99,842,748...99,887,298
Ensembl chr 3:99,842,757...99,886,744

G

CD86 molecule

increases expression

ISO

Dibutyl Phthalate results in increased expression of CD86 protein

NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361

G

CD9 molecule

increases expression

EXP

Dibutyl Phthalate results in increased expression of CD9 mRNA

NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444

G

CD93 molecule

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of CD93 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CD93 mRNA

PMID:38954831 PMID:39150890

NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537

G

CD99 molecule (Xg blood group)

increases expression

ISO

Dibutyl Phthalate results in increased expression of CD99 mRNA

NCBI chr20:56,000,494...56,005,140

G

CD99 molecule-like 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CD99L2 mRNA

NCBI chr15:6,861,242...6,906,838
Ensembl chr15:6,864,268...6,906,952

G

cell division cycle 123

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDC123 mRNA

PMID:17361019 PMID:21266533

NCBI chr17:77,368,376...77,412,659
Ensembl chr17:77,368,397...77,412,659

G

cell division cycle 14A

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CDC14A mRNA
Dibutyl Phthalate results in decreased expression of CDC14A mRNA

NCBI chr 2:206,910,475...207,070,537
Ensembl chr 2:206,910,475...207,091,722

G

cell division cycle 16

increases expression

EXP

Dibutyl Phthalate results in increased expression of CDC16 mRNA

NCBI chr16:82,475,234...82,498,797
Ensembl chr16:82,474,523...82,498,765

G

cell division cycle 20

decreases expression
increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of CDC20 mRNA
Dibutyl Phthalate results in increased expression of CDC20 mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of CDC20 mRNA]

PMID:17361019 PMID:21266533 PMID:28973377 PMID:36828243

NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799

G

cell division cycle 23

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDC23 mRNA

NCBI chr18:26,511,019...26,534,872
Ensembl chr18:26,510,355...26,532,646

G

cell division cycle 25A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDC25A mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188

G

cell division cycle 25B

increases expression

ISO

Dibutyl Phthalate results in increased expression of CDC25B mRNA

NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492

G

cell division cycle 25C

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDC25C mRNA

PMID:17361019 PMID:21266533

NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292

G

CDC42 binding protein kinase alpha

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CDC42BPA mRNA

NCBI chr13:94,215,359...94,435,681
Ensembl chr13:94,215,959...94,435,681

G

CDC42 effector protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CDC42EP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:112,275,759...112,283,665
Ensembl chr 7:112,275,792...112,283,664

G

CDC42 effector protein 2

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of CDC42EP2 mRNA
Dibutyl Phthalate results in increased expression of CDC42EP2 mRNA

NCBI chr 1:212,631,317...212,640,231
Ensembl chr 1:212,629,881...212,640,234

G

CDC42 effector protein 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of CDC42EP3 mRNA

NCBI chr 6:21,463,081...21,483,553
Ensembl chr 6:21,461,762...21,508,540

G

CDC42 effector protein 5

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CDC42EP5 mRNA

NCBI chr 1:79,108,036...79,110,550

G

CDC42 small effector 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CDC42SE1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:185,494,692...185,502,519
Ensembl chr 2:185,496,547...185,502,514

G

cell division cycle 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDC6 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241

G

cell division cycle 7

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDC7 mRNA

NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,949,539...2,969,656

G

cell division cycle associated 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDCA2 mRNA

NCBI chr15:46,071,360...46,117,524
Ensembl chr15:46,071,360...46,116,639

G

cell division cycle associated 3

decreases expression
increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of CDCA3 mRNA
Dibutyl Phthalate results in increased expression of CDCA3 mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of CDCA3 mRNA]

PMID:17361019 PMID:21266533 PMID:36828243

NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068

G

cell division cycle associated 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDCA4 mRNA

NCBI chr 6:137,713,390...137,722,652
Ensembl chr 6:137,713,051...137,722,580

G

cell division cycle associated 5

decreases expression
increases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of CDCA5 mRNA
Dibutyl Phthalate results in increased expression of CDCA5 mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of CDCA5 mRNA]

PMID:17361019 PMID:21266533 PMID:36828243

NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:212,804,014...212,821,309

G

cell division cycle associated 7

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of CDCA7 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:77,730,315...77,740,950
Ensembl chr 3:77,729,970...77,740,947

G

cell division cycle associated 7 like

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDCA7L mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:144,936,885...144,982,844
Ensembl chr 6:144,908,171...144,982,843

G

cell division cycle associated 8

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of CDCA8 mRNA

NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:142,461,084...142,483,283

G

cadherin 1

decreases expression
increases expression
multiple interactions
affects expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CDH1 protein
Dibutyl Phthalate results in increased expression of CDH1 mRNA; Dibutyl Phthalate results in increased expression of CDH1 protein
GJA1 protein promotes the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein]
Dibutyl Phthalate results in decreased expression of CDH1 mRNA; Dibutyl Phthalate results in decreased expression of CDH1 protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of CDH1 protein; ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 mRNA]; ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein]
Dibutyl Phthalate affects the expression of CDH1 mRNA; Dibutyl Phthalate affects the expression of CDH1 protein
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein]; Chloroquine inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 mRNA]; Chloroquine inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein]; Cycloheximide inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 mRNA]; Cycloheximide promotes the reaction [necrostatin-1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein]]; necrostatin-1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein]; Sirolimus promotes the reaction [Dibutyl Phthalate results in decreased expression of CDH1 mRNA]; Sirolimus promotes the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein]; Y 27632 affects the reaction [Dibutyl Phthalate affects the expression of CDH1 mRNA]; Y 27632 affects the reaction [Dibutyl Phthalate affects the expression of CDH1 protein]; Y 27632 inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 mRNA]; Y 27632 inhibits the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein]

PMID:22552774 PMID:30053495 PMID:30453174 PMID:32028152 PMID:32860865 More...

NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565

G

cadherin 11

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of CDH11 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CDH11 promoter

PMID:21266533 PMID:23359474 PMID:28415704

NCBI chr19:2,152,961...2,312,140
Ensembl chr19:2,154,840...2,312,140

G

cadherin 17

increases expression

EXP

Dibutyl Phthalate results in increased expression of CDH17 mRNA

NCBI chr 5:30,024,544...30,112,226
Ensembl chr 5:30,060,090...30,112,226

G

cadherin 2

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of CDH2 mRNA; Dibutyl Phthalate results in decreased expression of CDH2 protein
Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of CDH2 mRNA]; Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of CDH2 protein]; necrostatin-1 inhibits the reaction [Dibutyl Phthalate results in increased expression of CDH2 protein]; Sirolimus promotes the reaction [Dibutyl Phthalate results in increased expression of CDH2 mRNA]; Sirolimus promotes the reaction [Dibutyl Phthalate results in increased expression of CDH2 protein]
Dibutyl Phthalate results in increased expression of CDH2 mRNA; Dibutyl Phthalate results in increased expression of CDH2 protein

PMID:17361019 PMID:21266533 PMID:30053495 PMID:30453174 PMID:32028152 More...

NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288

G

cadherin-related 23

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CDH23 mRNA

NCBI chr20:28,783,124...29,165,624
Ensembl chr20:28,783,564...29,165,332

G

cadherin 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of CDH3 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:51,303,414...51,353,900
Ensembl chr19:51,300,083...51,354,257

G

cadherin 8

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CDH8 promoter

NCBI chr19:5,494,552...5,901,950
Ensembl chr19:5,500,221...5,902,627

G

cadherin-related family member 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDHR1 mRNA

NCBI chr16:12,863,696...12,883,579
Ensembl chr16:12,863,696...12,883,579

G

cyclin-dependent kinase 1

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of CDK1 mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of CDK1 mRNA]

PMID:21266533 PMID:36828243

NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455

G

cyclin-dependent kinase 17

increases expression

EXP

Dibutyl Phthalate results in increased expression of CDK17 mRNA

NCBI chr 7:29,570,982...29,677,613
Ensembl chr 7:29,570,816...29,652,008

G

cyclin-dependent kinase 20

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDK20 mRNA

NCBI chr17:706,863...717,828
Ensembl chr17:706,865...713,567

G

cyclin-dependent kinase 2 associated protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDK2AP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr12:37,910,718...37,919,446
Ensembl chr12:37,910,718...37,919,446

G

cyclin-dependent kinase 2 associated protein 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDK2AP2 mRNA

NCBI chr 1:210,819,155...210,822,604
Ensembl chr 1:210,820,507...210,823,010

G

cyclin-dependent kinase 4

increases expression
multiple interactions
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CDK4 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDK4 mRNA
Dibutyl Phthalate results in decreased expression of CDK4 mRNA

PMID:17361019 PMID:21266533 PMID:22179484 PMID:35762964

NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163

G

cyclin-dependent kinase 5 regulatory subunit 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDK5R1 mRNA

NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272

G

CDK5 regulatory subunit associated protein 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CDK5RAP2 mRNA

NCBI chr 5:88,807,402...88,976,005
Ensembl chr 5:88,807,402...88,976,069

G

CDK5 regulatory subunit associated protein 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDK5RAP3 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:82,390,845...82,402,814
Ensembl chr10:82,390,845...82,400,001

G

cyclin-dependent kinase 7

increases expression

EXP

Dibutyl Phthalate results in increased expression of CDK7 mRNA

NCBI chr 2:33,574,623...33,599,485
Ensembl chr 2:33,574,623...33,599,485

G

cyclin-dependent kinase inhibitor 1A

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of CDKN1A mRNA; Dibutyl Phthalate results in increased expression of CDKN1A protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CDKN1A mRNA; Ascorbic Acid inhibits the reaction [Dibutyl Phthalate results in increased expression of CDKN1A mRNA]; Ascorbic Acid inhibits the reaction [Dibutyl Phthalate results in increased expression of CDKN1A protein]
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1A mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA]

PMID:21266533 PMID:23242528 PMID:28415704 PMID:28486587 PMID:33316053 More...

NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969

G

cyclin-dependent kinase inhibitor 1B

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1B mRNA

NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498

G

cyclin-dependent kinase inhibitor 1C

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of CDKN1C mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDKN1C mRNA
Dibutyl Phthalate results in increased expression of CDKN1C mRNA

PMID:17379624 PMID:21266533 PMID:21745491 PMID:39150890

NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498

G

cyclin-dependent kinase inhibitor 2A

multiple interactions
increases expression
increases methylation
decreases expression

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CDKN2A mRNA
Dibutyl Phthalate results in increased expression of CDKN2A mRNA
Dibutyl Phthalate results in increased methylation of CDKN2A promoter
Dibutyl Phthalate results in decreased expression of CDKN2A mRNA

PMID:28013214 PMID:28486587 PMID:35487445

NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248

G

CDKN2A interacting protein N-terminal like

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CDKN2AIPNL mRNA

NCBI chr10:36,731,983...36,741,500
Ensembl chr10:36,732,013...36,741,495

G

cyclin-dependent kinase inhibitor 2C

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CDKN2C mRNA

NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891

G

cyclin dependent kinase inhibitor 2D

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDKN2D mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:28,108,036...28,110,809
Ensembl chr 8:28,108,044...28,110,809

G

cyclin-dependent kinase inhibitor 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CDKN3 mRNA

NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722

G

cysteine dioxygenase type 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDO1 mRNA

NCBI chr18:41,619,076...41,633,719
Ensembl chr18:41,619,070...41,633,891

G

cysteine rich, DPF motif domain containing 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CDPF1 mRNA

NCBI chr 7:118,773,497...118,785,283
Ensembl chr 7:118,780,845...118,783,161

G

cerebellar degeneration-related protein 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CDR2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:184,934,128...184,959,036
Ensembl chr 1:184,934,129...184,968,863

G

cerebellar degeneration-related protein 2-like

increases expression

ISO

Dibutyl Phthalate results in increased expression of CDR2L mRNA

NCBI chr10:101,123,777...101,137,634
Ensembl chr10:101,123,777...101,137,634

G

chromatin licensing and DNA replication factor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CDT1 mRNA

NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194

G

carnitine deficiency-associated gene expressed in ventricle 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of CDV3 mRNA

NCBI chr 8:112,812,898...112,826,073
Ensembl chr 8:112,813,952...112,826,056

G

CCAAT/enhancer binding protein alpha

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of CEBPA mRNA
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA

PMID:17361019 PMID:21266533 PMID:37021957

NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309

G

CCAAT/enhancer binding protein beta

multiple interactions
decreases expression

EXP

Dibutyl Phthalate inhibits the reaction [CEBPB binds to CYP11A1 promoter]; Dibutyl Phthalate inhibits the reaction [CEBPB binds to CYP17A1 promoter]; Dibutyl Phthalate inhibits the reaction [CEBPB binds to STAR promoter]
Dibutyl Phthalate results in decreased expression of CEBPB mRNA; Dibutyl Phthalate results in decreased expression of CEBPB protein

PMID:15728792 PMID:17884934 PMID:21266533 PMID:21745491

NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072

G

CCAAT/enhancer binding protein delta

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CEBPD mRNA

PMID:17361019 PMID:21266533 PMID:21745491

NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824

G

chymotrypsin like elastase 2A

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of CELA2A mRNA
[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of CELA2A protein
Dibutyl Phthalate results in increased expression of CELA2A protein

PMID:21266533 PMID:34864091

NCBI chr 5:159,409,900...159,420,282
Ensembl chr 5:159,409,899...159,426,208

G

chymotrypsin like elastase 3B

increases expression

EXP

Dibutyl Phthalate results in increased expression of ELA3B mRNA

PMID:21266533 PMID:33983380

NCBI chr 5:154,912,170...154,920,333
Ensembl chr 5:154,912,170...154,920,333

G

CUGBP, Elav-like family member 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CELF1 mRNA

NCBI chr 3:97,380,407...97,455,253
Ensembl chr 3:97,380,424...97,452,791

G

CUGBP, Elav-like family member 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CELF2 mRNA

NCBI chr17:75,813,928...76,639,300
Ensembl chr17:75,813,704...76,636,362

G

cadherin, EGF LAG seven-pass G-type receptor 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CELSR1 mRNA

NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856

G

cadherin, EGF LAG seven-pass G-type receptor 3

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CELSR3 mRNA

NCBI chr 8:118,409,136...118,438,593
Ensembl chr 8:118,409,136...118,436,847

G

centrosomal AT-AC splicing factor

increases expression

EXP

Dibutyl Phthalate results in increased expression of CENATAC mRNA

NCBI chr 8:53,632,777...53,639,661
Ensembl chr 8:53,632,044...53,639,650

G

centromere protein B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CENPB mRNA

NCBI chr 3:138,850,003...138,852,796
Ensembl chr 3:138,841,679...138,854,372

G

centromere protein H

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CENPH mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:33,630,738...33,644,258
Ensembl chr 2:33,630,738...33,644,242

G

centromere protein K

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CENPK mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:37,094,163...37,155,158
Ensembl chr 2:37,094,248...37,119,488

G

centromere protein M

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of CENPM mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CENPM mRNA

PMID:21266533 PMID:39150890

NCBI chr 7:115,628,117...115,639,401
Ensembl chr 7:115,628,129...115,643,866

G

centromere protein N

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CENPN mRNA

NCBI chr19:61,880,101...61,902,850
Ensembl chr19:61,877,148...61,902,918

G

centromere protein O

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CENPO mRNA

NCBI chr 6:32,923,127...32,937,879
Ensembl chr 6:32,908,025...32,937,853

G

centromere protein P

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CENPP mRNA

NCBI chr17:15,220,521...15,395,741
Ensembl chr17:15,220,291...15,395,739

G

centromere protein Q

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CENPQ mRNA

NCBI chr 9:27,454,339...27,469,371
Ensembl chr 9:27,454,252...27,469,366

G

centromere protein S

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CENPS mRNA

NCBI chr 5:164,847,009...164,856,705

G

centromere protein U

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CENPU mRNA

NCBI chr16:52,448,446...52,471,662
Ensembl chr16:52,425,096...52,471,662

G

centromere protein V

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CENPV mRNA

NCBI chr10:47,713,778...47,746,800
Ensembl chr10:47,713,778...47,727,679

G

centrosomal protein 15

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CEP15 mRNA

NCBI chr15:15,247,627...15,265,560
Ensembl chr15:15,247,932...15,265,475

G

centrosomal protein 164

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CEP164 mRNA

NCBI chr 8:54,967,621...55,031,264
Ensembl chr 8:54,967,621...55,031,206

G

centrosomal protein 20

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CEP20 mRNA

NCBI chr10:1,221,294...1,243,144
Ensembl chr10:1,221,371...1,245,241

G

centrosomal protein 250

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CEP250 mRNA

NCBI chr 3:164,931,033...164,976,210
Ensembl chr 3:164,931,066...164,976,210

G

centrosomal protein 295

increases expression

EXP

Dibutyl Phthalate results in increased expression of CEP295 mRNA

NCBI chr 8:20,437,967...20,475,968
Ensembl chr 8:20,437,338...20,476,115

G

centrosomal protein 43

increases expression

ISO

Dibutyl Phthalate results in increased expression of CEP43 mRNA

NCBI chr 1:55,080,983...55,111,509
Ensembl chr 1:55,082,712...55,111,509

G

centrosomal protein 44

increases expression

EXP

Dibutyl Phthalate results in increased expression of CEP44 mRNA

NCBI chr16:38,722,259...38,741,603
Ensembl chr16:38,721,513...38,741,614

G

centrosomal protein 55

multiple interactions
increases expression

EXP
ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CEP55 promoter
Dibutyl Phthalate results in increased expression of CEP55 mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of CEP55 mRNA]

PMID:23359474 PMID:36828243

NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890

G

centrosomal protein 57

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CEP57 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:18,951,179...18,971,205
Ensembl chr 8:18,932,808...18,970,890

G

centrosomal protein 57-like 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CEP57L1 mRNA

NCBI chr20:46,820,350...46,876,911
Ensembl chr20:46,820,353...46,876,926

G

centrosomal protein 78

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CEP78 mRNA

NCBI chr 1:222,674,193...222,702,124
Ensembl chr 1:222,674,194...222,702,120

G

centrosomal protein 85

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CEP85 promoter

NCBI chr 5:151,640,316...151,687,891
Ensembl chr 5:151,639,282...151,687,860

G

centrosomal protein 89

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CEP89 mRNA

NCBI chr 1:97,195,116...97,237,015
Ensembl chr 1:97,195,135...97,237,016

G

cerebral endothelial cell adhesion molecule

increases expression

EXP

Dibutyl Phthalate results in increased expression of CERCAM mRNA

NCBI chr 3:33,515,513...33,553,817
Ensembl chr 3:33,486,664...33,553,813

G

ceramide kinase

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of CERK mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA

PMID:21266533 PMID:39150890

NCBI chr 7:119,105,674...119,149,885
Ensembl chr 7:119,105,674...119,148,570

G

ceramide synthase 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CERS2 mRNA

NCBI chr 2:185,579,511...185,587,789
Ensembl chr 2:185,579,119...185,588,839

G

ceramide synthase 4

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CERS4 mRNA

NCBI chr12:7,649,610...7,688,066
Ensembl chr12:7,649,610...7,688,070

G

ceramide synthase 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of CERS6 mRNA

NCBI chr 3:74,038,520...74,287,544
Ensembl chr 3:74,038,851...74,287,544

G

carboxylesterase 1D

increases hydrolysis

ISO

CES1 protein results in increased hydrolysis of Dibutyl Phthalate

NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449

G

carboxylesterase 2H

increases hydrolysis

ISO

CES2 protein results in increased hydrolysis of Dibutyl Phthalate

NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752

G

carboxylesterase 5A

increases expression

ISO

Dibutyl Phthalate results in increased expression of CES5A mRNA

NCBI chr19:11,198,829...11,504,887
Ensembl chr19:11,419,189...11,504,887

G

centrin 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of CETN2 mRNA

PMID:17361019 PMID:21266533

NCBI chr X:155,812,212...155,817,186
Ensembl chr X:155,812,003...155,817,744

G

centrin 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CETN3 mRNA

NCBI chr 2:13,817,760...13,837,502
Ensembl chr 2:13,824,803...13,837,502

G

cilia and flagella associated protein 299

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CFAP299 mRNA

NCBI chr14:11,091,314...11,576,981
Ensembl chr14:11,090,449...11,577,999

G

cilia and flagella associated protein 410

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CFAP410 mRNA

NCBI chr20:10,687,506...10,694,366
Ensembl chr20:10,687,506...10,694,366

G

cilia and flagella associated protein 43

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CFAP43 mRNA

NCBI chr 1:256,566,558...256,653,816
Ensembl chr 1:256,566,559...256,653,840

G

cilia and flagella associated protein 44

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CFAP44 mRNA

NCBI chr11:69,704,997...69,789,998
Ensembl chr11:69,705,719...69,789,905

G

cilia and flagella associated protein 77

increases expression

EXP

Dibutyl Phthalate results in increased expression of CFAP77 mRNA

NCBI chr 3:32,656,410...32,779,261
Ensembl chr 3:32,656,410...32,779,261

G

cofilin 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CFL1 mRNA

NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353

G

cofilin 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CFL2 mRNA

NCBI chr 6:78,090,843...78,094,888
Ensembl chr 6:78,090,843...78,094,888

G

glycoprotein hormones, alpha polypeptide

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein affects the expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CXCR4 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CYP11A1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of HSD3B2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PTX3 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of RGS2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of STAR mRNA]; Cyclic AMP inhibits the reaction [[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]]; Dibutyl Phthalate inhibits the reaction [CGA protein results in increased secretion of Dinoprostone]; Dibutyl Phthalate inhibits the reaction [CGA protein results in increased secretion of Progesterone]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of EDN2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of MMP9 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PGR mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PLAT mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of IL6 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINB2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINE1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of TIMP1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP14 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP16 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of SLCO2A1 mRNA]

PMID:25016925 PMID:33316053 PMID:37552060

NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:54,235,019...54,295,464

G

CGG triplet repeat binding protein 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CGGBP1 mRNA

NCBI chr11:16,012,251...16,019,388
Ensembl chr11:16,011,456...16,020,356

G

cingulin-like 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CGNL1 mRNA

NCBI chr 8:81,154,169...81,305,598
Ensembl chr 8:81,140,091...81,305,747

G

cholesterol 25-hydroxylase

increases expression

EXP

Dibutyl Phthalate results in increased expression of CH25H mRNA

NCBI chr 1:241,428,048...241,429,366
Ensembl chr 1:241,331,619...241,431,190

G

ChaC glutathione-specific gamma-glutamylcyclotransferase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CHAC1 mRNA

NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361

G

ChaC glutathione specific gamma-glutamylcyclotransferase 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CHAC2 mRNA

NCBI chr14:108,921,669...108,929,215
Ensembl chr14:108,921,341...108,929,469

G

chromatin assembly factor 1 subunit B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CHAF1B mRNA

PMID:17361019 PMID:21266533

NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733

G

coiled-coil-helix-coiled-coil-helix domain containing 10

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CHCHD10 mRNA

NCBI chr20:12,725,274...12,730,295
Ensembl chr20:12,725,277...12,745,677

G

coiled-coil-helix-coiled-coil-helix domain containing 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CHCHD3 mRNA

NCBI chr 4:62,327,574...62,584,085
Ensembl chr 4:62,327,576...62,584,035

G

coiled-coil-helix-coiled-coil-helix domain containing 4 like 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CHCHD4L1 mRNA

NCBI chr X:62,690,390...62,696,524
Ensembl chr X:62,689,804...62,696,727

G

coiled-coil-helix-coiled-coil-helix domain containing 5

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CHCHD5 mRNA

NCBI chr 3:136,815,034...136,819,230
Ensembl chr 3:136,815,048...136,821,914

G

coiled-coil-helix-coiled-coil-helix domain containing 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CHCHD6 mRNA

NCBI chr 4:123,360,729...123,581,429
Ensembl chr 4:123,349,187...123,581,421

G

chromodomain helicase DNA binding protein 8

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CHD8 mRNA

NCBI chr15:27,379,285...27,438,959
Ensembl chr15:27,379,285...27,417,851

G

checkpoint kinase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CHEK1 mRNA

NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359

G

checkpoint kinase 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CHEK2 mRNA

NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667

G

chromogranin A

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CHGA mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CHGA mRNA

PMID:25607892 PMID:31199487

NCBI chr 6:127,460,895...127,472,238
Ensembl chr 6:127,460,854...127,472,237

G

chromogranin B

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CHGB mRNA

NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:140,495,951...140,510,054

G

cysteine-rich hydrophobic domain 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CHIC2 mRNA

NCBI chr14:33,511,839...33,546,181
Ensembl chr14:33,511,535...33,548,558

G

chitinase domain containing 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CHID1 mRNA

NCBI chr 1:206,024,059...206,059,259
Ensembl chr 1:205,998,801...206,059,227

G

CHM Rab escort protein

increases expression

ISO

Dibutyl Phthalate results in increased expression of CHM mRNA

NCBI chr X:82,395,463...82,554,249
Ensembl chr X:82,396,816...82,568,642

G

charged multivesicular body protein 1B

increases expression

EXP

Dibutyl Phthalate results in increased expression of CHMP1B mRNA

NCBI chr18:63,010,270...63,012,800
Ensembl chr18:63,010,251...63,011,415

G

charged multivesicular body protein 4C

increases expression

ISO

Dibutyl Phthalate results in increased expression of CHMP4C mRNA

NCBI chr 2:93,299,152...93,336,075
Ensembl chr 2:93,299,157...93,360,850

G

chimerin 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CHN2 mRNA

NCBI chr 4:84,478,989...84,738,068
Ensembl chr 4:84,704,862...84,738,068

G

calcineurin-like EF-hand protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CHP1 mRNA

NCBI chr 3:126,989,800...127,025,071
Ensembl chr 3:126,989,579...127,042,443

G

cholinergic receptor, muscarinic 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of CHRM3 mRNA

NCBI chr17:64,696,549...65,158,622
Ensembl chr17:64,696,066...65,173,304

G

cholinergic receptor nicotinic alpha 6 subunit

increases expression

EXP

Dibutyl Phthalate results in increased expression of CHRNA6 mRNA

NCBI chr16:71,400,615...71,407,315
Ensembl chr16:71,400,615...71,407,315

G

cholinergic receptor nicotinic beta 1 subunit

increases expression

ISO

Dibutyl Phthalate results in increased expression of CHRNB1 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:54,999,943...55,015,137
Ensembl chr10:55,002,788...55,015,107

G

carbohydrate sulfotransferase 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CHST2 mRNA

NCBI chr 8:104,839,716...104,845,961
Ensembl chr 8:104,831,292...104,860,301

G

chromosome transmission fidelity factor 18

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CHTF18 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:15,247,525...15,255,573
Ensembl chr10:15,246,362...15,255,685

G

cytosolic iron-sulfur assembly component 2A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CIAO2A mRNA

NCBI chr 8:75,565,620...75,577,542
Ensembl chr 8:75,565,567...75,577,541

G

cell death-inducing DFFA-like effector a

increases expression

ISO

Dibutyl Phthalate results in increased expression of CIDEA mRNA

PMID:17361019 PMID:21266533

NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382

G

cyclin-dependent kinase 2-interacting protein

increases expression

EXP

Dibutyl Phthalate results in increased expression of CINP mRNA

NCBI chr 6:135,698,477...135,720,798
Ensembl chr 6:135,706,793...135,720,689

G

CDGSH iron sulfur domain 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CISD1 mRNA

NCBI chr20:17,254,462...17,267,843
Ensembl chr20:17,254,187...17,271,042

G

CDGSH iron sulfur domain 2

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of CISD2 mRNA
Dibutyl Phthalate results in increased expression of CISD2 mRNA

NCBI chr 2:226,502,517...226,527,325
Ensembl chr 2:226,502,517...226,540,080

G

CDGSH iron sulfur domain 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CISD3 mRNA

NCBI chr10:83,175,708...83,178,739
Ensembl chr10:83,175,568...83,178,751

G

Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1

increases expression
multiple interactions
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CITED1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CITED1 mRNA
Dibutyl Phthalate results in decreased expression of CITED1 mRNA

PMID:17361019 PMID:21266533 PMID:31199487

NCBI chr X:71,390,328...71,395,023
Ensembl chr X:71,390,331...71,393,649

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CITED2 mRNA

NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782

G

cytoskeleton associated protein 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CKAP2 mRNA

PMID:17361019 PMID:21266533

NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352

G

creatine kinase B

increases expression

ISO

Dibutyl Phthalate results in increased expression of CKB mRNA

NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478

G

CDC28 protein kinase regulatory subunit 1B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CKS1B mRNA

NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365

G

CDC28 protein kinase regulatory subunit 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CKS2 mRNA

PMID:17361019 PMID:21266533

NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519

G

cytoplasmic linker associated protein 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CLASP2 mRNA

NCBI chr 8:122,555,532...122,736,934
Ensembl chr 8:122,555,524...122,737,587

G

CLK4-associating serine/arginine rich protein

increases expression

EXP

Dibutyl Phthalate results in increased expression of SFRS16 mRNA

NCBI chr 1:88,360,235...88,384,343
Ensembl chr 1:88,360,235...88,384,343

G

clathrin binding box of aftiphilin containing 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CLBA1 mRNA

NCBI chr 6:137,703,947...137,710,743
Ensembl chr 6:137,703,619...137,710,742

G

chloride channel accessory 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CLCA1 mRNA

NCBI chr 2:236,599,022...236,624,714
Ensembl chr 2:236,599,022...236,624,714

G

chloride voltage-gated channel 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CLCN2 mRNA

NCBI chr11:93,702,382...93,716,059
Ensembl chr11:93,702,360...93,716,059

G

chloride voltage-gated channel 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of CLCN3 mRNA

NCBI chr16:34,138,004...34,210,984
Ensembl chr16:34,137,952...34,210,984

G

chloride voltage-gated channel 6

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CLCN6 mRNA

NCBI chr 5:163,715,593...163,748,301
Ensembl chr 5:163,717,439...163,748,198

G

claudin 1

increases expression
decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of CLDN1 mRNA
Dibutyl Phthalate results in decreased expression of CLDN1 mRNA; Dibutyl Phthalate results in decreased expression of CLDN1 protein
necrostatin-1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of CLDN1 protein]

PMID:21266533 PMID:33167028 PMID:39461407

NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529

G

claudin 11

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CLDN11 mRNA

NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539

G

claudin 12

increases expression

ISO

Dibutyl Phthalate results in increased expression of CLDN12 mRNA

NCBI chr 4:29,477,468...29,488,465
Ensembl chr 4:29,477,342...29,493,776

G

claudin 23

increases expression

ISO

Dibutyl Phthalate results in increased expression of CLDN23 mRNA

NCBI chr16:63,117,045...63,118,769
Ensembl chr16:63,116,781...63,118,957

G

claudin 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of CLDN4 mRNA

NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958

G

claudin domain containing 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CLDND1 mRNA

NCBI chr11:55,352,321...55,358,779
Ensembl chr11:55,352,321...55,358,907

G

C-type lectin domain containing 11A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CLEC11A mRNA

NCBI chr 1:103,938,029...103,941,170
Ensembl chr 1:103,935,185...103,946,784

G

C-type lectin domain family 2, member D

increases expression

EXP

Dibutyl Phthalate results in increased expression of CLEC2D mRNA

NCBI chr 4:163,902,124...163,925,587
Ensembl chr 4:163,902,547...163,925,587

G

C-type lectin domain family 2, member L

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CLEC2L mRNA

NCBI chr 4:68,359,021...68,381,431
Ensembl chr 4:68,358,973...68,381,432

G

C-type lectin domain family 4 member M

increases expression

ISO

Dibutyl Phthalate results in increased expression of CD209B mRNA

NCBI chr12:6,713,795...6,722,414
Ensembl chr12:6,713,812...6,722,410

G

chloride intracellular channel 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CLIC1 mRNA

NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,769,527...3,778,367

G

chloride intracellular channel 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of CLIC4 mRNA

NCBI chr 5:152,737,371...152,797,118
Ensembl chr 5:152,737,371...152,797,118

G

chloride intracellular channel 5

increases expression

ISO

Dibutyl Phthalate results in increased expression of CLIC5 mRNA

NCBI chr 9:24,208,455...24,310,964
Ensembl chr 9:24,208,456...24,358,780

G

CAP-GLY domain containing linker protein 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CLIP2 mRNA

NCBI chr12:27,798,289...27,863,486
Ensembl chr12:27,799,524...27,863,484

G

CAP-GLY domain containing linker protein 3

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of CLIP3 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CLIP3 mRNA

PMID:21266533 PMID:39150890

NCBI chr 1:94,674,492...94,690,643
Ensembl chr 1:94,674,661...94,690,642

G

CAP-GLY domain containing linker protein family, member 4

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CLIP4 mRNA

NCBI chr 6:29,359,628...29,449,365
NCBI chr 6:29,349,245...29,351,890
Ensembl chr 6:29,348,918...29,449,271

G

CLN3 lysosomal/endosomal transmembrane protein, battenin

increases expression

EXP

Dibutyl Phthalate results in increased expression of CLN3 mRNA

NCBI chr 1:190,586,649...190,600,034
Ensembl chr 1:190,586,650...190,597,929

G

CLN8, transmembrane ER and ERGIC protein

increases expression

ISO

Dibutyl Phthalate results in increased expression of CLN8 mRNA

NCBI chr16:81,451,941...81,462,046
Ensembl chr16:81,451,944...81,461,832

G

chloride nucleotide-sensitive channel 1A

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CLNS1A mRNA
Dibutyl Phthalate results in increased expression of CLNS1A mRNA

NCBI chr 1:161,429,437...161,450,904
Ensembl chr 1:161,421,808...161,450,902

G

caseinolytic mitochondrial matrix peptidase proteolytic subunit

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CLPP mRNA

NCBI chr 9:1,917,305...1,924,706
Ensembl chr 9:1,918,682...1,924,705

G

colipase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CLPS mRNA

NCBI chr20:6,622,234...6,624,414
Ensembl chr20:6,622,231...6,624,505

G

caseinolytic mitochondrial matrix peptidase chaperone subunit X

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CLPX mRNA

NCBI chr 8:74,700,602...74,740,244
Ensembl chr 8:74,700,662...74,744,762

G

claspin

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CLSPN mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:144,134,619...144,169,531
Ensembl chr 5:144,134,632...144,169,530

G

calsyntenin 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CLSTN1 mRNA

NCBI chr 5:165,314,128...165,377,627
Ensembl chr 5:165,314,309...165,377,625

G

calsyntenin 3

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CLSTN3 mRNA

NCBI chr 4:159,017,795...159,051,069
Ensembl chr 4:159,017,795...159,051,069

G

clathrin heavy chain

increases expression

EXP

Dibutyl Phthalate results in increased expression of CLTC mRNA

NCBI chr10:72,014,984...72,073,308
Ensembl chr10:72,014,986...72,070,691

G

clusterin

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CLU mRNA; Dibutyl Phthalate results in increased expression of CLU protein
Dibutyl Phthalate results in decreased expression of CLU mRNA

PMID:21266533 PMID:21745491 PMID:36215882

NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860

G

clusterin associated protein 1

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CLUAP1 mRNA
Dibutyl Phthalate results in increased expression of CLUAP1 mRNA

NCBI chr10:12,094,346...12,159,440
Ensembl chr10:12,094,346...12,131,693

G

clavesin 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CLVS2 mRNA

NCBI chr 1:25,553,981...25,661,806
Ensembl chr 1:25,554,375...25,580,830

G

citramalyl-CoA lyase

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CLYBL mRNA

NCBI chr15:105,690,283...105,912,347
Ensembl chr15:105,690,295...105,912,345

G

cytidine monophospho-N-acetylneuraminic acid hydroxylase

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CMAH mRNA

NCBI chr17:40,985,129...41,070,317
Ensembl chr17:41,011,641...41,070,252

G

cytidine monophosphate N-acetylneuraminic acid synthetase

increases expression

EXP

Dibutyl Phthalate results in increased expression of CMAS mRNA

NCBI chr 4:177,449,801...177,468,117
Ensembl chr 4:177,449,732...177,476,291

G

carboxymethylenebutenolidase homolog

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CMBL mRNA

NCBI chr 2:84,280,128...84,301,878
Ensembl chr 2:84,242,512...84,301,880

G

chemerin chemokine-like receptor 1

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of CMKLR1 mRNA
Dibutyl Phthalate results in decreased expression of CMKLR1 mRNA

PMID:17379624 PMID:21266533

NCBI chr12:48,634,929...48,687,833
Ensembl chr12:48,634,003...48,691,458

G

chemerin chemokine-like receptor 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CMKLR2 mRNA

NCBI chr 9:72,077,164...72,111,979
Ensembl chr 9:72,078,608...72,116,257

G

cms1 ribosomal small subunit homolog

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CMSS1 mRNA

NCBI chr11:56,403,620...56,701,751
Ensembl chr11:56,403,499...56,701,755

G

CKLF-like MARVEL transmembrane domain containing 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of CMTM3 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:629,000...637,152
Ensembl chr19:628,895...636,225

G

CKLF-like MARVEL transmembrane domain containing 6

increases expression

EXP

Dibutyl Phthalate results in increased expression of CMTM6 mRNA

NCBI chr 8:123,301,131...123,319,230
Ensembl chr 8:123,300,918...123,319,230

G

CKLF-like MARVEL transmembrane domain containing 8

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CMTM8 mRNA

NCBI chr 8:123,360,168...123,425,291
Ensembl chr 8:123,360,170...123,425,276

G

cap methyltransferase 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CMTR1 mRNA

NCBI chr20:7,724,286...7,784,787
Ensembl chr20:7,683,946...7,784,263

G

CCHC-type zinc finger, nucleic acid binding protein

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of CNBP mRNA
Dibutyl Phthalate results in increased expression of CNBP protein

PMID:17379624 PMID:34864091

NCBI chr 4:121,860,102...121,868,976
Ensembl chr 4:121,860,105...121,869,010

G

carnosine dipeptidase 2

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA

NCBI chr18:80,314,799...80,331,900
Ensembl chr18:80,314,801...80,331,900

G

cyclic nucleotide gated channel subunit alpha 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CNGA1 mRNA

NCBI chr14:35,920,948...35,959,065
Ensembl chr14:35,926,854...35,959,056

G

cornichon family member 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CNIH1 mRNA

NCBI chr15:22,517,755...22,529,651
Ensembl chr15:22,497,340...22,529,578

G

cornichon family AMPA receptor auxiliary protein 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CNIH2 mRNA

NCBI chr 1:211,828,791...211,834,474
Ensembl chr 1:211,828,794...211,834,437

G

Cnksr family member 3

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of CNKSR3 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CNKSR3 promoter

PMID:17361019 PMID:21266533 PMID:23359474

NCBI chr 1:45,904,581...45,996,921
Ensembl chr 1:45,904,581...45,996,921

G

calponin 1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CNN1 mRNA
Dibutyl Phthalate results in decreased expression of CNN1 mRNA; Dibutyl Phthalate results in decreased expression of CNN1 protein

PMID:21266533 PMID:35926758

NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:28,908,330...28,919,482

G

calponin 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CNN2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:10,363,141...10,370,312
Ensembl chr 7:10,363,102...10,370,312

G

calponin 3

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CNN3 mRNA
Dibutyl Phthalate results in decreased expression of CNN3 mRNA

PMID:17361019 PMID:17379624 PMID:21266533

NCBI chr 2:212,203,661...212,234,772
Ensembl chr 2:212,226,640...212,234,815

G

CCR4-NOT transcription complex, subunit 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CNOT2 mRNA

NCBI chr 7:54,016,447...54,117,511
Ensembl chr 7:54,016,447...54,107,960

G

CCR4-NOT transcription complex, subunit 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of CNOT6 mRNA

NCBI chr10:34,479,892...34,532,166
Ensembl chr10:34,481,938...34,524,416

G

CCR4-NOT transcription complex, subunit 8

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CNOT8 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:42,782,042...42,795,207
Ensembl chr10:42,782,283...42,795,207

G

CCR4-NOT transcription complex subunit 9

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CNOT9 mRNA

NCBI chr 9:83,533,369...83,558,207
Ensembl chr 9:83,533,369...83,558,197

G

2',3'-cyclic nucleotide 3' phosphodiesterase

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CNP mRNA
Dibutyl Phthalate results in increased expression of CNP mRNA

NCBI chr10:86,011,504...86,018,063
Ensembl chr10:86,011,495...86,018,063

G

canopy FGF signaling regulator 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CNPY2 mRNA

NCBI chr 7:1,332,293...1,338,081
Ensembl chr 7:1,334,335...1,340,333

G

canopy FGF signaling regulator 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CNPY4 mRNA

NCBI chr12:22,178,254...22,184,432
Ensembl chr12:22,178,160...22,184,425

G

cannabinoid receptor 1

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of CNR1 mRNA
Dibutyl Phthalate results in decreased expression of CNR1 mRNA

PMID:15620428 PMID:21266533

NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252

G

consortin, connexin sorting protein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CNST mRNA

NCBI chr13:93,828,694...93,905,497
Ensembl chr13:93,828,687...93,905,490

G

centlein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CNTLN mRNA

NCBI chr 5:104,340,801...104,622,491
Ensembl chr 5:104,342,173...104,630,976

G

contactin 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CNTN2 mRNA

NCBI chr13:46,497,269...46,528,112
Ensembl chr13:46,499,396...46,528,027

G

contactin associated protein 1

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CNTNAP1 mRNA

NCBI chr10:86,610,140...86,625,896
Ensembl chr10:86,611,890...86,631,730

G

contactin associated protein 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CNTNAP2 mRNA

NCBI chr 4:75,109,358...77,366,258
Ensembl chr 4:75,109,858...77,366,258

G

centriolin

increases expression

ISO

Dibutyl Phthalate results in increased expression of CNTRL mRNA

NCBI chr 3:38,825,575...38,897,835
Ensembl chr 3:38,825,624...38,897,833

G

centrobin, centriole duplication and spindle assembly protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CNTROB mRNA

PMID:17361019 PMID:21266533

NCBI chr10:54,521,338...54,546,569
Ensembl chr10:54,521,663...54,543,657

G

cytochrome C oxidase assembly factor 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COA3 mRNA

NCBI chr10:86,720,454...86,721,435
Ensembl chr10:86,720,456...86,721,440

G

cytochrome c oxidase assembly factor 4 homolog

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COA4 mRNA

NCBI chr 1:164,294,312...164,297,571
Ensembl chr 1:164,294,319...164,297,578

G

cytochrome c oxidase assembly factor 7

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COA7 mRNA

NCBI chr 5:128,298,084...128,308,935
Ensembl chr 5:128,298,093...128,309,664

G

Coenzyme A synthase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of COASY mRNA

PMID:17361019 PMID:21266533

NCBI chr10:86,514,850...86,519,130
Ensembl chr10:86,514,874...86,519,130

G

component of oligomeric golgi complex 8

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COG8 mRNA

NCBI chr19:51,861,376...51,872,126
Ensembl chr19:51,861,376...51,872,129

G

collagen type X alpha 1 chain

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL10A1 mRNA

NCBI chr20:39,737,536...39,744,518
Ensembl chr20:39,716,822...39,751,440

G

collagen type XII alpha 1 chain

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COL12A1 mRNA

NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711

G

collagen type XV alpha 1 chain

increases expression

ISO

Dibutyl Phthalate results in increased expression of COL15A1 mRNA

NCBI chr 5:66,297,546...66,403,172
Ensembl chr 5:66,297,461...66,403,170

G

collagen type XVIII alpha 1 chain

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of COL18A1 protein

NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112

G

collagen type I alpha 1 chain

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL1A1 mRNA

NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460

G

collagen type XXII alpha 1 chain

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COL22A1 mRNA

NCBI chr 7:105,619,776...105,857,246
Ensembl chr 7:105,619,757...105,856,960

G

collagen type XXIII alpha 1 chain

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COL23A1 mRNA

NCBI chr10:36,050,327...36,337,279
Ensembl chr10:36,050,259...36,337,897

G

collagen type XXVII alpha 1 chain

increases expression

EXP

Dibutyl Phthalate results in increased expression of COL27A1 mRNA

NCBI chr 5:81,662,822...81,781,502
Ensembl chr 5:81,661,685...81,781,502

G

collagen type III alpha 1 chain

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL3A1 mRNA

NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232

G

collagen type IV alpha 1 chain

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of COL4A1 mRNA

PMID:17361019 PMID:21266533

NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482

G

collagen type VI alpha 1 chain

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of COL6A1 protein
[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of COL6A1 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A1 mRNA

PMID:34864091 PMID:39150890

NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107

G

collagen type VI alpha 2 chain

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA

NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042

G

collagen type VI alpha 3 chain

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of COL6A3 protein
[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of COL6A3 protein

NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:98,809,171...98,886,990

G

collagen type VIII alpha 1 chain

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL8A1 mRNA

NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229

G

COMM domain containing 10

affects expression

EXP

Dibutyl Phthalate affects the expression of COMMD10 mRNA

NCBI chr18:41,927,802...42,061,384
Ensembl chr18:41,921,694...42,086,729

G

COMM domain containing 9

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COMMD9 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:108,630,903...108,645,427
Ensembl chr 3:108,630,980...108,666,091

G

catechol-O-methyltransferase

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of COMT mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COMT mRNA
fulvestrant inhibits the reaction [Dibutyl Phthalate results in decreased expression of COMT mRNA]

PMID:24040167 PMID:39150890

NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533

G

catechol-O-methyltransferase domain containing 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COMTD1 mRNA

NCBI chr15:2,509,121...2,512,232
Ensembl chr15:2,509,032...2,512,232

G

COPI coat complex subunit gamma 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COPG1 mRNA

NCBI chr 4:121,923,644...121,949,819
Ensembl chr 4:121,923,873...121,949,812

G

COPI coat complex subunit gamma 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COPG2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 4:60,333,455...60,468,953
Ensembl chr 4:60,333,455...60,469,145

G

COP9 signalosome subunit 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of COPS2 mRNA

NCBI chr 3:133,537,729...133,563,493
Ensembl chr 3:133,537,732...133,563,369

G

COP9 signalosome subunit 4

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of COPS4 mRNA
Dibutyl Phthalate results in decreased expression of COPS4 mRNA

PMID:17361019 PMID:21266533

NCBI chr14:9,382,897...9,413,216
Ensembl chr14:9,382,900...9,413,107

G

COPI coat complex subunit zeta 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COPZ1 mRNA

NCBI chr 7:136,287,696...136,314,131
Ensembl chr 7:136,288,032...136,314,135

G

COPI coat complex subunit zeta 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COPZ2 mRNA

NCBI chr10:82,328,888...82,341,959
Ensembl chr10:82,328,660...82,341,959

G

coenzyme Q10A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COQ10A mRNA

NCBI chr 7:1,376,591...1,387,694
Ensembl chr 7:1,376,591...1,382,722

G

coenzyme Q10B

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of COQ10B mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:64,048,168...64,068,082
Ensembl chr 9:64,048,103...64,068,322

G

coenzyme Q3 methyltransferase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COQ3 mRNA

NCBI chr 5:40,226,313...40,257,383
Ensembl chr 5:40,226,368...40,257,617

G

coenzyme Q6 monooxygenase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COQ6 mRNA

NCBI chr 6:109,738,934...109,750,315
Ensembl chr 6:109,738,951...109,750,310

G

coenzyme Q7, hydroxylase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COQ7 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:182,270,570...182,285,959
Ensembl chr 1:182,269,399...182,285,508

G

coenzyme Q8A

increases expression

EXP

Dibutyl Phthalate results in increased expression of COQ8A mRNA

NCBI chr13:94,436,680...94,465,535
Ensembl chr13:94,436,546...94,463,378

G

coenzyme Q9

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COQ9 mRNA

NCBI chr19:10,172,943...10,185,960
Ensembl chr19:10,172,949...10,185,937

G

coronin 1C

increases expression

EXP

Dibutyl Phthalate results in increased expression of CORO1C mRNA

NCBI chr12:48,373,573...48,445,718
Ensembl chr12:48,373,597...48,445,716

G

coronin 6

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CORO6 mRNA

NCBI chr10:62,808,172...62,817,788
Ensembl chr10:62,809,689...62,817,787

G

coronin 7

increases expression

ISO

Dibutyl Phthalate results in increased expression of CORO7 mRNA

NCBI chr10:11,386,683...11,447,422
Ensembl chr10:11,391,613...11,447,866

G

cytochrome c oxidase assembly homolog COX15

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COX15 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:252,554,811...252,571,471
Ensembl chr 1:252,554,811...252,571,471

G

cytochrome c oxidase assembly factor COX16

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COX16 mRNA

NCBI chr 6:106,745,424...106,912,523
Ensembl chr 6:106,899,494...106,912,484

G

cytochrome c oxidase copper chaperone COX17

increases expression

EXP

Dibutyl Phthalate results in increased expression of COX17 mRNA

NCBI chr11:75,906,245...75,912,036
Ensembl chr11:75,906,248...75,912,019

G

cytochrome c oxidase assembly factor COX18

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COX18 mRNA

NCBI chr14:18,147,558...18,161,622
Ensembl chr14:18,149,992...18,161,619

G

cytochrome c oxidase assembly factor COX20

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COX20 mRNA

NCBI chr13:92,592,260...92,604,129
Ensembl chr14:6,872,315...6,872,638

G

cytochrome c oxidase subunit 4i1

multiple interactions
decreases expression

EXP
ISO

7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine promotes the reaction [Dibutyl Phthalate results in decreased expression of COX4I1 protein]
Melatonin inhibits the reaction [Dibutyl Phthalate results in decreased expression of COX4I1 protein]; NFE2L2 protein affects the reaction [Dibutyl Phthalate results in decreased expression of COX4I1 protein]

NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624

G

cytochrome c oxidase subunit 5A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COX5A mRNA

PMID:17379624 PMID:21266533

NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279

G

cytochrome c oxidase subunit 6A1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of COX6A1 mRNA

NCBI chr12:46,922,709...46,925,762
Ensembl chr12:46,912,648...46,925,768

G

cytochrome c oxidase subunit 6A2

increases expression

ISO

Dibutyl Phthalate results in increased expression of COX6A2 mRNA

NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716

G

cytochrome c oxidase subunit 7A1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COX7A1 mRNA

NCBI chr 1:94,549,663...94,572,330
Ensembl chr 1:94,569,216...94,570,889

G

cytochrome c oxidase subunit 7A2

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of COX7A2 mRNA

PMID:17361019 PMID:17379624

NCBI chr 8:89,597,051...89,611,032
Ensembl chr14:55,514,261...55,514,512
Ensembl chr 8:55,514,261...55,514,512

G

cytochrome c oxidase subunit 7C

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of COX7C mRNA

NCBI chr 2:18,577,145...18,579,170
Ensembl chr 2:18,577,149...18,579,170

G

cytochrome c oxidase subunit 8A

increases expression

EXP

Dibutyl Phthalate results in increased expression of COX8A mRNA

NCBI chr 1:213,831,302...213,833,623
Ensembl chr 1:213,831,298...213,833,623

G

ceruloplasmin

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of CP mRNA
[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of CP protein

PMID:21266533 PMID:34864091

NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087

G

carboxypeptidase A1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CPA1 mRNA

PMID:17379624 PMID:21266533

NCBI chr 4:60,224,801...60,230,928
Ensembl chr 4:60,224,801...60,230,928

G

carboxypeptidase A2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CPA2 mRNA

NCBI chr 4:60,125,297...60,151,066
Ensembl chr 4:60,118,682...60,183,448

G

centrosome assembly and centriole elongation protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CPAP mRNA

PMID:17361019 PMID:21266533

NCBI chr15:34,742,838...34,806,020
Ensembl chr15:34,742,838...34,802,421

G

carboxypeptidase D

increases expression

ISO

Dibutyl Phthalate results in increased expression of CPD mRNA

NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638

G

carboxypeptidase E

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CPE mRNA

NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524

G

cytoplasmic polyadenylation element binding protein 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CPEB2 mRNA

NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263

G

cytoplasmic polyadenylation element binding protein 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of CPEB3 mRNA

NCBI chr 1:244,161,690...244,343,765
Ensembl chr 1:244,161,690...244,343,561

G

candidate plasticity gene 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CPG1 mRNA

NCBI chr 6:124,041,902...124,053,895
Ensembl chr 6:124,041,902...124,053,895

G

copine 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CPNE1 protein

NCBI chr 3:165,047,615...165,089,994

G

copine 8

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of CPNE8 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CPNE8 mRNA

PMID:21266533 PMID:39150890

NCBI chr 7:123,494,864...123,669,060
Ensembl chr 7:123,494,865...123,669,060

G

cleavage and polyadenylation specific factor 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CPSF3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:46,564,855...46,592,776
Ensembl chr 6:46,564,735...46,594,136

G

cleavage and polyadenylation specific factor 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of CPSF4 mRNA

NCBI chr12:14,543,536...14,559,350
Ensembl chr12:14,543,338...14,559,350

G

carnitine palmitoyltransferase 1A

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of CPT1A mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CPT1A mRNA; [Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of CPT1A protein

PMID:21266533 PMID:35739755 PMID:38285958

NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326

G

carnitine palmitoyltransferase 1B

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of CPT1B mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CPT1B mRNA

PMID:21266533 PMID:35739755

NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036

G

carnitine palmitoyltransferase 2

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of CPT2 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CPT2 mRNA

PMID:17361019 PMID:21266533 PMID:35739755

NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818

G

ceramide-1-phosphate transfer protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CPTP mRNA

NCBI chr 5:171,757,181...171,761,271
Ensembl chr 5:171,757,181...171,761,266

G

carboxypeptidase X (M14 family), member 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CPXM1 mRNA

NCBI chr 3:138,041,645...138,048,443
Ensembl chr 3:138,041,645...138,048,857

G

carboxypeptidase Z

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CPZ mRNA

NCBI chr14:79,448,242...79,471,557
Ensembl chr14:79,448,139...79,471,556

G

cellular retinoic acid binding protein 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CRABP2 mRNA; Dibutyl Phthalate results in decreased expression of CRABP2 protein

PMID:17379624 PMID:21266533 PMID:21745491

NCBI chr 2:175,714,862...175,719,208
Ensembl chr 2:175,707,312...175,728,385

G

cysteine-rich C-terminal 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CRCT1 mRNA

NCBI chr 2:181,329,392...181,330,877
Ensembl chr 2:181,329,392...181,330,877

G

cAMP responsive element binding protein 1

increases expression
decreases expression
decreases phosphorylation
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of CREB1 mRNA
Dibutyl Phthalate results in decreased expression of CREB1 protein
Dibutyl Phthalate results in decreased phosphorylation of CREB1 protein
[alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased phosphorylation of CREB1 protein]; ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of CREB1 protein]; Nimodipine inhibits the reaction [Dibutyl Phthalate results in decreased phosphorylation of CREB1 protein]
Dibutyl Phthalate results in decreased expression of CREB1 mRNA

PMID:21266533 PMID:30776390 PMID:31841868 PMID:33331133

NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339

G

cAMP responsive element binding protein 3

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CREB3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:62,613,652...62,619,019
Ensembl chr 5:62,613,638...62,619,500

G

cAMP responsive element binding protein 3-like 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CREB3L2 mRNA

NCBI chr 4:66,874,623...66,990,962
Ensembl chr 4:66,387,126...66,990,832

G

cAMP responsive element binding protein 5

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CREB5 mRNA

NCBI chr 4:83,723,587...84,124,786
Ensembl chr 4:83,723,194...84,120,793

G

CREB binding protein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CREBBP mRNA

NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266

G

CREB/ATF bZIP transcription factor

increases expression

ISO

Dibutyl Phthalate results in increased expression of CREBZF mRNA

NCBI chr 1:153,829,544...153,836,073
Ensembl chr 1:153,829,448...153,845,122

G

cellular repressor of E1A-stimulated genes 1

increases expression
multiple interactions
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CREG1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CREG1 mRNA
Dibutyl Phthalate results in decreased expression of CREG1 mRNA

PMID:21266533 PMID:39150890

NCBI chr13:80,552,779...80,565,272
Ensembl chr13:80,549,933...80,565,272

G

cAMP responsive element modulator

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CREM mRNA

PMID:17361019 PMID:21266533

NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160

G

corticotropin releasing hormone

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CRH mRNA

NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386

G

corticotropin releasing hormone receptor 1

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of CRHR1 mRNA
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CRHR1 mRNA

PMID:21266533 PMID:32518293

NCBI chr10:89,540,192...89,583,466
Ensembl chr10:89,540,192...89,583,466

G

corticotropin releasing hormone receptor 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CRHR2 mRNA

NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:85,554,268...85,596,318

G

cysteine rich transmembrane BMP regulator 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CRIM1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:22,447,983...22,622,459
Ensembl chr 6:22,449,948...22,622,416

G

CXXC repeat containing interactor of PDZ3 domain

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CRIPT mRNA

NCBI chr 6:13,334,978...13,342,934
Ensembl chr 6:13,334,954...13,345,044

G

cysteine-rich secretory protein LCCL domain containing 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CRISPLD2 mRNA

PMID:21266533 PMID:24893172

NCBI chr19:64,961,764...65,020,099
Ensembl chr19:64,961,771...65,020,349

G

cytokine receptor-like factor 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of CRLF3 mRNA

NCBI chr10:65,521,296...65,559,162
Ensembl chr10:65,521,492...65,558,804

G

cardiolipin synthase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CRLS1 mRNA

NCBI chr 3:140,572,680...140,591,543
Ensembl chr 3:140,572,716...140,591,599

G

collapsin response mediator protein 1

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA

NCBI chr14:77,734,675...77,780,916
Ensembl chr14:77,734,675...77,780,916

G

ciliary rootlet coiled-coil, rootletin

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CROCC mRNA

NCBI chr 5:158,603,979...158,646,728
Ensembl chr 5:158,603,556...158,640,238

G

C-reactive protein

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CRP protein

NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514

G

CREB regulated transcription coactivator 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CRTC1 mRNA

NCBI chr16:19,022,171...19,080,880
Ensembl chr16:19,022,005...19,080,880

G

CREB regulated transcription coactivator 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CRTC3 mRNA

NCBI chr 1:143,962,038...144,064,324
Ensembl chr 1:143,962,038...144,064,288

G

crystallin, alpha B

increases expression

EXP

Dibutyl Phthalate results in increased expression of CRYAB mRNA

NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528

G

crystallin, lambda 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CRYL1 mRNA

NCBI chr15:35,542,628...35,661,563
Ensembl chr15:35,542,628...35,661,563

G

crystallin, mu

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CRYM mRNA

NCBI chr 1:183,991,752...184,006,923
Ensembl chr 1:183,991,745...184,006,962

G

colony stimulating factor 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of CSF1 protein

NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468

G

colony stimulating factor 2 receptor subunit alpha

increases expression

EXP

Dibutyl Phthalate results in increased expression of CSF2RA mRNA

NCBI chr14:113,219...118,808
Ensembl chr14:113,225...118,117

G

casein kinase 1, alpha 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CSNK1A1 mRNA

NCBI chr18:57,285,156...57,320,540
Ensembl chr18:57,287,412...57,320,538

G

casein kinase 1, epsilon

increases expression

ISO

Dibutyl Phthalate results in increased expression of CSNK1E mRNA

NCBI chr 7:112,863,726...112,887,338
Ensembl chr 7:112,863,731...112,884,101

G

casein kinase 1, gamma 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CSNK1G2 mRNA

NCBI chr 7:9,727,430...9,746,341
Ensembl chr 7:9,727,431...9,745,741

G

casein kinase 2 beta

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of CSNK2B mRNA

PMID:17361019 PMID:21266533

NCBI chr20:3,704,833...3,709,999
Ensembl chr20:3,704,904...3,710,525

G

chondroitin sulfate proteoglycan 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CSPG4 mRNA

NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:66,160,942...66,200,806

G

chondroitin sulfate proteoglycan 5

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CSPG5 mRNA

NCBI chr 8:119,098,932...119,113,191
Ensembl chr 8:119,098,925...119,143,907

G

cysteine and serine rich nuclear protein 1

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of AXUD1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CSRNP1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469

G

cysteine and serine rich nuclear protein 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of CSRNP3 mRNA

NCBI chr 3:70,906,587...71,102,596
Ensembl chr 3:70,906,380...71,094,009

G

cysteine and glycine-rich protein 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CSRP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:49,709,928...49,731,141
Ensembl chr13:49,709,914...49,731,139

G

cysteine and glycine-rich protein 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CSRP2 mRNA

NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238

G

cystatin 8

increases expression

EXP

Dibutyl Phthalate results in increased expression of CST8 mRNA

NCBI chr 3:156,697,776...156,704,413
Ensembl chr 3:156,697,767...156,724,636

G

cleavage stimulation factor subunit 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CSTF2 mRNA

NCBI chr X:101,546,809...101,572,760
Ensembl chr X:101,546,819...101,572,764

G

cleavage stimulation factor subunit 3

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of CSTF3 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CSTF3 promoter

PMID:21266533 PMID:23359474

NCBI chr 3:111,421,291...111,492,539
Ensembl chr 3:111,421,234...111,497,046

G

C-terminal binding protein 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CTBP1 mRNA

NCBI chr14:81,679,956...81,707,331
Ensembl chr14:81,679,765...81,707,554

G

CCCTC-binding factor

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CTCF mRNA

PMID:17361019 PMID:21266533

NCBI chr19:50,431,478...50,481,013
Ensembl chr19:50,431,689...50,481,012

G

CTD nuclear envelope phosphatase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CTDNEP1 mRNA

NCBI chr10:55,203,047...55,212,469
Ensembl chr10:55,203,543...55,212,852

G

cytotoxic T lymphocyte-associated protein 2 alpha

increases expression

EXP

Dibutyl Phthalate results in increased expression of CTLA2A mRNA

NCBI chr17:3,809,052...3,828,872
Ensembl chr17:3,808,943...3,829,344

G

cytotoxic T-lymphocyte-associated protein 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of CTLA4 mRNA

NCBI chr 9:69,812,859...69,819,959
Ensembl chr 9:69,813,265...69,819,973

G

catenin alpha 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CTNNA1 mRNA

NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,999,820...27,135,007

G

catenin alpha 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CTNNA2 mRNA

NCBI chr 4:110,852,265...112,001,351
Ensembl chr 4:110,852,265...112,001,365

G

catenin alpha-like 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CTNNAL1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:76,309,546...76,375,869
Ensembl chr 5:76,309,546...76,364,637

G

catenin beta 1

affects localization
multiple interactions
increases expression

ISO
EXP

Dibutyl Phthalate affects the localization of CTNNB1 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased phosphorylation of CTNNB1 protein
Chloroquine inhibits the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA]; Sirolimus promotes the reaction [Dibutyl Phthalate results in increased expression of CTNNB1 mRNA]
Dibutyl Phthalate results in increased expression of CTNNB1 mRNA; Dibutyl Phthalate results in increased expression of CTNNB1 protein
HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate affects the localization of CTNNB1 protein]; trichostatin A inhibits the reaction [Dibutyl Phthalate affects the localization of CTNNB1 protein]

PMID:22552774 PMID:30053495 PMID:32028152 PMID:36308879 PMID:40323316

NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662

G

catenin delta 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CTNND1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:90,090,025...90,141,247
Ensembl chr 3:90,090,564...90,141,189

G

CTP synthase 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CTPS2 mRNA

NCBI chr X:35,277,658...35,418,505
Ensembl chr X:35,277,658...35,418,505

G

CTR9 homolog, Paf1/RNA polymerase II complex component

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CTR9 mRNA

NCBI chr 1:174,571,952...174,601,974
Ensembl chr 1:174,571,928...174,602,130

G

cathepsin B

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of CTSB mRNA
Dibutyl Phthalate results in increased expression of CTSB mRNA

NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478

G

cathepsin D

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CTSD mRNA

NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821

G

cathepsin L

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CTSL mRNA
Dibutyl Phthalate results in increased expression of CTSL mRNA

NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113

G

cortactin

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of CTTN mRNA
Dibutyl Phthalate results in decreased expression of CTTN mRNA

NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:209,029,048...209,058,211

G

cortactin binding protein 2

affects expression

EXP

Dibutyl Phthalate affects the expression of CTTNBP2 mRNA

NCBI chr 4:47,766,867...47,930,598
Ensembl chr 4:47,766,870...47,930,540

G

CUE domain containing 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CUEDC2 mRNA

NCBI chr 1:255,133,479...255,142,016
Ensembl chr 1:255,133,421...255,141,956

G

cutA divalent cation tolerance homolog

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CUTA mRNA

NCBI chr20:5,024,816...5,026,446
Ensembl chr20:5,024,816...5,026,631

G

cutC copper transporter

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CUTC mRNA

NCBI chr 1:252,571,489...252,586,269
Ensembl chr 1:252,571,521...252,597,272

G

cut-like homeobox 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of CUX2 mRNA

NCBI chr12:40,168,402...40,368,303
Ensembl chr12:40,149,292...40,366,528

G

CWC27 spliceosome associated cyclophilin

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of CWC27 mRNA

NCBI chr 2:37,498,462...37,709,691
Ensembl chr 2:37,498,468...37,709,355

G

C-X3-C motif chemokine ligand 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CX3CL1 mRNA

NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999

G

CXADR, Ig-like cell adhesion molecule

increases expression

ISO

Dibutyl Phthalate results in increased expression of CXADR mRNA

NCBI chr11:30,469,778...30,516,990
Ensembl chr11:30,469,526...30,516,988

G

C-X-C motif chemokine ligand 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CXCL1 mRNA; Dibutyl Phthalate results in increased expression of CXCL1 protein

PMID:21266533 PMID:21745491 PMID:27511800

NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811

G

C-X-C motif chemokine ligand 10

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CXCL10 mRNA

PMID:17361019 PMID:21266533

NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261

G

C-X-C motif chemokine ligand 12

decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of CXCL12 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of CXCL12 protein

PMID:21266533 PMID:24893172 PMID:38954831

NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627

G

C-X-C motif chemokine ligand 13

affects expression
multiple interactions

EXP
ISO

Dibutyl Phthalate affects the expression of CXCL13 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of CXCL13 protein

PMID:30934153 PMID:38954831

NCBI chr14:13,912,858...13,917,920
Ensembl chr14:13,912,858...13,917,920

G

C-X-C motif chemokine ligand 16

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CXCL16 mRNA

NCBI chr10:55,665,355...55,669,950
Ensembl chr10:55,664,742...55,670,226

G

C-X-C motif chemokine ligand 3

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CXCL1 mRNA

NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624

G

C-X-C motif chemokine receptor 4

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CXCR4 mRNA]

NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459

G

CXXC finger protein 5

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CXXC5 mRNA
Dibutyl Phthalate results in decreased expression of CXXC5 mRNA

PMID:17361019 PMID:21266533

NCBI chr18:27,701,650...27,732,633
Ensembl chr18:27,701,188...27,732,635

G

cytochrome b561 family, member A3

increases expression

ISO

Dibutyl Phthalate results in increased expression of CYB561A3 mRNA

NCBI chr 1:216,641,108...216,662,495
Ensembl chr 1:216,651,128...216,662,492

G

cytochrome b5 type A

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of CYB5A mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CYB5A mRNA

PMID:21266533 PMID:39150890

NCBI chr18:80,487,923...80,520,544
Ensembl chr18:14,453,966...14,455,094
Ensembl chr18:14,453,966...14,455,094

G

cytochrome b5 type B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CYB5B mRNA

NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980

G

cytochrome b5 reductase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CYB5R3 mRNA

NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306

G

cytochrome b-245 alpha chain

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CYBA mRNA

NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214

G

cytochrome b-245 beta chain

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CYBB mRNA

NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065

G

cytochrome b reductase 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CYBRD1 mRNA

NCBI chr 3:76,342,231...76,369,846
Ensembl chr 3:76,342,404...76,370,061

G

cytochrome c-1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of CYC1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:109,947,750...109,950,142
Ensembl chr 7:109,947,766...109,950,657

G

cytochrome c, somatic

increases expression
multiple interactions
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of CYCS mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of CYCS protein
Dibutyl Phthalate results in decreased expression of CYCS mRNA

PMID:21266533 PMID:35739755

NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816

G

cytochrome P450, family 11, subfamily a, polypeptide 1

multiple interactions
decreases activity
affects expression
decreases expression
increases expression

EXP
ISO

[Dexamethasone co-treated with Dibutyl Phthalate] results in decreased expression of CYP11A1 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate] results in decreased expression of CYP11A1; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA; Dibutyl Phthalate inhibits the reaction [CEBPB binds to CYP11A1 promoter]; Dibutyl Phthalate inhibits the reaction [NR5A1 binds to CYP11A1 promoter]; Dibutyl Phthalate inhibits the reaction [NR5A1 protein binds to CYP11A1 promoter]; taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of CYP11A1 mRNA]; taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of CYP11A1 protein]
Dibutyl Phthalate results in decreased activity of CYP11A1 protein
Dibutyl Phthalate affects the expression of CYP11A1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CYP11A1 mRNA]
Dibutyl Phthalate results in decreased expression of CYP11A1 mRNA; Dibutyl Phthalate results in decreased expression of CYP11A1 protein
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP11A1 mRNA; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP11A1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11A1 mRNA; [dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in decreased expression of CYP11A1 mRNA; [Nanotubes, Carbon co-treated with Dibutyl Phthalate] affects the expression of CYP11A1 mRNA
Dibutyl Phthalate results in increased expression of CYP11A1 mRNA
Dibutyl Phthalate results in decreased expression of CYP11A mRNA; Dibutyl Phthalate results in decreased expression of CYP11A protein; Dibutyl Phthalate results in decreased expression of CYP11A1 mRNA; Dibutyl Phthalate results in decreased expression of CYP11A1 protein

PMID:14617579 PMID:15141095 PMID:15987825 PMID:16037377 PMID:17379624 More...

NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196

G

cytochrome P450, family 11, subfamily b, polypeptide 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CYP11B1 mRNA

PMID:21266533 PMID:33983380

NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763

G

cytochrome P450, family 11, subfamily b, polypeptide 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CYP11B2 mRNA

PMID:33983380 PMID:34864161

NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:108,689,165...108,694,921

G

cytochrome P450, family 17, subfamily a, polypeptide 1

multiple interactions
decreases activity
increases expression
decreases expression

EXP
ISO

[Dexamethasone co-treated with Dibutyl Phthalate] results in decreased expression of CYP17A1 mRNA; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA; Dibutyl Phthalate inhibits the reaction [CEBPB binds to CYP17A1 promoter]; Dibutyl Phthalate inhibits the reaction [NR5A1 binds to CYP17A1 promoter]; Dibutyl Phthalate inhibits the reaction [NR5A1 protein binds to CYP17A1 promoter]
Dibutyl Phthalate results in decreased activity of CYP17A1 protein
Dibutyl Phthalate results in increased expression of CYP17A1 mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CYP17A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA; [Nanotubes, Carbon co-treated with Dibutyl Phthalate] affects the expression of CYP17A1 mRNA
Dibutyl Phthalate results in decreased expression of CYP17A1 mRNA; Dibutyl Phthalate results in decreased expression of CYP17A1 protein

PMID:14617579 PMID:15141095 PMID:15987825 PMID:17379624 PMID:17884934 More...

NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974

G

cytochrome P450, family 19, subfamily a, polypeptide 1

increases expression
decreases expression
decreases activity
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of CYP19A1 mRNA
Dibutyl Phthalate results in decreased expression of CYP19A1 mRNA
Dibutyl Phthalate results in decreased activity of CYP19A1 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP19A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of CYP19A1 protein; [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP19A1 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of CYP19A1 mRNA

PMID:18923996 PMID:19560483 PMID:25607892 PMID:25765776 PMID:27825933 More...

NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917

G

cytochrome P450, family 1, subfamily a, polypeptide 1

decreases activity
decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased activity of CYP1A1 protein
Dibutyl Phthalate results in decreased expression of CYP1A1 mRNA

PMID:27432241 PMID:32028152 PMID:34181028

NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012

G

cytochrome P450, family 1, subfamily a, polypeptide 2

decreases activity

EXP

Dibutyl Phthalate results in decreased activity of CYP1A2 protein

NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149

G

cytochrome P450, family 1, subfamily b, polypeptide 1

multiple interactions
increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of and results in increased activity of CYP1B1 protein
Dibutyl Phthalate results in increased expression of CYP1B1 mRNA
[Dibutyl Phthalate results in increased abundance of monobutyl phthalate] which affects the expression of CYP1B1 mRNA

PMID:16040568 PMID:34175954 PMID:34864161

NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142

G

cytochrome P450, family 21, subfamily a, polypeptide 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CYP21A1 mRNA

NCBI chr20:4,028,323...4,031,549
Ensembl chr20:4,028,391...4,031,543

G

cytochrome P450, family 26, subfamily a, polypeptide 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CYP26A1 promoter

NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657

G

cytochrome P450, family 26, subfamily b, polypeptide 1

multiple interactions

EXP
ISO

[diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in increased expression of CYP26B1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP26B1 mRNA

PMID:37788136 PMID:39150890

NCBI chr 4:118,599,356...118,616,176
Ensembl chr 4:118,599,356...118,616,176

G

cytochrome P450, family 27, subfamily a, polypeptide 1

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of CYP27A1 mRNA
Dibutyl Phthalate results in increased expression of CYP27A1 mRNA

PMID:21266533 PMID:26472102

NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215

G

cytochrome P450, family 2, subfamily b, polypeptide 1

increases expression
decreases activity

EXP

Dibutyl Phthalate results in increased expression of CYP2B1 mRNA; Dibutyl Phthalate results in increased expression of CYP2B1 protein
Dibutyl Phthalate results in decreased activity of CYP2B1 protein

PMID:15901914 PMID:27432241

NCBI chr 1:90,646,098...90,669,762

G

cytochrome P450, subfamily 2, polypeptide 11

decreases activity

EXP

Dibutyl Phthalate results in decreased activity of CYP2C11 protein

NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853

G

cytochrome P450, family 2, subfamily e, polypeptide 1

decreases activity

EXP

Dibutyl Phthalate results in decreased activity of CYP2E1 protein

NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495

G

cytochrome P450, family 2, subfamily f, polypeptide 4

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP2F2 mRNA

NCBI chr 1:91,543,768...91,557,553
Ensembl chr 1:91,543,768...91,557,553

G

cytochrome P450, family 3, subfamily a, polypeptide 2

multiple interactions

ISO

Dibutyl Phthalate promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Dibutyl Phthalate promotes the reaction [NR1I2 protein results in increased expression of CYP3A4]

PMID:21742782 PMID:36893891

NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857

G

cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CYP3A23-3A1 mRNA; Dibutyl Phthalate results in increased expression of CYP3A23-3A1 protein

NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813

G

cytochrome P450, family 3, subfamily a, polypeptide 62

decreases activity

EXP

Dibutyl Phthalate results in decreased activity of CYP3A62 protein

NCBI chr12:21,511,763...21,547,598
Ensembl chr12:21,471,542...21,547,598

G

cytochrome P450, family 46, subfamily a, polypeptide 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CYP46A1 mRNA

NCBI chr 6:133,011,948...133,039,167
Ensembl chr 6:133,011,989...133,041,971

G

cytochrome P450, family 4, subfamily a, polypeptide 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CYP4A1 mRNA; Dibutyl Phthalate results in increased expression of CYP4A1 protein

NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231

G

cytochrome P450, family 4, subfamily f, polypeptide 18

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP4F18 protein

NCBI chr16:17,797,558...17,838,958
Ensembl chr16:17,740,001...17,838,958

G

cytochrome P450, family 4, subfamily f, polypeptide 6

increases expression

EXP

Dibutyl Phthalate results in increased expression of CYP4F6 mRNA

NCBI chr 7:12,680,799...12,708,378
Ensembl chr 7:12,680,806...12,708,402

G

cytochrome P450, family 51

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CYP51 mRNA
Dibutyl Phthalate results in decreased expression of CYP51 mRNA

PMID:17361019 PMID:17379624 PMID:21266533 PMID:21745491 PMID:26472102 More...

NCBI chr 4:30,991,693...31,010,147
Ensembl chr 4:30,991,613...31,010,450

G

cytochrome P450 family 7 subfamily A member 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of CYP7A1 mRNA

NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202

G

CYFIP related Rac1 interactor B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CYRIB mRNA

NCBI chr 7:97,524,941...97,649,846
Ensembl chr 7:97,523,121...97,649,853

G

cysteinyl leukotriene receptor 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of CYSLTR1 mRNA

NCBI chr X:75,734,281...75,762,873
Ensembl chr X:75,734,270...75,763,050

G

cytohesin 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of CYTH2 mRNA

NCBI chr 1:105,419,631...105,427,542
Ensembl chr 1:105,419,631...105,427,542

G

cytohesin 3

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of CYTH3 mRNA

NCBI chr12:15,953,781...16,076,584
Ensembl chr12:15,953,791...16,047,506

G

cysteine and tyrosine rich 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of CYYR1 mRNA

NCBI chr11:38,044,003...38,150,391
Ensembl chr11:38,001,699...38,164,473

G

dishevelled associated activator of morphogenesis 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of DAAM1 mRNA

NCBI chr 6:96,125,521...96,286,049
Ensembl chr 6:96,125,621...96,286,049

G

dishevelled associated activator of morphogenesis 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of DAAM2 mRNA

NCBI chr 9:18,926,620...19,044,672
Ensembl chr 9:18,926,623...19,044,671

G

DAB adaptor protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DAB1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:123,621,510...124,742,585
Ensembl chr 5:124,369,415...124,742,584

G

dachshund family transcription factor 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DACH2 mRNA

NCBI chr X:82,644,374...83,210,181
Ensembl chr X:82,644,128...83,210,000

G

dishevelled-binding antagonist of beta-catenin 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DACT1 mRNA

NCBI chr 6:95,526,645...95,538,625
Ensembl chr 6:95,526,690...95,551,053

G

differentiation antagonizing non-protein coding RNA

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DANCR mRNA

NCBI chr14:34,481,052...34,482,032

G

death associated protein kinase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DAPK1 mRNA

NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,935,625...4,096,581

G

dual adaptor of phosphotyrosine and 3-phosphoinositides 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DAPP1 mRNA

NCBI chr 2:229,099,319...229,148,868
Ensembl chr 2:229,099,319...229,148,843

G

aspartyl-tRNA synthetase 2 (mitochondrial)

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of DARS2 mRNA
Dibutyl Phthalate results in decreased expression of DARS2 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:75,842,078...75,870,319
Ensembl chr13:75,836,565...75,869,904

G

deleted in azoospermia-like

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DAZL protein

NCBI chr 9:18,193,363...18,210,100
Ensembl chr 9:18,193,363...18,210,100

G

dopamine beta-hydroxylase

increases expression

ISO

Dibutyl Phthalate results in increased expression of DBH mRNA

NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:30,886,328...30,903,316

G

diazepam binding inhibitor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DBI mRNA

PMID:17379624 PMID:21266533 PMID:21745491

NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450

G

drebrin-like

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DBNL mRNA

NCBI chr14:84,880,085...84,895,122
Ensembl chr14:84,880,142...84,897,133

G

D-box binding PAR bZIP transcription factor

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of DBP mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205

G

debranching RNA lariats 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DBR1 mRNA

NCBI chr 8:109,018,364...109,030,092
Ensembl chr 8:109,018,325...109,031,406

G

dihydrolipoamide branched chain transacylase E2

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of DBT mRNA
Dibutyl Phthalate results in increased expression of DBT mRNA

NCBI chr 2:207,166,660...207,195,528
Ensembl chr 2:207,166,652...207,195,525

G

DDB1 and CUL4 associated factor 12

increases expression

ISO

Dibutyl Phthalate results in increased expression of DCAF12 mRNA

NCBI chr 5:61,256,353...61,278,155
Ensembl chr 5:61,256,353...61,278,119

G

DDB1 and CUL4 associated factor 12-like 1

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of DCAF12L1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DCAF12L1 mRNA

PMID:21266533 PMID:39150890

NCBI chr X:128,572,969...128,576,588
Ensembl chr X:128,572,811...128,577,222

G

DDB1 and CUL4 associated factor 7

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DCAF7 mRNA

NCBI chr10:91,473,900...91,496,080
Ensembl chr10:91,473,900...91,496,080

G

dephospho-CoA kinase domain containing

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DCAKD mRNA

NCBI chr10:88,457,829...88,489,011
Ensembl chr10:88,457,829...88,480,118

G

discoidin, CUB and LCCL domain containing 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of DCBLD2 mRNA

NCBI chr11:55,594,691...55,649,113
Ensembl chr11:55,594,691...55,649,085

G

DCC netrin 1 receptor

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of DCC mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DCC mRNA

PMID:21266533 PMID:25607892

NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541

G

doublecortin-like kinase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of DCLK1 mRNA

NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090

G

doublecortin-like kinase 3

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DCLK3 mRNA

NCBI chr 8:120,279,916...120,332,362
Ensembl chr 8:120,279,757...120,332,432

G

decorin

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DCN mRNA

NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926

G

decapping enzyme, scavenger

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of DCPS mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:41,729,507...41,782,222
Ensembl chr 8:41,724,563...41,782,222

G

dynactin subunit 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DCTN1 mRNA

NCBI chr 4:117,228,722...117,261,528
Ensembl chr 4:117,219,349...117,261,528

G

dCTP pyrophosphatase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DCTPP1 mRNA

NCBI chr 1:191,307,933...191,311,326
Ensembl chr 1:191,307,935...191,313,405

G

dicarbonyl and L-xylulose reductase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DCXR mRNA

NCBI chr10:106,504,730...106,506,619

G

dimethylarginine dimethylaminohydrolase 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of DDAH1 mRNA

NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626

G

DDAH family member 2, ADMA-independent

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DDAH2 mRNA

NCBI chr20:3,766,115...3,769,161
Ensembl chr20:3,766,120...3,769,183

G

damage specific DNA binding protein 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDB2 mRNA

NCBI chr 3:97,640,923...97,667,617
Ensembl chr 3:97,640,579...97,664,066

G

dopa decarboxylase

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of DDC mRNA; Dibutyl Phthalate results in decreased expression of DDC protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DDC mRNA

PMID:15728792 PMID:17379624 PMID:21266533 PMID:21745491 PMID:31199487

NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806

G

DNA-damage inducible transcript 3

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of DDIT3 mRNA; Dibutyl Phthalate results in increased expression of DDIT3 protein
4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of DDIT3 protein]
4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of DDIT3 protein]; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of DDIT3 mRNA; DDIT3 protein promotes the reaction [Dibutyl Phthalate results in decreased expression of BCL2 protein]; DDIT3 protein promotes the reaction [Dibutyl Phthalate results in increased expression of BAX protein]

PMID:21266533 PMID:26804720 PMID:37364641

NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509

G

DNA-damage-inducible transcript 4

decreases expression
affects expression

EXP

Dibutyl Phthalate results in decreased expression of DDIT4 mRNA
Dibutyl Phthalate affects the expression of DDIT4 mRNA

PMID:21266533 PMID:21745491 PMID:30934153

NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037

G

DNA-damage-inducible transcript 4-like

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of DDIT4L mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DDIT4L mRNA

PMID:21266533 PMID:39150890

NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225

G

discoidin domain receptor tyrosine kinase 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of DDR1 mRNA

PMID:17361019 PMID:21266533

NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,050,375...3,069,276

G

D-dopachrome tautomerase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DDT mRNA

PMID:17379624 PMID:21266533

NCBI chr20:12,883,025...12,886,121

G

DEAD-box helicase 17

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of DDX17 mRNA
Dibutyl Phthalate results in decreased expression of DDX17 mRNA

PMID:21266533 PMID:24893172

NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:112,971,523...112,989,747

G

DEAD-box helicase 18

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX18 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:35,282,391...35,296,038
Ensembl chr13:35,282,467...35,295,972

G

DEAD-box helicase 19A

increases expression

EXP

Dibutyl Phthalate results in increased expression of DDX19A mRNA

NCBI chr19:55,851,854...55,872,209
Ensembl chr19:55,851,854...55,872,209

G

DExD-box helicase 21

increases expression

EXP

Dibutyl Phthalate results in increased expression of DDX21 mRNA

NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238

G

DEAD-box helicase 23

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DDX23 mRNA

NCBI chr 7:131,676,636...131,693,917
Ensembl chr 7:131,676,636...131,689,074

G

DEAD-box helicase 24

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX24 mRNA

NCBI chr 6:128,329,554...128,346,818
Ensembl chr 6:128,329,554...128,349,625

G

DEAD-box helicase 27

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX27 mRNA

NCBI chr 3:176,163,220...176,182,418
Ensembl chr 3:176,163,203...176,182,410

G

DEAD-box helicase 28

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX28 mRNA

NCBI chr19:50,819,643...50,821,573
Ensembl chr19:50,819,313...50,822,803

G

DExD-box helicase 39A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX39A mRNA

PMID:17361019 PMID:21266533

NCBI chr19:41,323,465...41,331,413
Ensembl chr19:41,322,836...41,332,306

G

DExD-box helicase 39B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX39B mRNA

NCBI chr20:3,577,200...3,589,651
Ensembl chr20:3,576,734...3,589,651

G

DEAD-box helicase 3, X-linked

increases expression

EXP

Dibutyl Phthalate results in increased expression of DDX3X mRNA

NCBI chr X:12,152,346...12,165,983
Ensembl chr X:12,152,346...12,165,983

G

DEAD-box helicase 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX4 mRNA

NCBI chr 2:45,961,174...46,016,097
Ensembl chr 2:45,961,174...46,015,951

G

DEAD-box helicase 46

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX46 mRNA

NCBI chr17:8,947,237...8,993,705
Ensembl chr17:8,947,237...8,990,247

G

DEAD-box helicase 49

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX49 mRNA

NCBI chr16:19,159,353...19,167,003
Ensembl chr16:19,159,087...19,167,580

G

DEAD-box helicase 5

increases expression

EXP

Dibutyl Phthalate results in increased expression of DDX5 mRNA

NCBI chr10:92,224,393...92,231,928
Ensembl chr10:92,224,395...92,231,300

G

DEAD-box helicase 54

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of DDX54 mRNA
Dibutyl Phthalate results in increased expression of DDX54 mRNA

NCBI chr12:41,595,298...41,610,560
Ensembl chr12:41,595,555...41,611,053

G

DEAD-box helicase 55

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX55 mRNA

NCBI chr12:37,695,444...37,711,198
Ensembl chr12:37,695,444...37,711,198

G

DEAD-box helicase 56

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX56 mRNA

NCBI chr14:85,325,942...85,336,262
Ensembl chr14:85,325,942...85,336,262

G

DEAD-box helicase 59

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DDX59 mRNA

NCBI chr13:50,427,940...50,452,893
Ensembl chr13:50,427,936...50,453,208

G

dual endothelin 1, angiotensin II receptor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DEAR mRNA

NCBI chr 2:172,594,990...172,598,242
Ensembl chr 2:172,594,990...172,598,242

G

2,4-dienoyl-CoA reductase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DECR1 mRNA

NCBI chr 5:34,208,195...34,236,074
Ensembl chr 5:34,208,195...34,236,033

G

defensin beta 24

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DEFB19 mRNA

NCBI chr 3:161,506,850...161,512,983
Ensembl chr 3:161,506,851...161,512,983

G

DEK proto-oncogene

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DEK mRNA

NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122

G

DAP3 binding cell death enhancer 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DELE1 mRNA

NCBI chr18:30,325,369...30,349,285
Ensembl chr18:30,336,308...30,349,938

G

density regulated reinitiation and release factor

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DENR mRNA

NCBI chr12:38,323,433...38,346,207
Ensembl chr12:38,323,445...38,344,797

G

DEP domain containing MTOR-interacting protein

increases expression

EXP

Dibutyl Phthalate results in increased expression of DEPTOR mRNA

NCBI chr 7:88,404,745...88,574,065
Ensembl chr 7:88,404,620...88,574,041

G

deoxyribose-phosphate aldolase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DERA mRNA

NCBI chr 4:172,394,971...172,473,746
Ensembl chr 4:172,394,962...172,490,142

G

derlin 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DERL3 mRNA

NCBI chr20:12,753,926...12,766,478
Ensembl chr20:12,762,981...12,766,477

G

desmin

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DES mRNA

NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347

G

DET1 partner of COP1 E3 ubiquitin ligase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DET1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:142,159,120...142,175,366
Ensembl chr 1:142,127,876...142,175,336

G

deuterosome assembly protein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of DEUP1 mRNA

NCBI chr 8:20,661,687...20,724,083
Ensembl chr 8:20,661,689...20,723,585

G

Dexi homolog

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DEXI mRNA

NCBI chr10:5,632,400...5,645,653
Ensembl chr10:5,632,961...5,645,648

G

DNA fragmentation factor subunit beta

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DFFB mRNA

NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:169,804,889...169,817,225

G

diacylglycerol O-acyltransferase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of DGAT1 mRNA

NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016

G

DiGeorge syndrome critical region gene 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DGCR6 mRNA

PMID:17361019 PMID:21266533

NCBI chr11:96,432,024...96,442,766
Ensembl chr11:96,432,024...96,437,255

G

DGCR8 microprocessor complex subunit

increases expression

ISO

Dibutyl Phthalate results in increased expression of DGCR8 mRNA

NCBI chr11:96,208,959...96,241,560
Ensembl chr11:96,209,038...96,241,551

G

diacylglycerol kinase, alpha

increases expression

EXP

Dibutyl Phthalate results in increased expression of DGKA mRNA

NCBI chr 7:1,733,247...1,761,181
Ensembl chr 7:1,733,248...1,759,569

G

diacylglycerol kinase, beta

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DGKB mRNA

NCBI chr 6:60,368,101...61,124,420
Ensembl chr 6:60,368,519...61,124,420

G

diacylglycerol kinase epsilon

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DGKE mRNA

NCBI chr10:74,348,931...74,374,509
Ensembl chr10:74,350,246...74,374,478

G

diacylglycerol kinase zeta

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of DGKZ mRNA
Dibutyl Phthalate results in decreased expression of DGKZ mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:98,359,804...98,401,847
Ensembl chr 3:98,359,804...98,401,951

G

D-glutamate cyclase

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DGLUCY mRNA

NCBI chr 6:125,785,075...125,860,496
Ensembl chr 6:125,785,087...125,860,496

G

deoxyguanosine kinase

increases expression

EXP

Dibutyl Phthalate results in increased expression of DGUOK mRNA

NCBI chr 4:117,544,784...117,572,414
Ensembl chr 4:117,544,773...117,572,414

G

24-dehydrocholesterol reductase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DHCR24 mRNA

PMID:21266533 PMID:33983380

NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936

G

7-dehydrocholesterol reductase

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of DHCR7 mRNA
Dibutyl Phthalate results in decreased expression of DHCR7 mRNA

PMID:17361019 PMID:21266533 PMID:21745491 PMID:33983380

NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:208,444,434...208,461,382

G

dihydrofolate reductase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DHFR mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:25,320,895...25,346,004

G

desert hedgehog signaling molecule

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DHH mRNA

NCBI chr 7:131,929,857...131,935,352
Ensembl chr 7:131,929,857...131,935,352

G

dihydroorotate dehydrogenase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DHODH mRNA

PMID:17361019 PMID:21266533

NCBI chr19:54,460,636...54,483,049
Ensembl chr19:54,468,690...54,514,496

G

deoxyhypusine synthase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DHPS mRNA

NCBI chr19:39,987,328...39,991,418
Ensembl chr19:39,987,324...39,991,432

G

dehydrogenase/reductase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DHRS1 mRNA

PMID:17361019 PMID:21266533

NCBI chr15:33,206,449...33,213,776
Ensembl chr15:33,206,451...33,213,734

G

dehydrogenase/reductase 11

increases expression

ISO

Dibutyl Phthalate results in increased expression of DHRS11 mRNA

NCBI chr10:70,195,637...70,205,735
Ensembl chr10:70,195,637...70,205,893

G

dehydrogenase/reductase 13

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DHRS13 mRNA

NCBI chr10:63,418,790...63,424,005
Ensembl chr10:63,418,798...63,424,004

G

dehydrogenase/reductase 3

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of DHRS3 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DHRS3 promoter

PMID:21266533 PMID:23359474 PMID:39150890

NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653

G

dehydrogenase/reductase 4

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of DHRS4 mRNA
Dibutyl Phthalate results in decreased expression of DHRS4 mRNA

PMID:17361019 PMID:21266533

NCBI chr15:32,924,482...32,948,103
Ensembl chr15:32,936,522...32,948,101

G

dehydrogenase/reductase 7B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DHRS7B mRNA

NCBI chr10:46,003,845...46,036,498
Ensembl chr10:46,003,845...46,036,499

G

dehydrogenase/reductase 7C

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DHRS7C mRNA

NCBI chr10:52,994,205...53,012,281
Ensembl chr10:52,994,205...53,012,281

G

dehydrogenase E1 and transketolase domain containing 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DHTKD1 mRNA

NCBI chr17:77,242,512...77,316,074
Ensembl chr17:77,264,514...77,316,071

G

DEAH-box helicase 15

increases expression

EXP

Dibutyl Phthalate results in increased expression of DHX15 mRNA

NCBI chr14:62,999,886...63,037,829
Ensembl chr14:62,999,877...63,037,828

G

DEAH-box helicase 32 (putative)

increases expression

ISO

Dibutyl Phthalate results in increased expression of DHX32 mRNA

NCBI chr 1:197,954,503...198,013,779
Ensembl chr 1:197,954,503...198,007,489

G

DExH-box helicase 57

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of DHX57 mRNA
Dibutyl Phthalate results in decreased expression of DHX57 mRNA

NCBI chr 6:20,474,889...20,528,556
Ensembl chr 6:20,477,191...20,528,556

G

DEAH-box helicase 8

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of DHX8 protein

NCBI chr10:87,167,861...87,204,426
Ensembl chr10:87,168,062...87,205,875

G

diablo, IAP-binding mitochondrial protein

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of DIABLO mRNA

NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265

G

dicer 1 ribonuclease III

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of DICER1 mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of DICER1 mRNA

PMID:17361019 PMID:33086190

NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252

G

disco-interacting protein 2 homolog A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DIP2A mRNA

NCBI chr20:12,284,037...12,373,519
Ensembl chr20:12,284,038...12,370,532

G

divergent protein kinase domain 1B

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of DIPK1B mRNA

NCBI chr 3:29,852,710...29,862,248
Ensembl chr 3:29,853,973...29,862,255

G

divergent protein kinase domain 2A

increases expression

EXP

Dibutyl Phthalate results in increased expression of DIPK2A mRNA

NCBI chr 8:103,950,345...103,969,461
Ensembl chr 8:103,909,931...103,969,461

G

DIRAS family GTPase 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of DIRAS2 mRNA

NCBI chr17:12,882,224...12,913,366
Ensembl chr17:12,880,385...12,914,291

G

DIS3-like 3'-5' exoribonuclease 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DIS3L2 mRNA

NCBI chr 9:94,802,056...95,184,523
Ensembl chr 9:94,804,382...95,184,522

G

DIX domain containing 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DIXDC1 mRNA

NCBI chr 8:59,904,218...59,977,595
Ensembl chr 8:59,904,218...59,978,447

G

dickkopf WNT signaling pathway inhibitor 2

multiple interactions

EXP
ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DKK2 promoter
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DKK2 mRNA

PMID:23359474 PMID:39150890

NCBI chr 2:223,242,375...223,334,249
Ensembl chr 2:223,242,377...223,334,724

G

discs large MAGUK scaffold protein 1

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DLG1 mRNA

NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797

G

discs large MAGUK scaffold protein 4

multiple interactions
increases expression

EXP
ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of DLG4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLG4 mRNA
Dibutyl Phthalate results in increased expression of DLG4 protein

PMID:25607892 PMID:35278568

NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839

G

discs large MAGUK scaffold protein 5

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of DLG5 mRNA

NCBI chr15:125,287...237,334
Ensembl chr15:125,290...237,332

G

DLG associated protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of DLGAP1 mRNA

NCBI chr 9:117,304,144...118,173,463
Ensembl chr 9:117,614,061...118,173,463

G

DLG associated protein 3

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP3 mRNA

NCBI chr 5:144,776,414...144,847,097
Ensembl chr 5:144,777,295...144,847,097

G

DLG associated protein 4

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DLGAP4 mRNA

NCBI chr 3:165,584,271...165,731,868
Ensembl chr 3:165,584,360...165,730,604

G

DLG associated protein 5

decreases expression
increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of DLGAP5 mRNA
Dibutyl Phthalate results in increased expression of DLGAP5 mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of DLGAP5 mRNA]

PMID:21266533 PMID:36828243

NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176

G

delta like canonical Notch ligand 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of DLL4 mRNA; Dibutyl Phthalate results in increased expression of DLL4 protein

NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763

G

DNA methyltransferase 1-associated protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DMAP1 mRNA

NCBI chr 5:136,380,211...136,388,229
Ensembl chr 5:136,380,216...136,388,219

G

deleted in malignant brain tumors 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of DMBT1 mRNA

NCBI chr 1:195,047,702...195,126,704
Ensembl chr 1:195,047,713...195,126,704

G

dystrophin

increases expression

ISO

Dibutyl Phthalate results in increased expression of DMD mRNA

PMID:17361019 PMID:21266533

NCBI chr X:51,070,098...53,437,845
Ensembl chr X:51,070,273...53,437,835

G

dimethylglycine dehydrogenase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DMGDH mRNA

NCBI chr 2:26,647,540...26,722,496
Ensembl chr 2:26,647,565...26,723,071

G

dentin matrix acidic phosphoprotein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of DMP1 mRNA

NCBI chr14:5,833,111...5,867,154
Ensembl chr14:5,833,111...5,843,993

G

DM1 protein kinase

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of DMPK mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DMPK promoter

PMID:21266533 PMID:23359474

NCBI chr 1:87,858,294...87,868,624
Ensembl chr 1:87,858,316...87,868,910

G

doublesex and mab-3 related transcription factor 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DMRT1 mRNA

NCBI chr 1:232,569,179...232,667,646
Ensembl chr 1:232,569,072...232,668,370

G

DMRT-like family A1

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of DMRTA1 mRNA
Dibutyl Phthalate results in increased expression of DMRTA1 mRNA

NCBI chr 5:109,531,704...109,538,244
Ensembl chr 5:109,531,586...109,538,246

G

cyclin D binding myb-like transcription factor 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of DMTF1 mRNA

NCBI chr 4:25,864,891...25,905,916
Ensembl chr 4:25,865,447...25,905,943

G

dynein, axonemal, assembly factor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNAAF1 mRNA

NCBI chr19:64,532,859...64,560,942
Ensembl chr19:64,532,860...64,561,435

G

dynein axonemal assembly factor 10

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of WDR92 mRNA

NCBI chr14:95,820,272...95,841,449
Ensembl chr14:95,820,234...95,841,442

G

dynein, axonemal, heavy chain 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNAH1 mRNA

NCBI chr16:6,462,419...6,523,545
Ensembl chr16:6,462,419...6,524,760

G

DnaJ heat shock protein family (Hsp40) member A1

increases expression

EXP

Dibutyl Phthalate results in increased expression of DNAJA1 mRNA

NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160

G

DnaJ heat shock protein family (Hsp40) member A2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNAJA2 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:37,671,019...37,689,163
Ensembl chr19:37,670,945...37,690,120

G

DnaJ heat shock protein family (Hsp40) member B1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DNAJB1 mRNA

NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416

G

DnaJ heat shock protein family (Hsp40) member B4

increases expression

ISO

Dibutyl Phthalate results in increased expression of DNAJB4 mRNA

NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042

G

DnaJ heat shock protein family (Hsp40) member B9

increases expression

ISO

Dibutyl Phthalate results in increased expression of DNAJB9 mRNA

NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344

G

DnaJ heat shock protein family (Hsp40) member C11

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNAJC11 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:167,724,776...167,770,032
Ensembl chr 5:167,724,717...167,770,694

G

DnaJ heat shock protein family (Hsp40) member C16

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNAJC16 mRNA

NCBI chr 5:159,355,279...159,389,267
Ensembl chr 5:159,361,314...159,389,298

G

DnaJ heat shock protein family (Hsp40) member C19

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNAJC19 mRNA

NCBI chr 2:118,851,497...118,875,813
Ensembl chr 2:118,869,413...118,873,781

G

DnaJ heat shock protein family (Hsp40) member C2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNAJC2 mRNA

NCBI chr 4:14,162,490...14,189,662
Ensembl chr 4:14,163,838...14,192,846

G

DnaJ heat shock protein family (Hsp40) member C27

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNAJC27 mRNA

NCBI chr 6:32,788,215...32,842,418
Ensembl chr 6:32,788,184...32,817,940

G

DnaJ heat shock protein family (Hsp40) member C3

increases expression

ISO

Dibutyl Phthalate results in increased expression of DNAJC3 mRNA

NCBI chr15:102,432,667...102,475,643
Ensembl chr15:102,432,663...102,475,643

G

DnaJ heat shock protein family (Hsp40) member C8

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNAJC8 mRNA

NCBI chr 5:150,029,064...150,047,115
Ensembl chr 5:150,026,286...150,047,117

G

DnaJ heat shock protein family (Hsp40) member C9

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNAJC9 mRNA

NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304

G

delta/notch-like EGF repeat containing

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DNER mRNA

NCBI chr 9:93,035,108...93,350,568
Ensembl chr 9:93,035,108...93,350,568

G

DNL-type zinc finger

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DNLZ mRNA

NCBI chr 3:29,568,041...29,569,937
Ensembl chr 3:29,568,041...29,569,996

G

dynamin 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DNM3 mRNA

NCBI chr13:76,892,381...77,371,346
Ensembl chr13:76,892,171...77,371,350

G

dynamin binding protein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DNMBP mRNA

NCBI chr 1:252,685,406...252,778,642
Ensembl chr 1:252,685,406...252,778,688

G

DNA methyltransferase 1

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of DNMT1 mRNA
Dibutyl Phthalate results in increased expression of DNMT1 protein

PMID:21266533 PMID:31318015 PMID:36602389

NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119

G

DNA methyltransferase 3 alpha

multiple interactions
increases expression
decreases expression

EXP
ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DNMT3A promoter
Dibutyl Phthalate results in increased expression of DNMT3A protein
Dibutyl Phthalate results in decreased expression of DNMT3A protein

PMID:23359474 PMID:26745512 PMID:36602389

NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970

G

DNA methyltransferase 3 beta

decreases expression
multiple interactions
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of DNMT3B mRNA; Dibutyl Phthalate results in decreased expression of DNMT3B protein
DNMT3B protein inhibits the reaction [Dibutyl Phthalate results in decreased methylation of PTEN promoter]
Dibutyl Phthalate results in increased expression of DNMT3B protein

PMID:21266533 PMID:26745512 PMID:30952838 PMID:36602389

NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313

G

deoxynucleotidyltransferase, terminal, interacting protein 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of DNTTIP2 mRNA

NCBI chr 2:213,058,975...213,071,020
Ensembl chr 2:213,058,962...213,071,016

G

double C2 domain alpha

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DOC2A mRNA

NCBI chr 1:190,887,306...190,893,057
Ensembl chr 1:190,888,214...190,893,384

G

double C2 domain beta

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DOC2B mRNA

PMID:17361019 PMID:21266533

NCBI chr10:61,126,295...61,151,533
Ensembl chr10:61,126,295...61,151,533

G

dedicator of cyto-kinesis 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DOCK1 mRNA

NCBI chr 1:198,897,021...199,413,636
Ensembl chr 1:198,897,045...199,413,627

G

dedicator of cytokinesis 10

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DOCK10 mRNA

NCBI chr 9:89,291,936...89,549,871
Ensembl chr 9:89,291,800...89,549,973

G

dedicator of cyto-kinesis 3

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DOCK3 mRNA

NCBI chr 8:116,431,158...116,782,218
Ensembl chr 8:116,431,159...116,782,195

G

dedicator of cytokinesis 6

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DOCK6 promoter

NCBI chr 8:28,618,523...28,670,741
Ensembl chr 8:28,618,523...28,670,648

G

dedicator of cytokinesis 8

increases expression

EXP

Dibutyl Phthalate results in increased expression of DOCK8 mRNA

NCBI chr 1:232,075,468...232,268,830
Ensembl chr 1:232,075,588...232,268,833

G

docking protein 5

increases expression

EXP

Dibutyl Phthalate results in increased expression of DOK5 mRNA

NCBI chr 3:179,934,419...180,071,334
Ensembl chr 3:179,934,552...180,071,333

G

dolichol kinase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DOLK mRNA

NCBI chr 3:33,955,642...33,957,680
Ensembl chr 3:33,954,308...33,958,365

G

dolichyldiphosphatase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DOLPP1 mRNA

NCBI chr 3:34,063,825...34,072,133
Ensembl chr 3:34,063,825...34,072,132

G

DNA replication fork stabilization factor DONSON

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DONSON mRNA

PMID:17361019 PMID:21266533

NCBI chr11:44,405,794...44,419,099
Ensembl chr11:44,405,804...44,418,791

G

DOP1 leucine zipper like protein B

increases expression

EXP

Dibutyl Phthalate results in increased expression of DOP1B mRNA

NCBI chr11:46,494,058...46,595,601
Ensembl chr11:46,494,058...46,595,601

G

dopamine receptor interacting protein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of DORIP1 mRNA

NCBI chr 6:88,701,651...88,710,204
Ensembl chr 6:88,701,818...88,708,820

G

DOT1 like histone lysine methyltransferase

increases expression
affects expression

EXP

Dibutyl Phthalate results in increased expression of DOT1L mRNA
Dibutyl Phthalate affects the expression of DOT1L mRNA

PMID:21266533 PMID:30934153

NCBI chr 7:9,569,439...9,607,095
Ensembl chr 7:9,569,439...9,607,095

G

deleted in primary ciliary dyskinesia

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DPCD mRNA

NCBI chr 1:254,357,755...254,375,918
Ensembl chr 1:254,357,778...254,375,918

G

dipeptidase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of DPEP1 mRNA

NCBI chr19:68,118,270...68,143,781
Ensembl chr19:68,118,453...68,143,775

G

double PHD fingers 1

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DPF1 mRNA

NCBI chr 1:93,729,683...93,743,425
Ensembl chr 1:93,726,970...93,743,425

G

diphthamide biosynthesis 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DPH2 mRNA

NCBI chr 5:136,713,868...136,716,828

G

diphthamide biosynthesis 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of DPH3 mRNA

NCBI chr16:7,294,580...7,299,996
Ensembl chr16:7,294,580...7,299,996

G

diphthamide biosynthesis 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DPH5 mRNA

NCBI chr 2:206,489,556...206,540,590
Ensembl chr 2:206,489,556...206,523,556

G

diphthamine biosynthesis 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DPH6 mRNA

NCBI chr 3:121,761,495...121,891,727
Ensembl chr 3:121,676,141...121,891,658

G

diphthamide biosynthesis 7

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DPH7 mRNA

NCBI chr 3:28,168,466...28,177,173
Ensembl chr 3:28,168,547...28,177,173

G

dolichyl-phosphate mannosyltransferase subunit 1, catalytic

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DPM1 mRNA

NCBI chr 3:177,338,855...177,358,398
Ensembl chr 3:177,338,855...177,358,412

G

dipeptidyl peptidase like 10

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA

NCBI chr13:37,145,531...38,821,987
Ensembl chr13:37,145,531...38,822,801

G

dipeptidylpeptidase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DPP3 mRNA

NCBI chr 1:211,634,067...211,657,898
Ensembl chr 1:211,634,068...211,658,310

G

dipeptidyl peptidase like 6

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of DPP6 mRNA

NCBI chr 4:8,323,220...9,242,694
Ensembl chr 4:8,324,843...9,242,209

G

dipeptidylpeptidase 7

increases expression

EXP

Dibutyl Phthalate results in increased expression of DPP7 mRNA

NCBI chr 3:28,563,240...28,567,492
Ensembl chr 3:28,563,240...28,567,492

G

dpy-30 histone methyltransferase complex regulatory subunit

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DPY30 mRNA

NCBI chr 6:26,872,812...26,893,580
Ensembl chr 6:26,872,732...26,894,930

G

dihydropyrimidine dehydrogenase

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of DPYD mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPYD mRNA
Dibutyl Phthalate results in increased expression of DPYD mRNA

PMID:21266533 PMID:25607892

NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778

G

dihydropyrimidinase-like 2

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of DPYSL2 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DPYSL2 promoter

PMID:21266533 PMID:23359474

NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065

G

dihydropyrimidinase-like 3

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DPYSL3 mRNA

NCBI chr18:35,625,357...35,731,152
Ensembl chr18:35,625,357...35,731,152

G

dihydropyrimidinase-like 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DPYSL4 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:203,312,646...203,328,523
Ensembl chr 1:203,311,694...203,328,523

G

DNA damage regulated autophagy modulator 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of DRAM2 mRNA

NCBI chr 2:196,724,052...196,752,645
Ensembl chr 2:196,723,858...196,755,103

G

Dr1 associated protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DRAP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:212,161,107...212,163,833
Ensembl chr 1:212,161,125...212,163,762

G

dynein regulatory complex subunit 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of DRC3 mRNA

NCBI chr10:45,620,045...45,698,902
Ensembl chr10:45,648,410...45,698,900

G

dopamine receptor D1

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of DRD1 mRNA
Dibutyl Phthalate results in increased expression of DRD1A mRNA

PMID:15620428 PMID:31841868

NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166

G

dopamine receptor D2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of DRD2 mRNA
Dibutyl Phthalate results in increased expression of DRD2 mRNA; Dibutyl Phthalate results in increased expression of DRD2 protein

PMID:15620428 PMID:31841868

NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339

G

dopamine receptor D4

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DRD4 mRNA

NCBI chr 1:205,825,937...205,829,124
Ensembl chr 1:205,826,049...205,830,458

G

developmentally regulated GTP binding protein 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DRG2 mRNA

NCBI chr10:45,755,072...45,769,493
Ensembl chr10:45,755,059...45,769,523

G

drosha ribonuclease III

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of DROSHA mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of DROSHA mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of DROSHA mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of DROSHA protein

PMID:17361019 PMID:21266533 PMID:28611354 PMID:33086190

NCBI chr 2:63,591,885...63,703,688
Ensembl chr 2:63,591,968...63,703,687

G

desmocollin 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of DSC2 mRNA

NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466

G

DNA replication and sister chromatid cohesion 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of DSCC1 mRNA

NCBI chr 7:88,372,349...88,390,815
Ensembl chr 7:88,372,146...88,387,973

G

dermatan sulfate epimerase-like

increases expression

EXP

Dibutyl Phthalate results in increased expression of DSEL mRNA

NCBI chr13:194,738...200,959
Ensembl chr13:179,618...200,993

G

desmoglein 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DSG2 mRNA

PMID:17361019 PMID:21266533

NCBI chr18:12,121,287...12,179,590
Ensembl chr18:12,121,181...12,179,590

G

desmoplakin

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of DSP mRNA
Dibutyl Phthalate results in decreased expression of DSP mRNA

PMID:21266533 PMID:24893172

NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121

G

dystonin

increases expression

ISO

Dibutyl Phthalate results in increased expression of DST mRNA

NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:43,631,517...44,025,533

G

destrin, actin depolymerizing factor

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of DSTN mRNA
Dibutyl Phthalate results in decreased expression of DSTN protein

PMID:21266533 PMID:34864091

NCBI chr 3:151,737,711...151,764,752
Ensembl chr 3:151,737,849...151,764,769

G

denticleless E3 ubiquitin protein ligase homolog

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DTL mRNA

PMID:17361019 PMID:21266533

NCBI chr13:105,646,908...105,685,921
Ensembl chr13:105,646,908...105,686,174

G

dystrobrevin, alpha

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of DTNA mRNA

NCBI chr18:14,862,801...15,218,993
Ensembl chr18:14,862,818...15,218,993

G

dystrobrevin, beta

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DTNB mRNA

NCBI chr 6:32,286,022...32,483,007
Ensembl chr 6:32,285,941...32,485,872

G

dystrobrevin binding protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DTNBP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr17:19,891,313...19,982,770
Ensembl chr17:19,891,337...19,984,418

G

DTW domain containing 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of DTWD1 mRNA

NCBI chr 3:133,845,768...133,859,965
Ensembl chr 3:133,841,935...133,860,316

G

deltex E3 ubiquitin ligase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DTX1 mRNA

PMID:17361019 PMID:21266533

NCBI chr12:41,510,252...41,541,433
Ensembl chr12:41,510,264...41,541,430

G

deoxythymidylate kinase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DTYMK mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504

G

dihydrouridine synthase 4-like

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DUS4L mRNA

NCBI chr 6:53,955,609...53,970,050
Ensembl chr 6:53,955,609...53,970,087

G

dual specificity phosphatase 1

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of DUSP1 mRNA
Dibutyl Phthalate results in decreased expression of DUSP1 mRNA

PMID:17361019 PMID:21266533 PMID:31841868

NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644

G

dual specificity phosphatase 10

increases expression

ISO

Dibutyl Phthalate results in increased expression of DUSP10 mRNA

NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304

G

dual specificity phosphatase 11

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of DUSP11 mRNA

NCBI chr 4:119,928,533...119,942,643
Ensembl chr 4:119,928,537...119,942,567

G

dual specificity phosphatase 14

increases expression

EXP

Dibutyl Phthalate results in increased expression of DUSP14 mRNA

NCBI chr10:69,433,949...69,463,863
Ensembl chr10:69,426,730...69,462,837

G

dual specificity phosphatase 15

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of DUSP15 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DUSP15 promoter

PMID:21266533 PMID:23359474

NCBI chr 3:161,868,746...161,880,432
Ensembl chr 3:161,868,749...161,879,250

G

dual specificity phosphatase 16

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of DUSP16 mRNA

PMID:17361019 PMID:21266533

NCBI chr 4:169,278,118...169,361,508
Ensembl chr 4:169,278,118...169,361,508

G

dual specificity phosphatase 3

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of DUSP3 mRNA
Dibutyl Phthalate results in decreased expression of DUSP3 mRNA

PMID:21266533 PMID:24893172

NCBI chr10:87,420,213...87,434,202
Ensembl chr10:87,419,494...87,434,063

G

dual specificity phosphatase 4

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of DUSP4 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DUSP4 mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr16:64,079,893...64,101,396
Ensembl chr16:64,079,893...64,093,700

G

dual specificity phosphatase 5

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of DUSP5 mRNA

NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417

G

dual specificity phosphatase 6

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of DUSP6 mRNA

PMID:17361019 PMID:21266533 PMID:21745491

NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833

G

dual specificity phosphatase 8

increases expression

ISO

Dibutyl Phthalate results in increased expression of DUSP8 mRNA

NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441

G

deoxyuridine triphosphatase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of DUT mRNA

NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956

G

dishevelled segment polarity protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DVL1 mRNA

NCBI chr 5:171,738,911...171,750,967
Ensembl chr 5:171,739,133...171,750,966

G

dynein cytoplasmic 1 intermediate chain 1

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of DYNC1I1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DYNC1I1 mRNA

PMID:21266533 PMID:31199487

NCBI chr 4:34,819,313...35,132,647
Ensembl chr 4:34,819,430...35,142,319

G

dynein 2 intermediate chain 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DYNC2I2 mRNA

NCBI chr 3:33,703,882...33,719,960
Ensembl chr 3:33,703,882...33,719,960

G

dynein light chain LC8-type 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of DYNLL2 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:73,264,260...73,283,042
Ensembl chr10:73,264,261...73,272,285

G

dynein light chain Tctex-type 2B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DYNLT2B mRNA

NCBI chr11:81,864,195...81,872,555
Ensembl chr11:81,864,195...81,872,555

G

dual specificity tyrosine phosphorylation regulated kinase 1A

increases expression

ISO

Dibutyl Phthalate results in increased expression of DYRK1A mRNA

NCBI chr11:47,360,824...47,479,033
Ensembl chr11:47,360,850...47,479,033

G

dual specificity tyrosine phosphorylation regulated kinase 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of DYRK2 mRNA

NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:56,235,276...56,265,942

G

dysferlin

increases expression

ISO

Dibutyl Phthalate results in increased expression of DYSF mRNA

NCBI chr 4:118,048,460...118,248,273
Ensembl chr 4:118,047,989...118,248,273

G

DAZ interacting zinc finger protein 1-like

increases expression

ISO

Dibutyl Phthalate results in increased expression of DZIP1L mRNA

NCBI chr 8:109,067,466...109,108,390
Ensembl chr 8:109,067,775...109,108,393

G

DAZ interacting zinc finger protein 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of DZIP3 mRNA

NCBI chr11:65,286,190...65,356,314
Ensembl chr11:65,286,190...65,356,314

G

E2F transcription factor 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of E2F2 mRNA

NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087

G

E2F transcription factor 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of E2F3 mRNA

NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,809,998...34,887,725

G

E2F transcription factor 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of E2F4 mRNA

NCBI chr19:50,084,335...50,091,731
Ensembl chr19:50,084,335...50,091,834

G

E2F transcription factor 7

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of E2F7 mRNA

NCBI chr 7:48,036,881...48,079,055
Ensembl chr 7:48,037,749...48,079,055

G

E2F transcription factor 8

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of E2F8 mRNA

NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009

G

E2F-associated phosphoprotein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EAPP mRNA

NCBI chr 6:77,879,634...77,929,653
Ensembl chr 6:77,907,485...77,928,930

G

glutamyl-tRNA synthetase 2, mitochondrial

increases expression

ISO

Dibutyl Phthalate results in increased expression of EARS2 mRNA

NCBI chr 1:186,025,740...186,057,165

G

estrogen receptor binding site associated antigen 9

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EBAG9 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:77,695,213...77,713,565
Ensembl chr 7:77,695,072...77,713,557

G

EBF transcription factor 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EBF3 mRNA

NCBI chr 1:201,426,446...201,544,444
Ensembl chr 1:201,426,450...201,544,305

G

EBP, cholestenol delta-isomerase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EBP mRNA

PMID:21266533 PMID:26472102 PMID:33983380

NCBI chr X:16,971,372...16,977,782
Ensembl chr X:16,971,405...16,977,781

G

endothelin-converting enzyme 2

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA

NCBI chr11:93,767,559...93,782,896
Ensembl chr11:93,767,559...93,793,292

G

enoyl-CoA hydratase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ECH1 mRNA

NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440

G

enoyl CoA hydratase domain containing 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ECHDC2 promoter

NCBI chr 5:128,144,241...128,163,611
Ensembl chr 5:128,144,425...128,163,610

G

enoyl CoA hydratase domain containing 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ECHDC3 mRNA

NCBI chr17:76,980,112...77,002,934
Ensembl chr17:76,980,083...77,002,934

G

enoyl-CoA hydratase, short chain 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ECHS1 mRNA

NCBI chr 1:204,324,679...204,333,506
Ensembl chr 1:204,324,682...204,333,506

G

enoyl-CoA delta isomerase 2

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of ECI2 mRNA

PMID:17361019 PMID:21266533

NCBI chr17:30,056,274...30,092,169
Ensembl chr17:30,076,524...30,092,161

G

ECRG4 augurin precursor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ECRG4 mRNA

PMID:21266533 PMID:24893172

NCBI chr 9:53,485,040...53,504,691
Ensembl chr 9:53,485,040...53,504,703

G

endothelial cell surface expressed chemotaxis and apoptosis regulator

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of ECSCR mRNA
Dibutyl Phthalate results in increased expression of ECSCR mRNA

NCBI chr18:27,583,791...27,593,184
Ensembl chr18:27,583,195...27,593,195

G

endothelial differentiation-related factor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EDF1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:28,764,906...28,779,499

G

endothelin 1

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of EDN1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EDN1 mRNA

PMID:17361019 PMID:21266533 PMID:31199487

NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687

G

endothelin 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of EDN2 mRNA]

NCBI chr 5:139,036,576...139,042,074
Ensembl chr 5:139,036,492...139,043,070

G

endothelin receptor type A

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of EDNRA mRNA

PMID:17361019 PMID:21266533

NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284

G

endothelin receptor type B

increases expression

ISO

Dibutyl Phthalate results in increased expression of EDNRB mRNA

PMID:17361019 PMID:21266533

NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765

G

early endosome antigen 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of EEA1 mRNA

NCBI chr 7:32,441,281...32,608,808
Ensembl chr 7:32,441,272...32,608,476

G

eukaryotic translation elongation factor 1 alpha 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of EEF1A1 mRNA

NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072

G

eukaryotic translation elongation factor 1 delta

increases expression

ISO

Dibutyl Phthalate results in increased expression of EEF1D mRNA

NCBI chr 7:109,462,645...109,478,021
Ensembl chr 7:109,462,646...109,489,531

G

eukaryotic translation elongation factor 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EEF2 promoter

NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544

G

EEIG family member 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of FAM102B mRNA

NCBI chr 2:199,296,582...199,351,449
Ensembl chr 2:199,296,582...199,351,449

G

EF-hand calcium binding domain 14

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EFCAB14 mRNA

NCBI chr 5:134,454,908...134,493,714
Ensembl chr 5:134,454,924...134,495,384

G

EGF containing fibulin extracellular matrix protein 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of EFEMP2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:212,210,972...212,218,739

G

EF-hand domain family, member D1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of EFHD1 mRNA
Dibutyl Phthalate results in decreased expression of EFHD1 mRNA

NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:95,386,169...95,432,798

G

ephrin A2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EFNA2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:10,167,091...10,177,719
Ensembl chr 7:10,167,091...10,177,719

G

ephrin B1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EFNB1 mRNA

NCBI chr X:68,297,529...68,310,335
Ensembl chr X:68,297,492...68,349,546

G

embryonal Fyn-associated substrate

increases expression

ISO

Dibutyl Phthalate results in increased expression of EFS mRNA

PMID:17361019 PMID:21266533

NCBI chr15:32,362,401...32,374,490
Ensembl chr15:32,361,843...32,371,743

G

elongation factor Tu GTP binding domain containing 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EFTUD2 mRNA

NCBI chr10:88,304,992...88,352,229
Ensembl chr10:88,304,992...88,346,299

G

epidermal growth factor

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGF mRNA

NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297

G

EGF-like, fibronectin type III and laminin G domains

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EGFLAM promoter

NCBI chr 2:58,029,934...58,204,010
Ensembl chr 2:58,029,935...58,203,643

G

epidermal growth factor receptor

increases phosphorylation
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased phosphorylation of EGFR protein
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of EGFR mRNA
fulvestrant inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of EGFR protein]

PMID:22552774 PMID:25607892

NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358

G

egl-9 family hypoxia-inducible factor 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of EGLN1 mRNA

NCBI chr19:69,765,276...69,804,681

G

early growth response 1

increases expression
decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of EGR1 mRNA
Dibutyl Phthalate results in decreased expression of EGR1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EGR1 mRNA

PMID:15728792 PMID:17361019 PMID:21266533 PMID:21745491 PMID:31841868 More...

NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843

G

early growth response 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of EGR2 mRNA

PMID:17361019 PMID:21266533 PMID:21745491

NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748

G

early growth response 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of EGR3 mRNA

PMID:17361019 PMID:21266533

NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712

G

EH domain binding protein 1-like 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of EHBP1L1 mRNA

NCBI chr 1:212,423,444...212,444,357
Ensembl chr 1:212,423,447...212,443,598

G

EH-domain containing 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EHD2 mRNA

NCBI chr 1:85,767,757...85,786,974
Ensembl chr 1:85,768,667...85,786,943

G

EH-domain containing 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of EHD3 mRNA

NCBI chr 6:27,392,709...27,417,445
Ensembl chr 6:27,392,709...27,417,445

G

EH-domain containing 4

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of EHD4 mRNA

NCBI chr 3:127,511,973...127,575,856
Ensembl chr 3:127,511,954...127,576,072

G

enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of EHHADH mRNA; Dibutyl Phthalate results in increased expression of EHHADH protein
[PPARA protein affects the susceptibility to Dibutyl Phthalate] which results in increased expression of EHHADH protein

NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662

G

eukaryotic translation initiation factor 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of EIF1 mRNA

NCBI chr10:85,747,064...85,749,447
Ensembl chr 5:25,895,968...25,896,654
Ensembl chr10:25,895,968...25,896,654

G

eukaryotic translation initiation factor 1A

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of EIF1A mRNA

NCBI chr18:41,512,298...41,524,645
Ensembl chr18:41,503,180...41,549,696

G

eukaryotic translation initiation factor 2-alpha kinase 2

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of EIF2AK2 mRNA
[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of EIF2AK2 protein

PMID:17361019 PMID:21266533 PMID:30218697

NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116

G

eukaryotic translation initiation factor 2 alpha kinase 3

increases expression
increases phosphorylation
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of EIF2AK3 mRNA
Dibutyl Phthalate results in increased phosphorylation of EIF2AK3 protein
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of EIF2AK3 protein]

PMID:21266533 PMID:30173778 PMID:30910607

NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268

G

eukaryotic translation initiation factor 2 alpha kinase 4

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EIF2AK4 mRNA

NCBI chr 3:125,810,207...125,895,574
Ensembl chr 3:125,810,060...125,895,574

G

eukaryotic translation initiation factor 2B subunit alpha

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EIF2B1 mRNA

NCBI chr12:37,686,149...37,694,830
Ensembl chr12:37,686,559...37,708,078

G

eukaryotic translation initiation factor 2B subunit delta

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of EIF2B4 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:30,903,148...30,908,803
Ensembl chr 6:30,903,219...30,908,800

G

eukaryotic translation initiation factor 2D

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LGTN mRNA

NCBI chr13:45,168,161...45,189,362
Ensembl chr13:45,139,967...45,191,974

G

eukaryotic translation initiation factor 2 subunit alpha

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of EIF2S1 mRNA
4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of EIF2S1 protein modified form]
Dibutyl Phthalate results in increased expression of EIF2S1 mRNA

PMID:21266533 PMID:26804720

NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649

G

eukaryotic translation initiation factor 2 subunit beta

increases expression

EXP

Dibutyl Phthalate results in increased expression of EIF2S2 mRNA

NCBI chr 3:163,834,846...163,855,733
Ensembl chr 3:163,834,851...163,855,570

G

eukaryotic translation initiation factor 3, subunit C

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EIF3C mRNA

NCBI chr 1:190,565,183...190,583,067
Ensembl chr 1:190,565,184...190,583,067

G

eukaryotic translation initiation factor 3, subunit D

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of EIF3D mRNA
[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of EIF3D protein

PMID:17361019 PMID:34864091

NCBI chr 7:111,420,351...111,432,761
Ensembl chr 7:111,420,351...111,432,740

G

eukaryotic translation initiation factor 3, subunit G

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EIF3G mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:27,705,914...27,709,946
Ensembl chr 8:27,705,915...27,709,987

G

eukaryotic translation initiation factor 3, subunit H

increases expression

EXP

Dibutyl Phthalate results in increased expression of EIF3H mRNA

NCBI chr 7:84,980,891...85,064,284
Ensembl chr 7:84,980,891...85,071,546

G

eukaryotic translation initiation factor 3, subunit I

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EIF3I mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:147,219,457...147,226,910
Ensembl chr 5:147,219,366...147,241,232

G

eukaryotic translation initiation factor 3, subunit J

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EIF3J mRNA

NCBI chr 3:129,438,715...129,460,953
Ensembl chr 3:129,438,722...129,462,246

G

eukaryotic translation initiation factor 4A1

increases expression

EXP

Dibutyl Phthalate results in increased expression of EIF4A1 mRNA

NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602

G

eukaryotic translation initiation factor 4A3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EIF4A3 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:105,047,567...105,057,561
Ensembl chr10:105,047,568...105,058,207

G

eukaryotic translation initiation factor 4E

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of EIF4E mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of EIF4E mRNA

PMID:21266533 PMID:30698749

NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105

G

eukaryotic translation initiation factor 4E family member 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EIF4E2 mRNA

NCBI chr 9:95,333,439...95,362,366
Ensembl chr 9:95,333,989...95,362,362

G

eukaryotic translation initiation factor 4 gamma 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EIF4G1 promoter

NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367

G

eukaryotic translation initiation factor 6

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of EIF6 mRNA
Dibutyl Phthalate results in decreased expression of EIF6 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:164,785,162...164,791,410
Ensembl chr 3:164,785,163...164,791,525

G

ELAV like RNA binding protein 1

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ELAVL1 mRNA
Dibutyl Phthalate results in decreased expression of ELAVL1 mRNA

NCBI chr12:7,441,699...7,482,625
Ensembl chr12:7,441,699...7,482,631

G

ELAV like RNA binding protein 2

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of ELAVL2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ELAVL2 mRNA

PMID:21266533 PMID:39150890

NCBI chr 5:111,076,705...111,202,341
Ensembl chr 5:111,076,705...111,224,918

G

E74 like ETS transcription factor 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of ELF1 mRNA

NCBI chr15:61,354,026...61,395,762
Ensembl chr15:61,330,877...61,395,758

G

ETS transcription factor ELK4

increases expression

EXP

Dibutyl Phthalate results in increased expression of ELK4 mRNA

NCBI chr13:46,004,145...46,027,206
Ensembl chr13:46,004,182...46,027,199

G

elongation factor for RNA polymerase II

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ELL mRNA

NCBI chr16:18,877,751...18,925,449
Ensembl chr16:18,877,751...18,925,076

G

elongation factor for RNA polymerase II 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of ELL2 mRNA

NCBI chr 2:6,910,446...6,990,654
Ensembl chr 2:6,921,771...7,016,199

G

engulfment and cell motility 1

multiple interactions
decreases expression

ISO

ELMO1 protein inhibits the reaction [Dibutyl Phthalate results in decreased expression of and results in decreased activity of RAC1 protein]; RHOG protein inhibits the reaction [Dibutyl Phthalate results in decreased expression of ELMO1 protein]
Dibutyl Phthalate results in decreased expression of ELMO1 mRNA; Dibutyl Phthalate results in decreased expression of ELMO1 protein

NCBI chr17:48,982,188...49,518,525
Ensembl chr17:48,982,188...49,518,159

G

ELMO domain containing 1

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ELMOD1 mRNA

NCBI chr 8:63,194,539...63,251,526
Ensembl chr 8:63,137,295...63,251,322

G

ELMO domain containing 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ELMOD2 mRNA

NCBI chr19:41,690,713...41,710,194
Ensembl chr19:41,690,762...41,710,194
Ensembl chr18:41,690,762...41,710,194

G

elongin B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ELOB mRNA

NCBI chr10:13,353,413...13,358,484
Ensembl chr10:13,353,417...13,358,563

G

elongin C

decreases expression
increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of ELOC mRNA
Dibutyl Phthalate results in increased expression of ELOC mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ELOC promoter

PMID:17361019 PMID:21266533 PMID:23359474

NCBI chr 5:7,444,769...7,461,187
Ensembl chr20:25,752,857...25,753,279

G

ELOVL fatty acid elongase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ELOVL1 mRNA

NCBI chr 5:137,246,781...137,251,351
Ensembl chr 5:137,246,849...137,251,352

G

ELOVL fatty acid elongase 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ELOVL2 mRNA

NCBI chr17:23,750,350...23,790,601
Ensembl chr17:23,750,350...23,790,601

G

ELOVL fatty acid elongase 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of ELOVL3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:254,938,731...254,942,559
Ensembl chr 1:254,938,731...254,942,559

G

ELOVL fatty acid elongase 6

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ELOVL6 mRNA

NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549

G

elongator acetyltransferase complex subunit 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ELP3 mRNA

NCBI chr15:43,930,234...43,992,065
Ensembl chr15:43,930,234...43,992,214

G

elongator acetyltransferase complex subunit 5

increases expression

EXP

Dibutyl Phthalate results in increased expression of ELP5 mRNA

NCBI chr10:55,191,223...55,202,949
Ensembl chr10:55,191,227...55,203,617

G

embigin

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EMB mRNA

NCBI chr 2:50,803,468...50,858,001
Ensembl chr 2:50,801,973...50,862,920

G

ER membrane protein complex subunit 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EMC2 mRNA

NCBI chr 7:76,471,899...76,508,866
Ensembl chr 7:76,471,899...76,510,178

G

ER membrane protein complex subunit 7

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EMC7 mRNA

NCBI chr 3:119,714,617...119,728,748
Ensembl chr 3:119,718,357...119,730,486

G

endomucin

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EMCN mRNA

NCBI chr 2:228,564,445...228,644,370
Ensembl chr 2:228,564,430...228,645,155

G

emerin

increases expression

EXP

Dibutyl Phthalate results in increased expression of EMD mRNA

NCBI chr X:157,190,438...157,193,479
Ensembl chr X:157,189,819...157,197,095

G

essential meiotic structure-specific endonuclease 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EME1 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:80,083,585...80,092,450
Ensembl chr10:80,083,585...80,092,301

G

elastin microfibril interfacer 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of EMILIN1 mRNA

NCBI chr 6:31,175,919...31,183,657
Ensembl chr 6:31,175,919...31,183,657

G

elastin microfibril interfacer 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EMILIN3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:169,978,488...169,984,718
Ensembl chr 3:169,978,672...169,984,488

G

EMAP like 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EML2 mRNA

NCBI chr 1:87,955,924...87,987,366
Ensembl chr 1:87,955,606...87,987,366

G

epithelial membrane protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of EMP1 mRNA

NCBI chr 4:169,931,537...169,964,366
Ensembl chr 4:169,931,440...169,964,365

G

epithelial membrane protein 2

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of EMP2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EMP2 mRNA

PMID:21266533 PMID:39150890

NCBI chr10:5,866,869...5,901,533
Ensembl chr10:5,866,922...5,901,532

G

epithelial membrane protein 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EMP3 mRNA

NCBI chr 1:105,525,086...105,528,370
Ensembl chr 1:105,525,088...105,528,265

G

empty spiracles homeobox 2

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EMX2 mRNA

NCBI chr 1:268,612,663...268,619,671
Ensembl chr 1:268,612,663...268,619,671

G

ENAH, actin regulator

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ENAH mRNA

NCBI chr13:96,149,437...96,269,841
Ensembl chr13:96,149,437...96,269,796

G

ectodermal-neural cortex 1

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of ENC1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ENC1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721

G

endonuclease domain containing 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ENDOD1 mRNA

NCBI chr 8:19,490,615...19,520,007
Ensembl chr 8:19,490,615...19,520,007

G

endonuclease G

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ENDOG mRNA

NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573

G

endoglin

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ENG mRNA
Dibutyl Phthalate results in decreased expression of ENG mRNA

NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933

G

enkurin domain containing 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ENKD1 mRNA

NCBI chr19:50,501,963...50,506,447
Ensembl chr19:50,501,963...50,506,942

G

enolase 1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ENO1 mRNA
Dibutyl Phthalate results in decreased expression of ENO1 mRNA

PMID:17379624 PMID:21266533

NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003

G

enolase 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ENO4 mRNA

NCBI chr 1:268,073,318...268,113,494
Ensembl chr 1:268,082,522...268,106,300

G

enolase-phosphatase 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ENOPH1 promoter

NCBI chr14:9,835,626...9,862,051
Ensembl chr14:9,835,627...9,873,668

G

ectonucleotide pyrophosphatase/phosphodiesterase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of ENPP1 mRNA

NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044

G

ectonucleotide pyrophosphatase/phosphodiesterase 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of ENPP3 mRNA

NCBI chr 1:22,382,717...22,454,324
Ensembl chr 1:22,382,964...22,454,314

G

endosulfine alpha

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ENSA mRNA

NCBI chr 2:185,874,500...185,881,838
Ensembl chr 2:185,874,500...185,881,838

G

ectonucleoside triphosphate diphosphohydrolase 1

increases expression
decreases expression

ISO

Dibutyl Phthalate results in increased expression of ENTPD1 mRNA
Dibutyl Phthalate results in decreased expression of ENTPD1 mRNA

NCBI chr 1:249,374,810...249,502,310
Ensembl chr 1:249,374,836...249,502,317

G

ectonucleoside triphosphate diphosphohydrolase 5

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ENTPD5 mRNA

NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:109,753,204...109,786,495

G

endosomal transmembrane epsin interactor 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ENTREP3 mRNA

NCBI chr 2:176,886,903...176,893,047
Ensembl chr 2:176,887,135...176,893,047

G

ENY2, transcription and export complex 2 subunit

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ENY2 mRNA

NCBI chr 7:77,465,885...77,489,637
Ensembl chr 7:77,466,119...77,491,057

G

endothelium and lymphocyte associated ASCH domain 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EOLA2 mRNA

NCBI chr X:154,108,628...154,113,426
Ensembl chr X:154,108,836...154,113,436

G

endothelial PAS domain protein 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of EPAS1 mRNA

NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729

G

erythrocyte membrane protein band 4.1

increases expression

ISO

Dibutyl Phthalate results in increased expression of EPB41 mRNA

NCBI chr 5:149,394,080...149,548,178
Ensembl chr 5:149,394,096...149,543,540

G

erythrocyte membrane protein band 4.1-like 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of EPB41L2 mRNA

NCBI chr 1:21,682,336...21,857,106
Ensembl chr 1:21,682,335...21,857,105

G

erythrocyte membrane protein band 4.1-like 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EPB41L3 mRNA

NCBI chr 9:116,502,864...116,707,274
Ensembl chr 9:116,462,807...116,707,274

G

erythrocyte membrane protein band 4.2

increases expression

ISO

Dibutyl Phthalate results in increased expression of EPB42 mRNA

NCBI chr 3:128,433,460...128,451,683
Ensembl chr 3:128,433,464...128,451,683

G

ependymin related 1

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EPDR1 mRNA

NCBI chr17:50,029,591...50,054,254
Ensembl chr17:50,029,256...50,054,250

G

Eph receptor A2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of EPHA2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234

G

Eph receptor A3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EPHA3 mRNA

NCBI chr11:14,585,041...14,920,721
Ensembl chr11:14,586,727...14,920,425

G

Eph receptor A4

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EPHA4 mRNA

NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755

G

Eph receptor B3

affects expression

EXP

Dibutyl Phthalate affects the expression of EPHB3 mRNA

NCBI chr11:93,345,098...93,363,775
Ensembl chr11:93,345,098...93,363,775

G

epoxide hydrolase 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of EPHX1 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981

G

EPM2A interacting protein 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EPM2AIP1 mRNA

NCBI chr 8:120,112,265...120,119,613
Ensembl chr 8:120,112,084...120,121,458

G

epidermal growth factor receptor pathway substrate 15

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EPS15 mRNA

NCBI chr 5:129,274,487...129,374,856
Ensembl chr 5:129,274,502...129,374,856

G

EGFR pathway substrate 8, signaling adaptor

increases expression
decreases expression

ISO

Dibutyl Phthalate results in increased expression of EPS8 mRNA
Dibutyl Phthalate results in decreased expression of EPS8 mRNA

NCBI chr 4:172,119,497...172,291,670
Ensembl chr 4:172,119,497...172,218,160

G

EPS8 signaling adaptor L3

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EPS8L3 promoter

NCBI chr 2:198,202,862...198,216,255
Ensembl chr 2:198,200,486...198,216,255

G

Era-like 12S mitochondrial rRNA chaperone 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ERAL1 mRNA

NCBI chr10:63,459,774...63,466,829
Ensembl chr10:63,459,774...63,468,225

G

endoplasmic reticulum aminopeptidase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ERAP1 mRNA

NCBI chr 2:5,666,337...5,705,256
Ensembl chr 2:5,666,436...5,740,056

G

erb-b2 receptor tyrosine kinase 2

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of ERBB2 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB2 mRNA

PMID:17379624 PMID:25607892

NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481

G

erb-b2 receptor tyrosine kinase 3

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of ERBB3 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB3 mRNA

PMID:21266533 PMID:25607892

NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120

G

erb-b2 receptor tyrosine kinase 4

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of ERBB4 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ERBB4 mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ERBB4 mRNA

PMID:17361019 PMID:25607892

NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:76,973,227...78,045,772

G

ELKS/RAB6-interacting/CAST family member 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ERC2 mRNA

NCBI chr16:2,819,399...3,680,258
Ensembl chr16:2,819,512...3,680,258

G

ERCC excision repair 3, TFIIH core complex helicase subunit

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ERCC3 mRNA

PMID:17361019 PMID:21266533

NCBI chr18:24,157,831...24,188,543
Ensembl chr18:24,148,084...24,190,898

G

ERCC excision repair 5, endonuclease

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ERCC5 mRNA

NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:53,801,714...53,875,084

G

epiregulin

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EREG mRNA

NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260

G

Ets2 repressor factor

increases expression

EXP

Dibutyl Phthalate results in increased expression of ERF mRNA

NCBI chr 1:89,957,760...89,966,213
Ensembl chr 1:89,957,760...89,966,213

G

ERH, mRNA splicing and mitosis factor

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ERH mRNA

NCBI chr 6:106,012,255...106,022,521
Ensembl chr 6:106,012,255...106,022,623

G

exoribonuclease 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ERI1 mRNA

NCBI chr16:63,427,412...63,447,521
Ensembl chr16:63,427,403...63,447,896

G

glutamate-rich 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of ERICH6 mRNA

NCBI chr 2:145,001,833...145,027,935
Ensembl chr 2:145,001,833...145,028,223

G

endoplasmic reticulum metallopeptidase 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ERMP1 mRNA

NCBI chr 1:236,801,459...236,835,656
Ensembl chr 1:236,801,466...236,839,197

G

endoplasmic reticulum to nucleus signaling 1

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ERN1 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ERN1 protein

NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791

G

endoplasmic reticulum oxidoreductase 1 alpha

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ERO1A mRNA

NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039

G

ERBB receptor feedback inhibitor 1

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of ERRFI1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ERRFI1 mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432

G

esterase D

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ESD mRNA

PMID:17361019 PMID:21266533

NCBI chr15:56,453,082...56,472,582
Ensembl chr15:56,453,044...56,473,508

G

extra spindle pole bodies like 1, separase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ESPL1 mRNA

NCBI chr 7:135,302,460...135,329,570
Ensembl chr 7:135,302,716...135,329,570

G

espin

affects expression
multiple interactions

EXP

Dibutyl Phthalate affects the expression of ESPN mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ESPN mRNA

PMID:30934153 PMID:31199487

NCBI chr 5:167,909,271...167,943,168
Ensembl chr 5:167,909,271...167,942,984

G

estrogen receptor 1

multiple interactions
decreases expression
affects expression
increases activity
increases expression
affects binding
decreases methylation

ISO
EXP

[Dibutyl Phthalate co-treated with Fulvestrant] results in decreased expression of ESR1 mRNA; Dibutyl Phthalate binds to and results in increased activity of ESR1 protein; Dibutyl Phthalate inhibits the reaction [Estradiol results in increased activity of ESR1 protein]; Tamoxifen inhibits the reaction [Dibutyl Phthalate binds to and results in increased activity of ESR1 protein]
Dibutyl Phthalate results in decreased expression of ESR1 mRNA
Dibutyl Phthalate affects the expression of ESR1 protein
Dibutyl Phthalate results in decreased expression of ESR1 protein
Dibutyl Phthalate results in increased expression of and affects the localization of ESR1 protein
Dibutyl Phthalate results in increased activity of ESR1 protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ESR1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ESR1 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ESR1 mRNA; ESR1 protein affects the reaction [Dibutyl Phthalate results in increased activity of CASP3 protein]
Dibutyl Phthalate results in increased expression of ESR1 mRNA; Dibutyl Phthalate results in increased expression of ESR1 protein
Dibutyl Phthalate binds to ESR1 protein
Dibutyl Phthalate results in decreased methylation of ESR1 promoter
Dibutyl Phthalate analog binds to ESR1 protein; Dibutyl Phthalate binds to ESR1 protein

PMID:15464722 PMID:15840436 PMID:16326419 PMID:18923996 PMID:19643168 More...

NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354

G

estrogen receptor 2

affects binding
affects expression
decreases expression
increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate analog binds to ESR2 protein
Dibutyl Phthalate affects the expression of ESR2 mRNA
Dibutyl Phthalate results in decreased expression of ESR2 protein
Dibutyl Phthalate results in increased expression of ESR2 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ESR2 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of ESR2 protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of ESR2 mRNA; ESR2 protein affects the reaction [Dibutyl Phthalate results in increased activity of CASP3 protein]
Dibutyl Phthalate inhibits the reaction [Estradiol results in increased activity of ESR2 protein]
Dibutyl Phthalate results in decreased expression of ESR2 mRNA; Dibutyl Phthalate results in decreased expression of ESR2 protein
Dibutyl Phthalate binds to ESR2 protein

PMID:15458795 PMID:15464722 PMID:24067674 PMID:27581038 PMID:28571686 More...

NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709

G

estrogen related receptor, alpha

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ESRRA promoter

NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811

G

ess-2 splicing factor homolog

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ESS2 mRNA

NCBI chr11:96,580,185...96,596,673
Ensembl chr11:96,580,169...96,590,146

G

extended synaptotagmin 1

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of ESYT1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ESYT1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 7:1,513,381...1,530,836
Ensembl chr 7:1,513,381...1,530,732

G

extended synaptotagmin 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of ESYT2 mRNA

NCBI chr 6:143,359,870...143,455,600
Ensembl chr 6:143,362,694...143,455,593

G

extended synaptotagmin 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of ESYT3 mRNA

NCBI chr 8:108,749,761...108,796,630
Ensembl chr 8:108,750,489...108,796,572

G

eukaryotic translation termination factor 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of ETF1 mRNA

NCBI chr18:26,776,518...26,804,857
Ensembl chr18:26,777,858...26,804,613

G

electron transfer flavoprotein subunit alpha

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ETFA mRNA

NCBI chr 8:64,731,192...64,787,965
Ensembl chr 8:64,731,193...64,788,080

G

electron transfer flavoprotein subunit beta

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ETFB mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:102,988,499...103,002,663
Ensembl chr 1:102,988,499...103,002,659

G

electron transfer flavoprotein dehydrogenase

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of ETFDH mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ETFDH mRNA

PMID:21266533 PMID:39150890

NCBI chr 2:167,038,707...167,060,758
Ensembl chr 2:167,025,823...167,060,770

G

enhancer trap locus 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of ETL4 mRNA

NCBI chr17:87,749,486...88,213,158
Ensembl chr17:87,403,819...88,213,158

G

ETS proto-oncogene 1, transcription factor

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ETS1 mRNA

NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021

G

ETS proto-oncogene 2, transcription factor

increases expression

ISO

Dibutyl Phthalate results in increased expression of ETS2 mRNA

NCBI chr11:48,491,057...48,507,843
Ensembl chr11:48,491,394...48,507,842

G

ETS variant transcription factor 4

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ETV4 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:87,206,977...87,222,202
Ensembl chr10:87,206,977...87,222,318

G

ETS variant transcription factor 5

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of ETV5 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ETV5 mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr11:92,113,171...92,170,758
Ensembl chr11:92,113,224...92,170,767

G

ETS variant transcription factor 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of ETV6 mRNA

NCBI chr 4:168,580,405...168,819,817
Ensembl chr 4:168,580,138...168,819,802

G

eva-1 homolog A, regulator of programmed cell death

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of EVA1A mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EVA1A mRNA

PMID:21266533 PMID:39150890

NCBI chr 4:116,151,595...116,200,827
Ensembl chr 4:116,151,173...116,200,827

G

eva-1 homolog B

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of EVA1B mRNA

NCBI chr 5:143,711,627...143,716,963
Ensembl chr 5:143,711,395...143,717,551

G

ecotropic viral integration site 2A

increases expression

EXP

Dibutyl Phthalate results in increased expression of EVI2A mRNA

NCBI chr10:64,983,727...64,987,627
Ensembl chr10:64,983,705...64,999,516

G

EWS RNA-binding protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EWSR1 mRNA

PMID:17361019 PMID:21266533

NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095

G

exonuclease 3'-5' domain containing 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of EXD2 mRNA

NCBI chr 6:105,847,931...105,881,780
Ensembl chr 6:105,848,305...105,883,665

G

exonuclease 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EXO1 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:90,341,947...90,366,861
Ensembl chr13:90,342,018...90,366,861

G

exocyst complex component 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EXOC2 mRNA

NCBI chr17:33,714,949...33,906,901
Ensembl chr17:33,715,008...33,901,944

G

exocyst complex component 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOC3 mRNA

NCBI chr 1:30,919,871...30,950,624

G

exocyst complex component 3-like 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOC3L2 mRNA

NCBI chr 1:88,241,784...88,273,352
Ensembl chr 1:88,240,477...88,276,847

G

exocyst complex component 3-like 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of EXOC3L4 mRNA

NCBI chr 6:136,273,857...136,287,877
Ensembl chr 6:136,273,854...136,287,881

G

exocyst complex component 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of EXOC4 mRNA

NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:62,774,935...63,552,943

G

exocyst complex component 5

increases expression

ISO

Dibutyl Phthalate results in increased expression of EXOC5 mRNA

PMID:17361019 PMID:21266533

NCBI chr15:24,788,738...24,834,941
Ensembl chr15:24,790,337...24,834,970

G

exocyst complex component 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of EXOC6 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:244,727,084...244,870,263
Ensembl chr 1:244,711,981...244,870,396

G

exocyst complex component 8

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOC8 mRNA
Dibutyl Phthalate results in increased expression of EXOC8 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:69,752,387...69,754,876
Ensembl chr19:69,727,231...69,804,820

G

exo/endonuclease G

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOG mRNA
Dibutyl Phthalate results in increased expression of EXOG mRNA

NCBI chr 8:128,062,688...128,082,529
Ensembl chr 8:128,059,126...128,083,460

G

exosome component 10

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOSC10 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:164,278,414...164,302,067
Ensembl chr 5:164,278,440...164,302,067

G

exosome component 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOSC2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:35,360,652...35,370,948
Ensembl chr 3:35,360,666...35,371,373

G

exosome component 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOSC4 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:109,928,491...109,931,233
Ensembl chr 7:109,928,498...109,931,820

G

exosome component 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOSC5 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:90,295,495...90,305,047
Ensembl chr 1:90,293,797...90,305,046

G

exosome component 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOSC6 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:55,931,523...55,932,937
Ensembl chr19:55,931,523...55,932,937

G

exosome component 7

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOSC7 mRNA

NCBI chr 8:131,650,988...131,676,399
Ensembl chr 8:131,651,050...131,696,825

G

exosome component 8

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of EXOSC8 mRNA

NCBI chr 2:141,080,568...141,087,112
Ensembl chr 2:141,080,568...141,087,229

G

exostosin glycosyltransferase 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of EXT1 mRNA

NCBI chr 7:86,265,651...86,544,488
Ensembl chr 7:86,259,900...86,544,567

G

exostosin glycosyltransferase 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of EXT2 mRNA

NCBI chr 3:100,120,776...100,253,424
Ensembl chr 3:100,120,776...100,253,596

G

EYA transcriptional coactivator and phosphatase 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EYA2 mRNA

NCBI chr 3:174,754,772...174,938,035
Ensembl chr 3:174,818,554...174,938,034

G

enhancer of zeste 1 polycomb repressive complex 2 subunit

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of EZH1 mRNA

NCBI chr10:86,626,307...86,662,257
Ensembl chr10:86,626,308...86,652,620

G

enhancer of zeste 2 polycomb repressive complex 2 subunit

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of EZH2 mRNA

NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183

G

ezrin

affects expression

EXP

Dibutyl Phthalate affects the expression of EZR mRNA

NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573

G

coagulation factor X

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of F10 mRNA

NCBI chr16:83,170,973...83,190,280
Ensembl chr16:83,170,977...83,190,280

G

F11 receptor

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of F11R mRNA

NCBI chr13:86,406,229...86,429,819
Ensembl chr13:86,406,218...86,429,816

G

coagulation factor II (thrombin) receptor

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of F2R mRNA
Dibutyl Phthalate results in decreased expression of F2R mRNA

PMID:15620428 PMID:17361019 PMID:21266533

NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579

G

F2R like trypsin receptor 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of F2RL1 mRNA

NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954

G

coagulation factor III, tissue factor

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of F3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369

G

FA core complex associated protein 20

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FAAP20 mRNA

NCBI chr 5:171,083,328...171,097,599
Ensembl chr 5:171,087,847...171,097,599

G

fatty acid binding protein 1

multiple interactions

ISO

Dibutyl Phthalate inhibits the reaction [Oleic Acid results in decreased expression of FABP1 mRNA]

NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113

G

fatty acid binding protein 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FABP3 mRNA

PMID:21266533 PMID:21745491

NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881

G

fatty acid binding protein 4

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FABP4 protein

NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972

G

fatty acid binding protein 5

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of FABP5 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA

PMID:17379624 PMID:31199487

NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127

G

Fas associated via death domain

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FADD mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976

G

fatty acid desaturase 1

decreases expression
affects expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of FADS1 mRNA
Dibutyl Phthalate affects the expression of FADS1 mRNA
Dibutyl Phthalate results in increased expression of FADS1 mRNA

PMID:17379624 PMID:21266533 PMID:21745491

NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615

G

fatty acid desaturase 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FADS2 mRNA

NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066

G

fatty acid desaturase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FADS3 mRNA

NCBI chr 1:216,110,547...216,127,431
Ensembl chr 1:216,110,201...216,141,758

G

fumarylacetoacetate hydrolase

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of FAH mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAH mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FAH promoter

PMID:21266533 PMID:23359474 PMID:39150890

NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:147,957,935...147,981,046

G

fumarylacetoacetate hydrolase domain containing 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAHD1 mRNA

NCBI chr10:14,378,058...14,379,497
Ensembl chr10:14,378,120...14,379,867

G

Fas apoptotic inhibitory molecule

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAIM mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:108,423,259...108,445,365
Ensembl chr 8:108,423,221...108,440,151

G

family with sequence similarity 107, member A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAM107A mRNA

NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219

G

family with sequence similarity 110, member A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAM110A mRNA

NCBI chr 3:160,934,815...160,945,405
Ensembl chr 3:160,931,777...160,949,897

G

family with sequence similarity 110, member B

increases expression

EXP

Dibutyl Phthalate results in increased expression of FAM110B mRNA

NCBI chr 5:23,587,093...23,727,188
Ensembl chr 5:23,586,867...23,799,583

G

family with sequence similarity 110, member C

increases expression

EXP

Dibutyl Phthalate results in increased expression of FAM110C mRNA

NCBI chr 6:53,366,013...53,372,270
Ensembl chr 6:53,352,870...53,401,117

G

family with sequence similarity 114, member A1

increases expression

ISO

Dibutyl Phthalate results in increased expression of FAM114A1 mRNA

NCBI chr14:43,629,349...43,699,800
Ensembl chr14:43,629,375...43,699,800

G

family with sequence similarity 117, member A

increases expression

EXP

Dibutyl Phthalate results in increased expression of FAM117A mRNA

NCBI chr10:80,778,229...80,822,119
Ensembl chr10:80,755,883...80,822,119

G

family with sequence similarity 131, member B

increases expression

EXP

Dibutyl Phthalate results in increased expression of FAM131B mRNA

NCBI chr 4:72,167,667...72,176,924
Ensembl chr 4:72,165,578...72,176,858

G

family with sequence similarity 136, member A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAM136A mRNA

NCBI chr 4:120,362,563...120,368,479
Ensembl chr 4:120,362,561...120,368,479

G

family with sequence similarity 149, member B1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FAM149B1 mRNA

NCBI chr15:3,978,377...4,016,323
Ensembl chr15:3,978,377...4,016,317

G

family with sequence similarity 151, member B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FAM151B mRNA

NCBI chr 2:25,409,382...25,446,225
Ensembl chr 2:25,409,383...25,445,466

G

family with sequence similarity 162, member A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAM162A mRNA

NCBI chr11:78,186,260...78,215,186
Ensembl chr11:78,185,852...78,216,560

G

family with sequence similarity 163, member A

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FAM163A mRNA

NCBI chr13:70,813,129...70,891,410
Ensembl chr13:70,813,134...70,891,316

G

family with sequence similarity 167, member B

increases expression

ISO

Dibutyl Phthalate results in increased expression of FAM167B mRNA

NCBI chr 5:147,205,018...147,206,660
Ensembl chr 5:147,204,653...147,206,652

G

family with sequence similarity 168, member A

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of FAM168A mRNA

NCBI chr 1:164,469,447...164,615,542
Ensembl chr 1:164,469,471...164,615,506

G

family with sequence similarity 181, member B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAM181B mRNA

NCBI chr 1:156,578,821...156,580,318
Ensembl chr 1:156,491,094...156,595,845

G

family with sequence similarity 184, member B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAM184B mRNA

NCBI chr14:69,688,031...69,803,922
Ensembl chr14:69,688,031...69,803,922

G

family with sequence similarity 193, member A

increases expression

EXP

Dibutyl Phthalate results in increased expression of FAM193A mRNA

NCBI chr14:80,480,742...80,607,086
Ensembl chr14:80,480,742...80,607,024

G

family with sequence similarity 193, member B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FAM193B mRNA

NCBI chr17:9,071,974...9,104,659
Ensembl chr17:9,071,795...9,104,656

G

FAM20C, golgi associated secretory pathway kinase

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of FAM20C mRNA

NCBI chr12:20,940,654...20,999,072
Ensembl chr12:20,940,654...20,998,318

G

family with sequence similarity 210, member B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FAM210B mRNA

NCBI chr 3:181,536,665...181,546,830
Ensembl chr 3:181,536,673...181,546,834

G

family with sequence similarity 219, member A

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAM219A mRNA

NCBI chr 5:61,475,185...61,525,749
Ensembl chr 5:61,475,185...61,525,749

G

family with sequence similarity 222, member A

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAM222A mRNA

NCBI chr12:47,647,221...47,693,703
Ensembl chr12:47,647,405...47,693,703

G

family with sequence similarity 234, member A

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of FAM234A mRNA
Dibutyl Phthalate results in decreased expression of FAM234A mRNA

NCBI chr10:15,736,741...15,768,043
Ensembl chr10:15,736,742...15,749,835

G

FAM3 metabolism regulating signaling molecule C

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAM3C mRNA

NCBI chr 4:51,805,686...51,853,030
Ensembl chr 4:51,805,703...51,853,030

G

family with sequence similarity 50, member A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAM50A mRNA

PMID:17361019 PMID:21266533

NCBI chr X:157,246,533...157,253,650
Ensembl chr X:157,246,533...157,253,650

G

family with sequence similarity 53, member B

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of FAM53B mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:196,930,170...197,021,290
Ensembl chr 1:196,930,175...197,021,290

G

family with sequence similarity 72, member A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAM72A mRNA

NCBI chr13:45,519,940...45,531,322
Ensembl chr13:45,519,818...45,531,324

G

family with sequence similarity 78, member B

increases expression

ISO

Dibutyl Phthalate results in increased expression of FAM78B mRNA

NCBI chr13:81,695,329...81,783,881
Ensembl chr13:81,695,329...81,781,784

G

family with sequence similarity 83, member F

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FAM83F mRNA

NCBI chr 7:114,091,356...114,120,640
Ensembl chr 7:114,091,335...114,120,638

G

family with sequence similarity 83, member H

increases expression

ISO

Dibutyl Phthalate results in increased expression of FAM83H mRNA

NCBI chr 7:109,597,129...109,605,317
Ensembl chr 7:109,597,129...109,609,188

G

family with sequence similarity 98, member B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FAM98B mRNA

NCBI chr 3:124,588,827...124,618,275
Ensembl chr 3:124,588,827...124,618,275

G

FA complementation group A

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of FANCA mRNA

PMID:17361019 PMID:21266533

NCBI chr19:68,210,562...68,271,080
Ensembl chr19:68,212,643...68,271,019

G

FA complementation group C

increases expression

EXP

Dibutyl Phthalate results in increased expression of FANCC mRNA

NCBI chr17:1,686,374...1,818,672
Ensembl chr17:1,687,017...1,835,096

G

FA complementation group E

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FANCE mRNA

NCBI chr20:6,371,153...6,388,366
Ensembl chr20:6,377,234...6,388,365

G

FA complementation group L

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FANCL mRNA

PMID:17361019 PMID:21266533

NCBI chr14:104,449,403...104,515,297
Ensembl chr14:104,394,590...104,515,297

G

fatty acyl CoA reductase 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAR1 mRNA

NCBI chr 1:177,078,973...177,140,363
Ensembl chr 1:177,079,150...177,161,696

G

phenylalanyl-tRNA synthetase 2, mitochondrial

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FARS2 mRNA

NCBI chr17:28,524,737...28,951,818
Ensembl chr17:28,524,738...28,951,591

G

phenylalanyl-tRNA synthetase subunit alpha

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FARSA mRNA

PMID:17361019 PMID:21266533

NCBI chr19:40,196,255...40,205,830
Ensembl chr19:40,173,716...40,205,823

G

Fas cell surface death receptor

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of FAS mRNA

NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104

G

fatty acid synthase

decreases expression
increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of FASN mRNA
Dibutyl Phthalate results in increased expression of FASN mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of FASN mRNA
Dibutyl Phthalate results in increased expression of FASN protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FASN mRNA; Dibutyl Phthalate promotes the reaction [Dietary Fats results in increased expression of FASN protein]
[Oleic Acid co-treated with Dibutyl Phthalate] results in increased expression of FASN protein; acadesine inhibits the reaction [Dibutyl Phthalate results in increased expression of FASN protein]; GW 6471 inhibits the reaction [[Oleic Acid co-treated with Dibutyl Phthalate] results in increased expression of FASN protein]; GW 6471 inhibits the reaction [Dibutyl Phthalate results in increased expression of FASN protein]

PMID:21266533 PMID:31240115 PMID:33167028 PMID:33508418 PMID:35739755

NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583

G

Fas-activated serine/threonine kinase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FASTK mRNA

NCBI chr 4:11,624,697...11,628,769
Ensembl chr 4:11,624,689...11,629,867

G

FAST kinase domains 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FASTKD2 mRNA

NCBI chr 9:72,659,961...72,681,986
Ensembl chr 9:72,661,764...72,721,338

G

FAT atypical cadherin 1

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of FAT1 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FAT1 promoter

PMID:17379624 PMID:23359474

NCBI chr16:53,909,759...54,029,175
Ensembl chr16:53,909,556...54,028,609

G

FAT atypical cadherin 4

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FAT4 mRNA

NCBI chr 2:123,855,289...123,984,716
Ensembl chr 2:123,855,289...123,984,716

G

fibrillarin

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FBL mRNA

NCBI chr 1:92,597,407...92,606,507
Ensembl chr 1:92,597,258...92,606,506

G

filamin binding LIM protein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of FBLIM1 mRNA

NCBI chr 5:159,167,004...159,198,578
Ensembl chr 5:159,167,004...159,196,853

G

fibrillin 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of FBN2 mRNA

PMID:17361019 PMID:21266533

NCBI chr18:53,696,197...53,901,992
Ensembl chr18:53,697,708...53,902,191

G

fructose-bisphosphatase 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of FBP2 mRNA

NCBI chr17:2,241,767...2,259,371
Ensembl chr17:2,241,975...2,259,366

G

F-box and leucine-rich repeat protein 20

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FBXL20 mRNA

NCBI chr10:83,577,038...83,640,022
Ensembl chr10:83,577,038...83,639,977

G

F-box and leucine-rich repeat protein 3

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of FBXL3 mRNA

NCBI chr15:86,321,504...86,341,387
Ensembl chr15:86,321,504...86,341,387

G

F-box and leucine-rich repeat protein 6

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FBXL6 mRNA

NCBI chr 7:110,140,243...110,143,176
Ensembl chr 7:110,140,244...110,143,141

G

F-box and leucine-rich repeat protein 7

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA

NCBI chr 2:78,870,236...79,239,697
Ensembl chr 2:78,871,287...79,239,697

G

F-box and leucine-rich repeat protein 8

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FBXL8 promoter

NCBI chr19:50,048,221...50,057,191
Ensembl chr19:50,052,393...50,057,453

G

F-box protein 16

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FBXO16 mRNA

NCBI chr15:43,667,207...43,717,096
Ensembl chr15:43,667,855...43,734,346

G

F-box protein 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FBXO2 promoter

NCBI chr 5:163,876,079...163,881,508
Ensembl chr 5:163,875,757...163,881,508

G

F-box protein 21

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of FBXO21 mRNA

NCBI chr12:44,231,918...44,266,035
Ensembl chr12:44,231,923...44,266,035

G

F-box protein 31

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FBXO31 mRNA

NCBI chr19:66,533,437...66,564,674
Ensembl chr19:66,533,437...66,564,674

G

F-box protein 32

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of FBXO32 mRNA
Dibutyl Phthalate results in increased expression of FBXO32 mRNA

NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491

G

F-box protein 33

increases expression

ISO

Dibutyl Phthalate results in increased expression of FBXO33 mRNA

NCBI chr 6:82,635,509...82,669,441
Ensembl chr 6:82,635,521...82,667,440

G

F-box protein 34

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FBXO34 mRNA

NCBI chr15:23,199,103...23,266,929
Ensembl chr15:23,171,312...23,270,071

G

F-box protein 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FBXO5 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:44,601,412...44,607,781
Ensembl chr 1:44,601,412...44,607,781

G

f-box protein 9

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FBXO9 mRNA

NCBI chr 8:87,838,787...87,864,362
Ensembl chr 8:87,838,789...87,864,504

G

F-box and WD repeat domain containing 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of FBXW2 mRNA

NCBI chr 3:38,486,358...38,511,683
Ensembl chr 3:38,486,362...38,511,667

G

F-box and WD repeat domain containing 5

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FBXW5 mRNA

NCBI chr 3:28,720,670...28,725,237
Ensembl chr 3:28,720,778...28,725,235

G

Fc gamma receptor 2A

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of FCGR2A mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FCGR3 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FCGR2A promoter

PMID:21266533 PMID:23359474 PMID:39150890

NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394
Ensembl chr13:85,855,437...85,864,394

G

FCH and double SH3 domains 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of FCHSD1 mRNA

NCBI chr18:30,043,466...30,056,326
Ensembl chr18:30,045,106...30,055,673

G

FCH and double SH3 domains 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of FCHSD2 mRNA

NCBI chr 1:164,775,916...165,097,391
Ensembl chr 1:164,775,926...165,097,391

G

ficolin B

increases expression

EXP

Dibutyl Phthalate results in increased expression of FCN1 mRNA

NCBI chr 3:31,791,750...31,800,188
Ensembl chr 3:31,791,750...31,800,188

G

fucose kinase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FCSK mRNA

NCBI chr19:55,743,746...55,783,873
Ensembl chr19:55,739,842...55,800,496

G

farnesyl diphosphate farnesyl transferase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FDFT1 mRNA

PMID:17379624 PMID:21266533 PMID:21745491

NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168

G

farnesyl diphosphate synthase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FDPS mRNA

PMID:17379624 PMID:21266533 PMID:21745491 PMID:33983380

NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136

G

ferredoxin 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FDX1 mRNA

PMID:17379624 PMID:21266533 PMID:21745491

NCBI chr 8:61,164,839...61,183,645
Ensembl chr 8:61,164,839...61,183,583

G

ferredoxin reductase

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of FDXR mRNA

PMID:17379624 PMID:21266533 PMID:21745491

NCBI chr10:101,006,845...101,015,582
Ensembl chr10:101,006,849...101,015,542

G

ferrochelatase

increases expression

ISO

Dibutyl Phthalate results in increased expression of FECH mRNA

PMID:17361019 PMID:21266533

NCBI chr18:60,215,325...60,248,525
Ensembl chr18:60,215,325...60,249,546

G

flap structure-specific endonuclease 1

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of FEN1 mRNA
Dibutyl Phthalate results in increased expression of FEN1 mRNA

PMID:17361019 PMID:21266533 PMID:33120273

NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016

G

fer-1-like family member 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of FER1L4 mRNA

NCBI chr 3:164,996,183...165,031,719
Ensembl chr 3:164,996,183...165,031,719

G

FERM domain containing kindlin 2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of FERMT2 mRNA

PMID:17361019 PMID:21266533

NCBI chr15:21,162,603...21,257,995
Ensembl chr15:21,162,605...21,258,115

G

FERM domain containing kindlin 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FERMT3 mRNA

NCBI chr 1:213,618,691...213,636,889
Ensembl chr 1:213,618,208...213,636,273

G

fasciculation and elongation protein zeta 1

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of FEZ1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FEZ1 mRNA

PMID:21266533 PMID:31199487

NCBI chr 8:44,733,288...44,778,519
Ensembl chr 8:44,733,300...44,784,097

G

fibroblast growth factor 10

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of FGF10 mRNA
Dibutyl Phthalate results in decreased expression of FGF10 mRNA; Dibutyl Phthalate results in decreased expression of FGF10 protein

PMID:15829613 PMID:19464577 PMID:25213187 PMID:26514922 PMID:26948521 More...

NCBI chr 2:52,533,939...52,610,980
Ensembl chr 2:52,533,939...52,610,980

G

fibroblast growth factor 11

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of FGF11 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FGF11 mRNA

PMID:21266533 PMID:39150890

NCBI chr10:55,015,232...55,020,773
Ensembl chr10:55,016,411...55,020,454

G

fibroblast growth factor 13

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FGF13 mRNA

PMID:17361019 PMID:21266533

NCBI chr X:142,312,381...142,838,581
Ensembl chr X:142,312,391...142,423,536

G

fibroblast growth factor 19

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FGF15 promoter

NCBI chr 1:209,485,813...209,490,267
Ensembl chr 1:209,485,813...209,490,267

G

fibroblast growth factor 2

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of FGF2 mRNA

NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493

G

fibroblast growth factor 21

increases expression

EXP

Dibutyl Phthalate results in increased expression of FGF21 mRNA

NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056

G

fibroblast growth factor 5

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FGF5 mRNA

NCBI chr14:11,627,906...11,650,243
Ensembl chr14:11,627,906...11,650,243

G

fibroblast growth factor 8

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FGF8 mRNA

PMID:19464577 PMID:22273727 PMID:26948521

NCBI chr 1:254,533,504...254,539,605
Ensembl chr 1:254,533,504...254,539,605

G

fibroblast growth factor 9

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of FGF9 mRNA

NCBI chr15:36,325,552...36,369,995
Ensembl chr15:36,325,599...36,367,926

G

Fibroblast growth factor receptor 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FGFR1 mRNA

NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855

G

FGFR1 oncogene partner 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of FGFR1OP2 mRNA

NCBI chr 4:181,222,298...181,243,318
Ensembl chr 4:181,222,323...181,243,322

G

fibroblast growth factor receptor 2

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of FGFR2 mRNA; Dibutyl Phthalate results in decreased expression of FGFR2 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FGFR2 mRNA

PMID:19464577 PMID:21266533 PMID:25213187 PMID:26472102 PMID:26514922 More...

NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914

G

fibroblast growth factor receptor 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FGFR3 mRNA

NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209

G

fibroblast growth factor receptor 4

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FGFR4 mRNA

NCBI chr17:9,466,686...9,481,423
Ensembl chr17:9,466,692...9,481,389

G

fibrinogen-like 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of FGL2 mRNA

NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:14,602,771...14,608,405

G

fumarate hydratase

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of FH1 mRNA

NCBI chr13:90,056,565...90,082,450
Ensembl chr13:90,056,570...90,089,627

G

FHF complex subunit HOOK interacting protein 1B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FHIP1B mRNA

NCBI chr 1:169,137,866...169,160,305
Ensembl chr 1:169,122,654...169,160,252

G

four and a half LIM domains 2

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of FHL2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FHL2 mRNA

PMID:21266533 PMID:39150890

NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326

G

four and a half LIM domains 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of FHL3 mRNA

NCBI chr 5:142,238,634...142,246,011
Ensembl chr 5:142,235,109...142,246,034

G

formin homology 2 domain containing 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FHOD1 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:50,116,415...50,135,868
Ensembl chr19:50,116,415...50,135,330

G

formin homology 2 domain containing 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of FHOD3 mRNA

NCBI chr18:16,267,830...16,700,508
Ensembl chr18:16,267,977...16,700,508

G

FIG4 phosphoinositide 5-phosphatase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FIG4 mRNA

NCBI chr20:46,183,225...46,306,686
Ensembl chr20:46,183,225...46,306,477

G

fidgetin, microtubule severing factor

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FIGN mRNA

NCBI chr 3:69,045,918...69,169,148
Ensembl chr 3:69,045,050...69,169,988

G

filamin A interacting protein 1-like

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of FILIP1L mRNA

PMID:17361019 PMID:21266533

NCBI chr11:56,403,467...56,646,422
Ensembl chr11:56,410,582...56,646,402

G

factor interacting with PAPOLA and CPSF1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FIP1L1 mRNA

NCBI chr14:33,969,341...34,030,871
Ensembl chr14:33,971,914...34,029,753

G

fission, mitochondrial 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of FIS1 mRNA

NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335

G

four-jointed box kinase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of FJX1 mRNA

NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:109,227,170...109,232,479

G

FKBP prolyl isomerase family member 15

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FKBP15 mRNA

NCBI chr 5:80,766,356...80,830,622
Ensembl chr 5:80,766,356...80,830,565

G

FKBP prolyl isomerase 1A

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of FKBP1A mRNA
Dibutyl Phthalate results in increased expression of FKBP1A mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:160,500,726...160,524,233

G

FKBP prolyl isomerase 1B

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FKBP1B mRNA

NCBI chr 6:33,551,583...33,570,055
Ensembl chr 6:33,558,517...33,568,129

G

FKBP prolyl isomerase 4

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of FKBP4 mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of FKBP4 mRNA

PMID:17361019 PMID:21266533 PMID:30698749

NCBI chr 4:163,389,464...163,397,918
Ensembl chr 4:163,389,464...163,397,918

G

FKBP prolyl isomerase 5

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of FKBP5 mRNA
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FKBP5 mRNA
Dibutyl Phthalate results in increased expression of FKBP5 mRNA

PMID:21266533 PMID:32518293

NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118

G

FKBP prolyl isomerase 9

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FKBP9 mRNA

NCBI chr 4:87,436,439...87,486,909
Ensembl chr 4:87,436,478...87,508,940

G

flavin adenine dinucleotide synthetase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FLAD1 mRNA

NCBI chr 2:177,117,183...177,126,650
Ensembl chr 2:177,117,655...177,126,650

G

folliculin

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FLCN mRNA

NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309

G

filaggrin

multiple interactions

ISO

[FLG gene polymorphism affects the susceptibility to Dibutyl Phthalate] which affects the abundance of monobutyl phthalate

NCBI chr 2:181,583,801...181,596,464
Ensembl chr 2:181,583,808...181,595,968

G

filamin A

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of FLNA mRNA

PMID:17361019 PMID:21266533

NCBI chr X:157,159,051...157,185,559
Ensembl chr X:157,159,051...157,182,343

G

flotillin 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of FLOT1 mRNA

PMID:17361019 PMID:21266533

NCBI chr20:2,922,662...2,932,906
Ensembl chr20:2,922,655...2,932,771

G

fibronectin leucine rich transmembrane protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FLRT1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:213,704,983...213,782,958
Ensembl chr 1:213,704,038...213,782,981

G

fibronectin leucine rich transmembrane protein 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FLRT3 mRNA

NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:148,439,354...148,461,650

G

FLVCR choline and putative heme transporter 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of FLVCR2 mRNA

NCBI chr 6:111,139,352...111,203,345
Ensembl chr 6:111,139,295...111,203,345

G

FLYWCH-type zinc finger 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FLYWCH1 mRNA

NCBI chr10:13,279,232...13,298,955
Ensembl chr10:13,279,232...13,298,925

G

formation of mitochondrial complex V assembly factor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FMC1 mRNA

NCBI chr 4:68,241,009...68,249,045
Ensembl chr 4:68,241,009...68,268,534

G

formin-like 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of FMNL3 mRNA

NCBI chr 7:132,333,130...132,384,483
Ensembl chr 7:132,333,130...132,384,483

G

flavin containing dimethylaniline monoxygenase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FMO1 mRNA

NCBI chr13:77,715,405...77,747,666
Ensembl chr13:77,715,402...77,747,874

G

fragile X messenger ribonucleoprotein 1

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FMR1 mRNA

NCBI chr X:152,284,857...152,322,686
Ensembl chr X:152,284,841...152,322,675

G

fibronectin 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of FN1 mRNA; Dibutyl Phthalate results in increased expression of FN1 protein

NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137

G

formin binding protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of FNBP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:34,706,814...34,826,770
Ensembl chr 3:34,706,814...34,822,117

G

formin binding protein 1-like

increases expression

ISO

Dibutyl Phthalate results in increased expression of FNBP1L mRNA

NCBI chr 2:213,331,871...213,432,821
Ensembl chr 2:213,318,662...213,423,051

G

fibronectin type III domain containing 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FNDC5 mRNA

NCBI chr 5:146,765,951...146,775,611
Ensembl chr 5:146,751,416...146,778,540

G

folate receptor alpha

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FOLR1 mRNA

NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:165,631,462...165,642,669

G

Fos proto-oncogene, AP-1 transcription factor subunit

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of FOS mRNA

PMID:17361019 PMID:21266533 PMID:21745491

NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598

G

FosB proto-oncogene, AP-1 transcription factor subunit

affects expression
multiple interactions

ISO

Dibutyl Phthalate affects the expression of FOSB mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FOSB mRNA

PMID:36375677 PMID:39150890

NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:88,082,127...88,089,477

G

FOS like 1, AP-1 transcription factor subunit

increases expression

EXP

Dibutyl Phthalate results in increased expression of FOSL1 mRNA

NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391

G

FOS like 2, AP-1 transcription factor subunit

increases expression

ISO

Dibutyl Phthalate results in increased expression of FOSL2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406

G

forkhead box D1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FOXD1 mRNA

NCBI chr 2:31,436,802...31,439,222
Ensembl chr 2:31,436,813...31,439,399

G

forkhead box D3

increases expression

ISO

Dibutyl Phthalate results in increased expression of FOXD3 mRNA

NCBI chr 5:119,450,532...119,452,898
Ensembl chr 5:119,450,394...119,452,786

G

forkhead box M1

multiple interactions
decreases expression
increases expression

ISO
EXP

N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of FOXM1 mRNA]; N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of FOXM1 protein]
Dibutyl Phthalate results in decreased expression of FOXM1 protein
[Dibutyl Phthalate results in increased phosphorylation of STAT1 protein] which results in decreased expression of FOXM1 protein
Dibutyl Phthalate results in increased expression of FOXM1 mRNA; Dibutyl Phthalate results in increased expression of FOXM1 protein

PMID:32810643 PMID:36828243

NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172

G

forkhead box N3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FOXN3 mRNA

NCBI chr 6:124,191,695...124,572,070
Ensembl chr 6:124,195,701...124,572,040

G

forkhead box O4

increases expression

EXP

Dibutyl Phthalate results in increased expression of FOXO4 mRNA

NCBI chr X:70,425,218...70,432,120
Ensembl chr X:70,425,563...70,432,120

G

forkhead box P1

increases expression

ISO

Dibutyl Phthalate results in increased expression of FOXP1 mRNA

NCBI chr 4:133,117,346...133,808,647
Ensembl chr 4:133,122,055...133,500,272

G

forkhead box P2

increases expression

ISO

Dibutyl Phthalate results in increased expression of FOXP2 mRNA

NCBI chr 4:44,099,848...44,677,700
Ensembl chr 4:44,099,959...44,677,696

G

forkhead box P4

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FOXP4 promoter

NCBI chr 9:20,556,270...20,612,967
Ensembl chr 9:20,556,270...20,612,967

G

forkhead box Q1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of FOXQ1 mRNA

NCBI chr17:33,121,454...33,124,087
Ensembl chr17:33,121,545...33,123,720

G

FAD-dependent oxidoreductase domain containing 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of FOXRED1 mRNA

NCBI chr 8:41,789,557...41,818,064
Ensembl chr 8:41,808,843...41,817,980

G

forkhead box S1

increases expression

EXP

Dibutyl Phthalate results in increased expression of FOXS1 mRNA

NCBI chr 3:161,857,264...161,858,548
Ensembl chr 3:161,850,782...161,858,662

G

FRA10A associated CGG repeat 1

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of FRA10AC1 mRNA
Dibutyl Phthalate results in increased expression of FRA10AC1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:245,381,538...245,413,879
Ensembl chr 1:245,366,451...245,414,189

G

FERM domain containing 4A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FRMD4A mRNA

NCBI chr17:78,577,062...79,167,924
Ensembl chr17:78,579,277...79,167,663

G

FERM domain containing 4B

increases expression

ISO

Dibutyl Phthalate results in increased expression of FRMD4B mRNA

PMID:17361019 PMID:21266533

NCBI chr 4:131,452,361...131,778,734
Ensembl chr 4:131,452,365...131,640,287

G

FERM domain containing 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of FRMD6 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:95,081,958...95,155,561
Ensembl chr 6:95,081,985...95,155,560

G

FERM domain containing 8

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of FRMD8 mRNA
Dibutyl Phthalate results in increased expression of FRMD8 mRNA

NCBI chr 1:212,572,534...212,593,181
Ensembl chr 1:212,572,537...212,592,695

G

FRY like transcription coactivator

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FRYL mRNA

NCBI chr14:35,307,225...35,545,199
Ensembl chr14:35,310,656...35,545,147

G

fascin actin-bundling protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FSCN1 mRNA

NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734

G

fibronectin type III and SPRY domain containing 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FSD2 mRNA

NCBI chr 1:144,898,499...144,931,753
Ensembl chr 1:144,898,502...144,931,704

G

follicle stimulating hormone subunit beta

increases expression
affects expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of FSHB mRNA; Dibutyl Phthalate results in increased expression of FSHB protein
Dibutyl Phthalate affects the expression of FSHB protein
[Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of FSHB protein; ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in increased expression of FSHB protein]
4-vinyl-1-cyclohexene dioxide promotes the reaction [Dibutyl Phthalate results in increased expression of FSHB protein]; butylbenzyl phthalate promotes the reaction [Dibutyl Phthalate results in increased expression of FSHB protein]
Dibutyl Phthalate results in increased expression of FSHB; Dibutyl Phthalate results in increased expression of FSHB protein

PMID:21266533 PMID:22489061 PMID:25765776 PMID:29969652 PMID:33331133 More...

NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072

G

follicle stimulating hormone receptor

multiple interactions
decreases expression

ISO
EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FSHR mRNA; ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of FSHR protein]
Dibutyl Phthalate results in decreased expression of FSHR mRNA

PMID:28013214 PMID:33331133 PMID:35028925

NCBI chr 6:10,952,329...11,160,288
Ensembl chr 6:10,952,329...11,160,288

G

fibrous sheath-interacting protein 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FSIP2 mRNA

NCBI chr 3:88,369,218...88,439,756
Ensembl chr 3:88,369,251...88,440,697

G

formimidoyltransferase cyclodeaminase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FTCD mRNA

NCBI chr20:12,054,710...12,068,219
Ensembl chr20:12,054,711...12,068,237

G

FtsJ RNA 2'-O-methyltransferase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FTSJ1 mRNA

NCBI chr X:16,915,087...16,929,426
Ensembl chr X:16,916,033...16,923,999

G

alpha-L-fucosidase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FUCA1 mRNA

NCBI chr 5:153,436,262...153,453,512
Ensembl chr 5:153,436,248...153,453,511

G

furin (paired basic amino acid cleaving enzyme)

increases expression

ISO

Dibutyl Phthalate results in increased expression of FURIN mRNA

NCBI chr 1:143,757,389...143,770,430
Ensembl chr 1:143,757,391...143,773,497

G

Fus RNA binding protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of FUS mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884

G

fucosyltransferase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of FUT1 mRNA

NCBI chr 1:105,223,399...105,226,817
Ensembl chr 1:105,223,390...105,227,513

G

fucosyltransferase 9

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FUT9 promoter

NCBI chr 5:44,148,371...44,361,209
Ensembl chr 5:44,146,152...44,362,823

G

frataxin

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of FXN mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:231,300,457...231,323,989
Ensembl chr 1:231,300,150...231,323,989

G

FXYD domain-containing ion transport regulator 4

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of FXYD4 mRNA

NCBI chr 4:152,782,181...152,786,118
Ensembl chr 4:152,782,181...152,786,039

G

FXYD domain-containing ion transport regulator 5

increases expression

EXP

Dibutyl Phthalate results in increased expression of FXYD5 mRNA

NCBI chr 1:95,395,327...95,404,722
Ensembl chr 1:95,395,146...95,405,364

G

FXYD domain-containing ion transport regulator 6

increases expression

EXP

Dibutyl Phthalate results in increased expression of FXYD6 mRNA

NCBI chr 8:54,575,578...54,602,715
Ensembl chr 8:54,575,591...54,602,715

G

FXYD domain-containing ion transport regulator 7

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FXYD7 mRNA

NCBI chr 1:95,405,071...95,414,407
Ensembl chr 1:95,405,225...95,414,345

G

FYN proto-oncogene, Src family tyrosine kinase

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of FYN mRNA

NCBI chr20:44,322,635...44,514,498
Ensembl chr20:44,322,361...44,515,479

G

frizzled class receptor 1

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of FZD1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of FZD1 mRNA; Dietary Fats inhibits the reaction [[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of FZD1 mRNA]

PMID:21266533 PMID:30599393

NCBI chr 4:30,265,074...30,269,472
Ensembl chr 4:30,247,228...30,833,176

G

frizzled class receptor 2

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of FZD2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FZD2 mRNA

PMID:21266533 PMID:39150890

NCBI chr10:88,061,988...88,063,898
Ensembl chr10:88,061,667...88,065,396

G

frizzled class receptor 7

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of FZD7 mRNA

NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:68,411,259...68,432,585

G

frizzled class receptor 8

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of FZD8 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FZD8 mRNA

PMID:21266533 PMID:39150890

NCBI chr17:62,007,849...62,015,485
Ensembl chr17:62,007,627...62,015,961

G

frizzled class receptor 9

increases expression

ISO

Dibutyl Phthalate results in increased expression of FZD9 mRNA

PMID:17361019 PMID:21266533

NCBI chr12:27,063,640...27,065,954
Ensembl chr12:27,063,415...27,074,485

G

fizzy and cell division cycle 20 related 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of FZR1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:8,982,765...8,994,689
Ensembl chr 7:8,989,769...8,995,199

G

G3BP stress granule assembly factor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of G3BP1 mRNA

NCBI chr10:40,087,533...40,120,931
Ensembl chr10:40,087,533...40,120,931

G

G3BP stress granule assembly factor 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of G3BP2 mRNA

NCBI chr14:16,216,684...16,304,828
Ensembl chr14:16,248,744...16,304,823

G

glucose-6-phosphatase catalytic subunit 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of G6PC1 protein

NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033

G

GABA type A receptor-associated protein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GABARAP mRNA

NCBI chr10:55,213,465...55,216,787
Ensembl chr10:55,212,075...55,216,154

G

GABA type A receptor associated protein like 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of GABARAPL1 mRNA

NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:164,666,246...164,674,578

G

GABA type A receptor associated protein like 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of GABARAPL2 mRNA

NCBI chr19:56,819,826...56,830,662
Ensembl chr19:56,819,791...56,830,660

G

gamma-aminobutyric acid type B receptor subunit 1

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of GABBR1 mRNA
Dibutyl Phthalate results in increased expression of GABBR1 mRNA

PMID:15620428 PMID:21266533

NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,469,779...1,498,607

G

GA binding protein transcription factor subunit beta 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GABPB2 mRNA

NCBI chr 2:185,444,309...185,484,200
Ensembl chr 2:185,450,296...185,483,589

G

gamma-aminobutyric acid type A receptor subunit alpha 4

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRA4 mRNA

NCBI chr14:36,944,747...37,021,652
Ensembl chr14:36,944,388...37,021,648

G

gamma-aminobutyric acid type A receptor subunit beta1

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GABRB1 mRNA

NCBI chr14:36,434,339...36,917,920
Ensembl chr14:36,434,352...36,902,893

G

gamma-aminobutyric acid type A receptor subunit beta 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GABRB2 mRNA

NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171

G

glutamate decarboxylase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of GAD1 mRNA

NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759

G

growth arrest and DNA-damage-inducible, alpha

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of GADD45A mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GADD45A mRNA

PMID:21266533 PMID:39150890

NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807

G

growth arrest and DNA-damage-inducible, beta

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of GADD45B mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718

G

growth arrest and DNA-damage-inducible, gamma

decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of GADD45G mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of GADD45G promoter

PMID:21266533 PMID:23359474

NCBI chr17:13,528,606...13,530,351
Ensembl chr17:13,528,610...13,530,369

G

GADD45G interacting protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GADD45GIP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:40,225,503...40,228,052
Ensembl chr19:40,225,984...40,228,055

G

galanin and GMAP prepropeptide

increases expression

EXP

Dibutyl Phthalate results in increased expression of GAL mRNA

NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229

G

galactokinase 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GALK2 mRNA

NCBI chr 3:133,563,524...133,696,423
Ensembl chr 3:133,563,538...133,696,528

G

galactose mutarotase

decreases expression
affects expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GALM mRNA
Dibutyl Phthalate affects the expression of GALM mRNA

PMID:17361019 PMID:21266533 PMID:30934153

NCBI chr 6:20,589,775...20,641,516
Ensembl chr 6:20,589,776...20,644,417

G

polypeptide N-acetylgalactosaminyltransferase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of GALNT1 mRNA

NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,764,277...15,843,588

G

polypeptide N-acetylgalactosaminyltransferase 11

increases expression

ISO

Dibutyl Phthalate results in increased expression of GALNT11 mRNA

NCBI chr 4:10,571,464...10,604,974
Ensembl chr 4:10,571,464...10,604,974

G

polypeptide N-acetylgalactosaminyltransferase 2

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of GALNT2 mRNA

NCBI chr19:69,110,657...69,222,237
Ensembl chr19:69,110,657...69,222,237

G

polypeptide N-acetylgalactosaminyltransferase 4

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GALNT4 mRNA

NCBI chr 7:35,811,904...35,814,445

G

galanin receptor 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GALR1 mRNA

NCBI chr18:78,046,803...78,062,359
Ensembl chr18:78,046,805...78,062,359

G

galanin receptor 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GALR2 mRNA

NCBI chr10:102,012,086...102,016,057
Ensembl chr10:102,013,370...102,016,055

G

galactose-1-phosphate uridylyltransferase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GALT mRNA

NCBI chr 5:61,722,871...61,726,128
Ensembl chr 5:61,722,466...61,726,125

G

guanidinoacetate N-methyltransferase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GAMT mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:10,099,267...10,102,083
Ensembl chr 7:10,098,571...10,102,083

G

glucosidase II alpha subunit

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GANAB mRNA

NCBI chr 1:215,222,918...215,242,808
Ensembl chr 1:215,222,995...215,243,036

G

glyceraldehyde-3-phosphate dehydrogenase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GAPDH mRNA

PMID:17379624 PMID:21266533

NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377

G

GTPase activating protein and VPS9 domains 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GAPVD1 mRNA

NCBI chr 3:38,365,854...38,439,403
Ensembl chr 3:38,365,854...38,439,390

G

GAR1 ribonucleoprotein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GAR1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:221,049,471...221,056,749
Ensembl chr 2:221,049,473...221,056,749

G

phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GART mRNA

PMID:17361019 PMID:21266533

NCBI chr11:44,351,841...44,377,086
Ensembl chr11:44,351,851...44,377,086

G

growth arrest-specific 2 like 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of GAS2L2 mRNA

NCBI chr10:68,719,999...68,727,549
Ensembl chr10:68,719,999...68,727,171

G

growth arrest specific 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GAS6 mRNA

NCBI chr16:82,747,676...82,778,090
Ensembl chr16:82,747,345...82,778,088

G

growth arrest specific 7

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of GAS7 mRNA

NCBI chr10:52,651,690...52,882,244
Ensembl chr10:52,651,690...52,882,244

G

golgi associated kinase 1B

increases expression

ISO

Dibutyl Phthalate results in increased expression of GASK1B mRNA

NCBI chr 2:167,345,738...167,410,606
Ensembl chr 2:167,345,809...167,410,603

G

GATA binding protein 3

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Ovalbumin] results in increased phosphorylation of GATA3 protein; olcegepant inhibits the reaction [[Dibutyl Phthalate co-treated with Ovalbumin] results in increased phosphorylation of GATA3 protein]

NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670

G

GATA binding protein 4

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GATA4 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GATA4 mRNA

PMID:37364641 PMID:39150890

NCBI chr15:41,635,572...41,707,252
Ensembl chr15:41,635,572...41,681,609

G

GATA binding protein 6

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of GATA6 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of GATA6 promoter

PMID:21266533 PMID:23359474

NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,458,253...2,492,322

G

GATA zinc finger domain containing 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of GATAD1 mRNA

NCBI chr 4:31,462,251...31,473,827
Ensembl chr 4:31,462,309...31,503,921

G

glutamyl-tRNA amidotransferase subunit B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GATB mRNA

NCBI chr 2:173,228,562...173,315,144
Ensembl chr 2:173,228,568...173,314,661

G

glutamyl-tRNA amidotransferase subunit C

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GATC mRNA

NCBI chr12:46,930,820...46,938,790
Ensembl chr12:46,930,630...46,938,776

G

glutamine amidotransferase class 1 domain containing 3A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GATD3A mRNA

NCBI chr20:10,514,459...10,522,556
Ensembl chr20:10,514,443...10,522,555

G

glycine amidinotransferase

increases expression

EXP

Dibutyl Phthalate results in increased expression of GATM mRNA

NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355

G

glucosylceramidase beta 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GBA1 mRNA

NCBI chr 2:176,902,141...176,916,015
Ensembl chr 2:176,907,154...176,916,985

G

GC, vitamin D binding protein

increases expression

ISO

Dibutyl Phthalate results in increased expression of GC protein

NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,916,246...18,951,673

G

glycine C-acetyltransferase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GCAT mRNA

NCBI chr 7:112,475,572...112,481,920
Ensembl chr 7:112,475,496...112,482,664

G

glutaryl-CoA dehydrogenase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GCDH mRNA

PMID:17361019 PMID:21266533

NCBI chr19:40,168,038...40,174,536
Ensembl chr19:40,168,141...40,175,686

G

glucagon

increases expression

EXP

Dibutyl Phthalate results in increased expression of GCG mRNA

NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:67,522,489...67,531,533

G

glucagon receptor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GCGR mRNA

NCBI chr10:106,306,803...106,314,970
Ensembl chr10:106,306,559...106,314,969

G

GTP cyclohydrolase I feedback regulator

increases expression

EXP

Dibutyl Phthalate results in increased expression of GCHFR mRNA

NCBI chr 3:126,611,892...126,615,926
Ensembl chr 3:126,613,240...126,615,926

G

glutamate-cysteine ligase, catalytic subunit

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of GCLC mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GCLC mRNA

PMID:21266533 PMID:37364641

NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893

G

glutamate cysteine ligase, modifier subunit

increases expression

ISO

Dibutyl Phthalate results in increased expression of GCLM mRNA

NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003

G

glucosaminyl (N-acetyl) transferase family member 7

increases expression

ISO

Dibutyl Phthalate results in increased expression of GCNT7 mRNA

NCBI chr 3:181,637,406...181,647,839
Ensembl chr 3:181,637,406...181,641,460

G

germinal center-associated, signaling and motility

increases expression

ISO

Dibutyl Phthalate results in increased expression of GCSAM mRNA

NCBI chr11:68,658,350...68,669,598
Ensembl chr11:68,660,438...68,669,584

G

ganglioside-induced differentiation-associated-protein 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GDAP1 mRNA

NCBI chr 5:6,715,935...6,735,013
Ensembl chr 5:6,715,935...6,735,313

G

glycerophosphodiester phosphodiesterase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GDE1 mRNA

NCBI chr 1:182,451,182...182,466,569
Ensembl chr 1:182,451,184...182,466,772

G

growth differentiation factor 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GDF1 mRNA

NCBI chr16:19,131,271...19,146,480
Ensembl chr16:19,131,276...19,146,480

G

growth differentiation factor 10

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GDF10 mRNA

NCBI chr16:9,243,434...9,256,788
Ensembl chr16:9,243,317...9,256,794

G

growth differentiation factor 15

increases expression
multiple interactions
decreases expression

ISO

Dibutyl Phthalate results in increased expression of GDF15 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GDF15 mRNA
[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GDF15 protein
Dibutyl Phthalate results in decreased expression of GDF15 mRNA

PMID:17361019 PMID:21266533 PMID:30218697 PMID:39150890

NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022

G

glial cell derived neurotrophic factor

multiple interactions
decreases expression

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of GDNF promoter; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GDNF mRNA
Dibutyl Phthalate results in decreased expression of GDNF mRNA

PMID:23359474 PMID:25607892 PMID:28415704

NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240

G

glycerophosphodiester phosphodiesterase domain containing 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of GDPD2 protein

NCBI chr X:69,866,395...69,875,419
Ensembl chr X:69,866,799...69,875,414

G

glycerophosphodiester phosphodiesterase domain containing 5

increases expression

EXP

Dibutyl Phthalate results in increased expression of GDPD5 mRNA

NCBI chr 1:163,091,844...163,173,559
Ensembl chr 1:163,091,833...163,173,559

G

GTP binding protein overexpressed in skeletal muscle

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of GEM mRNA

NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:30,011,592...30,022,542

G

gem (nuclear organelle) associated protein 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GEMIN2 mRNA

NCBI chr 6:82,442,419...82,456,050
Ensembl chr 6:82,442,350...82,456,048

G

gem (nuclear organelle) associated protein 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GEMIN4 mRNA

NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,564,657...61,596,532

G

gem (nuclear organelle) associated protein 7

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GEMIN7 mRNA

NCBI chr 1:88,343,032...88,352,473
Ensembl chr 1:88,342,361...88,354,571

G

guided entry of tail-anchored proteins factor 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GET1 mRNA

NCBI chr11:48,915,298...48,929,235
Ensembl chr11:48,915,289...48,929,416

G

guided entry of tail-anchored proteins factor 3, ATPase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GET3 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:40,034,675...40,043,064
Ensembl chr19:40,034,967...40,043,061

G

glial fibrillary acidic protein

multiple interactions
increases expression

ISO

alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Dibutyl Phthalate results in increased expression of GFAP protein]
Dibutyl Phthalate results in increased expression of GFAP mRNA; Dibutyl Phthalate results in increased expression of GFAP protein

NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685

G

growth factor, augmenter of liver regeneration

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GFER mRNA

PMID:17361019 PMID:21266533

NCBI chr10:14,223,023...14,225,736
Ensembl chr10:14,223,023...14,225,935

G

G elongation factor, mitochondrial 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GFM1 mRNA

NCBI chr 2:154,010,601...154,055,523
Ensembl chr 2:154,010,614...154,065,805

G

glutamine fructose-6-phosphate transaminase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GFPT1 mRNA

NCBI chr 4:121,054,023...121,103,799
Ensembl chr 4:121,054,045...121,103,799

G

GDNF family receptor alpha 3

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GFRA3 mRNA

NCBI chr18:26,571,952...26,600,225
Ensembl chr18:26,571,921...26,600,225

G

GDNF family receptor alpha 4

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GFRA4 mRNA

NCBI chr 3:138,707,970...138,715,279
Ensembl chr 3:138,703,114...138,711,561

G

GDP-L-fucose synthase

increases expression

EXP

Dibutyl Phthalate results in increased expression of GFUS mRNA

NCBI chr 7:109,492,808...109,497,719
Ensembl chr 7:109,492,809...109,497,662

G

gamma-glutamyl carboxylase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GGCX mRNA

NCBI chr 4:106,027,918...106,043,653
Ensembl chr 4:106,027,912...106,043,923

G

gametogenetin binding protein 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GGNBP2 mRNA

NCBI chr10:70,208,950...70,240,554
Ensembl chr10:70,208,950...70,246,260

G

gamma-glutamyltransferase 1

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GGT1 protein

NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050

G

gamma-glutamyltransferase 7

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GGT7 mRNA

NCBI chr 3:164,438,240...164,464,059
Ensembl chr 3:164,437,812...164,463,068

G

glycoprotein alpha-galactosyltransferase 1

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GGTA1 mRNA

NCBI chr 3:39,130,466...39,208,652
Ensembl chr 3:39,130,467...39,206,870

G

growth hormone inducible transmembrane protein

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GHITM mRNA
Dibutyl Phthalate results in increased expression of GHITM mRNA

NCBI chr16:12,907,062...12,918,149
Ensembl chr16:12,905,806...12,918,123

G

glycosylated integral membrane protein 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GINM1 mRNA

NCBI chr 1:4,066,766...4,082,640
Ensembl chr 1:4,066,766...4,082,617

G

GINS complex subunit 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GINS1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:160,184,920...160,206,334
Ensembl chr 3:160,180,151...160,206,332

G

GINS complex subunit 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GINS2 mRNA

NCBI chr19:65,535,492...65,548,270
Ensembl chr19:65,535,492...65,548,052

G

GINS complex subunit 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GINS3 mRNA

NCBI chr19:9,426,140...9,435,192
Ensembl chr19:9,399,759...9,434,679

G

GINS complex subunit 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GINS4 mRNA

NCBI chr16:75,489,990...75,502,455
Ensembl chr16:75,490,126...75,505,000

G

gastric inhibitory polypeptide

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GIP mRNA

NCBI chr10:81,465,070...81,473,216
Ensembl chr10:81,465,062...81,473,216

G

gap junction protein, alpha 1

decreases expression
increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of GJA1 mRNA; Dibutyl Phthalate results in decreased expression of GJA1 protein
Dibutyl Phthalate results in increased expression of GJA1 mRNA; Dibutyl Phthalate results in increased expression of GJA1 protein
dorsomorphin inhibits the reaction [Dibutyl Phthalate results in increased expression of GJA1 mRNA]; dorsomorphin inhibits the reaction [Dibutyl Phthalate results in increased expression of GJA1 protein]; GJA1 protein promotes the reaction [Dibutyl Phthalate results in decreased expression of CDH1 protein]; Telmisartan inhibits the reaction [Dibutyl Phthalate results in increased expression of GJA1 protein]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of GJA1 mRNA; ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of GJA1 mRNA]; ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of GJA1 protein]

PMID:21266533 PMID:33331133 PMID:37356649 PMID:40323316

NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689

G

gap junction protein, beta 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of GJB2 mRNA

NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877

G

glycerol kinase

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of GK mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GK mRNA

PMID:21266533 PMID:35739755

NCBI chr X:54,106,708...54,189,940
Ensembl chr X:54,112,214...54,196,701

G

galactosidase, alpha

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GLA mRNA

NCBI chr X:102,062,497...102,073,915
Ensembl chr X:102,056,718...102,073,915

G

galactosidase, beta 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GLB1 mRNA

NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326

G

galactosidase, beta 1-like

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GLB1L mRNA

NCBI chr 9:84,141,993...84,154,176
Ensembl chr 9:84,143,841...84,154,176

G

glucuronic acid epimerase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GLCE mRNA

NCBI chr 8:71,441,607...71,507,639
Ensembl chr 8:71,441,616...71,507,587

G

GLI family zinc finger 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of GLI1 mRNA
Dibutyl Phthalate results in decreased expression of GLI1 mRNA; Dibutyl Phthalate results in decreased expression of GLI1 protein

PMID:21266533 PMID:31568847 PMID:32622864

NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540

G

GLI family zinc finger 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GLI2 mRNA

PMID:25213187 PMID:27079746

NCBI chr13:32,499,678...32,716,418
Ensembl chr13:32,499,678...32,716,418

G

GLI family zinc finger 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GLI3 mRNA

PMID:25213187 PMID:27079746

NCBI chr17:54,134,064...54,405,198
Ensembl chr17:54,134,064...54,405,198

G

GLI pathogenesis-related 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of GLIPR1 mRNA

NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:49,373,581...49,384,640

G

GLI pathogenesis-related 2

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of GLIPR2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GLIPR2 mRNA

PMID:21266533 PMID:39150890

NCBI chr 5:62,966,163...62,998,016
Ensembl chr 5:62,966,195...62,998,716

G

GLIS family zinc finger 2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of GLIS2 mRNA

NCBI chr10:11,457,594...11,484,948
Ensembl chr10:11,457,792...11,477,995

G

glycosylated lysosomal membrane protein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GLMP mRNA

NCBI chr 2:176,092,098...176,095,688
Ensembl chr 2:176,091,839...176,097,208

G

glyoxalase domain containing 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GLOD4 mRNA

NCBI chr10:61,575,770...61,594,111

G

glutaredoxin

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GLRX mRNA

NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543

G

glutaminase

multiple interactions

EXP
ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GLS mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GLS mRNA

PMID:25607892 PMID:39150890

NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861

G

glutaminase 2

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GLS2 mRNA

NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:1,201,838...1,218,013

G

glycolipid transfer protein

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of GLTP mRNA

NCBI chr12:47,567,797...47,587,949
Ensembl chr12:47,567,770...47,587,946

G

glucocorticoid modulatory element binding protein 1

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of GMEB1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GMEB1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 5:149,703,035...149,746,474
Ensembl chr 5:149,705,825...149,737,259

G

glia maturation factor, beta

increases expression

ISO

Dibutyl Phthalate results in increased expression of GMFB mRNA

NCBI chr15:22,549,705...22,560,125
Ensembl chr15:22,547,034...22,560,308

G

geminin, DNA replication inhibitor

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GMNN mRNA

NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,729,824...40,738,068

G

GDP-mannose pyrophosphorylase A

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GMPPA mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:84,375,373...84,382,917
Ensembl chr 9:84,375,425...84,382,916

G

guanosine monophosphate reductase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GMPR mRNA

NCBI chr17:19,357,992...19,395,807
Ensembl chr17:19,357,992...19,431,655

G

guanine monophosphate synthase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GMPS mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:150,587,824...150,641,564
Ensembl chr 2:150,587,854...150,648,986

G

G protein subunit alpha 14

increases expression

ISO

Dibutyl Phthalate results in increased expression of GNA14 mRNA

NCBI chr 1:223,141,802...223,324,210
Ensembl chr 1:223,141,802...223,324,210

G

G protein subunit alpha i1

increases expression

EXP

Dibutyl Phthalate results in increased expression of GNAI1 mRNA

NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:17,706,025...17,789,198

G

G protein subunit alpha i3

increases expression

ISO

Dibutyl Phthalate results in increased expression of GNAI3 mRNA

NCBI chr 2:198,430,920...198,468,874

G

G protein subunit alpha L

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of GNAL mRNA
Dibutyl Phthalate results in decreased expression of GNAL mRNA

PMID:17379624 PMID:21266533

NCBI chr18:62,892,257...63,032,510
Ensembl chr18:62,892,226...63,043,129

G

GNAS complex locus

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GNAS mRNA

NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536

G

G protein subunit beta 1 like

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GNB1L mRNA

NCBI chr11:95,933,994...96,011,933
Ensembl chr11:95,936,961...96,011,931

G

G protein subunit beta 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GNB5 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:84,956,629...84,985,576
Ensembl chr 8:84,953,815...84,986,888

G

glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GNE mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:63,062,953...63,103,320
Ensembl chr 5:63,062,850...63,103,251

G

G protein subunit gamma 10

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GNG10 mRNA

NCBI chr 5:78,651,167...78,658,060
Ensembl chr 5:78,651,167...78,658,059

G

G protein subunit gamma 12

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of GNG12 mRNA

NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:97,340,472...97,464,476

G

G protein subunit gamma 2

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GNG2 mRNA

NCBI chr15:4,365,222...4,466,060
Ensembl chr15:4,365,135...4,466,059

G

G protein subunit gamma 5

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of GNG5 mRNA
Dibutyl Phthalate results in increased expression of GNG5 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:238,054,954...238,063,451
Ensembl chr11:58,096,362...58,096,565
Ensembl chr 2:58,096,362...58,096,565

G

G protein subunit gamma 8

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of GNG8 promoter

NCBI chr 1:86,692,609...86,696,463
Ensembl chr 1:86,692,642...86,696,408

G

G protein subunit gamma transducin 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GNGT2 mRNA

NCBI chr10:81,271,916...81,280,980
Ensembl chr10:81,277,423...81,280,970

G

G protein nucleolar 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GNL2 mRNA

NCBI chr 5:142,577,798...142,603,185
Ensembl chr 5:142,577,731...142,603,178

G

G protein nucleolar 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of GNL3 mRNA

NCBI chr16:6,213,844...6,220,029
Ensembl chr16:6,213,871...6,219,845

G

glyceronephosphate O-acyltransferase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GNPAT mRNA

NCBI chr19:69,719,707...69,746,244
Ensembl chr19:69,719,394...69,746,244

G

glucosamine-6-phosphate deaminase 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GNPDA1 mRNA

NCBI chr18:30,416,599...30,428,630
Ensembl chr18:30,416,607...30,428,630

G

gonadotropin releasing hormone 1

affects expression
increases expression

ISO
EXP

Dibutyl Phthalate affects the expression of GNRH1 protein
Dibutyl Phthalate results in increased expression of GNRH1 mRNA

PMID:33920546 PMID:34280466

NCBI chr15:46,147,878...46,152,086
Ensembl chr15:46,148,301...46,148,977
Ensembl chr15:46,148,301...46,148,977

G

gonadotropin releasing hormone receptor

multiple interactions
decreases expression
increases expression

EXP

bisphenol A promotes the reaction [Dibutyl Phthalate results in increased expression of GNRHR mRNA]; Dibutyl Phthalate promotes the reaction [bisphenol A results in increased expression of GNRHR mRNA]
Dibutyl Phthalate results in decreased expression of GNRHR mRNA

PMID:21266533 PMID:23294617 PMID:28528174

NCBI chr14:22,211,666...22,229,654

G

golgin A7 family, member B

increases expression

ISO

Dibutyl Phthalate results in increased expression of GOLGA7B mRNA

NCBI chr 1:250,999,268...251,030,169
Ensembl chr 1:251,008,417...251,030,371

G

golgi phosphoprotein 3

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of GOLPH3 mRNA

NCBI chr 2:63,072,610...63,103,091
Ensembl chr 2:63,074,256...63,113,577

G

golgi reassembly stacking protein 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GORASP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:128,532,933...128,544,686
Ensembl chr 8:128,532,934...128,544,636

G

golgi SNAP receptor complex member 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of GOSR2 mRNA

NCBI chr10:89,085,323...89,105,665
Ensembl chr10:89,086,331...89,105,637

G

glutamic-oxaloacetic transaminase 1

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of GOT1 mRNA
Dibutyl Phthalate results in increased expression of GOT1 protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GOT1 protein; [Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of GOT1 protein

PMID:21266533 PMID:33167028 PMID:35739755 PMID:38285958

NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871

G

glutamic-oxaloacetic transaminase 1-like 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of GOT1L1 mRNA

NCBI chr16:71,563,562...71,576,446
Ensembl chr16:71,563,534...71,570,468

G

glutamic-oxaloacetic transaminase 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GOT2 mRNA

NCBI chr19:9,180,428...9,206,113
Ensembl chr19:9,180,431...9,206,111

G

glycerol-3-phosphate acyltransferase, mitochondrial

multiple interactions
increases expression

ISO
EXP

[Oleic Acid co-treated with Dibutyl Phthalate] results in increased expression of GPAM protein; acadesine inhibits the reaction [[Oleic Acid co-treated with Dibutyl Phthalate] results in increased expression of GPAM protein]; acadesine inhibits the reaction [Dibutyl Phthalate results in increased expression of GPAM protein]; GW 6471 inhibits the reaction [[Oleic Acid co-treated with Dibutyl Phthalate] results in increased expression of GPAM protein]; GW 6471 inhibits the reaction [Dibutyl Phthalate results in increased expression of GPAM protein]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GPAM mRNA; Dibutyl Phthalate promotes the reaction [Dietary Fats results in increased expression of GPAM protein]

PMID:31240115 PMID:33508418

NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:264,113,813...264,175,911

G

G patch domain containing 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GPATCH4 mRNA

NCBI chr 2:175,797,503...175,816,547
Ensembl chr 2:175,807,682...175,817,358

G

GC-rich promoter binding protein 1-like 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of GPBP1L1 mRNA

NCBI chr 5:135,245,188...135,287,299
Ensembl chr 5:135,247,342...135,287,298

G

glypican 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GPC1 mRNA

NCBI chr 9:100,843,645...100,871,458
Ensembl chr 9:100,843,645...100,879,933

G

glypican 4

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GPC4 mRNA

NCBI chr X:136,565,536...136,676,142
Ensembl chr X:136,565,591...136,676,057

G

glycerophosphocholine phosphodiesterase 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPCPD1 mRNA

NCBI chr 3:140,240,574...140,285,469
Ensembl chr 3:140,240,575...140,285,372

G

glycerol-3-phosphate dehydrogenase 1

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of GPD1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPD1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368

G

G protein-coupled estrogen receptor 1

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of GPER1 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GPER1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of GPER1 mRNA

PMID:15620428 PMID:35739755 PMID:37364641

NCBI chr12:20,331,073...20,336,527
Ensembl chr12:20,327,679...20,337,144

G

glycoprotein hormone subunit alpha 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of GPHA2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:212,954,579...212,956,536
Ensembl chr 1:212,955,387...212,956,535

G

glucose-6-phosphate isomerase

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of GPI mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GPI1 mRNA

PMID:21266533 PMID:37364641

NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:95,965,396...95,993,261

G

GPN-loop GTPase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GPN1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:30,667,337...30,685,011
Ensembl chr 6:30,666,868...30,685,011

G

glycoprotein nmb

increases expression

EXP

Dibutyl Phthalate results in increased expression of GPNMB mRNA

NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240

G

G protein-coupled receptor 107

increases expression

ISO

Dibutyl Phthalate results in increased expression of GPR107 mRNA

NCBI chr 3:34,832,462...34,893,692
Ensembl chr 3:34,832,480...34,893,654

G

G protein-coupled receptor 137B

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of GPR137B mRNA
Dibutyl Phthalate results in increased expression of GPR137B mRNA

NCBI chr17:92,987,792...93,026,003
Ensembl chr17:92,942,559...93,025,911

G

G protein-coupled receptor 149

increases expression

ISO

Dibutyl Phthalate results in increased expression of GPR149 mRNA

NCBI chr 2:149,059,333...149,130,798
Ensembl chr 2:149,059,336...149,130,785

G

G protein-coupled receptor 150

increases expression

EXP

Dibutyl Phthalate results in increased expression of GPR150 mRNA

NCBI chr 2:7,278,166...7,283,216
Ensembl chr 2:7,279,255...7,283,550

G

G protein-coupled receptor 182

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GPR182 mRNA
Dibutyl Phthalate results in increased expression of GPR182 mRNA

NCBI chr 7:65,471,254...65,474,110
Ensembl chr 7:65,452,965...65,474,998

G

G protein-coupled receptor 19

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GPR19 mRNA

NCBI chr 4:169,442,278...169,468,805
Ensembl chr 4:169,436,658...169,471,249

G

G protein-coupled receptor 3

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPR3 mRNA

NCBI chr 5:150,695,406...150,698,526
Ensembl chr 5:150,695,251...150,706,529

G

G-protein coupled receptor 88

increases expression

ISO

Dibutyl Phthalate results in increased expression of GPR88 mRNA

NCBI chr 2:206,876,373...206,885,034
Ensembl chr 2:206,868,585...206,884,945

G

G protein-coupled receptor associated sorting protein 1

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of GPRASP1 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of GPRASP1 promoter

PMID:21266533 PMID:23359474

NCBI chr X:103,556,493...103,564,275
Ensembl chr X:103,501,377...103,565,649

G

G protein-coupled receptor, class C, group 5, member A

increases expression

ISO

Dibutyl Phthalate results in increased expression of GPRC5A mRNA

NCBI chr 4:169,634,896...169,653,627
Ensembl chr 4:169,634,748...169,653,625

G

G protein-coupled receptor, class C, group 5, member B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GPRC5B mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:182,748,247...182,772,757

G

G protein-coupled receptor, class C, group 5, member D

increases expression

ISO

Dibutyl Phthalate results in increased expression of GPRC5D mRNA

NCBI chr 4:169,674,874...169,686,965
Ensembl chr 4:169,674,846...169,686,965

G

G protein regulated inducer of neurite outgrowth 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPRIN2 mRNA

NCBI chr16:9,502,697...9,518,901
Ensembl chr16:9,502,711...9,513,259

G

glutamic--pyruvic transaminase

increases activity
increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased activity of GPT protein
Dibutyl Phthalate results in increased expression of GPT protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of GPT protein; [Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of GPT protein
Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in increased expression of GPT protein]; Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in increased expression of GPT protein]; Dibutyl Phthalate promotes the reaction [Dietary Fats results in increased expression of GPT protein]

PMID:31979393 PMID:33167028 PMID:33508418 PMID:35378083 PMID:35739755 More...

NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160

G

glutathione peroxidase 1

increases expression
multiple interactions
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of GPX1 mRNA
2-aminoethoxydiphenyl borate inhibits the reaction [Ascorbic Acid inhibits the reaction [Dibutyl Phthalate results in decreased expression of GPX1 mRNA]]; Ascorbic Acid inhibits the reaction [Dibutyl Phthalate results in decreased expression of GPX1 mRNA]; taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of GPX1 mRNA]; taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of GPX1 protein]
Dibutyl Phthalate results in decreased expression of GPX1 mRNA; Dibutyl Phthalate results in decreased expression of GPX1 protein
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of GPX1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GPX1 mRNA

PMID:21266533 PMID:28013214 PMID:28415704 PMID:32028152 PMID:32525071 More...

NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581

G

glutathione peroxidase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GPX3 mRNA

NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405

G

glutathione peroxidase 4

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of GPX4 mRNA
Dibutyl Phthalate results in decreased expression of GPX4 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629

G

glutathione peroxidase 7

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GPX7 mRNA

NCBI chr 5:128,373,881...128,381,866
Ensembl chr 5:128,372,875...128,381,725

G

GRAM domain containing 1B

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of GRAMD1B mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GRAMD1B mRNA

PMID:21266533 PMID:39150890

NCBI chr 8:49,551,642...49,790,965
Ensembl chr 8:49,556,332...49,791,052

G

GRAM domain containing 2B

increases expression

EXP

Dibutyl Phthalate results in increased expression of GRAMD2B mRNA

NCBI chr18:52,082,128...52,180,056
Ensembl chr18:52,082,029...52,180,054

G

growth factor receptor bound protein 14

increases expression
affects expression

ISO
EXP

Dibutyl Phthalate results in increased expression of GRB14 mRNA
Dibutyl Phthalate affects the expression of GRB14 protein
Dibutyl Phthalate results in increased expression of GRB14 mRNA; Dibutyl Phthalate results in increased expression of GRB14 protein

PMID:15728792 PMID:17361019 PMID:21266533 PMID:21745491

NCBI chr 3:69,976,331...70,091,921
Ensembl chr 3:69,976,339...70,091,921

G

gene rich cluster, C10 gene

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GRCC10 mRNA

NCBI chr 4:159,237,562...159,239,223

G

gremlin 2, DAN family BMP antagonist

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of GREM2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GREM2 mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr13:89,310,897...89,403,856
Ensembl chr13:89,310,662...89,404,312

G

glyoxylate and hydroxypyruvate reductase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GRHPR mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:64,029,856...64,039,287
Ensembl chr 5:64,022,368...64,039,276

G

glutamate ionotropic receptor AMPA type subunit 2

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA2 mRNA

NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616

G

glutamate ionotropic receptor AMPA type subunit 4

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIA4 mRNA

NCBI chr 8:9,845,421...10,320,021
Ensembl chr 8:9,847,052...10,319,881

G

glutamate ionotropic receptor kainate type subunit 1

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIK1 mRNA

NCBI chr11:40,655,974...41,056,966
Ensembl chr11:40,655,975...41,056,517

G

glutamate ionotropic receptor kainate type subunit 2

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIK2 mRNA

NCBI chr20:53,717,564...54,415,283
Ensembl chr20:53,716,090...54,415,202

G

glutamate ionotropic receptor NMDA type subunit 1

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN1 mRNA

NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754

G

glutamate ionotropic receptor NMDA type subunit 2B

multiple interactions

EXP
ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of GRIN2B mRNA
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIN2B mRNA

PMID:25607892 PMID:32518293

NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570

G

glutamate ionotropic receptor NMDA type subunit associated protein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of GRINA mRNA

NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:109,843,196...109,846,042

G

glutamate receptor interacting protein 1

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of GRIP1 mRNA

NCBI chr 7:56,820,501...57,477,877
Ensembl chr 7:56,820,704...57,468,417

G

G protein-coupled receptor kinase 6

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of GRK6 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of GRK6 promoter

PMID:21266533 PMID:23359474

NCBI chr17:9,182,160...9,198,380
Ensembl chr17:9,182,160...9,197,954

G

glutamate metabotropic receptor 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GRM1 mRNA

NCBI chr 1:6,878,542...7,273,447
Ensembl chr 1:6,878,545...7,273,443

G

glutamate metabotropic receptor 7

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GRM7 mRNA

NCBI chr 4:145,286,714...146,169,099
Ensembl chr 4:145,286,924...146,169,201

G

glutamate metabotropic receptor 8

increases expression

EXP

Dibutyl Phthalate results in increased expression of GRM8 mRNA

NCBI chr 4:56,771,247...57,696,951
Ensembl chr 4:56,770,771...57,687,639

G

granulin precursor

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of GRN mRNA
Dibutyl Phthalate results in increased expression of GRN mRNA

PMID:16493179 PMID:21266533

NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936

G

GrpE-like 1, mitochondrial

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GRPEL1 mRNA

NCBI chr14:78,517,049...78,522,868
Ensembl chr14:78,517,052...78,522,861

G

G-rich RNA sequence binding factor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GRSF1 mRNA

NCBI chr14:19,696,925...19,713,427
Ensembl chr14:19,696,393...19,713,431

G

glutamate-rich WD repeat containing 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GRWD1 mRNA

NCBI chr 1:105,437,708...105,443,410
Ensembl chr 1:105,437,709...105,443,825

G

gasdermin D

multiple interactions

EXP

[Benzo(a)pyrene co-treated with Dibutyl Phthalate] results in increased expression of GSDMD mRNA; [Benzo(a)pyrene co-treated with Dibutyl Phthalate] results in increased expression of GSDMD protein

NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:109,422,910...109,430,722

G

gasdermin E

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GSDME mRNA

NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:80,588,614...80,641,525

G

Gse1 coiled-coil protein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GSE1 mRNA

NCBI chr19:65,182,678...65,538,183
Ensembl chr19:65,446,263...65,538,176

G

GSG1-like

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GSG1L mRNA

NCBI chr 1:189,871,034...190,084,947
Ensembl chr 1:189,871,034...190,084,947

G

glycogen synthase kinase 3 beta

decreases expression
multiple interactions
increases phosphorylation

ISO

Dibutyl Phthalate results in decreased expression of GSK3B mRNA
HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of GSK3B protein]

PMID:21266533 PMID:22552774

NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249

G

gelsolin

increases expression

ISO

Dibutyl Phthalate results in increased expression of GSN mRNA

NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850

G

G1 to S phase transition 2

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of GSPT2 mRNA
Dibutyl Phthalate results in decreased expression of GSPT2 mRNA

PMID:17361019 PMID:21266533

NCBI chr X:63,582,649...63,597,467
Ensembl chr X:63,582,690...63,700,401

G

glutathione-disulfide reductase

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of GSR mRNA; Dibutyl Phthalate results in decreased expression of GSR protein
Ascorbic Acid inhibits the reaction [Dibutyl Phthalate results in decreased expression of GSR mRNA]
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of GSR mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GSR mRNA

PMID:25172463 PMID:28013214 PMID:28415704 PMID:39947446

NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394

G

glutathione synthetase

increases expression

EXP

Dibutyl Phthalate results in increased expression of GSS mRNA

NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306

G

glutathione S-transferase alpha 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GSTA1 mRNA

NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528

G

glutathione S-transferase alpha 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GSTA2 mRNA

PMID:17379624 PMID:21266533

NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092

G

glutathione S-transferase alpha 3

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of GSTA3 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GSTA3 mRNA

PMID:21266533 PMID:21745491 PMID:31199487

NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:31,154,989...31,180,654

G

glutathione S-transferase alpha 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GSTA4 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:87,930,566...87,964,488

G

glutathione S-transferase mu 2

affects expression
multiple interactions
decreases expression

EXP
ISO

Dibutyl Phthalate affects the expression of GSTM2 mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of GSTM2 mRNA
Dibutyl Phthalate results in decreased expression of GSTM2 mRNA

PMID:21266533 PMID:21745491 PMID:30698749

NCBI chr 2:198,312,179...198,316,962

G

glutathione S-transferase, mu 7

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GSTM7 mRNA

NCBI chr 2:198,254,872...198,260,365
Ensembl chr 2:198,254,875...198,260,373

G

glutathione S-transferase omega 1

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of GSTO1 mRNA
Dibutyl Phthalate results in decreased expression of GSTO1 protein
[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of GSTO1 protein

PMID:21266533 PMID:34864091

NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167

G

glutathione S-transferase pi 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of GSTP1 mRNA

PMID:17379624 PMID:21266533

NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705

G

glutathione S-transferase zeta 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GSTZ1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:112,525,576...112,536,228
Ensembl chr 6:112,525,377...112,536,233

G

general transcription factor 2A subunit 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GTF2A1 mRNA

NCBI chr 6:116,219,614...116,252,220
Ensembl chr 6:116,219,614...116,252,220

G

general transcription factor IIF subunit 1

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of GTF2F1 mRNA
Dibutyl Phthalate results in decreased expression of GTF2F1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:1,931,033...1,940,197
Ensembl chr 9:1,930,055...1,940,197

G

general transcription factor IIH subunit 3

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of GTF2H3 mRNA

PMID:17361019 PMID:21266533

NCBI chr12:37,669,995...37,687,505
Ensembl chr12:37,669,997...37,686,466

G

GTF2I repeat domain containing 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GTF2IRD1 mRNA

NCBI chr12:27,890,594...27,997,506
Ensembl chr12:27,890,675...27,997,494

G

general transcription factor III A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GTF3A mRNA

PMID:17361019 PMID:21266533

NCBI chr12:13,250,643...13,258,587
Ensembl chr12:13,250,644...13,258,587

G

general transcription factor IIIC subunit 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of GTF3C1 mRNA

NCBI chr 1:189,634,645...189,700,848
Ensembl chr 1:189,634,645...189,700,995

G

GTP binding protein 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GTPBP3 mRNA

NCBI chr16:18,209,747...18,214,838
Ensembl chr16:18,209,682...18,214,838

G

GTP binding protein 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of GTPBP4 mRNA

NCBI chr17:65,997,472...66,019,530
Ensembl chr17:66,276,566...66,289,637

G

guanylate cyclase 1 soluble subunit beta 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of GUCY1B1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:169,646,897...169,697,060
Ensembl chr 2:169,646,898...169,696,987

G

guanylate kinase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of GUK1 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:44,471,075...44,488,332
Ensembl chr10:44,471,085...44,479,355

G

glucuronidase, beta

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of GUSB mRNA

NCBI chr12:32,337,281...32,350,838
Ensembl chr12:32,334,075...32,363,024

G

glycogenin 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of GYG1 mRNA

NCBI chr 2:104,540,927...104,583,038
Ensembl chr 2:104,540,533...104,582,818

G

glycophorin A

increases expression

ISO

Dibutyl Phthalate results in increased expression of GYPA mRNA

NCBI chr19:44,354,669...44,370,304
Ensembl chr19:44,354,706...44,370,291

G

H1.0 linker histone

decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of H1F0 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of H1F0 promoter

PMID:17379624 PMID:21266533 PMID:23359474

NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006

G

H1.10 linker histone

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of H1F10 mRNA

NCBI chr 4:121,997,834...121,998,897
Ensembl chr 4:121,997,831...121,998,966

G

H1.2 linker histone, cluster member

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of H1F2 mRNA

NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317

G

H1.7 linker histone

increases expression

ISO

Dibutyl Phthalate results in increased expression of H1F7 mRNA

NCBI chr 7:131,287,569...131,288,936
Ensembl chr 7:131,286,654...131,289,110

G

H2A clustered histone 18

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of H2AC18 mRNA

NCBI chr 2:186,497,271...186,497,865

G

H2A clustered histone 25

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of H2AC25 mRNA

NCBI chr10:44,233,283...44,234,835
Ensembl chr10:44,233,181...44,241,197

G

H2A.J histone

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of H2AJ mRNA

NCBI chr 4:171,406,922...171,407,406
Ensembl chr 4:171,406,177...171,408,845

G

H2A.X variant histone

decreases expression
multiple interactions
increases expression

ISO

Dibutyl Phthalate results in decreased expression of H2AX mRNA
AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased expression of H2AX protein]; AKT1 protein affects the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased expression of H2AX protein]]; MK 2206 inhibits the reaction [AKT activator SC79 inhibits the reaction [Dibutyl Phthalate results in increased expression of H2AX protein]]

PMID:17361019 PMID:21266533 PMID:30952838

NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079

G

H2A.Z variant histone 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of H2AZ1 mRNA

PMID:17361019 PMID:17379624 PMID:21266533

NCBI chr 2:229,026,464...229,031,411
Ensembl chr 2:229,028,843...229,031,411

G

H2A.Z variant histone 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of H2AZ2 mRNA

NCBI chr14:85,507,228...85,526,166
Ensembl chr14:85,507,228...85,526,207
Ensembl chr16:85,507,228...85,526,207

G

H2B clustered histone 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of H2BC4 mRNA

NCBI chr17:47,388,085...47,392,349
Ensembl chr17:47,404,375...47,419,020

G

H3 clustered histone 15

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of H3C14 protein

NCBI chr 2:186,526,162...186,526,587
Ensembl chr 2:186,521,116...186,550,846

G

H3.3 histone A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of H3F3A mRNA

NCBI chr13:95,065,085...95,076,695
Ensembl chr13:95,065,085...95,076,695

G

H3.3 histone B

decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of H3F3B mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of H3F3B mRNA

PMID:17379624 PMID:21266533 PMID:39150890

NCBI chr10:101,755,404...101,764,616
Ensembl chr10:101,755,404...101,757,636

G

hyaluronan binding protein 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of HABP4 mRNA

PMID:17361019 PMID:21266533

NCBI chr17:940,672...963,358
Ensembl chr17:941,389...963,300

G

3-hydroxyacyl-CoA dehydratase 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HACD2 mRNA

NCBI chr11:79,175,470...79,268,975
Ensembl chr11:79,175,482...79,268,126

G

3-hydroxyacyl-CoA dehydratase 3

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of HACD3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:74,396,441...74,433,700
Ensembl chr 8:74,396,442...74,433,700

G

hydroxyacyl-CoA dehydrogenase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of HADH mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:222,462,049...222,504,446

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of HADHA mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HADHA mRNA

PMID:21266533 PMID:39150890

NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of HADHB mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HADHB mRNA

PMID:17361019 PMID:39150890

NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:31,873,404...31,907,835

G

hydroxyacylglutathione hydrolase-like

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HAGHL mRNA

NCBI chr10:15,309,469...15,313,910
Ensembl chr10:15,308,668...15,312,181

G

hydroxyacid oxidase 2

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of HAO2 mRNA
Dibutyl Phthalate results in increased expression of HAO2 mRNA

NCBI chr 2:188,888,848...188,921,567
Ensembl chr 2:188,889,212...188,913,133

G

hyaluronan synthase 2

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of HAS2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HAS2 mRNA

PMID:24893172 PMID:39150890

NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:90,002,929...90,018,535

G

histone H3 associated protein kinase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HASPIN mRNA

PMID:17361019 PMID:21266533

NCBI chr10:58,246,244...58,249,031
Ensembl chr10:58,240,447...58,249,249

G

histone acetyltransferase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HAT1 mRNA

NCBI chr 3:76,624,442...76,672,701
Ensembl chr 3:76,624,869...76,672,696

G

HAUS augmin-like complex, subunit 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HAUS1 mRNA

PMID:17361019 PMID:21266533

NCBI chr18:73,550,549...73,561,757
Ensembl chr18:73,548,669...73,565,761

G

HAUS augmin like complex subunit 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HAUS2 mRNA

NCBI chr 3:128,006,894...128,019,730
Ensembl chr 3:128,006,932...128,019,729

G

HAUS augmin-like complex, subunit 4

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of HAUS4 mRNA

NCBI chr15:31,964,555...31,976,853
Ensembl chr15:31,964,556...31,975,941

G

HAUS augmin-like complex, subunit 7

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of HAUS7 mRNA

NCBI chr X:156,306,320...156,331,940
Ensembl chr X:156,306,320...156,352,158

G

HAUS augmin-like complex, subunit 8

increases expression

EXP

Dibutyl Phthalate results in increased expression of HAUS8 mRNA

NCBI chr16:17,964,813...17,979,313
Ensembl chr16:17,964,814...17,979,192

G

HCLS1 associated protein X-1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HAX1 mRNA

NCBI chr 2:177,731,918...177,735,670
Ensembl chr 2:177,731,921...177,735,390

G

hemoglobin subunit gamma 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of HBB-BH1 mRNA

NCBI chr 1:167,683,760...167,685,315
Ensembl chr 1:167,683,760...167,706,139

G

HMG-box transcription factor 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of HBP1 mRNA

NCBI chr 6:54,257,118...54,283,373
Ensembl chr 6:54,256,864...54,283,366

G

host cell factor C1 regulator 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of HCFC1R1 mRNA

NCBI chr10:13,209,757...13,211,445
Ensembl chr10:13,209,558...13,211,443

G

HCK proto-oncogene, Src family tyrosine kinase

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of HCK mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HCK mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr 3:162,031,833...162,074,933
Ensembl chr 3:162,031,817...162,074,935

G

hypocretin neuropeptide precursor

increases expression

ISO

Dibutyl Phthalate results in increased expression of HCRT mRNA

NCBI chr10:86,190,289...86,191,524
Ensembl chr10:86,189,775...86,191,524

G

hypocretin receptor 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of HCRTR2 mRNA

NCBI chr 8:85,870,279...85,986,405
Ensembl chr 8:85,870,279...85,986,405

G

histone deacetylase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HDAC1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387

G

histone deacetylase 11

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HDAC11 mRNA

NCBI chr 4:125,203,044...125,224,584
Ensembl chr 4:125,202,299...125,224,582

G

histone deacetylase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HDAC3 mRNA

NCBI chr18:30,021,847...30,041,061
Ensembl chr18:30,021,941...30,041,025

G

histone deacetylase 5

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of HDAC5 mRNA

NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244

G

histone deacetylase 6

increases expression
decreases expression
increases response to substance
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of HDAC6 mRNA; Dibutyl Phthalate results in increased expression of HDAC6 protein
Dibutyl Phthalate results in decreased expression of HDAC6 mRNA
HDAC6 results in increased susceptibility to Dibutyl Phthalate
[Dibutyl Phthalate promotes the reaction [TFAP2A protein binds to HDAC6 promoter]] which results in increased expression of HDAC6 mRNA; Dibutyl Phthalate promotes the reaction [TFAP2A protein binds to HDAC6 promoter]; HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate affects the localization of CTNNB1 protein]; HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]; HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate results in decreased expression of KRT7 protein]; HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate results in increased expression of VIM protein]; HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of AKT1 protein]; HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of GSK3B protein]; TFAP2A mutant form inhibits the reaction [Dibutyl Phthalate results in increased expression of HDAC6 protein]

PMID:17361019 PMID:21266533 PMID:22552774

NCBI chr X:17,222,538...17,244,373
Ensembl chr X:17,222,856...17,244,370

G

histone deacetylase 7

increases expression

EXP

Dibutyl Phthalate results in increased expression of HDAC7 mRNA

NCBI chr 7:130,803,013...130,841,181
Ensembl chr 7:130,803,013...130,841,017

G

histone deacetylase 8

affects expression

EXP

Dibutyl Phthalate affects the expression of HDAC8 mRNA

NCBI chr X:71,425,240...71,632,865
Ensembl chr X:71,394,928...71,632,865

G

HD domain containing 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HDDC2 mRNA

NCBI chr 1:28,100,669...28,133,008
Ensembl chr 1:28,083,521...28,132,977

G

HD domain containing 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HDDC3 mRNA

NCBI chr 1:143,708,703...143,711,010
Ensembl chr 1:143,705,320...143,711,010

G

haloacid dehalogenase-like hydrolase domain containing 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HDHD3 mRNA

NCBI chr 5:80,966,878...80,970,345
Ensembl chr 5:80,954,610...80,970,854

G

HEAT repeat containing 5B

increases expression

ISO

Dibutyl Phthalate results in increased expression of HEATR5B mRNA

NCBI chr 6:21,995,558...22,075,582
Ensembl chr 6:21,995,602...22,075,582

G

HEAT repeat containing 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HEATR6 mRNA

NCBI chr10:69,132,532...69,161,334
Ensembl chr10:69,132,181...69,162,945

G

hdc homolog, cell cycle regulator

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of HECA mRNA

NCBI chr 1:14,345,306...14,395,226
Ensembl chr 1:14,345,306...14,395,191

G

HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HECW2 mRNA

NCBI chr 9:62,853,904...63,247,472
Ensembl chr 9:62,859,645...63,074,758

G

heart development protein with EGF-like domains 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of HEG1 mRNA

NCBI chr11:80,512,096...80,600,150
Ensembl chr11:80,512,096...80,600,092

G

helicase, lymphoid specific

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HELLS mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:246,113,580...246,159,230
Ensembl chr 1:246,114,096...246,159,228

G

hemogen

increases expression

EXP

Dibutyl Phthalate results in increased expression of HEMGN mRNA

NCBI chr 5:65,475,228...65,495,384
Ensembl chr 5:65,475,228...65,494,375

G

HemK methyltransferase family member 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HEMK1 mRNA

NCBI chr 8:116,878,317...116,889,342
Ensembl chr 8:116,878,318...116,888,873

G

hepatic and glial cell adhesion molecule

increases expression

ISO

Dibutyl Phthalate results in increased expression of HEPACAM mRNA

NCBI chr 8:45,276,594...45,294,006
Ensembl chr 8:45,276,683...45,295,548

G

HECT and RLD domain containing E3 ubiquitin protein ligase 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HERC2 mRNA

NCBI chr 1:116,009,681...116,243,888
Ensembl chr 1:116,040,736...116,243,884

G

homocysteine inducible ER protein with ubiquitin like domain 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of HERPUD1 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081

G

HERPUD family member 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of HERPUD2 mRNA

NCBI chr 8:31,849,216...31,894,219
Ensembl chr 8:31,849,216...31,894,219

G

hes family bHLH transcription factor 1

increases expression
decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of HES1 mRNA; Dibutyl Phthalate results in increased expression of HES1 protein
Dibutyl Phthalate results in decreased expression of HES1 mRNA; Dibutyl Phthalate results in decreased expression of HES1 protein
3-methyladenine inhibits the reaction [Dibutyl Phthalate results in decreased expression of HES1 mRNA]; 3-methyladenine inhibits the reaction [Dibutyl Phthalate results in decreased expression of HES1 protein]; NOTCH2 protein alternative form inhibits the reaction [Dibutyl Phthalate results in decreased expression of HES1 mRNA]
Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in increased expression of HES1 mRNA]; Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in increased expression of HES1 protein]; Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in increased expression of HES1 mRNA]; Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in increased expression of HES1 protein]

PMID:21266533 PMID:35378083 PMID:37277016

NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061

G

hes family bHLH transcription factor 6

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of HES6 mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HES6 mRNA

PMID:21266533 PMID:25607892

NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:99,449,371...99,451,096

G

hes family bHLH transcription factor 7

increases expression

EXP

Dibutyl Phthalate results in increased expression of HES7 mRNA

NCBI chr10:54,322,971...54,327,776
Ensembl chr10:54,322,971...54,327,776

G

HEXIM P-TEFb complex subunit 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HEXIM1 mRNA

NCBI chr10:88,562,889...88,565,001
Ensembl chr10:88,560,519...88,580,000

G

hes-related family bHLH transcription factor with YRPW motif 1

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of HEY1 mRNA
Dibutyl Phthalate results in increased expression of HEY1 mRNA; Dibutyl Phthalate results in increased expression of HEY1 protein

PMID:26472102 PMID:29438945

NCBI chr 2:95,003,935...95,006,457
Ensembl chr 2:95,002,943...95,007,624

G

hes-related family bHLH transcription factor with YRPW motif 2

multiple interactions
decreases expression

ISO

3-methyladenine inhibits the reaction [Dibutyl Phthalate results in decreased expression of HEY2 mRNA]; 3-methyladenine inhibits the reaction [Dibutyl Phthalate results in decreased expression of HEY2 protein]; NOTCH2 protein alternative form inhibits the reaction [Dibutyl Phthalate results in decreased expression of HEY2 mRNA]
Dibutyl Phthalate results in decreased expression of HEY2 mRNA; Dibutyl Phthalate results in decreased expression of HEY2 protein

NCBI chr 1:28,641,100...28,651,187
Ensembl chr 1:28,641,057...28,651,187

G

hes-related family bHLH transcription factor with YRPW motif-like

increases expression

ISO

Dibutyl Phthalate results in increased expression of HEYL mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:140,793,271...140,810,262
Ensembl chr 5:140,793,271...140,810,262

G

heparan-alpha-glucosaminide N-acetyltransferase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HGSNAT mRNA

NCBI chr16:72,807,967...72,840,180
Ensembl chr16:72,807,849...72,840,176

G

Hedgehog-interacting protein

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of HHIP mRNA
Dibutyl Phthalate results in increased expression of HHIP mRNA; Dibutyl Phthalate results in increased expression of HHIP protein

PMID:17361019 PMID:21266533 PMID:24893172 PMID:31568847 PMID:32622864

NCBI chr19:44,768,038...44,856,878
Ensembl chr19:44,767,536...44,862,795

G

3-hydroxyisobutyryl-CoA hydrolase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HIBCH mRNA

NCBI chr 9:56,082,082...56,161,796
Ensembl chr 9:56,082,091...56,161,886

G

HIG1 hypoxia inducible domain family, member 2A

multiple interactions
decreases expression

EXP
ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of HIGD2A promoter
Dibutyl Phthalate results in decreased expression of HIGD2A mRNA

PMID:21266533 PMID:23359474

NCBI chr17:10,026,961...10,027,885
Ensembl chr17:10,026,961...10,027,874

G

HIG1 hypoxia inducible domain family, member 2A-like 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of HIGD2AL1 promoter

NCBI chr12:7,574,795...7,575,432
Ensembl chr12:7,574,944...7,575,425

G

histidine triad nucleotide binding protein 1

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of HINT1 mRNA

NCBI chr10:39,490,225...39,493,970
Ensembl chr 4:93,430,926...93,431,642
Ensembl chr10:93,430,926...93,431,642

G

huntingtin interacting protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of HIP1 mRNA

NCBI chr12:26,769,868...26,904,367
Ensembl chr12:26,769,961...26,904,296

G

homeodomain interacting protein kinase 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of HIPK1 mRNA

NCBI chr 2:193,937,261...193,988,247
Ensembl chr 2:193,937,261...193,975,164

G

homeodomain interacting protein kinase 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HIPK2 mRNA

NCBI chr 4:68,399,358...68,586,404
Ensembl chr 4:68,369,099...68,586,108

G

homeodomain interacting protein kinase 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of HIPK3 mRNA

NCBI chr 3:111,251,863...111,322,815
Ensembl chr 3:111,251,863...111,322,772

G

HIRA interacting protein 3

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of HIRIP3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:190,903,065...190,905,610
Ensembl chr 1:190,902,593...190,905,607

G

HIVEP zinc finger 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of HIVEP1 mRNA

NCBI chr17:22,790,855...22,920,359
Ensembl chr17:22,790,855...22,917,196

G

HIVEP zinc finger 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of HIVEP2 mRNA

NCBI chr 1:10,176,880...10,376,089
Ensembl chr 1:10,179,402...10,376,089

G

HIVEP zinc finger 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of HIVEP3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:138,610,592...139,013,058
Ensembl chr 5:138,943,312...139,010,430

G

hexokinase 1

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of HK1 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of HK1 mRNA

PMID:17361019 PMID:21266533 PMID:37364641

NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814

G

hexokinase 2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of HK2 mRNA

PMID:21266533 PMID:37703926

NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275

G

helicase-like transcription factor

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of HLTF mRNA
Dibutyl Phthalate results in decreased expression of HLTF mRNA

NCBI chr 2:104,478,725...104,538,531
Ensembl chr 2:104,478,772...104,538,818

G

hydroxymethylbilane synthase

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of HMBS mRNA

NCBI chr 8:53,570,364...53,577,758
Ensembl chr 8:53,570,364...53,577,802

G

high mobility group box 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HMGB1 mRNA

NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327

G

high mobility group box 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HMGB2 mRNA

NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860

G

high mobility group box 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HMGB3 mRNA

PMID:17361019 PMID:21266533

NCBI chr X:154,341,106...154,346,087
Ensembl chr X:154,340,935...154,346,097

G

3-hydroxy-3-methylglutaryl-CoA reductase

decreases expression
increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of HMGCR mRNA
Dibutyl Phthalate results in increased expression of HMGCR mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of HMGCR mRNA

PMID:17379624 PMID:21266533 PMID:21745491 PMID:33167028 PMID:33983380 More...

NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

increases expression
multiple interactions
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of HMGCS1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HMGCS1 mRNA
Dibutyl Phthalate results in decreased expression of HMGCS1 mRNA

PMID:17379624 PMID:21266533 PMID:21745491 PMID:33167028 PMID:33983380 More...

NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802

G

high mobility group nucleosome binding domain 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HMGN1 mRNA

NCBI chr11:48,891,813...48,897,732
Ensembl chr11:48,891,814...48,897,771

G

high mobility group nucleosomal binding domain 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HMGN3 mRNA

PMID:21266533 PMID:24893172

NCBI chr 8:92,902,555...92,939,980

G

hyaluronan-mediated motility receptor

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of HMMR mRNA

PMID:21266533 PMID:28973377

NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390

G

heme oxygenase 1

decreases expression
increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of HMOX1 mRNA; Dibutyl Phthalate results in decreased expression of HMOX1 protein
Dibutyl Phthalate results in increased expression of HMOX1 protein
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Dibutyl Phthalate results in increased expression of HMOX1 protein]; Resveratrol inhibits the reaction [Dibutyl Phthalate results in decreased expression of HMOX1 protein]
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of HMOX1 mRNA; [sulforaphane co-treated with Dibutyl Phthalate] results in increased expression of HMOX1 protein; NFE2L2 protein affects the reaction [Dibutyl Phthalate results in increased expression of HMOX1 protein]; Resveratrol inhibits the reaction [Dibutyl Phthalate results in decreased expression of HMOX1 protein]

PMID:21266533 PMID:28295950 PMID:30910607 PMID:33254669 PMID:37364641

NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818

G

HNF1 homeobox A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HNF1A mRNA

PMID:15728792 PMID:21745491

NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755

G

heterogeneous nuclear ribonucleoprotein A0

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HNRNPA0 mRNA

NCBI chr17:6,513,129...6,515,786
Ensembl chr17:6,512,629...6,516,127

G

heterogeneous nuclear ribonucleoprotein A1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HNRNPA1 mRNA

NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:136,253,278...136,260,085

G

heterogeneous nuclear ribonucleoprotein A/B

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of HNRNPAB mRNA

PMID:17379624 PMID:21266533

NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307

G

heterogeneous nuclear ribonucleoprotein D

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HNRNPD mRNA

PMID:17361019 PMID:21266533

NCBI chr14:9,918,630...9,938,072
Ensembl chr14:9,919,739...9,938,066

G

heterogeneous nuclear ribonucleoprotein D-like

decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of HNRNPDL mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of HNRNPDL promoter

PMID:17361019 PMID:21266533 PMID:23359474

NCBI chr14:9,861,716...9,867,945
Ensembl chr14:9,861,716...9,867,945

G

heterogeneous nuclear ribonucleoprotein H2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HNRNPH2 protein

NCBI chr X:102,074,175...102,080,115
Ensembl chr X:102,074,179...102,081,025

G

heterogeneous nuclear ribonucleoprotein H3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HNRNPH3 mRNA

PMID:17361019 PMID:21266533

NCBI chr20:25,619,540...25,624,397
Ensembl chr20:25,615,577...25,625,162

G

heterogeneous nuclear ribonucleoprotein M

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HNRPM mRNA

NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:15,129,287...15,178,871

G

heterogeneous nuclear ribonucleoprotein R

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HNRNPR mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:153,826,482...153,872,272
Ensembl chr 5:153,826,692...153,858,344

G

heterogeneous nuclear ribonucleoprotein U

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HNRNPU mRNA

NCBI chr13:92,609,791...92,618,580
Ensembl chr13:92,605,216...92,618,612

G

heterogeneous nuclear ribonucleoprotein U-like 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HNRNPUL2 mRNA

NCBI chr 1:215,142,750...215,154,668
Ensembl chr 1:215,142,644...215,155,161

G

homer scaffold protein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of HOMER1 mRNA

NCBI chr 2:26,279,012...26,388,279
Ensembl chr 2:26,278,105...26,381,657

G

homeobox and leucine zipper encoding

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HOMEZ mRNA

NCBI chr15:32,292,897...32,309,564
Ensembl chr15:32,291,048...32,321,319

G

hook microtubule-tethering protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HOOK1 mRNA

NCBI chr 5:115,940,199...116,003,482
Ensembl chr 5:115,940,080...116,003,482

G

hook microtubule-tethering protein 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of HOOK3 mRNA

NCBI chr16:72,656,929...72,751,696
Ensembl chr16:72,657,019...72,764,071

G

homeobox A1

multiple interactions

ISO

Dibutyl Phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Dibutyl Phthalate promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA]

PMID:23696197 PMID:27532513

NCBI chr 4:82,586,505...82,589,209
Ensembl chr 4:82,586,505...82,589,209

G

homeo box A13

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HOXA13 mRNA

PMID:25213187 PMID:27079746

NCBI chr 4:82,689,566...82,691,701
Ensembl chr 4:82,689,566...82,691,701

G

homeo box B3

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of HOXB3 promoter

NCBI chr10:81,786,001...81,810,655
Ensembl chr10:81,795,882...81,809,628

G

homeo box B6

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of HOXB6 promoter

NCBI chr10:81,755,263...81,763,999

G

homeo box B8

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXB8 mRNA

NCBI chr10:81,745,430...81,747,181
Ensembl chr10:81,739,704...81,747,802

G

homeo box D13

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HOXD13 mRNA

PMID:25213187 PMID:27079746

NCBI chr 3:79,978,077...79,981,393
Ensembl chr 3:79,978,076...79,981,393

G

homeo box D3

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of HOXD3 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXD3 mRNA

PMID:21266533 PMID:31199487

NCBI chr 3:80,041,598...80,057,700
Ensembl chr 3:80,046,126...80,057,700

G

homeo box D9

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HOXD9 mRNA

NCBI chr 3:80,008,006...80,010,186
Ensembl chr 3:80,007,668...80,010,171

G

haptoglobin

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of HP mRNA

NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518

G

heterochromatin protein 1, binding protein 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HP1BP3 mRNA

NCBI chr 5:155,719,109...155,746,329
Ensembl chr 5:155,719,115...155,746,325

G

15-hydroxyprostaglandin dehydrogenase

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of HPGD mRNA
[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] results in increased expression of HPGD mRNA; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] results in increased expression of HPGD protein
Dibutyl Phthalate results in increased expression of HPGD mRNA

PMID:21266533 PMID:38995844

NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831

G

hypoxanthine phosphoribosyltransferase 1

multiple interactions
increases mutagenesis

ISO

[Ozone co-treated with Dibutyl Phthalate] results in increased mutagenesis of HPRT1 gene; Dibutyl Phthalate promotes the reaction [[Ozone co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased mutagenesis of HPRT1 gene]
Dibutyl Phthalate results in increased mutagenesis of HPRT1 gene

NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712

G

HPS3, biogenesis of lysosomal organelles complex 2 subunit 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HPS3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:104,413,618...104,455,091
Ensembl chr 2:104,413,417...104,455,091

G

HPS6, biogenesis of lysosomal organelles complex 2 subunit 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HPS6 mRNA

NCBI chr 1:254,802,250...254,804,859
Ensembl chr 1:254,802,119...254,804,937

G

heparanase

increases expression

EXP

Dibutyl Phthalate results in increased expression of HPSE mRNA

NCBI chr14:9,200,971...9,241,377
Ensembl chr14:9,188,275...9,241,754

G

harakiri, BCL2 interacting protein

increases expression

ISO

Dibutyl Phthalate results in increased expression of HRK mRNA

NCBI chr12:44,048,402...44,070,561
Ensembl chr12:44,048,402...44,070,561

G

heparan sulfate-glucosamine 3-sulfotransferase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of HS3ST1 mRNA

NCBI chr14:75,398,101...75,429,628
Ensembl chr14:75,398,026...75,436,848

G

hydroxysteroid 11-beta dehydrogenase 1

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of HSD11B1 protein
Dibutyl Phthalate results in decreased expression of HSD11B1 mRNA

PMID:19815848 PMID:23314658 PMID:28528174

NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432

G

hydroxysteroid 11-beta dehydrogenase 2

decreases activity
decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased activity of HSD11B2 protein
Dibutyl Phthalate results in decreased expression of HSD11B2 mRNA

PMID:17361019 PMID:19560483 PMID:19786001 PMID:21266533

NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812

G

hydroxysteroid (17-beta) dehydrogenase 1

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of HSD17B1 mRNA
Dibutyl Phthalate results in decreased expression of HSD17B1 mRNA; Dibutyl Phthalate results in decreased expression of HSD17B1 protein
Dibutyl Phthalate results in increased expression of HSD17B1 mRNA

PMID:17361019 PMID:21266533 PMID:25765776 PMID:26706031

NCBI chr10:86,510,011...86,512,211
Ensembl chr10:86,510,011...86,512,210

G

hydroxysteroid (17-beta) dehydrogenase 10

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HSD17B10 mRNA

NCBI chr X:24,568,551...24,571,012
Ensembl chr X:24,568,551...24,574,681

G

hydroxysteroid (17-beta) dehydrogenase 11

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of HSD17B11 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD17B11 mRNA

PMID:21266533 PMID:26472102 PMID:39150890

NCBI chr14:5,997,893...6,047,816
Ensembl chr14:5,997,906...6,047,811

G

hydroxysteroid (17-beta) dehydrogenase 3

decreases expression
increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of HSD17B3 mRNA; Dibutyl Phthalate results in decreased expression of HSD17B3 protein
Dibutyl Phthalate results in increased expression of HSD17B3 mRNA
[Nanotubes, Carbon co-treated with Dibutyl Phthalate] results in decreased expression of HSD17B3 mRNA
taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of HSD17B3 mRNA]; taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of HSD17B3 protein]

PMID:17361019 PMID:21266533 PMID:23314658 PMID:25434310 PMID:27148549 More...

NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,032,958...1,064,283

G

hydroxysteroid (17-beta) dehydrogenase 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of HSD17B4 protein

NCBI chr18:45,515,427...45,604,467
Ensembl chr18:45,515,373...45,604,467

G

hydroxysteroid (17-beta) dehydrogenase 7

increases expression

ISO

Dibutyl Phthalate results in increased expression of HSD17B7 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:84,702,875...84,722,810
Ensembl chr13:84,705,631...84,722,754

G

hydroxysteroid (17-beta) dehydrogenase 8

increases expression

EXP

Dibutyl Phthalate results in increased expression of HSD17B8 mRNA

PMID:19560483 PMID:26472102

NCBI chr20:4,828,571...4,830,635
Ensembl chr20:4,828,608...4,830,634

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1

decreases expression
increases expression
multiple interactions
affects expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of HSD3B1 mRNA; Dibutyl Phthalate results in decreased expression of HSD3B1 protein
Dibutyl Phthalate results in increased expression of HSD3B1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of HSD3B1 mRNA
Dibutyl Phthalate affects the expression of HSD3B1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD3B1 mRNA; [dimethyl phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of HSD3B1 mRNA; [Nanotubes, Carbon co-treated with Dibutyl Phthalate] affects the expression of HSD3B1 mRNA

PMID:15141095 PMID:21266533 PMID:26706031 PMID:27148549 PMID:28013214 More...

NCBI chr 2:188,858,574...188,864,694

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2

multiple interactions
decreases expression

ISO
EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of HSD3B2 mRNA]
Dibutyl Phthalate results in decreased expression of HSD3B6 mRNA

PMID:26948521 PMID:37552060

NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:188,784,614...188,790,569

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HSD3B3 mRNA

NCBI chr 2:188,826,756...188,832,734
Ensembl chr 2:188,826,110...188,904,981

G

hydroxysteroid dehydrogenase like 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HSDL1 mRNA

NCBI chr19:64,524,435...64,540,527
Ensembl chr19:64,525,891...64,540,762

G

hydroxysteroid dehydrogenase like 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSDL2 mRNA

NCBI chr 5:79,238,881...79,274,051
Ensembl chr 5:79,212,525...79,274,798

G

heat shock transcription factor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HSF1 mRNA

NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665

G

heat shock protein 90 alpha family class A member 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of HSP90AA1 mRNA

NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499

G

heat shock protein 90 alpha family class B member 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of HSP90AB1 promoter

NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926

G

heat shock protein 90 beta family member 1

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of HSP90B1 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSP90B1 mRNA

PMID:17361019 PMID:37364641

NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293

G

heat shock protein family A (Hsp70) member 12A

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of HSPA12A mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA

PMID:21266533 PMID:31199487

NCBI chr 1:267,921,780...268,083,171
Ensembl chr 1:267,921,782...268,082,794

G

heat shock protein family A (Hsp70) member 5

multiple interactions
increases expression

ISO
EXP

4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of HSPA5 protein]; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of HSPA5 protein

PMID:26804720 PMID:37364641

NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790

G

heat shock protein family A (Hsp70) member 8

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of HSPA8 mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of HSPA8 mRNA

PMID:21266533 PMID:30698749

NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372

G

heat shock protein family A (Hsp70) member 9

increases expression

EXP

Dibutyl Phthalate results in increased expression of HSPA9 mRNA

NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398

G

heat shock protein family B (small) member 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of HSPB1 mRNA

NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301

G

heat shock protein family B (small) member 6

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HSPB6 mRNA

NCBI chr 1:94,934,372...94,936,516
Ensembl chr 1:94,933,543...94,936,512

G

heat shock protein family B (small) member 7

increases expression

EXP

Dibutyl Phthalate results in increased expression of HSPB7 mRNA

NCBI chr 5:159,010,759...159,014,245
Ensembl chr 5:159,010,629...159,014,243

G

heat shock protein family B (small) member 8

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSPB8 mRNA

NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937

G

heat shock protein family D (Hsp60) member 1

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of HSPD1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSPD1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037

G

heat shock protein family E (Hsp10) member 1

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of HSPE1 mRNA
Dibutyl Phthalate results in decreased expression of HSPE1 mRNA

PMID:17379624 PMID:21266533

NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502

G

5-hydroxytryptamine receptor 1A

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of HTR1A mRNA

NCBI chr 2:38,427,169...38,431,733
Ensembl chr 2:38,427,083...38,540,760

G

5-hydroxytryptamine receptor 2A

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of HTR2A mRNA

NCBI chr15:56,360,647...56,428,703
Ensembl chr15:56,359,596...56,431,619

G

5-hydroxytryptamine receptor 2C

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of HTR2C mRNA

PMID:15620428 PMID:21266533

NCBI chr X:115,453,190...115,682,325
Ensembl chr X:115,452,842...115,682,324

G

5-hydroxytryptamine receptor 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of HTR4 mRNA

NCBI chr18:58,036,277...58,221,327
Ensembl chr18:58,036,277...58,219,622

G

5-hydroxytryptamine (serotonin) receptor 5B

increases expression

EXP

Dibutyl Phthalate results in increased expression of HTR5B mRNA

NCBI chr13:35,239,662...35,252,586
Ensembl chr13:35,239,662...35,252,586

G

HtrA serine peptidase 1

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of HTRA1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HTRA1 mRNA

PMID:24893172 PMID:39150890

NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:194,927,687...194,977,620

G

HtrA serine peptidase 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of HTRA2 mRNA

NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:117,114,633...117,117,793

G

HtrA serine peptidase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HTRA3 mRNA

NCBI chr14:79,293,535...79,321,936
Ensembl chr14:79,293,541...79,321,936

G

HUS1 checkpoint clamp component

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HUS1 mRNA

NCBI chr14:87,902,458...87,917,221
Ensembl chr14:87,902,458...87,917,134

G

hyaluronidase 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of HYAL2 mRNA

NCBI chr 8:117,121,802...117,125,494
Ensembl chr 8:117,121,787...117,125,493

G

hyccin PI4KA lipid kinase complex subunit 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of HYCC1 mRNA

NCBI chr 4:12,024,692...12,131,504
Ensembl chr 4:12,024,739...12,131,501

G

hypoxia up-regulated 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of HYOU1 mRNA

NCBI chr 8:53,602,882...53,614,998
Ensembl chr 8:53,602,604...53,614,997

G

Huntingtin interacting protein K

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of HYPK mRNA

NCBI chr 3:128,888,709...128,890,089
Ensembl chr 3:128,888,717...128,891,405

G

intercellular adhesion molecule 1

increases expression
decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of ICAM1 mRNA
Dibutyl Phthalate results in decreased expression of ICAM1 mRNA
[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of ICAM1 protein

PMID:21266533 PMID:30218697 PMID:34902519

NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617

G

isoprenylcysteine carboxyl methyltransferase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ICMT mRNA

NCBI chr 5:168,084,487...168,097,519
Ensembl chr 5:168,086,057...168,093,094

G

inducible T-cell co-stimulator

increases expression

ISO

Dibutyl Phthalate results in increased expression of ICOS mRNA

NCBI chr 9:69,862,042...69,900,864
Ensembl chr 9:69,877,785...69,900,960

G

inhibitor of DNA binding 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ID1 mRNA

NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685

G

inhibitor of DNA binding 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of ID2 mRNA

NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961

G

insulin degrading enzyme

increases expression

ISO

Dibutyl Phthalate results in increased expression of IDE mRNA

NCBI chr 1:244,415,495...244,516,925
Ensembl chr 1:244,416,343...244,514,526

G

isocitrate dehydrogenase (NADP(+)) 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IDH1 mRNA

PMID:21266533 PMID:21745491

NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555

G

isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IDH3A mRNA

NCBI chr 8:63,867,882...63,887,223
Ensembl chr 8:63,867,820...63,887,223

G

isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of IDH3G mRNA

NCBI chr X:156,666,573...156,675,482
Ensembl chr X:156,666,577...156,675,799

G

isopentenyl-diphosphate delta isomerase 1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of IDI1 mRNA
Dibutyl Phthalate results in decreased expression of IDI1 mRNA

PMID:17361019 PMID:17379624 PMID:21266533 PMID:21745491 PMID:33983380

NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524

G

isopentenyl-diphosphate delta isomerase 2 like 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IDI2L3 mRNA

NCBI chr17:66,243,932...66,258,028

G

indoleamine 2,3-dioxygenase 2

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of IDO2 mRNA

NCBI chr16:74,161,761...74,200,651
Ensembl chr16:74,161,774...74,200,650

G

iduronate 2-sulfatase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IDS mRNA

NCBI chr X:154,070,781...154,093,681
Ensembl chr X:154,070,781...154,091,444

G

immediate early response 2

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of IER2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IER2 mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708

G

immediate early response 3

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of IER3 mRNA

PMID:17361019 PMID:21266533 PMID:21745491

NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377

G

immediate early response 5-like

increases expression

EXP

Dibutyl Phthalate results in increased expression of IER5L mRNA

NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:34,139,672...34,144,452

G

intermediate filament family orphan 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of IFFO2 mRNA

NCBI chr 5:157,114,089...157,160,135
Ensembl chr 5:157,114,089...157,160,135

G

IFI30, lysosomal thiol reductase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IFI30 mRNA

NCBI chr16:18,709,570...18,713,635
Ensembl chr16:18,709,563...18,715,711

G

interferon-induced protein 35

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IFI35 mRNA

NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,887,122...86,889,750

G

interferon induced transmembrane protein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of IFITM1 mRNA

NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776

G

interferon induced transmembrane protein 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of IFITM3 mRNA

NCBI chr 1:205,540,649...205,541,758
Ensembl chr 1:205,481,168...205,547,920

G

interferon gamma

multiple interactions

EXP
ISO

[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IFNG protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IFNG protein]
[Dibutyl Phthalate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA
[Dibutyl Phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IFNG protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of IFNG protein

PMID:29198882 PMID:29385629 PMID:29594315 PMID:38954831

NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216

G

interferon gamma receptor 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of IFNGR2 mRNA

NCBI chr11:44,265,703...44,283,975
Ensembl chr11:44,265,703...44,283,975

G

interferon-related developmental regulator 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of IFRD1 mRNA

PMID:21266533 PMID:21745491

NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131

G

interferon-related developmental regulator 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of IFRD2 mRNA

NCBI chr 8:117,139,612...117,144,834
Ensembl chr 8:117,139,550...117,144,836

G

intraflagellar transport 46

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of IFT46 mRNA
Dibutyl Phthalate results in increased expression of IFT46 mRNA

NCBI chr 8:53,975,085...54,000,837
Ensembl chr 8:53,984,242...54,000,836

G

intraflagellar transport 52

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IFT52 mRNA

NCBI chr 3:172,091,591...172,116,497
Ensembl chr 3:172,092,017...172,116,493

G

immunoglobulin superfamily, DCC subclass, member 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of IGDCC3 mRNA

NCBI chr 8:74,556,348...74,603,136
Ensembl chr 8:74,556,348...74,603,136

G

immunoglobulin superfamily, DCC subclass, member 4

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IGDCC4 mRNA

NCBI chr 8:74,517,082...74,552,834
Ensembl chr 8:74,517,086...74,552,834

G

insulin-like growth factor 1

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of IGF1 mRNA
Dibutyl Phthalate results in decreased expression of IGF1 mRNA

PMID:15829613 PMID:21266533 PMID:26472102 PMID:36993736 PMID:37439711

NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764

G

insulin-like growth factor 1 receptor

increases expression
decreases phosphorylation
decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of IGF1R mRNA
Dibutyl Phthalate results in decreased phosphorylation of IGF1R protein
Dibutyl Phthalate results in decreased expression of IGF1R mRNA
Dibutyl Phthalate results in decreased expression of and results in decreased phosphorylation of IGF1R protein
Dibutyl Phthalate results in increased expression of IGF1R mRNA; Dibutyl Phthalate results in increased expression of IGF1R protein

PMID:15829613 PMID:21266533 PMID:36993736 PMID:37439711

NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664

G

insulin-like growth factor 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of IGF2 mRNA

PMID:15829613 PMID:21266533

NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667

G

insulin-like growth factor 2 mRNA binding protein 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of IGF2BP1 promoter

NCBI chr10:81,405,021...81,447,814
Ensembl chr10:81,404,797...81,447,846

G

insulin-like growth factor 2 mRNA binding protein 3

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of IGF2BP3 mRNA

NCBI chr 4:79,391,367...79,525,923
Ensembl chr 4:79,393,067...79,525,730

G

insulin-like growth factor 2 receptor

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of IGF2R mRNA

NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265

G

insulin-like growth factor binding protein 2

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of IGFBP2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of IGFBP2 protein

PMID:21266533 PMID:38954831

NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171

G

insulin-like growth factor binding protein 5

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of IGFBP5 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IGFBP5 mRNA
Dibutyl Phthalate results in increased expression of IGFBP5 mRNA

PMID:15829613 PMID:21266533 PMID:39150890

NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390

G

insulin-like growth factor binding protein 6

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of IGFBP6 protein

NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795

G

insulin-like growth factor binding protein 7

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IGFBP7 mRNA

NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620

G

IGF-like family receptor 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of IGFLR1 mRNA

NCBI chr 1:94,945,866...94,948,476
Ensembl chr 1:94,945,967...94,948,473

G

immunoglobulin superfamily, member 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of IGSF1 mRNA

NCBI chr X:133,947,717...133,963,154
Ensembl chr X:133,947,429...133,962,962

G

immunoglobulin superfamily, member 8

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of IGSF8 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:87,282,015...87,314,018
Ensembl chr13:87,302,536...87,310,941

G

immunoglobulin superfamily, member 9

increases expression

ISO

Dibutyl Phthalate results in increased expression of IGSF9 mRNA

NCBI chr13:87,480,979...87,497,974
Ensembl chr13:87,481,279...87,497,974

G

interferon gamma induced GTPase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IGTP mRNA

NCBI chr10:42,875,047...42,882,866
Ensembl chr10:42,876,790...42,882,858

G

inhibitor of nuclear factor kappa B kinase regulatory subunit gamma

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of IKBKG mRNA

NCBI chr X:157,358,279...157,397,563
Ensembl chr X:157,367,639...157,392,757

G

interleukin 10

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of IL10 mRNA

NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580

G

interleukin 10 receptor subunit beta

increases expression

ISO

Dibutyl Phthalate results in increased expression of IL10RB mRNA

PMID:17361019 PMID:21266533

NCBI chr11:44,132,471...44,154,062
Ensembl chr11:44,132,189...44,154,053

G

interleukin 11 receptor subunit alpha 1

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of IL11RA1 mRNA
Dibutyl Phthalate results in decreased expression of IL11RA1 mRNA

NCBI chr 5:61,727,650...61,737,265
Ensembl chr 5:61,727,931...61,737,264

G

interleukin 13

multiple interactions
increases expression

ISO
EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of IL13 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of IL13 protein; Dibutyl Phthalate promotes the reaction [OVAL results in increased expression of IL13 protein]; Melatonin inhibits the reaction [Dibutyl Phthalate promotes the reaction [OVAL results in increased expression of IL13 protein]]
Dibutyl Phthalate results in increased expression of IL13 protein
Resveratrol inhibits the reaction [Dibutyl Phthalate results in increased expression of IL13 protein]

PMID:32446102 PMID:33254669 PMID:35739755 PMID:38954831

NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483

G

interleukin 13 receptor subunit alpha 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of IL13RA1 mRNA

NCBI chr X:120,213,670...120,294,777
Ensembl chr X:120,214,075...120,274,461

G

interleukin 13 receptor subunit alpha 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of IL13RA2 mRNA

NCBI chr X:115,814,620...115,886,080
Ensembl chr X:115,814,622...115,841,455

G

interleukin 17A

multiple interactions

EXP
ISO

[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL17A protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL17A protein]
Dibutyl Phthalate promotes the reaction [OVAL results in increased expression of IL17A protein]; Melatonin inhibits the reaction [Dibutyl Phthalate promotes the reaction [OVAL results in increased expression of IL17A protein]]

PMID:29385629 PMID:32446102

NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331

G

interleukin 17 receptor A

increases expression

ISO

Dibutyl Phthalate results in increased expression of IL17RA mRNA

NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:155,339,400...155,362,382

G

interleukin 17 receptor C

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of IL17RC mRNA

NCBI chr 4:148,174,573...148,187,071
Ensembl chr 4:148,174,578...148,187,068

G

interleukin 17 receptor E

increases expression

EXP

Dibutyl Phthalate results in increased expression of IL17RE mRNA

NCBI chr 4:148,160,384...148,173,830
Ensembl chr 4:148,159,475...148,173,827

G

interleukin 18

multiple interactions

EXP

[Benzo(a)pyrene co-treated with Dibutyl Phthalate] results in increased expression of IL18 mRNA; [Benzo(a)pyrene co-treated with Dibutyl Phthalate] results in increased expression of IL18 protein

NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286

G

interleukin 1 alpha

increases secretion

EXP

Dibutyl Phthalate results in increased secretion of IL1A protein

NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013

G

interleukin 1 beta

multiple interactions
increases expression
decreases expression
increases cleavage
increases secretion

EXP
ISO

[Benzo(a)pyrene co-treated with Dibutyl Phthalate] results in increased expression of IL1B mRNA; [Benzo(a)pyrene co-treated with Dibutyl Phthalate] results in increased expression of IL1B protein; [Benzo(a)pyrene co-treated with Dibutyl Phthalate] results in increased secretion of IL1B protein; [Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL1B protein; [Nanotubes, Carbon co-treated with Dibutyl Phthalate] results in increased expression of IL1B protein; Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in increased expression of IL1B protein]; Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in increased expression of IL1B protein]
[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of IL1B mRNA; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of IL1B protein]; Curcumin inhibits the reaction [Dibutyl Phthalate results in increased expression of IL1B protein]
Dibutyl Phthalate results in increased expression of IL1B mRNA; Dibutyl Phthalate results in increased expression of IL1B protein
Dibutyl Phthalate results in decreased expression of IL1B mRNA
Dibutyl Phthalate results in increased cleavage of IL1B protein
Dibutyl Phthalate results in increased expression of and results in increased secretion of IL1B; KN 62 inhibits the reaction [Dibutyl Phthalate results in increased cleavage of IL1B protein]
Dibutyl Phthalate results in increased secretion of IL1B protein

PMID:20655936 PMID:22723514 PMID:26586371 PMID:29385629 PMID:29594315 More...

NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601

G

interleukin 1 receptor type 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of IL1R1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579

G

interleukin 1 receptor type 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of IL1R2 mRNA

NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374

G

interleukin 1 receptor accessory protein-like 1

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of IL1RAPL1 mRNA

NCBI chr X:55,322,779...56,827,486
Ensembl chr X:55,328,964...56,826,613

G

interleukin 1 receptor accessory protein-like 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of IL1RAPL2 mRNA

NCBI chr X:105,547,403...107,080,369
Ensembl chr X:105,754,490...107,065,223

G

interleukin 1 receptor-like 1

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Ovalbumin] results in increased expression of IL1RL1 protein; olcegepant inhibits the reaction [[Dibutyl Phthalate co-treated with Ovalbumin] results in increased expression of IL1RL1 protein]

NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891

G

interleukin 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA

NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672

G

interleukin 33

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Ovalbumin] results in increased expression of IL33 protein; olcegepant inhibits the reaction [[Dibutyl Phthalate co-treated with Ovalbumin] results in increased expression of IL33 protein]

NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901

G

interleukin 4

multiple interactions
increases expression

ISO
EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in decreased expression of IL4 mRNA; [Dibutyl Phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IL4 protein; Dibutyl Phthalate promotes the reaction [OVAL results in increased expression of IL4 protein]; Melatonin inhibits the reaction [Dibutyl Phthalate promotes the reaction [OVAL results in increased expression of IL4 protein]]
Dibutyl Phthalate results in increased expression of IL4 protein
Resveratrol inhibits the reaction [Dibutyl Phthalate results in increased expression of IL4 protein]

PMID:29198882 PMID:32446102 PMID:33254669 PMID:35739755

NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549

G

interleukin 4 receptor

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of IL4RA mRNA

NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636

G

interleukin 5

multiple interactions

ISO

Dibutyl Phthalate promotes the reaction [OVAL results in increased expression of IL5 protein]; Melatonin inhibits the reaction [Dibutyl Phthalate promotes the reaction [OVAL results in increased expression of IL5 protein]]

NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003

G

interleukin 6

increases secretion
increases expression
increases phosphorylation
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased secretion of IL6
Dibutyl Phthalate results in increased expression of IL6 mRNA
Dibutyl Phthalate results in increased phosphorylation of IL6 protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of IL6 mRNA; [Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of IL6 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of IL6 mRNA]
[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL6 protein; [Nanotubes, Carbon co-treated with Dibutyl Phthalate] results in increased expression of IL6 mRNA; [Nanotubes, Carbon co-treated with Dibutyl Phthalate] results in increased expression of IL6 protein; pyrazolanthrone inhibits the reaction [[Iodine co-treated with Dibutyl Phthalate] results in increased expression of IL6 protein]
Dibutyl Phthalate results in increased expression of IL6 protein

PMID:22723514 PMID:27511800 PMID:29385629 PMID:33167028 PMID:33316053 More...

NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610

G

immunoglobulin-like domain containing receptor 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of ILDR2 mRNA

NCBI chr13:81,051,723...81,113,590
Ensembl chr13:81,051,647...81,109,861

G

integrin-linked kinase

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ILK mRNA

NCBI chr 1:169,500,716...169,506,972
Ensembl chr 1:169,498,681...169,506,964

G

ilvB acetolactate synthase like

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ILVBL mRNA

NCBI chr 7:11,690,445...11,700,498
Ensembl chr 7:11,690,445...11,700,498

G

inner membrane mitochondrial protein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IMMT mRNA

NCBI chr 4:105,438,657...105,477,370
Ensembl chr 4:105,438,712...105,477,368

G

IMP U3 small nucleolar ribonucleoprotein 4

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of IMP4 mRNA
Dibutyl Phthalate results in decreased expression of IMP4 mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:44,150,029...44,155,167
Ensembl chr 9:44,150,337...44,157,751

G

impact RWD domain protein

increases expression

ISO

Dibutyl Phthalate results in increased expression of IMPACT mRNA

NCBI chr18:4,383,546...4,422,280
Ensembl chr18:4,383,575...4,422,278

G

inosine monophosphate dehydrogenase 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of IMPDH2 mRNA

NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873

G

inner centromere protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of INCENP mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:215,945,558...216,017,247
Ensembl chr 1:215,948,283...215,977,084

G

inverted formin 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of INF2 mRNA

NCBI chr 6:137,470,259...137,497,039
Ensembl chr 6:137,470,286...137,497,039

G

inhibitor of growth family, member 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ING1 promoter

NCBI chr16:84,639,378...84,649,498
Ensembl chr16:84,639,381...84,647,616

G

inhibitor of growth family, member 2

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ING2 mRNA
Dibutyl Phthalate results in decreased expression of ING2 mRNA

PMID:17361019 PMID:21266533

NCBI chr16:51,305,311...51,316,177
Ensembl chr16:51,307,466...51,316,177

G

inhibitor of growth family, member 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of ING3 mRNA

NCBI chr 4:51,439,218...51,469,502
Ensembl chr 4:51,443,763...51,470,951

G

inhibin subunit alpha

increases expression
multiple interactions
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of INHA mRNA
ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of INHA protein]
Dibutyl Phthalate results in decreased expression of INHA mRNA; Dibutyl Phthalate results in decreased expression of INHA protein

PMID:17379624 PMID:18214805 PMID:21266533 PMID:21745491 PMID:26472102 More...

NCBI chr 9:84,443,109...84,446,010
Ensembl chr 9:84,443,109...84,446,009

G

inhibin subunit beta A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of INHBA mRNA

NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508

G

inhibin subunit beta B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of INHBB mRNA

NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609

G

inka box actin regulator 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of INKA1 mRNA

NCBI chr 8:117,552,875...117,554,565
Ensembl chr 8:117,552,875...117,554,565

G

inositol polyphosphate-5-phosphatase A

increases expression

ISO

Dibutyl Phthalate results in increased expression of INPP5A mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:203,619,676...203,810,035
Ensembl chr 1:203,619,637...203,810,028

G

inositol polyphosphate-5-phosphatase E

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of INPP5E mRNA

NCBI chr 3:29,614,868...29,627,542
Ensembl chr 3:29,614,868...29,627,542

G

inositol polyphosphate-5-phosphatase J

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of INPP5J mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of INPP5J mRNA

PMID:21266533 PMID:39150890

NCBI chr14:82,597,789...82,608,930
Ensembl chr14:82,597,790...82,609,678

G

INSC, spindle orientation adaptor protein

increases expression

ISO

Dibutyl Phthalate results in increased expression of INSC mRNA

NCBI chr 1:178,427,360...178,534,827
Ensembl chr 1:178,427,423...178,535,047

G

insulin induced gene 1

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of INSIG1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of INSIG1 mRNA

PMID:15728792 PMID:21266533 PMID:21745491 PMID:31240115 PMID:33983380

NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778

G

insulin induced gene 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of INSIG2 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:35,025,160...35,052,937
Ensembl chr13:35,025,164...35,047,658

G

insulin-like 3

multiple interactions
increases expression
decreases expression

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate] results in decreased expression of INSL3; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of INSL3 mRNA; taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of INSL3 mRNA]; taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of INSL3 protein]
Dibutyl Phthalate results in increased expression of INSL3 protein
Dibutyl Phthalate results in decreased expression of INSL3 mRNA; Dibutyl Phthalate results in decreased expression of INSL3 protein

PMID:14687758 PMID:16037377 PMID:16102138 PMID:17379624 PMID:17400582 More...

NCBI chr16:18,432,668...18,434,539

G

integrator complex subunit 11

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of INTS11 mRNA

NCBI chr 5:171,761,370...171,779,883
Ensembl chr 5:171,761,371...171,779,883

G

integrator complex subunit 13

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of INTS13 protein

NCBI chr 4:181,190,438...181,222,235
Ensembl chr 4:181,189,765...181,222,235

G

integrator complex subunit 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of INTS5 mRNA

NCBI chr 1:215,218,012...215,222,790
Ensembl chr 1:215,218,017...215,223,240

G

integrator complex subunit 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of INTS6 mRNA

NCBI chr15:41,080,584...41,224,350
Ensembl chr15:41,109,125...41,197,519

G

inositol hexakisphosphate kinase 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of IP6K2 mRNA

NCBI chr 8:118,362,154...118,388,668
Ensembl chr 8:118,362,795...118,388,667

G

interaction protein for cytohesin exchange factors 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of IPCEF1 mRNA

NCBI chr 1:45,654,252...45,857,045
Ensembl chr 1:45,662,818...45,856,993

G

IQ motif containing GTPase activating protein 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of IQGAP2 mRNA

NCBI chr 2:28,629,558...28,904,649
Ensembl chr 2:28,629,558...28,904,649

G

inositol 1,4,5-triphosphate receptor associated 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of IRAG1 mRNA

NCBI chr 1:174,416,383...174,528,913
Ensembl chr 1:174,416,385...174,528,851

G

interleukin-1 receptor-associated kinase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of IRAK1 mRNA

NCBI chr X:156,919,927...156,929,825
Ensembl chr X:156,920,081...156,929,825

G

interleukin-1 receptor-associated kinase 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of IRAK2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:148,341,719...148,398,210

G

interleukin-1 receptor-associated kinase 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of IRAK4 mRNA

NCBI chr 7:127,561,777...127,588,762
Ensembl chr 7:127,561,717...127,597,109

G

interferon regulatory factor 1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of IRF1 mRNA
Dibutyl Phthalate results in decreased expression of IRF1 mRNA

NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947

G

interferon regulatory factor 2 binding protein 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRF2BP2 mRNA

NCBI chr19:71,456,689...71,462,368
Ensembl chr19:71,456,689...71,462,368

G

interferon regulatory factor 3

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of IRF3 mRNA

NCBI chr 1:104,616,608...104,621,402
Ensembl chr 1:104,616,469...104,621,401

G

interferon regulatory factor 6

increases expression

EXP

Dibutyl Phthalate results in increased expression of IRF6 mRNA

NCBI chr13:107,200,876...107,220,083
Ensembl chr13:107,200,731...107,220,049

G

interferon regulatory factor 8

increases expression

EXP

Dibutyl Phthalate results in increased expression of IRF8 mRNA

NCBI chr19:65,699,284...65,721,066
Ensembl chr19:65,699,284...65,721,062

G

immunity-related GTPase M

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGM1 mRNA

NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,732,961...33,743,228

G

immunity-related GTPase Q

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGQ mRNA

NCBI chr 1:89,251,846...89,259,799
Ensembl chr 1:89,239,205...89,259,799

G

insulin receptor substrate 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of IRS2 mRNA

PMID:17361019 PMID:17379624 PMID:21266533

NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543

G

iroquois homeobox 5

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of IRX5 promoter

NCBI chr19:30,812,033...30,816,885
Ensembl chr19:30,797,202...30,815,029

G

iron-sulfur cluster assembly 1

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ISCA1 mRNA
Dibutyl Phthalate results in increased expression of ISCA1 mRNA

NCBI chr17:4,910,816...4,923,478
Ensembl chr17:4,910,795...4,923,476

G

iron-sulfur cluster assembly 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ISCA2 promoter

NCBI chr 6:110,149,593...110,151,103
Ensembl chr14:71,931,399...71,934,660
Ensembl chr 6:71,931,399...71,934,660

G

ISG15 ubiquitin-like modifier

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ISG15 mRNA

NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:172,066,369...172,067,656

G

interferon stimulated exonuclease gene 20

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ISG20 mRNA
Dibutyl Phthalate results in decreased expression of ISG20 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401

G

isochorismatase domain containing 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of ISOC1 mRNA

NCBI chr18:54,356,757...54,377,170
Ensembl chr18:54,356,734...54,377,170

G

inositol-3-phosphate synthase 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of ISYNA1 mRNA

PMID:17361019 PMID:21266533

NCBI chr16:18,873,119...18,876,116
Ensembl chr16:18,873,121...18,875,955

G

integrin subunit alpha 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ITGA1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:48,379,181...48,545,336
Ensembl chr 2:48,386,249...48,545,284

G

integrin subunit alpha 11

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGA11 mRNA

NCBI chr 8:72,041,432...72,150,137
Ensembl chr 8:72,016,652...72,150,137

G

integrin subunit alpha 2

multiple interactions
decreases expression

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGA2 mRNA
Dibutyl Phthalate results in decreased expression of ITGA2 mRNA

PMID:38944327 PMID:39150890

NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509

G

integrin subunit alpha 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of ITGA3 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901

G

integrin subunit alpha 5

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ITGA5 mRNA

PMID:15829613 PMID:21266533 PMID:34902519

NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305

G

integrin subunit alpha 6

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of ITGA6 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:77,017,766...77,097,076

G

integrin subunit alpha 7

multiple interactions

EXP
ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ITGA7 promoter
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGA7 mRNA

PMID:23359474 PMID:39150890

NCBI chr 7:1,944,447...1,973,347
Ensembl chr 7:1,944,460...1,973,339

G

integrin subunit alpha V

increases expression
decreases expression

ISO

Dibutyl Phthalate results in increased expression of ITGAV mRNA
Dibutyl Phthalate results in decreased expression of ITGAV mRNA

PMID:21266533 PMID:34902519 PMID:38944327

NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511

G

integrin subunit beta 1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ITGB1 mRNA
Dibutyl Phthalate results in decreased expression of ITGB1 mRNA

PMID:21266533 PMID:34902519 PMID:38944327

NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269

G

integrin subunit beta 3

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of ITGB3 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGB3 mRNA

PMID:34902519 PMID:39150890

NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800

G

integrin subunit beta 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of ITGB6 mRNA

NCBI chr 3:65,454,964...65,579,179
Ensembl chr 3:65,456,713...65,530,333

G

integrin subunit beta 8

increases expression

ISO

Dibutyl Phthalate results in increased expression of ITGB8 mRNA

NCBI chr 6:146,267,982...146,351,245
Ensembl chr 6:146,165,484...146,351,245

G

inter-alpha trypsin inhibitor, heavy chain 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ITIH1 protein

NCBI chr16:6,128,696...6,142,813
Ensembl chr16:6,128,698...6,142,853

G

inter-alpha-trypsin inhibitor heavy chain 5

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITIH5 mRNA

NCBI chr17:73,161,886...73,261,930
Ensembl chr17:73,161,611...73,262,496

G

integral membrane protein 2C

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of ITM2C mRNA

NCBI chr 9:93,993,922...94,007,737
Ensembl chr 9:93,993,895...94,007,704

G

inosine triphosphatase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ITPA mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:138,338,549...138,350,329
Ensembl chr 3:138,338,349...138,350,329

G

inositol-tetrakisphosphate 1-kinase

increases expression

ISO

Dibutyl Phthalate results in increased expression of ITPK1 mRNA

NCBI chr 6:127,475,589...127,609,320
Ensembl chr 6:127,476,808...127,609,062

G

inositol-trisphosphate 3-kinase A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ITPKA mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:127,179,841...127,188,405
Ensembl chr 3:127,179,808...127,188,414

G

inositol 1,4,5-trisphosphate receptor, type 1

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of ITPR1 mRNA; Dibutyl Phthalate results in increased expression of ITPR1 protein
Ascorbic Acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ITPR1 mRNA]

PMID:21266533 PMID:32028152

NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504

G

inositol 1,4,5-trisphosphate receptor, type 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ITPR3 mRNA

NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,118,834...5,204,184

G

ITPR interacting domain containing 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of ITPRID2 mRNA

NCBI chr 3:84,943,572...84,980,993
Ensembl chr 3:84,939,808...84,980,899

G

inositol 1,4,5-trisphosphate receptor interacting protein

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of ITPRIP mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITPRIP mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr 1:256,704,087...256,727,661
Ensembl chr 1:256,699,832...256,727,644

G

intersectin 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of ITSN1 mRNA

NCBI chr11:44,464,515...44,646,598
Ensembl chr11:44,513,186...44,646,598

G

intersectin 2

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of ITSN2 mRNA
Dibutyl Phthalate results in increased expression of ITSN2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:33,336,086...33,446,818
Ensembl chr 6:33,336,441...33,446,818

G

isovaleryl-CoA dehydrogenase

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of IVD mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of IVD mRNA

PMID:17361019 PMID:21266533 PMID:30698749

NCBI chr 3:126,305,584...126,326,016
Ensembl chr 3:126,305,364...126,328,160

G

influenza virus NS1A binding protein

increases expression

EXP

Dibutyl Phthalate results in increased expression of IVNS1ABP mRNA

NCBI chr13:65,977,069...65,996,685
Ensembl chr13:65,977,045...65,997,547

G

iodotyrosine deiodinase

multiple interactions

ISO

Dibutyl Phthalate inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]

NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386

G

jagged canonical Notch ligand 1

multiple interactions
decreases expression
increases expression

EXP
ISO

Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in increased expression of JAG1 mRNA]; Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in increased expression of JAG1 protein]; Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in increased expression of JAG1 mRNA]; Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in increased expression of JAG1 protein]
3-methyladenine inhibits the reaction [Dibutyl Phthalate results in decreased expression of JAG1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of JAG1 mRNA
Dibutyl Phthalate results in increased expression of JAG1 mRNA; Dibutyl Phthalate results in increased expression of JAG1 protein

PMID:35378083 PMID:37277016 PMID:39150890

NCBI chr 3:144,859,453...144,894,883
Ensembl chr 3:144,859,453...144,894,872

G

jagged canonical Notch ligand 2

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of JAG2 mRNA
3-methyladenine inhibits the reaction [Dibutyl Phthalate results in decreased expression of JAG2 mRNA]

NCBI chr 6:137,804,133...137,826,738
Ensembl chr 6:137,804,133...137,826,738

G

jagunal homolog 1

affects expression

EXP

Dibutyl Phthalate affects the expression of JAGN1 mRNA

NCBI chr 4:148,147,213...148,151,915
Ensembl chr 4:148,147,229...148,151,915

G

Janus kinase 1

multiple interactions
increases expression

EXP

Resveratrol inhibits the reaction [Dibutyl Phthalate results in increased expression of JAK1 protein]

NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758

G

Janus kinase 2

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of JAK2 mRNA
[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in increased expression of JAK2 protein

PMID:21266533 PMID:38285958

NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762

G

junctional adhesion molecule 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of JAM2 mRNA

NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510

G

JAZF zinc finger 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of JAZF1 mRNA

NCBI chr 4:83,210,054...83,513,790
Ensembl chr 4:83,210,058...83,513,644

G

Jun dimerization protein 2

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of JDP2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:110,988,927...111,033,392
Ensembl chr 6:110,992,806...111,033,392

G

jumonji domain containing 6, arginine demethylase and lysine hydroxylase

increases expression

EXP

Dibutyl Phthalate results in increased expression of JMJD6 mRNA

NCBI chr10:102,539,935...102,545,986
Ensembl chr10:102,539,894...102,545,986

G

jumonji domain containing 7

increases expression

ISO

Dibutyl Phthalate results in increased expression of JMJD7 mRNA

NCBI chr 3:127,452,238...127,458,326
Ensembl chr 3:127,452,255...127,458,325

G

junction mediating and regulatory protein, p53 cofactor

increases expression

ISO

Dibutyl Phthalate results in increased expression of JMY mRNA

NCBI chr 2:26,401,047...26,465,959
Ensembl chr 2:26,409,969...26,465,649

G

Josephin domain containing 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of JOSD1 mRNA

NCBI chr 7:113,110,709...113,124,632
Ensembl chr 7:113,110,717...113,124,632

G

junctophilin 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of JPH2 mRNA

NCBI chr 3:172,414,246...172,478,678
Ensembl chr 3:172,414,256...172,478,348

G

junctophilin 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of JPH3 mRNA

NCBI chr19:66,702,497...66,763,948
Ensembl chr19:66,702,680...66,763,937

G

Jupiter microtubule associated homolog 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of JPT1 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:101,243,428...101,261,464
Ensembl chr10:101,243,424...101,261,469

G

Jupiter microtubule associated homolog 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of JPT2 mRNA

NCBI chr10:14,467,652...14,487,769
Ensembl chr10:14,467,661...14,535,664

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression
increases phosphorylation
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of JUN mRNA
Dibutyl Phthalate results in increased phosphorylation of JUN protein
[Iodine co-treated with Dibutyl Phthalate] results in increased phosphorylation of and results in increased activity of JUN protein

PMID:21266533 PMID:29385629 PMID:32738922

NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285

G

JunB proto-oncogene, AP-1 transcription factor subunit

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of JUNB mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of JUNB mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218

G

junction plakoglobin

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of JUP mRNA

PMID:17361019 PMID:21266533

NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,800,814...85,827,429

G

KN motif and ankyrin repeat domains 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of KANK1 mRNA

NCBI chr 1:232,381,720...232,500,834
Ensembl chr 1:232,445,658...232,500,839

G

KN motif and ankyrin repeat domains 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of KANK3 mRNA

NCBI chr 7:15,296,538...15,309,838
Ensembl chr 7:15,296,585...15,311,408

G

KN motif and ankyrin repeat domains 4

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KANK4 mRNA

NCBI chr 5:118,516,994...118,581,024
Ensembl chr 5:118,517,971...118,581,002

G

lysine acetyltransferase 2A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KAT2A mRNA

NCBI chr10:86,132,535...86,140,877
Ensembl chr10:86,132,535...86,140,485

G

lysine acetyltransferase 2B

increases expression

ISO

Dibutyl Phthalate results in increased expression of KAT2B mRNA

NCBI chr 9:6,799,101...6,903,616
Ensembl chr 9:6,799,145...6,903,616

G

lysine acetyltransferase 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KAT5 mRNA

NCBI chr 1:212,325,089...212,332,640
Ensembl chr 1:212,325,090...212,332,587

G

lysine acetyltransferase 6A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KAT6A mRNA

NCBI chr16:75,787,411...75,868,584
Ensembl chr16:75,787,411...75,866,099

G

Kazal-type serine peptidase inhibitor domain 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KAZALD1 mRNA

NCBI chr 1:253,888,639...253,892,211
Ensembl chr 1:253,888,783...253,892,305

G

kazrin, periplakin interacting protein

increases expression

EXP

Dibutyl Phthalate results in increased expression of KAZN mRNA

NCBI chr 5:159,675,803...160,666,084
Ensembl chr 5:159,675,803...160,664,154

G

kelch repeat and BTB domain containing 11

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KBTBD11 mRNA

NCBI chr16:81,318,596...81,340,334
Ensembl chr16:81,313,093...81,340,390

G

kelch repeat and BTB domain containing 13

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KBTBD13 mRNA

NCBI chr 8:74,804,981...74,806,718

G

kelch repeat and BTB domain containing 4

increases expression
decreases expression

EXP

Dibutyl Phthalate results in increased expression of KBTBD4 mRNA
Dibutyl Phthalate results in decreased expression of KBTBD4 mRNA

NCBI chr 3:97,339,500...97,345,599
Ensembl chr 3:97,339,084...97,345,598

G

potassium voltage-gated channel subfamily A member 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of KCNA6 mRNA

PMID:17361019 PMID:21266533

NCBI chr 4:161,229,103...161,262,352
Ensembl chr 4:161,191,961...161,263,240

G

potassium voltage-gated channel subfamily E regulatory subunit 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KCNE1 mRNA

NCBI chr11:45,066,875...45,080,024
Ensembl chr11:45,064,162...45,081,247

G

potassium voltage-gated channel subfamily H member 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of KCNH1 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:106,253,101...106,555,712
Ensembl chr13:106,253,213...106,555,710

G

potassium voltage-gated channel subfamily H member 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KCNH2 mRNA

NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421

G

potassium inwardly-rectifying channel, subfamily J, member 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of KCNJ2 promoter

NCBI chr10:96,560,225...96,570,788
Ensembl chr10:96,565,600...96,570,901

G

potassium inwardly-rectifying channel, subfamily J, member 5

increases expression

ISO

Dibutyl Phthalate results in increased expression of KCNJ5 mRNA

NCBI chr 8:38,981,598...39,011,197
Ensembl chr 8:38,983,034...39,011,101

G

potassium two pore domain channel subfamily K member 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of KCNK2 mRNA

NCBI chr13:103,297,387...103,494,686
Ensembl chr13:103,297,393...103,494,686

G

potassium two pore domain channel subfamily K member 5

increases expression

ISO

Dibutyl Phthalate results in increased expression of KCNK5 mRNA

PMID:17361019 PMID:21266533

NCBI chr15:4,171,625...4,213,896
Ensembl chr15:4,171,610...4,213,897

G

potassium two pore domain channel subfamily K member 6

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of KCNK6 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:93,652,888...93,661,419

G

potassium calcium-activated channel subfamily M alpha 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KCNMA1 mRNA

NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117

G

potassium calcium-activated channel subfamily M regulatory beta subunit 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of KCNMB1 mRNA

NCBI chr10:19,062,014...19,119,005
Ensembl chr10:19,062,291...19,073,204

G

potassium calcium-activated channel subfamily M regulatory beta subunit 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KCNMB4 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:53,952,150...54,005,101
Ensembl chr 7:53,949,881...54,005,281

G

potassium calcium-activated channel subfamily N member 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of KCNN2 promoter

NCBI chr18:40,004,693...40,445,043
Ensembl chr18:40,155,939...40,445,045

G

potassium calcium-activated channel subfamily N member 3

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of KCNN3 promoter

NCBI chr 2:177,227,276...177,378,849
Ensembl chr 2:177,234,327...177,379,693

G

potassium voltage-gated channel, modifier subfamily S, member 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KCNS2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:67,907,492...67,913,562
Ensembl chr 7:67,906,467...67,931,276

G

potassium sodium-activated channel subfamily T member 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of KCNT1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 3:29,081,071...29,136,902
Ensembl chr 3:29,081,321...29,134,768

G

potassium channel tetramerization domain containing 10

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of KCTD10 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KCTD10 mRNA

PMID:21266533 PMID:39150890

NCBI chr12:47,890,777...47,909,391
Ensembl chr12:47,890,819...47,909,390

G

potassium channel tetramerization domain containing 11

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KCTD11 mRNA

NCBI chr10:55,101,292...55,103,455
Ensembl chr10:55,100,801...55,103,583

G

potassium channel tetramerization domain containing 14

increases expression
decreases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of KCTD14 mRNA
Dibutyl Phthalate results in decreased expression of KCTD14 mRNA

NCBI chr 1:161,172,906...161,177,914
Ensembl chr 1:161,171,451...161,178,413

G

potassium channel tetramerization domain containing 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KCTD3 mRNA

NCBI chr13:103,041,488...103,080,069
Ensembl chr13:103,041,490...103,080,009

G

KDEL endoplasmic reticulum protein retention receptor 3

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of KDELR3 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KDELR3 mRNA

PMID:21266533 PMID:39150890

NCBI chr 7:112,959,632...112,969,858
Ensembl chr 7:112,959,718...112,969,858

G

lysine demethylase 2B

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of KDM2B promoter

NCBI chr12:39,224,422...39,362,126
Ensembl chr12:39,235,301...39,362,127

G

lysine demethylase 3B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KDM3B mRNA

NCBI chr18:26,655,004...26,710,814
Ensembl chr18:26,655,687...26,710,814

G

lysine demethylase 4A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KDM4A mRNA

NCBI chr 5:136,958,178...137,004,942
Ensembl chr 5:136,958,178...137,004,951

G

lysine demethylase 7A

increases expression

ISO

Dibutyl Phthalate results in increased expression of KDM7A mRNA

NCBI chr 4:68,866,263...68,992,979
Ensembl chr 4:68,871,677...68,931,506

G

kinase insert domain receptor

affects expression

ISO

Dibutyl Phthalate affects the expression of KDR mRNA

NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192

G

Kelch-like ECH-associated protein 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of KEAP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042

G

keratocan

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KERA mRNA

NCBI chr 7:34,284,100...34,291,555
Ensembl chr 7:34,284,100...34,291,555

G

alpha-ketoglutarate dehydrogenase subunit 4

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of KGD4 mRNA
Dibutyl Phthalate results in decreased expression of MRPS36 mRNA

NCBI chr 2:33,604,611...33,614,988
Ensembl chr 2:33,604,613...33,615,095

G

KH domain containing 4, pre-mRNA splicing factor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KHDC4 mRNA

NCBI chr 2:176,446,895...176,475,405
Ensembl chr 2:176,446,910...176,475,392

G

ketohexokinase

increases expression

EXP

Dibutyl Phthalate results in increased expression of KHK mRNA

NCBI chr 6:31,165,246...31,175,779
Ensembl chr 6:31,165,248...31,175,481

G

KH and NYN domain containing

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of SDR39U1 mRNA

NCBI chr15:33,335,290...33,349,553
Ensembl chr15:33,335,274...33,349,552

G

kinesin family member 15

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of KIF15 mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of KIF15 mRNA]

PMID:17361019 PMID:21266533 PMID:36828243

NCBI chr 8:131,479,340...131,550,209
Ensembl chr 8:131,479,337...131,550,202

G

kinesin family member 17

increases expression

ISO

Dibutyl Phthalate results in increased expression of KIF17 mRNA

NCBI chr 5:155,765,592...155,802,941
Ensembl chr 5:155,765,592...155,803,247

G

kinesin family member 18B

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of KIF18B mRNA

NCBI chr10:88,370,520...88,392,388
Ensembl chr10:88,370,524...88,389,691

G

kinesin family member 1A

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of KIF1A mRNA

NCBI chr 9:101,010,447...101,094,891
Ensembl chr 9:101,010,447...101,094,777

G

kinesin family member 1B

increases expression

ISO

Dibutyl Phthalate results in increased expression of KIF1B mRNA

NCBI chr 5:164,890,778...165,025,848
Ensembl chr 5:164,894,763...165,008,841

G

kinesin family member 20A

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of KIF20A mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of KIF20A mRNA]

PMID:21266533 PMID:36828243

NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909

G

kinesin family member 21B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KIF21B mRNA

PMID:17361019 PMID:21266533

NCBI chr13:50,127,842...50,177,822
Ensembl chr13:50,127,842...50,177,822

G

kinesin family member 22

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KIF22 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:191,065,875...191,080,955
Ensembl chr 1:191,065,875...191,080,878

G

kinesin family member 24

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KIF24 mRNA

NCBI chr 5:61,357,078...61,423,882
Ensembl chr 5:61,357,940...61,399,379

G

kinesin family member 26A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KIF26A mRNA

NCBI chr 6:137,035,986...137,072,027
Ensembl chr 6:137,033,789...137,072,022

G

kinesin family member 2A

increases expression
affects expression

EXP

Dibutyl Phthalate results in increased expression of KIF2A mRNA
Dibutyl Phthalate affects the expression of KIF2A mRNA

PMID:21266533 PMID:30934153

NCBI chr 2:40,101,548...40,164,780
Ensembl chr 2:40,101,548...40,186,618

G

kinesin family member 2C

decreases expression
increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of KIF2C mRNA
Dibutyl Phthalate results in increased expression of KIF2C mRNA
N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of KIF2C mRNA]

PMID:21266533 PMID:36828243

NCBI chr 5:135,873,925...135,899,267
Ensembl chr 5:135,873,925...135,899,212

G

kinesin family member 3C

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KIF3C mRNA

NCBI chr 6:32,086,879...32,125,812
Ensembl chr 6:32,086,124...32,126,066

G

kinesin family member 5A

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5A mRNA

NCBI chr 7:64,937,210...64,974,339
Ensembl chr 7:64,934,740...64,978,272

G

kinesin family member 5C

multiple interactions

EXP
ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5C mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5C mRNA

PMID:31199487 PMID:39150890

NCBI chr 3:54,441,266...54,591,630
Ensembl chr 3:54,441,310...54,594,813

G

kinesin family member 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of KIF6 mRNA

NCBI chr 9:18,573,925...18,870,789
Ensembl chr 9:18,573,789...18,870,729

G

kinesin family member C1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KIFC1 mRNA

NCBI chr20:5,000,929...5,018,967
Ensembl chr20:5,000,648...5,018,988

G

kirre like nephrin family adhesion molecule 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of KIRREL1 mRNA

NCBI chr 2:174,819,564...174,912,998
Ensembl chr 2:174,819,572...174,912,960

G

KiSS-1 metastasis-suppressor

increases expression

EXP

Dibutyl Phthalate results in increased expression of KISS1 mRNA

NCBI chr13:47,327,159...47,332,759
Ensembl chr13:47,327,004...47,332,906

G

KISS1 receptor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KISS1R mRNA

NCBI chr 7:10,435,766...10,439,424
Ensembl chr 7:10,435,766...10,439,424

G

KIT proto-oncogene receptor tyrosine kinase

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of KIT mRNA; Dibutyl Phthalate results in decreased expression of KIT protein
resveratrol inhibits the reaction [Dibutyl Phthalate results in decreased expression of KIT protein]

PMID:21745491 PMID:24285609

NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812

G

KIT ligand

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of KITLG mRNA
Dibutyl Phthalate results in increased expression of KITLG protein

NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793

G

KLF transcription factor 10

increases expression

EXP

Dibutyl Phthalate results in increased expression of KLF10 mRNA

NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:71,350,573...71,358,948

G

KLF transcription factor 11

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KLF11 mRNA

NCBI chr 6:47,014,312...47,026,152
Ensembl chr 6:47,014,326...47,037,044

G

KLF transcription factor 3

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of KLF3 mRNA

PMID:17361019 PMID:21266533

NCBI chr14:43,828,387...43,859,418
Ensembl chr14:43,828,387...43,850,826

G

KLF transcription factor 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of KLF4 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592

G

KLF transcription factor 5

increases expression

EXP

Dibutyl Phthalate results in increased expression of KLF5 mRNA

NCBI chr15:82,472,081...82,487,267
Ensembl chr15:82,472,065...82,487,262

G

KLF transcription factor 6

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of KLF6 mRNA

NCBI chr17:69,449,483...69,458,478
Ensembl chr17:69,441,493...69,498,601

G

KLF transcription factor 7

increases expression

ISO

Dibutyl Phthalate results in increased expression of KLF7 mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:72,927,485...73,020,167
Ensembl chr 9:72,933,136...73,020,056

G

KLF transcription factor 9

increases expression

ISO

Dibutyl Phthalate results in increased expression of KLF9 mRNA

NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641

G

kelch domain containing 10

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KLHDC10 mRNA

NCBI chr 4:59,988,710...60,046,518
Ensembl chr 4:59,988,646...60,046,516

G

kelch domain containing 3

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of KLHDC3 promoter

NCBI chr 9:21,799,870...21,806,337
Ensembl chr 9:21,799,729...21,806,334

G

kelch domain containing 8A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KLHDC8A mRNA

NCBI chr13:46,287,011...46,296,429
Ensembl chr13:46,288,344...46,296,429

G

kelch-like family member 14

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of KLHL14 promoter

NCBI chr18:13,079,159...13,192,728
Ensembl chr18:13,079,159...13,193,557

G

kelch-like family member 22

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KLHL22 mRNA

NCBI chr11:96,695,168...96,736,079
Ensembl chr11:96,695,171...96,738,065

G

kelch-like family member 23

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KLHL23 mRNA

NCBI chr 3:74,988,778...75,002,347
Ensembl chr 3:74,988,704...75,024,200

G

kelch-like family member 24

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of KLHL24 mRNA
Dibutyl Phthalate results in decreased expression of KLHL24 mRNA

PMID:21266533 PMID:24893172

NCBI chr11:94,348,024...94,382,085
Ensembl chr11:94,351,157...94,382,050

G

kelch-like family member 25

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KLHL25 mRNA

NCBI chr 1:139,134,655...139,159,898
Ensembl chr 1:139,122,977...139,165,970

G

kelch-like family member 38

increases expression

EXP

Dibutyl Phthalate results in increased expression of KLHL38 mRNA

NCBI chr 7:91,744,634...91,753,843
Ensembl chr 7:91,734,345...91,753,826

G

kelch-like family member 40

increases expression

EXP

Dibutyl Phthalate results in increased expression of KLHL40 mRNA

NCBI chr 8:130,318,793...130,324,309
Ensembl chr 8:130,318,794...130,326,299

G

kallikrein 1-related peptidase C10

increases secretion

ISO

Dibutyl Phthalate results in increased secretion of KLK3 protein

NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586

G

kallikrein B1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KLKB1 mRNA

PMID:17361019 PMID:21266533

NCBI chr16:53,690,180...53,714,570
Ensembl chr16:53,691,220...53,716,339

G

lysine methyltransferase 2A

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KMT2A mRNA

NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:54,013,547...54,089,317

G

lysine methyltransferase 2C

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KMT2C mRNA

NCBI chr 4:10,353,698...10,755,965
Ensembl chr 4:10,353,735...10,568,620

G

lysine methyltransferase 2E

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of KMT2E mRNA

NCBI chr 4:12,550,570...12,655,329
Ensembl chr 4:12,550,570...12,619,721

G

lysine methyltransferase 5A

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of KMT5A mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KMT5A mRNA

PMID:21266533 PMID:39150890

NCBI chr12:37,800,339...37,823,706
Ensembl chr12:37,800,344...37,823,783

G

kininogen 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of KNG2 mRNA

NCBI chr11:91,418,470...91,440,841
Ensembl chr11:91,414,207...91,441,259

G

kinetochore scaffold 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KNL1 mRNA

NCBI chr 3:126,483,498...126,545,774
Ensembl chr 3:126,483,544...126,545,774

G

kinetochore-localized astrin/SPAG5 binding protein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of KNSTRN mRNA

NCBI chr 3:126,254,633...126,274,412
Ensembl chr 3:126,254,663...126,274,418

G

karyopherin subunit alpha 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of KPNA1 mRNA

NCBI chr11:78,221,165...78,279,778
Ensembl chr11:78,222,884...78,267,067

G

karyopherin subunit alpha 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KPNA2 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:92,433,678...92,445,841
Ensembl chr10:92,433,679...92,445,937

G

karyopherin subunit alpha 6

increases expression

EXP

Dibutyl Phthalate results in increased expression of KPNA6 mRNA

NCBI chr 5:147,272,466...147,307,523
Ensembl chr 5:147,275,918...147,305,851

G

karyopherin subunit alpha 7

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KPNA7 mRNA

NCBI chr12:14,690,124...14,728,478
Ensembl chr12:14,686,886...14,726,604

G

KRAB-A domain containing 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of KRBA1 mRNA

NCBI chr 4:78,672,384...78,693,984
Ensembl chr 4:78,672,400...78,693,987

G

KRR1, small subunit processome component homolog

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KRR1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:49,361,794...49,374,222
Ensembl chr 7:49,361,901...49,374,216

G

keratin 13

increases expression

ISO

Dibutyl Phthalate results in increased expression of KRT13 mRNA

NCBI chr10:85,552,287...85,556,499
Ensembl chr10:85,552,287...85,556,499

G

keratin 14

increases expression

ISO

Dibutyl Phthalate results in increased expression of KRT14 mRNA

NCBI chr10:85,638,182...85,642,450

G

keratin 18

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of KRT18 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KRT18 mRNA

PMID:21266533 PMID:39150890

NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848
Ensembl chr10:135,035,982...135,039,848

G

keratin 19

increases expression

ISO

Dibutyl Phthalate results in increased expression of KRT19 mRNA

NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952

G

keratin 7

decreases expression
increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of KRT7 protein
Dibutyl Phthalate results in increased expression of KRT7 mRNA
HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate results in decreased expression of KRT7 protein]

PMID:21266533 PMID:22552774 PMID:24893172

NCBI chr 7:134,407,626...134,423,787
Ensembl chr 7:134,407,584...134,423,786

G

keratin 72

increases expression

ISO

Dibutyl Phthalate results in increased expression of KRT72 mRNA

NCBI chr 7:134,789,082...134,799,547
Ensembl chr 7:134,789,082...134,799,547

G

keratin 8

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of KRT8 mRNA
Dibutyl Phthalate results in increased expression of KRT8 protein

PMID:21266533 PMID:34864091

NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403

G

keratin associated protein 1-1

increases expression

EXP

Dibutyl Phthalate results in increased expression of KRTAP1-5 mRNA

NCBI chr10:85,041,910...85,042,476
Ensembl chr10:85,041,910...85,042,476

G

keratin associated protein 13

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KRTAP13 mRNA

NCBI chr11:41,561,053...41,561,595
Ensembl chr11:41,561,071...41,561,595

G

keratin associated protein 8-1

increases expression

ISO

Dibutyl Phthalate results in increased expression of KRTAP8-1 mRNA

NCBI chr11:42,204,006...42,204,563
Ensembl chr11:42,204,006...42,204,563

G

keratinocyte associated protein 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KRTCAP2 mRNA

NCBI chr 2:176,952,167...176,956,163
Ensembl chr 2:176,949,809...176,956,163

G

kinase suppressor of ras 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KSR1 mRNA

NCBI chr10:64,459,786...64,596,083
Ensembl chr10:64,459,786...64,596,082

G

kyphoscoliosis peptidase

increases expression

EXP

Dibutyl Phthalate results in increased expression of KY mRNA

NCBI chr 8:111,965,862...112,005,206
Ensembl chr 8:111,965,862...112,005,206

G

kynurenine aminotransferase 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of KYAT3 mRNA

NCBI chr 2:234,362,306...234,407,646
Ensembl chr 2:234,362,322...234,407,878

G

L1 cell adhesion molecule

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of L1CAM protein

PMID:31199487 PMID:37690569

NCBI chr X:156,748,597...156,775,116
Ensembl chr X:156,748,597...156,775,077

G

trans-L-3-hydroxyproline dehydratase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of L3HYPDH mRNA

NCBI chr 6:96,372,243...96,383,039

G

L antigen family, member 3

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of LAGE3 mRNA

NCBI chr X:157,289,497...157,290,920

G

laminin subunit alpha 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LAMA1 mRNA

NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:115,139,548...115,264,251

G

laminin subunit alpha 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of LAMA2 mRNA

NCBI chr 1:19,492,126...20,140,056
Ensembl chr 1:19,244,599...20,140,056

G

laminin subunit alpha 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LAMA3 mRNA

PMID:17361019 PMID:21266533

NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449

G

laminin subunit gamma 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of LAMC1 mRNA

NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986

G

lysosomal-associated membrane protein 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of LAMP2 mRNA

NCBI chr X:122,038,734...122,087,745
Ensembl chr X:121,922,187...122,087,675

G

late endosomal/lysosomal adaptor, MAPK and MTOR activator 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of LAMTOR2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:176,306,353...176,310,617
Ensembl chr 2:176,306,280...176,310,730

G

late endosomal/lysosomal adaptor, MAPK and MTOR activator 3

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of LAMTOR3 mRNA
Dibutyl Phthalate results in increased expression of LAMTOR3 mRNA

NCBI chr 2:229,084,795...229,097,028
Ensembl chr 2:229,084,858...229,099,383

G

late endosomal/lysosomal adaptor, MAPK and MTOR activator 4

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LAMTOR4 mRNA

NCBI chr12:22,372,269...22,376,090
Ensembl chr12:22,372,269...22,376,090

G

late endosomal/lysosomal adaptor, MAPK and MTOR activator 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LAMTOR5 mRNA

NCBI chr 2:197,588,242...197,593,598
Ensembl chr 2:197,588,242...197,593,598

G

lysosomal protein transmembrane 5

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LAPTM5 mRNA

NCBI chr 5:148,371,880...148,393,927
Ensembl chr 5:148,339,435...148,393,927

G

LARGE xylosyl- and glucuronyltransferase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LARGE1 mRNA

NCBI chr19:11,609,004...12,057,174
Ensembl chr19:11,609,004...12,054,707

G

La ribonucleoprotein 1, translational regulator

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LARP1 mRNA

NCBI chr10:42,691,833...42,746,816
Ensembl chr10:42,691,600...42,746,816

G

La ribonucleoprotein 7, transcriptional regulator

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LARP7 mRNA

NCBI chr 2:218,672,145...218,687,332
Ensembl chr 2:218,672,208...218,687,308

G

leucyl-tRNA synthetase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of LARS1 mRNA

NCBI chr18:34,452,567...34,507,030
Ensembl chr18:34,452,561...34,506,938

G

LIM and SH3 protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of LASP1 mRNA

NCBI chr10:83,290,820...83,331,989
Ensembl chr10:83,290,865...83,331,988

G

large tumor suppressor kinase 2

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of LATS2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LATS2 mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr15:35,940,632...35,992,225
Ensembl chr15:35,940,632...35,980,842

G

LBH regulator of WNT signaling pathway

increases expression

ISO

Dibutyl Phthalate results in increased expression of LBH mRNA

NCBI chr 6:28,321,040...28,344,855
Ensembl chr 6:28,321,040...28,370,238

G

leucine carboxyl methyltransferase 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of LCMT1 mRNA

NCBI chr 1:187,335,173...187,391,195
Ensembl chr 1:187,327,706...187,391,516

G

lipocalin 2

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of LCN2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LCN2 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA

PMID:21266533 PMID:31199487 PMID:38954831

NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842

G

lymphocyte cytosolic protein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of LCP1 mRNA

NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092

G

LIM domain binding 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of LDB1 promoter

NCBI chr 1:254,813,161...254,838,931
Ensembl chr 1:254,826,160...254,838,998

G

LIM domain binding 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of LDB3 mRNA

NCBI chr16:9,862,161...9,926,338
Ensembl chr16:9,862,161...9,926,985

G

lactate dehydrogenase A

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of LDHA mRNA
Dibutyl Phthalate results in increased expression of LDHA protein

PMID:17379624 PMID:18923996 PMID:21266533 PMID:36736749

NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521

G

lactate dehydrogenase C

affects expression

ISO

Dibutyl Phthalate affects the expression of LDHC mRNA

NCBI chr 1:106,522,140...106,539,649
Ensembl chr 1:106,522,236...106,542,802

G

low density lipoprotein receptor

increases expression
multiple interactions
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of LDLR mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of LDLR mRNA
Dibutyl Phthalate results in decreased expression of LDLR mRNA

PMID:15728792 PMID:21266533 PMID:21745491 PMID:33983380 PMID:35739755

NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675

G

low density lipoprotein receptor adaptor protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of LDLRAP1 mRNA

NCBI chr 5:152,239,296...152,262,290
Ensembl chr 5:152,229,505...152,262,290

G

lymphoid enhancer binding factor 1

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of LEF1 mRNA
Dibutyl Phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]; HDAC6 mutant form inhibits the reaction [Dibutyl Phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]; trichostatin A inhibits the reaction [Dibutyl Phthalate promotes the reaction [[TCF4 protein binds to LEF1 protein] which binds to VIM protein]]

PMID:21266533 PMID:22552774

NCBI chr 2:222,340,541...222,453,931
Ensembl chr 2:222,340,704...222,453,929

G

LEO1 homolog, Paf1/RNA polymerase II complex component

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LEO1 mRNA

NCBI chr 8:85,080,036...85,104,471
Ensembl chr 8:85,079,996...85,105,094

G

leptin

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LEP protein

NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661

G

leptin receptor

increases expression

EXP

Dibutyl Phthalate results in increased expression of LEPR mRNA

NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215

G

leptin receptor overlapping transcript

increases expression
decreases expression

ISO

Dibutyl Phthalate results in increased expression of LEPROT mRNA
Dibutyl Phthalate results in decreased expression of LEPROT mRNA

NCBI chr 5:121,405,170...121,417,273
Ensembl chr 5:121,404,759...121,417,275

G

leptin receptor overlapping transcript-like 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of LEPROTL1 mRNA

NCBI chr16:64,744,148...64,756,776
Ensembl chr16:64,743,717...64,756,776

G

LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase

increases expression

ISO

Dibutyl Phthalate results in increased expression of LFNG mRNA

PMID:17361019 PMID:21266533

NCBI chr12:19,144,474...19,152,951
Ensembl chr12:19,124,662...19,152,918

G

galectin 7

increases expression

ISO

Dibutyl Phthalate results in increased expression of LGALS7 mRNA

NCBI chr 1:93,275,092...93,279,529
Ensembl chr 1:93,273,836...93,279,528

G

legumain

increases expression

ISO

Dibutyl Phthalate results in increased expression of LGMN mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:127,308,913...127,347,355
Ensembl chr 6:127,308,913...127,347,328

G

leucine-rich repeat-containing G protein-coupled receptor 4

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of LGR4 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LGR4 mRNA

PMID:21266533 PMID:39150890

NCBI chr 3:116,901,968...117,004,584
Ensembl chr 3:116,901,968...117,004,153

G

leucine-rich repeat-containing G protein-coupled receptor 6

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LGR6 mRNA

NCBI chr13:48,976,193...49,095,870
Ensembl chr13:48,976,193...49,095,857

G

luteinizing hormone subunit beta

increases expression
affects expression
decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of LHB protein
Dibutyl Phthalate affects the expression of LHB protein
Dibutyl Phthalate results in decreased expression of LHB protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased secretion of LHB protein; [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased secretion of LHB protein; ginsenoside Rg1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of LHB protein]
Dibutyl Phthalate results in decreased expression of LHB mRNA

PMID:22489061 PMID:24753613 PMID:28528174 PMID:33331133 PMID:34280466 More...

NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445

G

luteinizing hormone/choriogonadotropin receptor

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of LHCGR mRNA; Dibutyl Phthalate results in decreased expression of LHCGR protein

PMID:15620428 PMID:15728792 PMID:21266533 PMID:21745491 PMID:25434310 More...

NCBI chr 6:11,415,361...11,480,834
Ensembl chr 6:11,415,415...11,478,061

G

LHFPL tetraspan subfamily member 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of LHFPL2 mRNA

NCBI chr 2:27,016,404...27,169,830
Ensembl chr 2:27,016,700...27,162,859

G

phospholysine phosphohistidine inorganic pyrophosphate phosphatase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LHPP mRNA

NCBI chr 1:196,833,516...196,924,687
Ensembl chr 1:196,833,523...196,924,871

G

LIM homeobox 4

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of LHX4 promoter

NCBI chr13:70,423,768...70,477,337
Ensembl chr13:70,427,399...70,467,505

G

LIM homeobox 6

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of LHX6 promoter

NCBI chr 3:39,829,846...39,853,681
Ensembl chr 3:39,830,990...39,853,559

G

LIM homeobox 9

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LHX9 mRNA

NCBI chr13:52,941,207...52,961,436
Ensembl chr13:52,941,210...52,962,266

G

lipoic acid synthetase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LIAS mRNA

NCBI chr14:43,230,369...43,247,469
Ensembl chr14:43,230,375...43,247,423

G

DNA ligase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LIG1 mRNA

NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708

G

DNA ligase 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LIG3 mRNA

NCBI chr10:68,215,371...68,238,705
Ensembl chr10:68,215,407...68,238,704

G

LIM domain and actin binding 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of LIMA1 mRNA

NCBI chr 7:132,780,556...132,880,343
Ensembl chr 7:132,780,556...132,880,386

G

LIM and calponin homology domains 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of LIMCH1 mRNA

NCBI chr14:41,466,433...41,779,477
Ensembl chr14:41,466,433...41,778,837

G

LIM domain containing 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LIMD2 mRNA

NCBI chr10:91,590,079...91,592,747
Ensembl chr10:91,590,082...91,592,439

G

LIM domain kinase 2

multiple interactions
increases phosphorylation

EXP

Y 27632 inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of LIMK2 protein]

NCBI chr14:82,384,256...82,509,755
Ensembl chr14:82,435,480...82,509,644

G

LIM zinc finger domain containing 1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of LIMS1 mRNA
Dibutyl Phthalate results in decreased expression of LIMS1 mRNA

PMID:17361019 PMID:21266533 PMID:24893172

NCBI chr20:26,851,364...26,961,607
Ensembl chr20:26,852,996...26,961,606

G

lin-7 homolog B, crumbs cell polarity complex component

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LIN7B mRNA

NCBI chr 1:104,983,368...104,986,795
Ensembl chr 1:104,982,771...104,986,078

G

lipase A, lysosomal acid type

increases expression

EXP

Dibutyl Phthalate results in increased expression of LIPA mRNA

NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:241,437,524...241,470,740

G

lipase E, hormone sensitive type

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LIPE mRNA

NCBI chr 1:90,093,433...90,112,117
Ensembl chr 1:90,093,433...90,112,117

G

lipase G, endothelial type

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of LIPG mRNA
Dibutyl Phthalate results in decreased expression of LIPG mRNA

NCBI chr18:70,790,077...70,811,259
Ensembl chr18:70,790,077...70,812,260

G

lipoyl(octanoyl) transferase 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LIPT2 mRNA

NCBI chr 1:163,916,695...163,919,022
Ensembl chr 1:163,916,695...163,919,022

G

lipopolysaccharide-induced TNF factor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LITAF mRNA

NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930

G

LLGL scribble cell polarity complex component 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of LLGL1 mRNA

NCBI chr10:45,878,936...45,893,609
Ensembl chr10:45,879,012...45,893,603

G

leishmanolysin like peptidase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LMLN mRNA

NCBI chr11:81,161,330...81,230,972
Ensembl chr11:81,161,330...81,229,447

G

lamin A/C

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of LMNA mRNA

NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072

G

LIM domain only 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LMO2 mRNA

NCBI chr 3:110,810,162...110,832,895
Ensembl chr 3:110,809,912...110,833,075

G

LIM domain only 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LMO3 mRNA

NCBI chr 4:172,965,944...173,028,980
Ensembl chr 4:172,965,951...173,025,156

G

LIM domain only 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of LMO4 mRNA

NCBI chr 2:235,924,574...235,941,609
Ensembl chr 2:235,924,403...235,941,275

G

leiomodin 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of LMOD1 mRNA

NCBI chr13:49,305,693...49,347,970
Ensembl chr13:49,305,830...49,348,116

G

leucyl and cystinyl aminopeptidase

increases expression

ISO

Dibutyl Phthalate results in increased expression of LNPEP mRNA

NCBI chr 1:66,931,712...67,027,610
Ensembl chr 1:66,931,712...67,027,610

G

LON peptidase N-terminal domain and ring finger 2

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA

NCBI chr 9:48,524,962...48,566,353
Ensembl chr 9:48,530,549...48,570,807

G

LON peptidase N-terminal domain and ring finger 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LONRF3 mRNA

NCBI chr X:120,430,975...120,469,648
Ensembl chr X:120,430,996...120,464,572

G

loricrin cornified envelope precursor protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LORICRIN mRNA

NCBI chr 2:180,253,674...180,256,572
Ensembl chr 2:180,253,674...180,256,572

G

lysyl oxidase

increases expression

EXP

Dibutyl Phthalate results in increased expression of LOX mRNA

NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810

G

lysyl oxidase-like 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of LOXL2 mRNA

NCBI chr15:51,091,547...51,182,843
Ensembl chr15:51,069,997...51,182,842

G

lysophosphatidic acid receptor 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LPAR1 mRNA

PMID:21266533 PMID:24893172

NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:78,024,139...78,142,188

G

lysophosphatidic acid receptor 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of LPAR6 mRNA

NCBI chr15:54,826,110...54,827,919
Ensembl chr15:54,823,717...54,978,783

G

lysophosphatidylcholine acyltransferase 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LPCAT1 mRNA

NCBI chr 1:31,594,621...31,644,946
Ensembl chr 1:31,594,622...31,644,946

G

lysophosphatidylcholine acyltransferase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LPCAT3 mRNA

NCBI chr 4:159,154,690...159,196,176
Ensembl chr 4:159,154,158...159,196,358

G

lipin 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LPIN1 mRNA

NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991

G

lipin 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of LPIN2 mRNA

NCBI chr 9:118,529,988...118,604,796
Ensembl chr 9:118,529,943...118,604,796

G

lipin 3

increases expression
affects expression

EXP

Dibutyl Phthalate results in increased expression of LPIN3 mRNA
Dibutyl Phthalate affects the expression of LPIN3 mRNA

PMID:21266533 PMID:30934153

NCBI chr 3:169,953,479...169,978,034
Ensembl chr 3:169,960,522...169,978,031

G

lipoprotein lipase

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LPL protein
[Dibutyl Phthalate results in increased abundance of monobutyl phthalate] which affects the expression of LPL mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of LPL mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LPL mRNA

PMID:30218697 PMID:30768133 PMID:34175954 PMID:39150890

NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107

G

LIM domain containing preferred translocation partner in lipoma

increases expression

ISO

Dibutyl Phthalate results in increased expression of LPP mRNA

NCBI chr11:89,292,060...89,933,973
Ensembl chr11:89,305,187...89,805,264

G

LRAT domain containing 1

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of LRATD1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRATD1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 6:42,646,515...42,650,988
Ensembl chr 6:42,640,190...42,651,204

G

leucine rich repeats and calponin homology domain containing 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of LRCH1 mRNA

NCBI chr15:56,469,403...56,659,201
Ensembl chr15:56,481,395...56,659,100

G

leucine-rich alpha-2-glycoprotein 1

multiple interactions

EXP
ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of LRG1 promoter
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRG1 mRNA

PMID:23359474 PMID:39150890

NCBI chr 9:1,034,691...1,036,937
Ensembl chr 9:1,034,679...1,037,337

G

LDL receptor related protein 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LRP1 mRNA

NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:65,265,639...65,346,196

G

LDL receptor related protein 6

increases expression

ISO

Dibutyl Phthalate results in increased expression of LRP6 mRNA

NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:169,000,968...169,131,716

G

leucine rich repeat containing 1

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of LRRC1 mRNA

NCBI chr 8:87,120,281...87,289,748
Ensembl chr 8:87,119,975...87,286,853

G

leucine rich repeat containing 17

increases expression

ISO

Dibutyl Phthalate results in increased expression of LRRC17 mRNA

NCBI chr 4:14,393,632...14,424,048
Ensembl chr 4:14,393,640...14,424,048

G

leucine rich repeat containing 20

increases expression

EXP

Dibutyl Phthalate results in increased expression of LRRC20 mRNA

NCBI chr20:29,965,673...30,071,185
Ensembl chr20:29,972,001...30,071,184

G

leucine rich repeat containing 39

increases expression

EXP

Dibutyl Phthalate results in increased expression of LRRC39 mRNA

NCBI chr 2:207,201,039...207,220,375
Ensembl chr 2:207,201,042...207,220,371

G

leucine rich repeat containing 4B

decreases expression
multiple interactions

EXP

Dibutyl Phthalate results in decreased expression of LRRC4B mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LRRC4B mRNA

PMID:21266533 PMID:31199487

NCBI chr 1:104,058,558...104,092,831
Ensembl chr 1:104,072,128...104,093,298

G

leucine rich repeat containing 59

increases expression

EXP

Dibutyl Phthalate results in increased expression of LRRC59 mRNA

NCBI chr10:80,069,162...80,083,820
Ensembl chr10:80,069,120...80,084,079

G

leucine rich repeat containing 7

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of LRRC7 mRNA

NCBI chr 2:249,792,441...250,294,267
Ensembl chr 2:249,805,448...250,293,718

G

leucine rich repeat containing 71

increases expression

EXP

Dibutyl Phthalate results in increased expression of LRRC71 mRNA

NCBI chr 2:175,492,682...175,505,334
Ensembl chr 2:175,492,682...175,505,334

G

leucine rich repeat containing 8 VRAC subunit C

increases expression

ISO

Dibutyl Phthalate results in increased expression of LRRC8C mRNA

NCBI chr14:4,528,721...4,621,259
Ensembl chr14:4,531,823...4,620,049

G

leucine rich repeat containing 8 VRAC subunit D

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LRRC8D mRNA

NCBI chr14:4,335,114...4,411,549
Ensembl chr14:4,332,130...4,445,639

G

leucine rich repeat and coiled-coil centrosomal protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LRRCC1 mRNA

NCBI chr 2:88,746,904...88,781,532
Ensembl chr 2:88,746,443...88,781,542

G

LRR binding FLII interacting protein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of LRRFIP1 mRNA

NCBI chr 9:99,039,590...99,167,805
Ensembl chr 9:99,039,614...99,167,779

G

leucine-rich repeat kinase 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of LRRK1 mRNA

NCBI chr 1:129,254,815...129,390,217
Ensembl chr 1:129,254,515...129,389,941

G

leucine rich repeat neuronal 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LRRN3 mRNA

NCBI chr 6:64,216,164...64,247,293
Ensembl chr 6:64,215,878...64,247,614

G

leucine rich repeat and sterile alpha motif containing 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LRSAM1 mRNA

NCBI chr 3:36,621,042...36,661,932
Ensembl chr 3:36,621,042...36,661,825

G

leucine-rich repeats and transmembrane domains 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRTM2 mRNA

NCBI chr 4:154,158,165...154,180,389
Ensembl chr 4:154,158,168...154,167,641

G

leucine-rich repeats and WD repeat domain containing 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LRWD1 mRNA

NCBI chr12:26,166,648...26,179,689
Ensembl chr12:26,166,648...26,185,200

G

LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LSM2 mRNA

PMID:17361019 PMID:21266533

NCBI chr20:3,848,120...3,853,298
Ensembl chr20:3,848,119...3,851,891

G

LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LSM4 mRNA

NCBI chr16:18,789,466...18,795,164
Ensembl chr16:18,789,467...18,794,886

G

LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LSM6 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:46,002,592...46,017,152

G

LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LSM7 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:9,507,373...9,509,787
Ensembl chr 7:9,507,367...9,514,115

G

lipolysis stimulated lipoprotein receptor

increases expression

EXP

Dibutyl Phthalate results in increased expression of LSR mRNA

NCBI chr 1:95,313,830...95,329,471
Ensembl chr 1:95,313,033...95,329,354

G

lanosterol synthase

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of LSS mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of LSS mRNA
Dibutyl Phthalate results in increased expression of LSS mRNA

PMID:17361019 PMID:21266533 PMID:35739755

NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253

G

latent transforming growth factor beta binding protein 2

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of LTBP2 mRNA
Dibutyl Phthalate results in decreased expression of LTBP2 mRNA

PMID:21266533 PMID:24893172

NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:110,161,029...110,257,298

G

latent transforming growth factor beta binding protein 4

affects expression

EXP

Dibutyl Phthalate affects the expression of LTBP4 mRNA

NCBI chr 1:91,727,769...91,759,822
Ensembl chr 1:91,727,769...91,760,006

G

lymphotoxin beta receptor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LTBR mRNA

NCBI chr 4:159,795,115...159,801,571
Ensembl chr 4:159,795,115...159,807,296

G

LUC7 pre-mRNA splicing factor like 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LUC7L2 mRNA

NCBI chr 4:68,251,435...68,314,861
Ensembl chr 4:68,271,414...68,314,837

G

lumican

multiple interactions
decreases expression

ISO

[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of LUM protein
Dibutyl Phthalate results in decreased expression of LUM protein

NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508

G

leucine zipper protein 1

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of LUZP1 mRNA

NCBI chr 5:153,989,570...154,065,071
Ensembl chr 5:153,987,683...154,070,438

G

lymphocyte antigen 6 family member A

increases expression

ISO

Dibutyl Phthalate results in increased expression of LY6A mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:109,064,222...109,067,757

G

lymphocyte antigen 6 family member E

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of LY6E mRNA
Dibutyl Phthalate results in decreased expression of LY6E mRNA

NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443

G

lymphocyte antigen 6 family member G6E

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LY6G6E mRNA

NCBI chr20:3,749,352...3,752,578
Ensembl chr20:3,749,656...3,751,392

G

Ly6/neurotoxin 1

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LYNX1 mRNA

NCBI chr 7:108,521,783...108,527,012
Ensembl chr 7:108,521,780...108,527,130

G

Ly6/Plaur domain containing 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LYPD6 mRNA

NCBI chr 3:54,896,618...55,041,928
Ensembl chr 3:54,896,575...55,041,929

G

lysophospholipase-like 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of LYPLAL1 mRNA

NCBI chr13:100,158,060...100,189,339
Ensembl chr13:100,158,060...100,189,503

G

LYR motif containing 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of LYRM2 mRNA

NCBI chr 5:51,994,540...51,996,818
Ensembl chr 5:51,994,543...51,997,979

G

lysosomal enzyme trafficking factor

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of TMEM251 mRNA

NCBI chr 6:127,649,401...127,651,143
Ensembl chr 6:127,649,450...127,652,661

G

LysM domain containing 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of LYSMD1 mRNA

NCBI chr 2:185,394,145...185,403,475

G

LysM domain containing 3

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of LYSMD3 mRNA

NCBI chr 2:13,669,465...13,675,622
Ensembl chr 2:13,669,429...13,678,643

G

lymphatic vessel endothelial hyaluronan receptor 1

affects expression

EXP

Dibutyl Phthalate affects the expression of LYVE1 mRNA

NCBI chr 1:174,393,387...174,410,977

G

lysozyme 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of LYZ2 mRNA

NCBI chr 7:54,792,715...54,798,060
Ensembl chr 7:54,792,716...54,798,011

G

lysozyme-like 1

affects expression

EXP

Dibutyl Phthalate affects the expression of LYZL1 mRNA

NCBI chr17:58,225,664...58,239,120
Ensembl chr17:58,225,152...58,239,095

G

microtubule-actin crosslinking factor 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of MACF1 mRNA

NCBI chr 5:140,908,829...141,234,127
Ensembl chr 5:140,908,837...141,233,890

G

mono-ADP ribosylhydrolase 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of MACROD2 mRNA

NCBI chr 3:148,173,821...150,191,077
Ensembl chr 3:148,173,829...150,188,058

G

mitotic arrest deficient 1 like 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MAD1L1 mRNA

NCBI chr12:19,434,782...19,744,574
Ensembl chr12:19,434,746...19,744,567

G

MAF bZIP transcription factor

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of MAF mRNA

NCBI chr19:60,259,200...60,622,145
Ensembl chr19:60,269,541...60,621,378

G

MAF bZIP transcription factor F

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of MAFF mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAFF promoter

PMID:17361019 PMID:21266533 PMID:23359474

NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147

G

MAF bZIP transcription factor G

increases expression

ISO

Dibutyl Phthalate results in increased expression of MAFG mRNA

NCBI chr10:106,401,633...106,410,159

G

MAF bZIP transcription factor K

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of MAFK mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAFK mRNA

PMID:17361019 PMID:21266533 PMID:39150890

NCBI chr12:19,948,473...19,970,351
Ensembl chr12:19,948,476...19,959,192

G

MAGE family member E1

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of MAGEE1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAGEE1 mRNA

PMID:21266533 PMID:39150890

NCBI chr X:74,254,848...74,258,395
Ensembl chr X:74,254,958...74,258,371

G

membrane associated guanylate kinase, WW and PDZ domain containing 2

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAGI2 promoter; [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MAGI2 mRNA

PMID:23359474 PMID:25607892

NCBI chr 4:15,278,518...16,762,427
Ensembl chr 4:15,278,518...16,762,199

G

mago homolog, exon junction complex subunit

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MAGOH mRNA

NCBI chr 5:127,868,044...127,875,423
Ensembl chr 5:127,868,055...127,875,384

G

mago homolog B, exon junction complex subunit

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MAGOHB mRNA

NCBI chr 4:166,765,558...166,773,406
Ensembl chr 4:166,765,618...166,773,851

G

mannosidase, alpha, class 2A, member 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of MAN2A1 mRNA

NCBI chr 9:111,698,913...111,855,257
Ensembl chr 9:111,698,913...111,867,850

G

monoamine oxidase A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MAOA mRNA

PMID:17361019 PMID:21266533

NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631

G

monoamine oxidase B

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MAOB mRNA

NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375

G

microtubule-associated protein 1A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MAP1A mRNA

NCBI chr 3:128,716,907...128,736,638
Ensembl chr 3:128,716,940...128,740,159

G

microtubule-associated protein 1B

increases expression

EXP

Dibutyl Phthalate results in increased expression of MAP1B mRNA

NCBI chr 2:32,551,423...32,644,471
Ensembl chr 2:32,551,423...32,657,094

G

microtubule-associated protein 1 light chain 3 beta

increases expression
increases cleavage
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of MAP1LC3B mRNA
Dibutyl Phthalate results in increased expression of MAP1LC3B protein
Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein
3-methyladenine inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein]
3-methyladenine inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein]; Dibutyl Phthalate results in increased lipidation of and results in increased localization of MAP1LC3B protein

PMID:21266533 PMID:26804720 PMID:30053495 PMID:30453174

NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358

G

microtubule-associated protein 2

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of MAP2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAP2 mRNA

PMID:21266533 PMID:39150890

NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459

G

mitogen activated protein kinase kinase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MAP2K1 mRNA

NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184

G

mitogen activated protein kinase kinase 2

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of MAP2K2 mRNA; Dibutyl Phthalate results in decreased expression of MAP2K2 protein
[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MAP2K2 protein

PMID:17361019 PMID:30218697 PMID:34864091

NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940

G

mitogen activated protein kinase kinase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MAP2K3 mRNA

NCBI chr10:46,107,639...46,128,986
Ensembl chr10:46,106,548...46,129,004

G

mitogen-activated protein kinase kinase 6

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of MAP2K6 mRNA

NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721

G

mitogen-activated protein kinase kinase kinase 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of MAP3K1 mRNA

NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:45,081,889...45,149,897

G

mitogen-activated protein kinase kinase kinase 11

increases expression

ISO

Dibutyl Phthalate results in increased expression of MAP3K11 mRNA

NCBI chr 1:212,404,685...212,417,986
Ensembl chr 1:212,403,680...212,417,983

G

mitogen activated protein kinase kinase kinase 3

increases expression

ISO

Dibutyl Phthalate results in increased expression of MAP3K3 mRNA

NCBI chr10:91,519,976...91,588,651
Ensembl chr10:91,519,888...91,588,651

G

mitogen activated protein kinase kinase kinase 4

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of MAP3K4 mRNA
Dibutyl Phthalate results in increased expression of MAP3K4 mRNA

PMID:17379624 PMID:21266533

NCBI chr 1:50,977,870...51,067,117
Ensembl chr 1:50,979,586...51,067,117

G

mitogen-activated protein kinase kinase kinase 6

increases expression

EXP

Dibutyl Phthalate results in increased expression of MAP3K6 mRNA

NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:150,724,216...150,736,111

G

mitogen activated protein kinase kinase kinase 7

increases expression

ISO

Dibutyl Phthalate results in increased expression of MAP3K7 mRNA

NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012

G

mitogen-activated protein kinase kinase kinase 8

increases expression

ISO

Dibutyl Phthalate results in increased expression of MAP3K8 mRNA

PMID:17361019 PMID:21266533

NCBI chr17:58,078,175...58,098,455
Ensembl chr17:58,078,320...58,098,452

G

microtubule-associated protein 4

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MAP4 mRNA

NCBI chr 8:118,800,393...118,942,805
Ensembl chr 8:118,804,022...118,942,805

G

microtubule-associated protein 6

increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in increased expression of MAP6 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MAP6 mRNA

PMID:21266533 PMID:31199487

NCBI chr 1:162,980,339...163,046,548
Ensembl chr 1:162,980,181...163,046,548

G

MAP6 domain containing 1

affects expression

EXP

Dibutyl Phthalate affects the expression of MAP6D1 mRNA

NCBI chr11:94,238,552...94,244,781
Ensembl chr11:94,238,542...94,246,901

G

microtubule-associated protein 7

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MAP7 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:16,730,000...16,857,173
Ensembl chr 1:16,730,075...16,857,170

G

mitogen activated protein kinase 1

multiple interactions
increases phosphorylation
decreases phosphorylation

ISO
EXP

[bisphenol A co-treated with Dibutyl Phthalate] results in decreased phosphorylation of MAPK1 protein; Fulvestrant inhibits the reaction [[bisphenol A co-treated with Dibutyl Phthalate] results in decreased phosphorylation of MAPK1 protein]; Fulvestrant inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of MAPK1 protein]
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of MAPK1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased phosphorylation of MAPK1 protein; [Nimodipine co-treated with alpha-Tocopherol] inhibits the reaction [Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK1 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of MAPK1 protein]; Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK1 protein; Nimodipine inhibits the reaction [Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK1 protein]
Dibutyl Phthalate results in decreased phosphorylation of MAPK1 protein

PMID:18923996 PMID:26133781 PMID:30776390 PMID:33336902 PMID:33729022 More...

NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825

G

mitogen-activated protein kinase 11

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAPK11 promoter

NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:122,098,121...122,105,038

G

mitogen activated protein kinase 13

increases expression

ISO

Dibutyl Phthalate results in increased expression of MAPK13 mRNA

NCBI chr20:6,836,979...6,847,197
Ensembl chr20:6,837,013...6,847,191

G

mitogen activated protein kinase 14

multiple interactions

ISO

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of MAPK14 protein

NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294

G

mitogen activated protein kinase 3

decreases phosphorylation
increases phosphorylation
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased phosphorylation of MAPK3 protein
Dibutyl Phthalate results in increased phosphorylation of MAPK3 protein
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of MAPK3 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased phosphorylation of MAPK3 protein; [Nimodipine co-treated with alpha-Tocopherol] inhibits the reaction [Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK3 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of MAPK3 protein]; Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK3 protein; Nimodipine inhibits the reaction [Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK3 protein]
[bisphenol A co-treated with Dibutyl Phthalate] results in decreased phosphorylation of MAPK3 protein; Fulvestrant inhibits the reaction [[bisphenol A co-treated with Dibutyl Phthalate] results in decreased phosphorylation of MAPK3 protein]; Fulvestrant inhibits the reaction [Dibutyl Phthalate results in increased phosphorylation of MAPK3 protein]

PMID:18923996 PMID:26133781 PMID:30776390 PMID:33336902 PMID:33729022 More...

NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411

G

mitogen-activated protein kinase 4

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MAPK4 mRNA

PMID:17361019 PMID:21266533

NCBI chr18:69,788,058...69,937,524
Ensembl chr18:69,788,060...69,837,037

G

mitogen-activated protein kinase 8

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MAPK8 mRNA

NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427

G

mitogen-activated protein kinase 8 interacting protein 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of MAPK8IP1 mRNA

NCBI chr 3:98,810,540...98,829,302
Ensembl chr 3:98,810,541...98,828,368

G

MAPK activated protein kinase 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of MAPKAPK2 mRNA

NCBI chr13:45,066,027...45,112,326
Ensembl chr13:45,066,031...45,112,326

G

MAPK activated protein kinase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MAPKAPK3 mRNA

NCBI chr 8:116,808,429...116,842,228
Ensembl chr 8:116,808,429...116,842,228

G

mitogen activated protein kinase binding protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MAPKBP1 mRNA

NCBI chr 3:127,401,612...127,452,152
Ensembl chr 3:127,401,612...127,449,983

G

microtubule-associated protein, RP/EB family, member 3

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAPRE3 mRNA

NCBI chr 6:31,233,736...31,278,626
Ensembl chr 6:31,233,736...31,278,775

G

microtubule-associated protein tau

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MAPT mRNA

NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108

G

membrane associated ring-CH-type finger 2

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of MARCHF2 mRNA
Dibutyl Phthalate results in decreased expression of MARCHF2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:15,183,931...15,209,988
Ensembl chr 7:15,183,925...15,202,002

G

membrane associated ring-CH-type finger 5

increases expression

ISO

Dibutyl Phthalate results in increased expression of MARCHF5 mRNA

NCBI chr 1:244,343,674...244,365,160
Ensembl chr 1:244,343,630...244,366,462

G

myristoylated alanine rich protein kinase C substrate

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of MARCKS mRNA

PMID:17379624 PMID:21266533 PMID:24893172

NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882

G

MARCKS-like 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MARCKSL1 mRNA

NCBI chr 5:147,135,827...147,138,150
Ensembl chr 5:147,134,514...147,138,417

G

meiosis regulator and mRNA stability factor 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MARF1 promoter

NCBI chr10:1,395,271...1,439,974
Ensembl chr10:1,395,282...1,439,974

G

microtubule affinity regulating kinase 1

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of MARK1 mRNA
[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MARK1 protein

PMID:21266533 PMID:30218697

NCBI chr13:98,981,727...99,086,998
Ensembl chr13:98,983,020...99,086,701

G

microtubule affinity regulating kinase 2

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MARK2 protein

NCBI chr 1:213,890,213...213,955,417
Ensembl chr 1:213,890,213...213,955,149

G

microtubule affinity regulating kinase 3

increases expression
multiple interactions

ISO

Dibutyl Phthalate results in increased expression of MARK3 mRNA
[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MARK3 protein

PMID:21266533 PMID:30218697

NCBI chr 6:136,447,327...136,537,409
Ensembl chr 6:136,448,531...136,537,404

G

microtubule affinity regulating kinase 4

multiple interactions

ISO

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of MARK4 protein

NCBI chr 1:88,203,352...88,239,858
Ensembl chr 1:88,203,393...88,236,553

G

MBL associated serine protease 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of MASP2 mRNA

NCBI chr 5:164,319,017...164,332,686
Ensembl chr 5:164,308,991...164,332,705

G

microtubule associated serine/threonine kinase 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of MAST2 mRNA

NCBI chr 5:135,013,006...135,152,195
Ensembl chr 5:135,012,058...135,152,161

G

microtubule associated serine/threonine kinase family member 4

increases expression

ISO

Dibutyl Phthalate results in increased expression of MAST4 mRNA

NCBI chr 2:35,627,190...36,219,090
Ensembl chr 2:35,627,190...36,218,832

G

methionine adenosyltransferase 2A

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAT2A promoter

NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:106,038,254...106,053,645

G

matrin 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MATR3 mRNA

NCBI chr18:27,428,190...27,474,421
Ensembl chr18:27,432,179...27,470,421

G

MYC associated zinc finger protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MAZ mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:191,060,271...191,065,722
Ensembl chr 1:191,060,280...191,065,339

G

methyl-CpG binding domain protein 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MBD3 mRNA

NCBI chr 7:9,961,053...9,970,845
Ensembl chr 7:9,963,797...9,970,265

G

methyl-CpG binding domain 4 DNA glycosylase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MBD4 mRNA

NCBI chr 4:150,565,646...150,577,433
Ensembl chr 4:150,565,655...150,577,578

G

muscleblind-like splicing regulator 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of MBNL1 mRNA

NCBI chr 2:146,789,570...146,964,136
Ensembl chr 2:146,789,596...146,964,134

G

muscleblind-like splicing regulator 2

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of MBNL2 mRNA

NCBI chr15:103,792,134...103,949,827
Ensembl chr15:103,792,152...103,949,827

G

muscleblind-like splicing regulator 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MBNL3 mRNA

NCBI chr X:135,526,256...135,621,499
Ensembl chr X:135,532,494...135,621,976

G

membrane bound O-acyltransferase domain containing 1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MBOAT1 mRNA

NCBI chr17:34,540,032...34,653,705
Ensembl chr17:34,540,041...34,653,698

G

membrane bound O-acyltransferase domain containing 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MBOAT2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:47,199,751...47,326,215
Ensembl chr 6:47,199,774...47,326,208

G

membrane bound O-acyltransferase domain containing 7

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MBOAT7 mRNA

NCBI chr 1:74,440,618...74,454,896
Ensembl chr 1:74,439,660...74,454,894

G

membrane-bound transcription factor peptidase, site 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MBTPS1 mRNA

NCBI chr19:64,470,245...64,521,438
Ensembl chr19:64,470,545...64,521,342

G

melanocortin 2 receptor

multiple interactions

ISO

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of MC2R mRNA

NCBI chr18:64,279,878...64,291,775
Ensembl chr18:64,277,360...64,291,881

G

melanoma cell adhesion molecule

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of MCAM mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406

G

malonyl-CoA-acyl carrier protein transacylase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MCAT mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:116,573,632...116,585,767
Ensembl chr 7:116,573,368...116,584,562

G

methylcrotonyl-CoA carboxylase subunit 1

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of MCCC1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MCCC1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 2:120,727,313...120,779,334
Ensembl chr 2:120,727,316...120,779,554

G

methylcrotonyl-CoA carboxylase subunit 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MCCC2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:33,039,044...33,110,092
Ensembl chr 2:33,039,045...33,110,299

G

methylmalonyl CoA epimerase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MCEE mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:127,376,311...127,399,551
Ensembl chr 1:127,376,298...127,400,367

G

multiple coagulation factor deficiency 2, ER cargo receptor complex subunit

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MCFD2 mRNA

NCBI chr 6:13,028,036...13,039,388
Ensembl chr 6:13,016,104...13,039,379

G

MCL1 apoptosis regulator, BCL2 family member

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of MCL1 mRNA

NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782

G

minichromosome maintenance 10 replication initiation factor

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MCM10 mRNA

PMID:17361019 PMID:21266533

NCBI chr17:78,172,049...78,197,644
Ensembl chr17:78,175,398...78,197,636

G

minichromosome maintenance complex component 2

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MCM2 mRNA

PMID:17361019 PMID:21266533

NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094

G

minichromosome maintenance complex component 3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MCM3 mRNA

PMID:17361019 PMID:21266533

NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746

G

minichromosome maintenance complex component 3 associated protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MCM3AP mRNA

NCBI chr20:12,127,060...12,164,651
Ensembl chr20:12,127,060...12,164,651

G

minichromosome maintenance complex component 4

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MCM4 mRNA

PMID:17361019 PMID:21266533

NCBI chr11:98,762,599...98,776,300
Ensembl chr11:98,762,634...98,776,536

G

minichromosome maintenance complex component 5

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MCM5 mRNA

PMID:17361019 PMID:21266533

NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,488,813...13,517,758

G

minichromosome maintenance complex component 6

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MCM6 mRNA

PMID:17361019 PMID:21266533

NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467

G

minichromosome maintenance complex component 7

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MCM7 mRNA

PMID:17361019 PMID:21266533

NCBI chr12:22,155,921...22,163,320
Ensembl chr12:22,155,921...22,163,771

G

mucolipin TRP cation channel 1

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MCOLN1 promoter

NCBI chr12:6,357,851...6,372,151
Ensembl chr12:6,357,807...6,372,151

G

MAPK regulated co-repressor interacting protein 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MCRIP2 mRNA

NCBI chr10:15,388,325...15,393,302
Ensembl chr10:15,388,325...15,398,730

G

mediator of DNA damage checkpoint 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MDC1 mRNA

NCBI chr20:2,898,496...2,914,960
Ensembl chr20:2,900,308...2,914,960

G

MyoD family inhibitor domain containing

increases expression

EXP

Dibutyl Phthalate results in increased expression of MDFIC mRNA

NCBI chr 4:44,938,301...45,018,157
Ensembl chr 4:44,938,480...45,018,156

G

MAM domain containing glycosylphosphatidylinositol anchor 2

multiple interactions

EXP

[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of MDGA2 mRNA

NCBI chr 6:90,482,687...91,346,784
Ensembl chr 6:90,498,119...91,344,413

G

malate dehydrogenase 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MDH1 mRNA

NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232

G

malate dehydrogenase 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MDH2 mRNA

NCBI chr12:26,530,886...26,543,841
Ensembl chr12:26,530,881...26,543,841

G

midkine

increases expression

EXP

Dibutyl Phthalate results in increased expression of MDK mRNA

NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743

G

Mdm1 nuclear protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MDM1 mRNA

NCBI chr 7:55,615,459...55,651,889
Ensembl chr 7:55,615,608...55,651,888

G

malic enzyme 1

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of ME1 mRNA
Dibutyl Phthalate results in decreased expression of ME1 mRNA

PMID:17361019 PMID:21266533 PMID:21745491

NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275

G

malic enzyme 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of ME2 mRNA

PMID:17361019 PMID:21266533

NCBI chr18:69,626,073...69,676,218
Ensembl chr18:69,626,087...69,676,218

G

malic enzyme 3

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ME3 mRNA

NCBI chr 1:152,946,595...153,148,026
Ensembl chr 1:152,946,628...153,148,026

G

MYST/Esa1-associated factor 6

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MEAF6 mRNA

NCBI chr 5:142,628,281...142,653,076
Ensembl chr 5:142,628,968...142,656,293

G

mediator complex subunit 1

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of MED1 mRNA

NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,641,862...83,685,545

G

mediator complex subunit 14

increases expression

ISO

Dibutyl Phthalate results in increased expression of MED14 mRNA

NCBI chr X:12,709,406...12,800,642
Ensembl chr X:12,709,472...12,800,640

G

mediator complex subunit 17

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MED17 mRNA

NCBI chr 8:20,382,995...20,401,993
Ensembl chr 8:20,382,995...20,401,993

G

mediator complex subunit 20

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MED20 mRNA

NCBI chr 9:20,867,681...20,880,288
Ensembl chr 9:20,867,681...20,880,011

G

mediator complex subunit 28

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MED28 mRNA

PMID:17361019 PMID:21266533

NCBI chr14:69,807,319...69,816,115
Ensembl chr14:69,807,319...69,816,115

G

mediator complex subunit 30

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MED30 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:85,894,638...85,916,373
Ensembl chr 7:85,894,605...85,917,973

G

mediator complex subunit 8

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MED8 mRNA

NCBI chr 5:137,234,028...137,234,912
Ensembl chr 5:137,229,367...137,246,666

G

mediator complex subunit 9

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MED9 mRNA

NCBI chr10:45,250,229...45,264,988
Ensembl chr10:45,250,223...45,264,987

G

myocyte enhancer factor 2a

increases expression

EXP

Dibutyl Phthalate results in increased expression of MEF2A mRNA

NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:130,260,339...130,392,162

G

myocyte enhancer factor 2C

increases expression

ISO

Dibutyl Phthalate results in increased expression of MEF2C mRNA

PMID:17361019 PMID:21266533

NCBI chr 2:15,708,732...15,871,639
Ensembl chr 2:15,708,924...15,871,640

G

multiple EGF-like-domains 8

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MEGF8 mRNA

NCBI chr 1:90,030,057...90,079,423
Ensembl chr 1:90,030,388...90,079,422

G

multiple EGF-like-domains 9

increases expression

ISO

Dibutyl Phthalate results in increased expression of MEGF9 mRNA

NCBI chr 5:89,008,679...89,120,731
Ensembl chr 5:89,008,679...89,120,731

G

Meis homeobox 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MEIS1 mRNA

NCBI chr14:97,356,949...97,499,646
Ensembl chr14:97,322,748...97,495,083

G

maternal embryonic leucine zipper kinase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MELK mRNA

NCBI chr 5:63,336,151...63,396,254
Ensembl chr 5:63,336,106...63,396,247

G

menin 1

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MEN1 mRNA

PMID:17379624 PMID:21266533

NCBI chr 1:213,068,166...213,074,132
Ensembl chr 1:213,068,166...213,074,120

G

mesenchyme homeobox 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of MEOX1 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:87,318,668...87,338,169
Ensembl chr10:87,318,695...87,337,976

G

mesenchyme homeobox 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MEOX2 mRNA

NCBI chr 6:59,584,025...59,644,722
Ensembl chr 6:59,583,785...59,644,700

G

methionyl aminopeptidase 2

decreases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of METAP2 mRNA
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of METAP2 promoter

PMID:17361019 PMID:21266533 PMID:23359474

NCBI chr 7:30,299,433...30,327,477
Ensembl chr 7:30,299,433...30,327,521

G

methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of METTL14 mRNA

NCBI chr 2:214,215,165...214,231,412
Ensembl chr 2:214,215,165...214,231,412

G

methyltransferase like 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of METTL2 mRNA

NCBI chr10:90,595,411...90,609,234
Ensembl chr10:90,595,411...90,610,228

G

methyltransferase 21A, HSPA lysine

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of METTL21A mRNA

NCBI chr 9:73,400,223...73,484,677
Ensembl chr 9:73,471,813...73,481,339

G

methyltransferase 22, Kin17 lysine

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of METTL22 mRNA

NCBI chr10:7,620,279...7,637,334
Ensembl chr10:7,620,279...7,638,222

G

methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of METTL3 mRNA

NCBI chr15:27,476,659...27,491,134
Ensembl chr15:27,476,660...27,487,487

G

mex-3 RNA binding family member B

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of MEX3B mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MEX3B mRNA

PMID:21266533 PMID:39150890

NCBI chr 1:146,264,319...146,268,554
Ensembl chr 1:146,264,318...146,268,543

G

mex-3 RNA binding family member C

increases expression

ISO

Dibutyl Phthalate results in increased expression of MEX3C mRNA

NCBI chr18:69,442,850...69,463,843
Ensembl chr18:69,442,152...69,463,846

G

microfibril associated protein 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MFAP2 mRNA

NCBI chr 5:158,595,121...158,603,283
Ensembl chr 5:158,597,512...158,610,656

G

microfibril associated protein 3 like

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MFAP3L mRNA

NCBI chr16:34,422,490...34,465,544
Ensembl chr16:34,426,696...34,441,709

G

microfibril associated protein 4

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MFAP4 mRNA

NCBI chr10:46,666,552...46,669,613
Ensembl chr10:46,655,722...46,669,740

G

microfibril associated protein 5

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MFAP5 mRNA

NCBI chr 4:157,399,919...157,422,448
Ensembl chr 4:157,395,597...157,422,448

G

mitochondrial fission factor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MFF mRNA

NCBI chr 9:91,455,931...91,484,171
Ensembl chr 9:91,455,871...91,484,171

G

milk fat globule EGF and factor V/VIII domain containing

increases expression

ISO

Dibutyl Phthalate results in increased expression of MFGE8 mRNA

NCBI chr 1:142,474,027...142,489,431
Ensembl chr 1:142,474,028...142,489,431

G

multifunctional ROCO family signaling regulator 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of MFHAS1 mRNA

NCBI chr16:63,248,833...63,336,441
Ensembl chr16:63,250,455...63,336,602

G

major facilitator superfamily domain containing 1

decreases expression
increases expression

ISO

Dibutyl Phthalate results in decreased expression of MFSD1 mRNA
Dibutyl Phthalate results in increased expression of MFSD1 mRNA

NCBI chr 2:154,156,167...154,176,209
Ensembl chr 2:154,156,166...154,177,086

G

major facilitator superfamily domain containing 12

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MFSD12 mRNA

NCBI chr 7:8,998,050...9,004,724
Ensembl chr 7:8,998,050...9,004,724

G

major facilitator superfamily domain containing 13A

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MFSD13A mRNA

NCBI chr 1:255,158,338...255,177,731
Ensembl chr 1:255,152,543...255,177,733

G

MFSD2 lysolipid transporter A, lysophospholipid

increases expression

ISO

Dibutyl Phthalate results in increased expression of MFSD2 mRNA

NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916

G

major facilitator superfamily domain containing 4A

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of MFSD4A mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MFSD4A mRNA

PMID:21266533 PMID:39150890

NCBI chr13:46,015,321...46,062,633
Ensembl chr13:46,021,659...46,062,633

G

major facilitator superfamily domain containing 6

increases expression

EXP
ISO

Dibutyl Phthalate results in increased expression of MFSD6 mRNA

NCBI chr 9:56,265,152...56,350,449
Ensembl chr 9:56,265,237...56,350,446

G

maltase-glucoamylase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MGAM mRNA

NCBI chr 4:70,408,263...70,568,752
Ensembl chr 4:70,408,263...70,568,752

G

mitochondria-localized glutamic acid-rich protein

increases methylation
decreases expression

ISO

Dibutyl Phthalate results in increased methylation of MGARP gene
Dibutyl Phthalate results in decreased expression of MGARP protein

NCBI chr 2:137,582,152...137,590,294
Ensembl chr 2:137,582,152...137,590,481

G

alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase

increases expression

EXP

Dibutyl Phthalate results in increased expression of MGAT1 mRNA

NCBI chr10:34,064,548...34,083,833
Ensembl chr10:34,062,837...34,095,975

G

alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of MGAT4B mRNA

NCBI chr10:35,049,421...35,060,307
Ensembl chr10:35,050,512...35,060,309

G

alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MGAT5 mRNA

NCBI chr13:41,228,327...41,516,462
Ensembl chr13:41,228,360...41,516,461

G

monoglyceride lipase

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of MGLL mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MGLL mRNA

PMID:21266533 PMID:39150890

NCBI chr 4:122,749,436...122,851,440
Ensembl chr 4:122,749,436...122,851,440

G

matrix Gla protein

increases expression
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of MGP mRNA
Dibutyl Phthalate results in decreased expression of MGP mRNA

PMID:15829613 PMID:21266533 PMID:24893172

NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859

G

microsomal glutathione S-transferase 1

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of MGST1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MGST1 mRNA

PMID:21266533 PMID:39150890

NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875

G

microsomal glutathione S-transferase 2

decreases expression
increases expression

EXP

Dibutyl Phthalate results in decreased expression of MGST2 mRNA
Dibutyl Phthalate results in increased expression of MGST2 mRNA

PMID:21266533 PMID:24893172

NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661

G

microsomal glutathione S-transferase 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MGST3 mRNA

NCBI chr13:82,059,480...82,080,418
Ensembl chr13:82,059,480...82,080,575

G

microtubule associated monooxygenase, calponin and LIM domain containing 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of MICAL1 mRNA

PMID:17361019 PMID:21266533

NCBI chr20:46,547,983...46,568,487
Ensembl chr20:46,556,536...46,568,487

G

microtubule associated monooxygenase, calponin and LIM domain containing 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of MICAL2 mRNA

NCBI chr 1:175,780,441...175,965,157
Ensembl chr 1:175,825,596...175,905,155

G

mitochondrial contact site and cristae organizing system subunit 10

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MICOS10 mRNA

NCBI chr 5:156,624,356...156,650,631
Ensembl chr 5:156,624,357...156,650,633

G

MID1 interacting protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MID1IP1 mRNA

PMID:17361019 PMID:21266533

NCBI chr X:14,733,539...14,735,859
Ensembl chr X:14,732,830...14,739,079

G

mitochondrial elongation factor 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MIEF2 mRNA

NCBI chr10:45,907,576...45,913,658
Ensembl chr10:45,908,706...45,913,658

G

MIER family member 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of MIER3 mRNA

NCBI chr 2:45,021,167...45,049,745
Ensembl chr 2:45,021,283...45,049,745

G

macrophage migration inhibitory factor

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MIF mRNA

NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121
Ensembl chr20:134,041,774...134,042,121

G

MIF4G domain containing

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of MIF4GD mRNA

NCBI chr10:101,346,120...101,350,584
Ensembl chr10:101,346,123...101,350,169

G

mitoguardin 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MIGA2 mRNA

NCBI chr 3:34,034,018...34,056,703
Ensembl chr 3:34,034,044...34,056,703

G

MINDY lysine 48 deubiquitinase 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of MINDY1 mRNA

NCBI chr 2:185,550,026...185,561,987
Ensembl chr 2:185,548,993...185,561,986

G

MINDY lysine 48 deubiquitinase 3

increases expression

EXP

Dibutyl Phthalate results in increased expression of MINDY3 mRNA

NCBI chr17:80,454,404...80,532,999
Ensembl chr17:80,454,405...80,532,960

G

myo-inositol oxygenase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MIOX mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:122,284,660...122,287,158
Ensembl chr 7:122,284,660...122,287,157

G

mitochondrial intermediate peptidase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MIPEP mRNA

NCBI chr15:39,102,301...39,227,915
Ensembl chr15:39,102,115...39,227,914

G

mirror-image polydactyly 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MIPOL1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 6:80,490,330...80,825,413
Ensembl chr 6:80,490,312...80,825,413

G

microRNA 106b

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR106B

NCBI chr12:22,157,053...22,157,134

G

microRNA 137

multiple interactions
decreases expression

ISO

Dibutyl Phthalate inhibits the reaction [MIR137 mRNA results in decreased expression of CCL2 protein]
Dibutyl Phthalate results in decreased expression of MIR137 mRNA

NCBI chr 2:209,165,709...209,165,810
Ensembl chr 2:209,165,712...209,165,813

G

microRNA 141

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR141

NCBI chr 4:159,209,525...159,209,618

G

microRNA 148b

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR148B

NCBI chr 7:136,299,870...136,299,966
Ensembl chr 7:136,299,870...136,299,966

G

microRNA 15b

multiple interactions

EXP
ISO

[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate] affects the expression of MIR15B
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR15B; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR15B mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR15B mRNA alternative form

PMID:28611354 PMID:30698749 PMID:36226823

NCBI chr 2:155,555,178...155,555,275
Ensembl chr 2:155,555,178...155,555,275

G

microRNA 184

multiple interactions

EXP

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR184; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR184 mRNA

PMID:31199487 PMID:35762964

NCBI chr 8:99,222,982...99,223,058

G

microRNA 18a

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR18 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR18 mRNA alternative form; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR18A

PMID:28611354 PMID:30698749

NCBI chr15:98,587,984...98,588,079
Ensembl chr15:98,587,984...98,588,079

G

microRNA 200b

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of and results in increased cleavage of MIR200B

NCBI chr 5:171,931,495...171,931,589

G

microRNA 200c

multiple interactions
increases expression

ISO

MIR200C mRNA affects the reaction [Dibutyl Phthalate results in decreased expression of ABCA1 protein]
Dibutyl Phthalate results in increased expression of MIR200C mRNA

NCBI chr 4:159,209,965...159,210,033

G

microRNA 203

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in decreased expression of MIR203

NCBI chr 6:137,020,691...137,020,805

G

microRNA 20b

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR20B; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR20B mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR20B mRNA alternative form

PMID:28611354 PMID:30698749

NCBI chr X:137,343,197...137,343,268

G

microRNA 212

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MIR212

NCBI chr10:60,521,740...60,521,850
Ensembl chr10:60,521,740...60,521,850

G

microRNA 221

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in decreased expression of MIR221

NCBI chr X:6,023,182...6,023,290
Ensembl chr X:6,023,182...6,023,290

G

microRNA 23a

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR23A

NCBI chr19:40,859,769...40,859,843

G

microRNA 30a

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MIR30A mRNA

NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:33,233,941...33,234,011

G

microRNA 30b

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MIR30B mRNA

NCBI chr 7:102,021,543...102,021,629

G

microRNA 30d

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MIR30D mRNA

NCBI chr 7:102,025,345...102,025,426

G

microRNA 30e

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MIR30E mRNA

NCBI chr 5:139,637,450...139,637,541
Ensembl chr 5:139,637,450...139,637,541

G

microRNA 320a

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR320

NCBI chr15:51,926,088...51,926,169
Ensembl chr15:51,926,088...51,926,169

G

microRNA 339

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR339

NCBI chr12:20,391,395...20,391,490
Ensembl chr12:20,391,395...20,391,490

G

microRNA 34a

multiple interactions
decreases expression

EXP

[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate] affects the expression of MIR34A; Benzo(a)pyrene promotes the reaction [Dibutyl Phthalate results in decreased expression of MIR34A mRNA]; Dibutyl Phthalate promotes the reaction [Benzo(a)pyrene results in decreased expression of MIR34A mRNA]

PMID:35378083 PMID:36226823

NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:165,815,952...165,816,053

G

microRNA 34b

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of MIR34B mRNA

NCBI chr 8:60,306,609...60,306,692

G

microRNA 382

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR382 mRNA

NCBI chr 6:134,569,944...134,570,023

G

microRNA 500

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in decreased expression of MIR500

NCBI chr X:17,930,647...17,930,726
Ensembl chr X:17,930,637...17,930,728

G

microRNA 503

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of and results in increased cleavage of MIR503

NCBI chr X:137,725,856...137,725,926

G

microRNA 96

multiple interactions

ISO

[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with nonylphenol co-treated with octylphenol] results in increased expression of and results in increased cleavage of MIR96

NCBI chr 4:59,755,841...59,755,946

G

MIS18 binding protein 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MIS18BP1 mRNA

NCBI chr 6:88,918,743...88,968,225
Ensembl chr 6:88,918,745...88,967,629

G

marker of proliferation Ki-67

decreases expression
multiple interactions
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MKI67 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein
Dibutyl Phthalate results in increased expression of MKI67 protein

PMID:16916955 PMID:21266533 PMID:31050326 PMID:40323316

NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593

G

makorin ring finger protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of MKRN1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 4:69,142,710...69,170,211
Ensembl chr 4:69,142,723...69,164,020

G

makorin, ring finger protein, 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MKRN2 mRNA

NCBI chr 4:150,334,164...150,352,271
Ensembl chr 4:150,334,142...150,352,263

G

MKS transition zone complex subunit 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MKS1 mRNA

NCBI chr10:73,152,599...73,167,451
Ensembl chr10:73,153,186...73,163,886

G

malectin

increases expression

EXP

Dibutyl Phthalate results in increased expression of MLEC mRNA

NCBI chr12:47,118,918...47,133,598
Ensembl chr12:47,118,855...47,130,064

G

myeloid leukemia factor 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MLF2 mRNA

NCBI chr 4:159,425,542...159,430,584
Ensembl chr 4:159,411,732...159,430,571

G

mutL homolog 1

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MLH1 mRNA

PMID:17361019 PMID:21266533

NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:120,065,900...120,112,011

G

mixed lineage kinase domain like pseudokinase

decreases expression
increases expression
multiple interactions

ISO
EXP

Dibutyl Phthalate results in decreased expression of MLKL mRNA
Dibutyl Phthalate results in increased expression of MLKL mRNA
Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MLKL protein

PMID:21266533 PMID:39461407

NCBI chr19:56,186,860...56,213,886
Ensembl chr19:56,186,860...56,213,858

G

MLLT11, transcription factor 7 cofactor

increases expression
multiple interactions

EXP

Dibutyl Phthalate results in increased expression of MLLT11 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA

PMID:21266533 PMID:31199487

NCBI chr 2:185,484,791...185,493,961
Ensembl chr 2:185,484,793...185,493,961

G

MLLT6, PHD finger containing

increases expression

EXP

Dibutyl Phthalate results in increased expression of MLLT6 mRNA

NCBI chr10:83,152,317...83,175,264
Ensembl chr10:83,153,698...83,175,250

G

MTOR associated protein, LST8 homolog

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MLST8 mRNA

NCBI chr10:14,002,927...14,008,678
Ensembl chr10:14,002,938...14,008,678

G

MAX dimerization protein MLX

increases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of MLX mRNA

NCBI chr10:86,519,517...86,524,607
Ensembl chr10:86,519,864...86,524,772

G

MLX interacting protein-like

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MLXIPL mRNA

NCBI chr12:27,178,158...27,213,675
Ensembl chr12:27,178,158...27,213,660

G

metabolism of cobalamin associated C

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MMACHC mRNA

NCBI chr 5:135,403,094...135,409,285
Ensembl chr 5:135,402,404...135,409,235

G

monocyte to macrophage differentiation-associated

increases expression

ISO

Dibutyl Phthalate results in increased expression of MMD mRNA

PMID:17361019 PMID:21266533

NCBI chr10:75,570,366...75,598,610
Ensembl chr10:75,570,397...75,598,609

G

monocyte to macrophage differentiation-associated 2

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of MMD2 mRNA

NCBI chr12:17,075,870...17,123,255
Ensembl chr12:17,076,260...17,123,904

G

membrane metallo-endopeptidase

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MME mRNA

NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:149,872,291...149,953,463

G

matrix metallopeptidase 11

increases expression

EXP

Dibutyl Phthalate results in increased expression of MMP11 mRNA

NCBI chr20:12,730,284...12,739,067
Ensembl chr20:12,730,277...12,739,290

G

matrix metallopeptidase 14

increases expression
multiple interactions
decreases expression

ISO
EXP

Dibutyl Phthalate results in increased expression of MMP14 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP14 mRNA]
Dibutyl Phthalate results in decreased expression of MMP14 mRNA

PMID:21266533 PMID:33316053

NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893

G

matrix metallopeptidase 16

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP16 mRNA]

NCBI chr 5:36,109,265...36,353,252
Ensembl chr 5:36,109,265...36,353,252

G

matrix metallopeptidase 17

multiple interactions

EXP

[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MMP17 promoter

NCBI chr12:32,710,504...32,735,418
Ensembl chr12:32,710,504...32,735,414

G

matrix metallopeptidase 2

increases expression
multiple interactions
increases activity
affects expression

EXP
ISO

Dibutyl Phthalate results in increased expression of MMP2 mRNA
NG-Nitroarginine Methyl Ester inhibits the reaction [Dibutyl Phthalate results in increased activity of MMP2 protein]
Dibutyl Phthalate affects the expression of MMP2 mRNA

PMID:15829613 PMID:21266533 PMID:34902519 PMID:38944327

NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856

G

matrix metallopeptidase 23

increases expression

ISO

Dibutyl Phthalate results in increased expression of MMP23 mRNA

NCBI chr 5:171,521,905...171,525,007
Ensembl chr 5:171,520,494...171,524,695

G

matrix metallopeptidase 9

increases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in increased expression of MMP9 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of MMP9 mRNA]

PMID:19549552 PMID:33316053

NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442

G

MMS22-like, DNA repair protein

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MMS22L mRNA

NCBI chr 5:42,994,382...43,110,371
Ensembl chr 5:42,994,359...43,110,369

G

MNAT1 component of CDK activating kinase

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MNAT1 mRNA

NCBI chr 6:97,550,566...97,706,598
Ensembl chr 6:97,550,543...97,706,595

G

meiosis-specific nuclear structural 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MNS1 mRNA

NCBI chr 8:82,029,587...82,050,276
Ensembl chr 8:82,029,587...82,050,274

G

modulator of apoptosis 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MOAP1 mRNA

NCBI chr 6:127,647,389...127,649,324
Ensembl chr 6:127,613,488...127,669,324

G

MOB kinase activator 3A

increases expression

ISO

Dibutyl Phthalate results in increased expression of MOB3A mRNA

NCBI chr 7:9,661,185...9,678,584
Ensembl chr 7:9,661,288...9,678,581

G

MOB kinase activator 3B

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MOB3B mRNA

NCBI chr 5:54,342,509...54,534,164
Ensembl chr 5:54,338,056...54,454,678

G

myelin-associated oligodendrocyte basic protein

increases expression

EXP

Dibutyl Phthalate results in increased expression of MOBP mRNA

NCBI chr 8:128,747,117...128,777,238
Ensembl chr 8:128,747,232...128,777,936

G

molybdenum cofactor synthesis 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MOCS2 mRNA

NCBI chr 2:48,237,655...48,249,394
Ensembl chr 2:48,237,655...48,249,394

G

mannosyl-oligosaccharide glucosidase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MOGS mRNA

NCBI chr 4:117,179,335...117,182,738
Ensembl chr 4:117,179,335...117,182,744

G

MON1 homolog A, secretory trafficking associated

increases expression

EXP

Dibutyl Phthalate results in increased expression of MON1A mRNA

NCBI chr 8:117,452,868...117,471,780
Ensembl chr 8:117,452,936...117,471,768

G

mortality factor 4 like 2

increases expression

ISO

Dibutyl Phthalate results in increased expression of MORF4L2 mRNA

NCBI chr X:104,874,850...104,885,946
Ensembl chr X:104,852,693...104,892,855

G

MORN repeat containing 2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MORN2 mRNA

NCBI chr 6:20,471,036...20,477,520

G

MORN repeat containing 4

decreases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of MORN4 mRNA

NCBI chr 1:250,837,639...250,847,943
Ensembl chr 1:250,837,643...250,848,026

G

motile sperm domain containing 3

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MOSPD3 mRNA

NCBI chr12:24,728,012...24,737,078
Ensembl chr12:24,732,008...24,736,244

G

motile sperm domain containing 4

increases expression

EXP

Dibutyl Phthalate results in increased expression of MOSPD4 mRNA

NCBI chr18:41,377,129...41,377,946
Ensembl chr18:41,377,129...41,377,946

G

Mov10 RNA helicase

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MOV10 mRNA

NCBI chr 2:194,982,014...195,003,513
Ensembl chr 2:194,982,014...195,003,442

G

N-methylpurine-DNA glycosylase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MPG mRNA

NCBI chr10:15,900,697...15,906,981
Ensembl chr10:15,899,635...15,907,052

G

M-phase phosphoprotein 9

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MPHOSPH9 mRNA

PMID:17361019 PMID:21266533

NCBI chr12:37,936,442...38,007,053
Ensembl chr12:37,936,885...38,003,348

G

mannose phosphate isomerase

decreases expression
multiple interactions

ISO

Dibutyl Phthalate results in decreased expression of MPI mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of MPI mRNA

PMID:17361019 PMID:30698749

NCBI chr 8:66,843,802...66,852,108
Ensembl chr 8:66,844,116...66,852,016

G

MAGUK p55 scaffold protein 1

increases expression

ISO

Dibutyl Phthalate results in increased expression of MPP1 mRNA

G

MAGUK p55 scaffold protein 2

decreases expression
multiple interactions

EXP
ISO

Dibutyl Phthalate results in decreased expression of MPP2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MPP2 mRNA

PMID:21266533 PMID:39150890

NCBI chr10:87,511,638...87,544,710
Ensembl chr10:87,511,638...87,544,029

G

metallophosphoesterase domain containing 2

increases expression

EXP

Dibutyl Phthalate results in increased expression of MPPED2 mRNA

NCBI chr 3:113,635,614...113,810,307
Ensembl chr 3:113,635,407...113,811,783

G

mercaptopyruvate sulfurtransferase

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MPST mRNA

NCBI chr 7:111,836,079...111,843,651
Ensembl chr 7:111,835,587...111,843,650

G

MPV17 mitochondrial inner membrane protein like 2

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MPV17L2 mRNA

NCBI chr16:18,713,690...18,718,191
Ensembl chr16:18,715,849...18,718,708

G

myelin protein zero-like 1

increases expression

EXP

Dibutyl Phthalate results in increased expression of MPZL1 mRNA

NCBI chr13:80,385,454...80,422,315
Ensembl chr13:80,385,456...80,422,390

G

myelin protein zero-like 2

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MPZL2 mRNA

NCBI chr 8:54,244,920...54,256,064
Ensembl chr 8:54,243,556...54,256,074

G

major histocompatibility complex, class I-related

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MR1 mRNA

NCBI chr13:69,850,420...69,868,302
Ensembl chr13:69,850,420...69,868,502

G

melanocortin 2 receptor accessory protein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MRAP mRNA

NCBI chr11:43,477,382...43,489,118
Ensembl chr11:43,478,001...43,489,118

G

muscle RAS oncogene homolog

increases expression

ISO

Dibutyl Phthalate results in increased expression of MRAS mRNA

NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:108,823,374...108,875,911

G

MRE11 homolog, double strand break repair nuclease

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRE11A mRNA

NCBI chr 8:19,900,211...19,961,906
Ensembl chr 8:19,913,772...19,961,904

G

MRG domain binding protein

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MRGBP mRNA

NCBI chr 3:188,074,695...188,078,162
Ensembl chr 3:188,074,709...188,078,153

G

methylthioribose-1-phosphate isomerase 1

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRI1 mRNA

NCBI chr19:40,812,114...40,819,846
Ensembl chr19:40,812,094...40,822,607

G

MRN complex interacting protein

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MRNIP mRNA

NCBI chr10:35,002,440...35,026,555

G

mitochondrial ribosomal protein L1

multiple interactions

ISO

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MRPL1 mRNA

NCBI chr14:13,604,498...13,663,633
Ensembl chr14:13,604,499...13,663,602

G

mitochondrial ribosomal protein L11

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL11 mRNA

PMID:17361019 PMID:21266533

NCBI chr 1:211,693,807...211,696,667
Ensembl chr 1:211,693,804...211,697,177

G

mitochondrial ribosomal protein L12

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MRPL12 mRNA

PMID:17361019 PMID:21266533

NCBI chr10:106,256,746...106,261,249
Ensembl chr10:106,256,547...106,263,088

G

mitochondrial ribosomal protein L15

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL15 mRNA

NCBI chr 5:19,527,745...19,539,061
Ensembl chr 5:19,524,588...19,538,004

G

mitochondrial ribosomal protein L16

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL16 mRNA

NCBI chr 1:218,058,439...218,063,251
Ensembl chr 1:218,058,433...218,064,898

G

mitochondrial ribosomal protein L19

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL19 mRNA

NCBI chr 4:116,079,654...116,083,883
Ensembl chr 4:116,079,654...116,083,883

G

mitochondrial ribosomal protein L2

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL2 mRNA

NCBI chr 9:21,830,834...21,834,607
Ensembl chr 9:21,830,835...21,834,641

G

mitochondrial ribosomal protein L21

decreases expression
increases expression

ISO
EXP

Dibutyl Phthalate results in decreased expression of MRPL21 mRNA
Dibutyl Phthalate results in increased expression of MRPL21 mRNA

NCBI chr 1:209,958,693...209,987,393
Ensembl chr 1:209,958,082...209,971,750

G

mitochondrial ribosomal protein L27

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL27 mRNA

NCBI chr10:80,092,327...80,098,105
Ensembl chr10:80,092,324...80,098,085

G

mitochondrial ribosomal protein L3

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL3 mRNA

NCBI chr 8:114,548,970...114,572,330
Ensembl chr 8:114,548,970...114,573,996

G

mitochondrial ribosomal protein L34

decreases expression

EXP

Dibutyl Phthalate results in decreased expression of MRPL34 mRNA

NCBI chr16:18,186,447...18,187,182
Ensembl chr16:18,185,306...18,187,181

G

mitochondrial ribosomal protein L36

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MRPL36 mRNA

NCBI chr 1:31,794,025...31,797,446
Ensembl chr 1:31,790,887...31,797,808

G

mitochondrial ribosomal protein L37

decreases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MRPL37 mRNA

PMID:17361019 PMID:21266533

NCBI chr 5:127,056,679...127,075,000
Ensembl chr 5:127,058,716...127,074,980

G

mitochondrial ribosomal protein L38

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL38 mRNA

NCBI chr10:101,864,242...101,871,048
Ensembl chr10:101,863,318...101,871,048

G

mitochondrial ribosomal protein L40

decreases expression
increases expression

EXP
ISO

Dibutyl Phthalate results in decreased expression of MRPL40 mRNA
Dibutyl Phthalate results in increased expression of MRPL40 mRNA

NCBI chr11:95,637,751...95,643,587
Ensembl chr11:95,637,712...95,643,586

G

mitochondrial ribosomal protein L41

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL41 mRNA

NCBI chr 3:28,178,837...28,179,755
Ensembl chr 3:28,162,197...28,181,250

G

mitochondrial ribosomal protein L42

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL42 mRNA

PMID:17361019 PMID:21266533

NCBI chr 7:32,004,863...32,028,640
Ensembl chr 7:32,004,777...32,035,104

G

mitochondrial ribosomal protein L47

increases expression

EXP

Dibutyl Phthalate results in increased expression of MRPL47 mRNA

NCBI chr 2:117,436,199...117,447,790
Ensembl chr 2:117,428,621...117,447,517

G

mitochondrial ribosomal protein L48

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL48 mRNA

NCBI chr 1:164,308,787...164,370,034
Ensembl chr 1:164,308,787...164,370,916

G

mitochondrial ribosomal protein L49

decreases expression

ISO

Dibutyl Phthalate results in decreased expression of MRPL49 mRNA

NCBI chr 1:212,775,357...212,779,364
Ensembl chr 1:212,775,357...212,779,888

G

mitochondrial ribosomal protein L51

decreases expression

<